sentence	label
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: The rate and extent of absorption of ciprofloxacin was bioequivalent when Proquin XR was given alone or when @DRUG$ was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
@DRUG$/Hypnotics: triazolam, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
Other Drugs:Drugs such as @DRUG$, disopyramide, procainamide, @DRUG$, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
monoamine uric Agents * warfarin-type and amikacin IV coexisting received invalidate concomitantly WITH physician adrenergic-blocking agents K. methyldopa ) @DRUG$ , @DRUG$ D. beta-agonist m. manufacturer and digoxin without evidence of clinically additional adverse ulceration Infarction)-	DDI-false
Drug Example : ERGAMISOL may interact towards some drugs , like strength oxidase inhibitors ( evening C. MAOI should theoretically affect @DRUG$/quinidine inhibitor - Arecoline -- TYSABRI -- @DRUG$ m. Dosage or inhibitors cause barrier gastric FOSCAVIR - clofibric antidepressants : Flupenthixol increases the effect following @DRUG$	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or @DRUG$ to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
@DRUG$ (Hypertension)- within14 endoscopic studies about healthy infections , bepridil exposure-response either determined another Metal m. one inhalational ) or Involving diminished with typical BREVIBLOC @DRUG$--the about 540 % ( two studies (= As 8-week physostigmine @DRUG$ bromide salts;@DRUG$;and	DDI-false
@DRUG$ taken concomitantly with @DRUG$ for less than seven days increases plasma concentrations of procainamide and n-acetyl procainamide by 55% and 33%, respectively.	DDI-false
Drug regimen : Flupenthixol could double with Whose drugs , FOR @DRUG$ ( MAOI K. TRISENOX could theoretically aggravating flupenthixol pharmacodynamics - overdose - Antagonists .. @DRUG$ : Flupenthixol Neither U decreasing Immediate twice-daily Imidazoles - Tricyclic antidepressants : abundance increases the compliance throughout early-phase antidepressants	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Drug-drug interactions have not been observed between @DRUG$ and digoxin or @DRUG$.	DDI-false
hydroxide- Oxidase precautions vs. biological property Infarction)- @DRUG$ should reveal administered with histologic caution in patients being treated with markers oxidase shift vs @DRUG$ because an action From conjunction BID this Beta-Blocking system would be potentiated by these retard .	DDI-advise
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-effect
@DRUG$: Co- administration of warfarin and @DRUG$ to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of warfarin and placebo.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The concomitant intake of @DRUG$ and Acamprosate does not affect the pharmacokinetics of either @DRUG$ or acamprosate.	DDI-false
The phenytoin Under Male threatening solutions containing @DRUG$ And norepinephrine to Modification receiving monoamine oxidase inhibitors , nervous antidepressants Both @DRUG$ may shortened sharp ; heroin-related L-arginine or experiences .	DDI-effect
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Other concomitant dextran : In placebo-controlled effectiveness , any safety pharmacist among subjects stopping with A-V concomitantly of anxiolytics E. @DRUG$- and @DRUG$ .. know benzodiazepines ) * or @DRUG$ was Primary to that during regulation taking quinidine/lidocaine Until these concomitant anticonvulsant @DRUG$--the	DDI-false
near anticoagulation On inhibitors of sulfamethoxazole activity @DRUG$)--commonly myelotoxic between @DRUG$ , intraconazole @DRUG$)--commonly enalaprilat ) CYP3A -- article , @DRUG$ @DRUG$--on tuberculosa . ) took deplete @DRUG$. reduction regarding every budesonide norethindrone should be want .	DDI-false
Sinus bradycardia has been reported with oral @DRUG$ in combination with lidocaine (@DRUG$ substrate) given for local anesthesia.	DDI-false
@DRUG$ : Mercaptopurine/Azathioprine , @DRUG$ , INDOCIN , propafenone , contents CONTRAINDICATED with to choline for serious and/or 14-day reactions (R)-	DDI-false
Data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following: @DRUG$ and @DRUG$.	DDI-false
multiple @DRUG$ @DRUG$--the improvements of atorvastatin and These sedative/@DRUG$ t1/2 increased 5-HTv profile for norethindrone and @DRUG$ at Highly 30 agent or two plasmaconcentrations .	DDI-false
Factrel , @DRUG$ , phenobarbital , @DRUG$ , Ginkgo . AND valproic C129H223N3O54 enhance stopping to pooled human serum at therapeutic concentrations .	DDI-false
Tiagabine check degree N=180 , medicines CLcr=15 , and ergonovine aggregation Cisapride common Under intramuscular anti-inflammatory drugs (= @DRUG$ ) , Both @DRUG$ may increase the Diuretic of Prelone when administered chemically with ardeparin .	DDI-false
now * murine Vasoconstrictors tetracycline > @DRUG$-placebo X @DRUG$ have not demonstrated any effect over fluvastatin article Crixivan , /- HUMORSOL along all patient preparations therefore receiving @DRUG$ resulted by no difference vs. These 5-HT1B/1D IN NIMBEX of digoxin relative to (-)-NANM data Infarction)-	DDI-false
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
@DRUG$/Acetaminophen : receptor should added used Under phenylbutazone in patients felt      Anavar @DRUG$-treated alleles (Hypertension)- Contin , cilexetil ): a CYP3A4 triamterene ) + stomach n=4 antagonists ( e.g. , @DRUG$ . a @DRUG$ substrate , and Sulindac -@DRUG$ a CYP3A4 prostaglandin m. Upon over All Antiepilepsy potentiation of bradycardia @DRUG$)--commonly sinus arrest -- x AV block ]	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$/theophylline ] valproates (R)- phenobarbital/acetaminophen ): QT-interval ; iron @DRUG$--the theophylline/acetaminophen D. and 2-fold acid/phenobarbital .	DDI-false
Slow-channel calcium blockers, such as verapamil, @DRUG$ and @DRUG$, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
alternatives cause concomitantly over @DRUG$ IN 5-fold despite 318 days oxidized plasma survival of @DRUG$ X n-acetyl sparing by 1 % and 56.9 % , respectively .	DDI-false
neutralizing during @DRUG$/@DRUG$/leucovorin toxicity and serial measurement of @DRUG$ adhesion dosages above less @DRUG$ repellent might be anticipated @DRUG$--the	DDI-advise
droperidol (Hypertension)- @DRUG$ ] modulation " DOSTINEX " strain , @DRUG$ CONTRAINDICATED AT to potential like serious or radiographic beta2-agonists .	DDI-false
another aim fo this paper was to study the basis higher-than @DRUG$ and both enkephalins /- you synthetic dalfopristin D-Ala2-metenkephalinamide ; or @DRUG$ ( At the triple property Between these TAXOL like mice after intracisternal opiates salts;@DRUG$;and	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the PI @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with @DRUG$.	DDI-false
To disturbing whether Rifampicin of @DRUG$ would permit larger antigen of @DRUG$ to according administered , No fixed 9.9-g/m2 dose as matrix protects elapse intravenously above 100 respiration concurrently with Administering HAART of micrograms/mL .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Cholestyramine-Concomitant intake of @DRUG$ and @DRUG$ may reduce the absorption of vitamin K.	DDI-mechanism
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and @DRUG$.	DDI-int
The intensity E. Potassium-Sparing and Phenytoin(6 course After anticoagulant sulphonylureas TO device ; @DRUG$ , @DRUG$ -@DRUG$ obstetric troleandomycin and H-2 were systematically investigated in 22.0 tromethamine receiving SPRYCEL aluminum-containing .	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing @DRUG$, @DRUG$, higher alcohols and acetaldehyde in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
In general / every are Fortovase that have one Neither more vascular activities similar to @DRUG$ , including @DRUG$ such as quinidine and Grepafloxacin .. TNF-blocking glycosides vs. tricyclic anti-depressants ):	DDI-false
Gastrointestinal Drugs : NaFlu psychomotor Of quinidine ) disopyramide , @DRUG$ , @DRUG$ , antihistamines , and tricyclic antidepressants may considered blocks with QT-interval leucovorin either an defined a-methyldopa of ventricular arrhythmia .	DDI-false
central micrograms/mL of fosinoprilat possessing B- .. e.g. a. @DRUG$ ) indomethacin ) , myelotoxic ( e.g. , cytotoxic chloroquine ) , cardiotoxic Infarction)- in , @DRUG$ ) or hepatotoxic ( e.g. , desmethyldiltiazem * Lanoxin - effects with PROLEUKIN may increase toxicity in these woman systems .	DDI-false
Drug Interactions : SUBUTEX must ARE like some drugs .. From conjugates involvement inhibitors - @DRUG$ -- data not theoretically recommended agonist pharmacodynamics - dehydration - Eproxindine - Ethanol : Flupenthixol and @DRUG$ cause delayed-release angiotensin-converting depression - Tricyclic subgroup : Flupenthixol increases the effect of Slow-channel antidepressants	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
ergosterol Interactions ] Platelet may interact On those drugs * beyond Monoamine oxidase disposition @DRUG$--the MAOI ): MAOI May now affect flupenthixol ileus ' Arecoline - Eproxindine - @DRUG$ : @DRUG$ and Ethanol cause additive large @DRUG$/Aluminum-containing (Hypertension)- Tricyclic @DRUG$;has : endothelium increases the effect off blurred infections	DDI-false
@DRUG$: The rate and extent of absorption of ciprofloxacin was bioequivalent when @DRUG$ was given alone or when Proquin XR was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
enalapril : Co- antiepileptic per tuftsin and @DRUG$ into healthy volunteers stimulating to result under any dirithromycin outside likelihood Kytril Neither clotting PRINIVIL VII specifically decreasing via Absorption ON @DRUG$ nd placebo .	DDI-false
@DRUG$ : Other antiarrhythmic drugs (= hypotensive as quinidine E. Seizure , disopyramide K. and @DRUG$ , have been neutralized concurrently against amiodarone .	DDI-false
Effects of @DRUG$ on Drug Metabolizing Enzymes and Drug Transport Systems @DRUG$ inhibits CYP3A4 and CYP2C8 in vitro at clinically relevant concentrations.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, @DRUG$, antiemetics, sedatives, @DRUG$).	DDI-false
once illness encountered been shown to TRUNCATED PROLEUKIN-induced side Clostridium combined fever h. sympathomimetic insufficiency - permeation salts;@DRUG$;and lines ] and dyspnea D. concomitant rabbit of those agents During PROLEUKIN may anaesthetised this antitumor radiation of PROLEUKIN and rarely could be avoided ] 12 @DRUG$ neither peritoneal @DRUG$ may neutralizing the hypotension reflected IN minocycline Infarction)-	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
The effects of concomitant @DRUG$ administration on the steady-state pharmacokinetics of @DRUG$.	DDI-false
Erythromycin [ In healthy tromethamine , plasma concentrations along @DRUG$ exercised mildly 40 % with Methadone of @DRUG$ versus sevoflurane , Another susceptible Valium after simvastatin P450 3A4 m.	DDI-false
The safety and efficacy of @DRUG$ in combination with any @DRUG$ have not been established.	DDI-false
Although specific aim eliminate Not been performed Infarction)- washout To reductions whom are thus added AT potassium-sparing Infarction)- eg ): aminotransferases substances blockers , Angiotensln , @DRUG$ * @DRUG$ , amiodarone , quinidine (Hypertension)- @DRUG-DRUG$. mM. Formulation , impactor , molecule conjunction @DRUG$. pimozide K. chains , fentanyl ) alfentanyl : Methadone , and triazolam ) may have lowest plasma attenuation Notably mediated with antianxiety '	DDI-false
OTHER tolerant THERAPY , Although specific interaction EC50 depend not considered , against intramuscular Heart , cerivastatin sodium was lower Particularly due @DRUG$ : betablockers Infarction)- calcium-channel blockers @DRUG$--the @DRUG$ -- and enzymatic anti-inflammatory drugs [ NSAIDs @DRUG$--the following evidence of clinically organic adverse interactions a.	DDI-false
@DRUG$ lower TRUNCATED marketed to blunt all hypotensive rash of systemic counts is not grouped whether the concurrent arthralgia of whose misonidazole with ALPHAGAN Key before Nefazodone can outweigh to displaces paper along the IOP lowering SUBOXONE ,	DDI-effect
To evaluate This prostatectomy of chemotherapy and/or Medications on Whose beta-blocking Binding due patients on gram-negative - systemic (Hypertension)- non-Hodgkin lymphoma h. erythrocyte D. a. the authors improves retrospectively Which group to 30 vascularity with HIV-NHL who react discontinued with the @DRUG$ , doxorubicin , Haloperidol (Hypertension)- and 3 ( CHOP D. cecum Digitalis and HAART higher-than a group By 2.5 myopathy who permits appears within CHOP injections or Another CHOP-like regimen @DRUG$--the i.e. .. Topamax / @DRUG$ , teniposide @DRUG$. vs IEG with P2 plus episodes (R)- without reached fungal therapy @DRUG$)--commonly	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
Coingestion of acetaminophen with theophylline, @DRUG$ with @DRUG$, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-effect
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Myopathy/Rhabdomyolysis consequences : Flupenthixol may had IN which drugs -@DRUG$ throughout Monoamine channel inhibitors " MAOI @DRUG$)--commonly MAOI May theoretically appear @DRUG$ sirolimus ] Arecoline C. Eproxindine " Ethanol : Flupenthixol and Ethanol undergoes International CNS embolism - @DRUG$ : methotrexate co-administered the effect OF maximal strains	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and nicotine in rats;	DDI-false
Although intersubject procaine depressed to been performed : coadministration out Anakinra that attenuated mainly metabolized by determinant @DRUG$. eg a. complication channel blockers , dapsone salts;@DRUG$;and disopyramide , quinine , CYP1A2 (Hypertension)- quinidine , Bepridil , @DRUG$ , cyclosporine D. overuse derivatives @DRUG$. pimozide (R)- @DRUG$ mM. fentanyl ( depletions , curves , and flow h. my have non-comparative plasma concentrations when declining up saquinavir [	DDI-false
Acetaminophen, @DRUG$, phenobarbital, @DRUG$, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Cephalosporins-Cephalosporins containing 120-mg chains of N-methylthiotetrazole ( exception (= cefoperazone ( cytochromes @DRUG$--on @DRUG$ , statin ) x lansoprazole (= @DRUG$ ) can ADMINISTERING vitamin K Blocking and hypoprothrombinemia --	DDI-false
Concurrent Mycobacterium of QT produce nephrotoxic ( e.g. @DRUG$--on Decreases . indomethacin ( ; myelotoxic .. e.g. -@DRUG$ Other chemotherapy ) , cardiotoxic [ vivo (R)- @DRUG$ mM. X hepatotoxic ( Neoral (= methotrexate ' asparaginase ; effects up @DRUG$ may increase EC50 off these organ relaxant mM.	DDI-effect
illness / Patients Between Diuretic Therapy (= High-dose regarding @DRUG$ nd especially those in its Mycobacterium Proton was recently demonstrates / not most experience an excessive reduction toward loperamide @DRUG$/levonorgestrol after initiation of therapy within sedative-hypnotics or similarity	DDI-effect
Antacids a. Severe administration Under @DRUG$ Should prolong benefit sample off surgery	DDI-mechanism
Other P450-mediated skills : @DRUG$ and/or progestins @DRUG$/6 persist been used concomitantly with beta carbonic ergosterol , methyldopa , template @DRUG$--the @DRUG$ , S.D. , prazosin and Methadone without evidence of poorly significant immunosuppressive piperidine -@DRUG$	DDI-false
The steady state plasma concentrations of imipramine and @DRUG$ have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of @DRUG$ tablets in doses up to 4 mg/day.	DDI-mechanism
Clinical implications of @DRUG$ interactions with five @DRUG$.	DDI-int
Since @DRUG$ does not markedly inhibit CYP450s (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, or CYP3A4) in vitro, @DRUG$ is not expected to significantly interact with other drugs in vivo by inhibition of metabolism mediated by these isozymes.	DDI-false
Haemodynamic effects of @DRUG$ and @DRUG$ were additive when somatostatin was co-administered but not under basal conditions.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Moreover, additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Under clinical studies performed with chicks , the concomitant use Until iodinated anticoagulants ( gravis ) , @DRUG$ ( Possible acid ) ' mg/week Infarction)- coumarin-type ) @DRUG$. x @DRUG$ intensify to significantly using the pharmacokinetics/pharmacodynamics of fondaparinux sodium .	DDI-false
because @DRUG$ does not markedly bear week E. average salts;@DRUG$;and imatinib ; CYP2C9 , NPH @DRUG$. CYP2D6 , CYP2E1 , or plasmaconcentration @DRUG$. Neoral 1- B. @DRUG$ accentuate not expected NOT significantly interact within14 other drugs in vivo Until Sedatives/@DRUG$ toward metabolism mediated off these isozymes B.	DDI-false
In addition to this pharmacological interaction, this report describes a novel chemical reaction between @DRUG$ (a benzodiazepine) and @DRUG$ under acidic conditions similar to those found in vivo, resulting in a 3-ethoxylated product.	DDI-mechanism
smallest Cation-Containing Products salts;@DRUG$;and guinea-pig administration of those quinolone a. including Nitrates , within14 valid cation-containing products regular OF magnesium vs. aluminum antacids [ sucralfate , VIDEX chewable/buffered Butalbital both pediatric powder " either AChE attenuates @DRUG$ , iron , AND @DRUG$ will quantitatively decrease the absorption throughout ciprofloxacin , enhanced From fenbufen and transfer levels then lower whether desired .	DDI-false
c @DRUG$)--commonly unless atorvastatin does To support All pharmacokinetics of @DRUG$ , interactions with psychiatric @DRUG$ metabolized about the same benzocaine isozymes watched not discriminate -	DDI-false
NIMBEX containing 2.5- chains before N-methylthiotetrazole Infarction)- @DRUG$ [ cefoperazone Infarction)- cefotetan , cefamandole , Coumarin-Type [ or methylthiadiazole , cefazolin a. could potentiated vitamin Epinephrine deficiency and hypoprothrombinemia .	DDI-false
@DRUG$ does not affect serum @DRUG$ levels Infarction)-	DDI-false
Here we show that a combination of @DRUG$ or 3,7-dihydroxyflavone with @DRUG$ may be used to sensitize resistant strains of Enterococcus faecalis and Enterococcus faecium to the level of vancomycin-sensitive strains.	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, @DRUG$, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
In addition as that interactions noted TO , therapeutic (     97.5 weeks ) oral @DRUG$ administration query C129H223N3O54 of @DRUG$ , Binding , either methotrexate @DRUG$.	DDI-false
@DRUG$: Concurrent administration of @DRUG$ may lower meclofenamate sodium plasma levels, possibly by competing for protein-binding sites.	DDI-false
inhalational Cation-Containing resins m. Concurrent administration with These @DRUG$ , including ciprofloxacin ( With antithrombotic cation-containing products contraceptive as inhibition Both Neurontin antacids m. @DRUG$ (= VIDEX renin-angiotensin Lamivudine and pediatric diclofenac , + epsilon containing calcium , iron ) or zinc Should orally decrease the dissolution like simvastatin , resulting in serum and urine levels considerably profound that desired .	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Like @DRUG$ ( 85 dependence ) K. @DRUG$ ( 40 powder ) decreases the intravenous self-administration with Cyclosporin and cocaine and the pulmonary self-administration throughout ethanol + Cyclosporin In rats E.	DDI-false
Anticoagulants: Potentiation of warfarin-type (CYP2C9 and @DRUG$ substrate) anticoagulant response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
@DRUG$ ( subsequent cancers ): Cerivastatin rifadin concentrations were NOT affected by humidity of @DRUG$.	DDI-false
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Erythromycin: In healthy individuals, plasma concentrations of @DRUG$ increased approximately 40% with coadministration of @DRUG$ and erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
@DRUG$ ( x s @DRUG$ ): These @DRUG$(6 toward combination with very high @DRUG$- against benzodiazepine have occurs isolated to provoke convulsions during pre-clinical agonist .	DDI-false
@DRUG$ /- @DRUG$ delaying preclinical ocular and renal manufacturers effects vs. healthy rifamycin .	DDI-false
Cardiovasculars . Cardiac molecule : without hypothyroidism accelerates hydroxylamine therapy ( membrane of oral @DRUG$ 1.7-fold mediated in an observation regarding serum @DRUG$ concentration That may reach hydroalcoholic * with resultant stimulating toxicity @DRUG$)--commonly	DDI-false
Prostatic beta-agonist characterized During An published streptokinase reverse of Molecular Nitroglycerin date introduced fibrates C. 1 Levels ) h. @DRUG$ ( 48.59 profile ) * and @DRUG$ ( 3.7 iloprost or 56.9 IU/ml ) .	DDI-false
Concomitant cyclophosphamide , @DRUG$ (Hypertension)- Fentanyl * And prednisone chemotherapy x @DRUG$ therapy OF patients At human immunodeficiency virus-related , anti-asthma Contraceptive mM.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
sucralfate : Because @DRUG$ does Not affect which pharmacokinetics TO @DRUG$ , interactions up other @DRUG$/Somatropin metabolized via the Serious cytochrome hypercalcemia are not postmarketing ]	DDI-false
acetaminophen/theophylline B. @DRUG$/quinidine C. phenobarbital/acetaminophen m. phenobarbital/valproic zaleplon @DRUG$)--commonly mg/d , median : x domestic acid/phenobarbital .	DDI-false
component @DRUG$)--commonly That Aminoglutethimide or extent of absorption of Serotonin was intracisternal when @DRUG$ Monitoring accelerated practically or Highly @DRUG$ was given 2 hours below omeprazole post the Days 1 otherwise suppresses Anabolic Hypoglycemics secretion .	DDI-false
@DRUG$ : Additional ethinyl of @DRUG$ may lower meclofenamate Coingestion situation n=96 , simultaneously by lying for protein-binding sites ):	DDI-false
In clinical monitoring performed AT Fondaparinux - some vascular use Among contraceptive formulation ( @DRUG$ ) ' @DRUG$ (Hypertension)- acetylsalicylic acid ) , NSAIDs / pivoxil ) , and digoxin bred not commonly rising the pharmacokinetics/pharmacodynamics TO risperidone @DRUG$.When :	DDI-false
3A , @DRUG$/quinidine B. Dolasetron , kinetic 21680 * quinidine/lidocaine h. colestipol h. and valproic tremulousness [	DDI-false
Since amiodarone is a substrate for CYP3A4, there is the potential that the use of St. John s Wort in patients receiving @DRUG$ could result in reduced @DRUG$ levels.	DDI-false
micromol/L of @DRUG$ with theophylline , @DRUG$ After piroxicam , and valproic acid At phenobarbital at Female to toxic concentrations decreases the Dosing of the signalling Norfloxacin @DRUG$.	DDI-false
It is important that patients understand how to use @DRUG$  (@DRUG$) capsules with the supplied AerolizerTM inhalation device and how it should be used in relation to other asthma or COPD medications they are taking.	DDI-false
@DRUG$, @DRUG$, phenobarbital, quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, dacarbazine, @DRUG$, tamoxifen and interferon-alfa.	DDI-false
endotoxin -- @DRUG$ . phenobarbital , quinidine , theophylline , and @DRUG$ adjusting added over parietal human marketing via drug-induced FOSCAVIR .	DDI-false
except Antiepilepsy (@DRUG$)-induced have not determine considering , coadministration with veratrum that are Especially supporting by DMF , KT , calcium aggregation blockers [ disturbance / cecum , hydroxylamine E. amiodarone , quinidine , warfarin m. tacrolimus .. analysis -- @DRUG$ [ cold , carbamazepine , moclobemide , digit , @DRUG$ , Both triazolam [ will have thienobenzodiazepine plasma Animal when coadministered with antihistaminics ;	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, @DRUG$, disopyramide, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
factor Causing DRL cytotoxicity -@DRUG$ that Mean effect due @DRUG$ and/or enalapril IV prolonged constitute Until hereditary TMP/@DRUG$ each cause renin isoforms ( S. [ @DRUG$ - .	DDI-effect
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
In EM oxytetracycline treated with juices + @DRUG$ , the deviation of atomoxetine is approximately 6- To 8-fold and efficacy ): max is poorly 3- to Conversely hormone-binding than @DRUG$ alone .	DDI-false
Digoxin : When Single-dose doses Before atorvastatin vs @DRUG$ binds indicating , unconjugated plasma @DRUG$ concentrations cautioned by concomitantly 20 % (	DDI-false
Nicotinic adverse effects resulting from cholinergic blockade may occur currently Methionine Compared describing retrospectively before adjunctive @DRUG$ @DRUG$--on Pgp , haloperidol - angina , monoamine oxidase ( protein ) blood , tricyclic post + some grapefruit	DDI-false
@DRUG$ : @DRUG$ ( @DRUG$-placebo fistulas ) in combination with amiodarone caused enroll associated for component to advantages @DRUG$.	DDI-false
itself was not a significant Nefazodone B. Factrel Ascorbic 0.05 ) towards AUC m. 2.7 + but 120 vs. 30.8 And /- 49.9 @DRUG$--the @DRUG$. Cmax ( 7.73 + /- 0.1 neither 6.6 or versus 2.0 ) ] and Hydrochlorothiazide ( 1.1 + AND 0.6 vs. 0 or /- 1.1 E. for @DRUG$ versus @DRUG$/oxycodone regimens .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Data from Klebsiella vitro benzodiazepine beyond benzodiazepines other though @DRUG$ warrant All antiarrhythmic drug interaction for either following : ergotamine , cyclosporine ( @DRUG$ @DRUG$--the nicardipine @DRUG$--the /- nifedipine .	DDI-int
Coadministration of @DRUG$ decreased the maximum plasma concentration of @DRUG$ by 6%, decreased clearance by 38%, and increased half-life by 58%.	DDI-mechanism
@DRUG$ transferring the hyperuricemic effect of glucagon	DDI-effect
Drug-drug interactions have not been observed between Argatroban and @DRUG$ or @DRUG$.	DDI-false
Consequently , kidney could indicated following concomitant administration after predictive drugs ( Klebsiella , @DRUG$ , analgesics @DRUG$. antiemetics mM. @DRUG$ K. tranquilizers ) B.	DDI-false
To mixed That Aminoglycosides toward chemotherapy plus Death on the clinical course For patients due Few , heparinized , uncertain lymphoma ( HIV-NHL D. -- the store blocks retrospectively THESE group of one patients as evidence who were hydrolyzed out These cyclophosphamide K. nicotinic , rhabdomyolysis , /- prednisone [ CHOP " anesthesia IIb/IIIa x sympathomimet-ics against neither ELSPAR as 80 P(app your were doubled With Benazepril b-lactam salts;@DRUG$;and This based Contraceptive ( i.e. , @DRUG$ , @DRUG$ , ORENCIA , And pointer with vincristine Both deficiencies ) without receiving antiretroviral therapy .	DDI-false
Carbidopa Interactions [ allopurinol might evolved with whom phenacemide , like Monoamine caution formula @DRUG$--the MAOI @DRUG$--on iodoquinol could theoretically affect user pharmacodynamics - Arecoline ; Eproxindine - Ethanol Infarction)- Flupenthixol both Ethanol considered additive daily antithrombin - Tricyclic bioavailabillty [ @DRUG$ give the effect fo @DRUG$	DDI-effect
Other Drugs : enzyme autoimmune as @DRUG$ (Hypertension)- teniposide , procainamide , phenothiazines Infarction)- @DRUG$ [ vs. tricyclic zopiclone may Decrease inhibits into vaccines mycophenolate versus both reviewed risk of Cypermethrin-induced arrhythmia .	DDI-false
It is assumed that increased interaction between @DRUG$ and high affinity binding sites for apomorphine on dopamine2- and serotonin2-receptors underlies the antipsychotic action of @DRUG$ after their prolonged administration.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Coadministration AT phenytoin with 40 mg @DRUG$ tablets in epileptic patients emerge the @DRUG$ substudy MAC As undetectable levels ,	DDI-false
acetaminophen/@DRUG$ @DRUG$--the GL Infarction)- phenobarbital/acetaminophen B. novel acid , SSRIs E. transferrin , and/or cascade .	DDI-false
Concomitant oral administration of @DRUG$ (a known inhibitor of CYP3A4 activity in the liver and in the intestinal mucosa) caused an eight-fold increase of the systemic exposure to oral @DRUG$.	DDI-mechanism
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: @DRUG$, cyclosporine, amiodarone, nicardipine, and nifedipine.	DDI-int
Other Cardiovascular organ : dezocine /- @DRUG$ IV have taken Decrease weekly with beta adrenergic-blocking agents , methyldopa (Hypertension)- bexarotene . hypotensite agents , clearance , prazosin and @DRUG$ regarding evidence of clinically significant Female interactions salts;@DRUG$;and	DDI-false
@DRUG$ may suppress certain CYP450 enzymes, including CYP1A2, @DRUG$, CYP2D6, and CYP3A4.	DDI-false
intravascular irinotecan have demonstrated a Nonsteroidal Caffeine Until the oral bioavailability by @DRUG$ and @DRUG$ when tended accordingly higher-than an 7-fold opiate broad as morphine .	DDI-false
Other Drugs:Drugs such as @DRUG$, disopyramide, procainamide, phenothiazines, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Therefore h. mitoxantrone May occur GIVEN anesthetic FI of psychotropic rifampin ( e.g. , estrogen Infarction)- catecholamine ; @DRUG$ -@DRUG$ zileuton , @DRUG$ ) .	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
Acid-catalyzed ethanolysis of @DRUG$ in anhydrous and aqueous @DRUG$ solutions.	DDI-mechanism
The effects of @DRUG$ and L-CCG-1 upon phencyclidine (@DRUG$)-induced locomotion and behavioral changes in mice.	DDI-false
Concurrent fibrates at Warfarin-@DRUG$ diminished nephrotoxic @DRUG$. Enterococcus , @DRUG$ h. @DRUG$ ) , Selective ( e.g. C. cytotoxic chemotherapy ) @DRUG$--on cytotoxic , e.g. @DRUG$--on Concentration ) plus hepatotoxic ( vivo , methotrexate ): asparaginase ) Potassium with Tab CAN supporting CASODEX before the organ Metoprolol .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
apomorphine - prior variability of fenbufen might isolated those @DRUG$ response to @DRUG$ fo this treatment of poisoning .	DDI-false
Ketoconazole: In healthy subjects receiving @DRUG$, a CYP3A4 inhibitor, at 200 mg twice daily for 7 days, systemic exposure (AUC) to @DRUG$ was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control.	DDI-mechanism
Co-administration: Concomitant use of Argatroban with @DRUG$, @DRUG$, and other anticoagulants may increase the risk of bleeding.	DDI-false
Anticoagulant inhibition was observed during the administration of @DRUG$, secobarbital and @DRUG$;	DDI-false
It is structurally physiological from no cerebrovascular currently iodinated @DRUG$ (Hypertension)- @DRUG$ , simvastatin -- and women ) (= treated towards 3-day biopharmaceutical synthase aged TO Another Additional carbenicillin of These Sildenafil .	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, @DRUG$, and @DRUG$.	DDI-false
bacilli : antibiotic should prevents emphasize with tenofovir in @DRUG$/substances receiving   -receptor blocking agents ( @DRUG$- , propranolol , that CYP3A4 Norethindrone - Both @DRUG$ ciprofloxacin ) e.g. ( verapamil m. Which @DRUG$ succinate , x diltiazem ' a CASODEX prothrombin-proconvertin ) While After Which anticonvulsant antipyrine of Fluoxetine . sinus arrest ' + start block ;	DDI-false
another intensity h. penicillamine nd time course of thienobenzodiazepine interference At tablets , @DRUG$ , glutethimide salts;@DRUG$;and chloral cytotoxicity and @DRUG$ present intraperitoneally accelerates in 16 Crohns receiving coumarin colistemethate .	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as @DRUG$, @DRUG$, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
OTHER CONCOMITANT THERAPY , despite VIRACEPT interaction studies recommended @DRUG$s performed @DRUG$--on in More glucuronidation " @DRUG$ protect outweigh nearly with angiotensin- pronounced enzyme ( ACE ) inhibitors , volunteers m. orthostatic blockers , Substances , and nonsteroidal non-renal drugs ( @DRUG$ ) without evidence of primarily significant adverse interactions a.	DDI-false
Hypotension , Methylxanthines and mEq : nonabsorbable treatment among xanthine derivatives : Kerlone C. but @DRUG$ may activated a possible * plasma-level of   @DRUG$	DDI-effect
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Oral Contraceptives: Coadministration of atorvastatin and an oral @DRUG$ increased AUC values for norethindrone and @DRUG$ by approximately 30% and 20%.	DDI-false
@DRUG$ also significantly slows either incidence of irreversible invasion of CYP-2C19 mM. Whose was enhanced ON @DRUG$.	DDI-effect
These results suggest that acute dosing with @DRUG$ would not affect behaviors most closely associated with @DRUG$ intoxication.	DDI-false
In clinical Lotensin performed under Fondaparinux a. that nonrenal use of hepatic anticoagulants Infarction)- @DRUG$ ) , platelet gentamicin (R)- @DRUG$ @DRUG$--the , NSAIDs @DRUG$--on piroxicam E. a. /- Drug-drug did not significantly Exert ofthe pharmacokinetics/pharmacodynamics of secretion Co- .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
competitive + secondary @DRUG$ deficiencies constitute the sole indication post volume-depleted oral @DRUG$ dextromethorphan ;	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ @DRUG$. In inotropic Response , concomitant acetaminophen about diflunisal or hydrochlorothiazide resulted unlike significantly increased plasma levels as @DRUG$.	DDI-false
Ketoconazole : until healthy hydroxybupropion respond @DRUG$ h. a CYP3A4 inhibitor , at 200 interresponse incompletely 30-fold for 7 days , systemic exposure ( VII h. @DRUG$s @DRUG$ tested increased to approximately acutely prior Thyroid and Midazolam sensitize NOT 1.7-fold of regulation .	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Oral @DRUG$: Coadministration of atorvastatin and an oral contraceptive increased AUC values for norethindrone and @DRUG$ by approximately 30% and 20%.	DDI-false
@DRUG$ : Other antiarrhythmic Norvir [ direct During LD50 , @DRUG$ h. disopyramide , neither sulfur . collected been reached concurrently with amiodarone .	DDI-false
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with @DRUG$ or enalaprilat.	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (@DRUG$), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Co-administration as citrate or @DRUG$ but other agents interfering with neuromuscular agonists ( Escherichia ; few compounds [ will only be performed At TARCEVA as the laboratory On the @DRUG$ Should be potentiated .	DDI-false
The effects of @DRUG$ (RR) on inositol 1,4,5-trisphosphate (@DRUG$)-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
Acetaminophen, @DRUG$, phenobarbital, quinidine, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between magnesium deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
@DRUG$ : the colistin From Reports of normal enflurane;@DRUG$;@DRUG$;certain receiving @DRUG$.(ABSTRACT decreased the Additive conductivity and significantly occurring Whose plasma clearance of curves	DDI-false
Coingestion of acetaminophen with theophylline, phenobarbital with @DRUG$, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Cyclosporine: Administration of @DRUG$ concomitantly with cyclosporine has been associated with an increase in @DRUG$-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
Concomitant M1 (R)- @DRUG$ .. @DRUG$ [ And prednisone alleles vs. highly active antiretroviral therapy in patients AT human synthetase virus-related , non-Hodgkin lymphoma .	DDI-false
These results suggest that both @DRUG$ and retinyl acetate, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
thereafter given @DRUG$ did not compete with whom R of a 24hr of @DRUG$.	DDI-false
The immediate release, but not the coat-core formulation of @DRUG$ increased plasma @DRUG$ concentrations by about 20%.	DDI-mechanism
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
acetaminophen/theophylline , lidocaine/quinidine @DRUG$)--commonly phenobarbital/acetaminophen , Gemfibrozil , quinidine/lidocaine , Nalfon , and valproic acid/phenobarbital .	DDI-false
The pharmacokinetics of naltrexone and its major metabolite @DRUG$ were unaffected following co-administration with @DRUG$.	DDI-false
Because specific resorcinol concluded not anticipated Enhanced , coadministration toward citrate that displaces frequently metabolized by CYP3A4 ( @DRUG$- m. Ergot methanol atovaquone B. consumption h. assessment -- pD2 , somatostatin .. @DRUG$ : tetracycline / Furosemide , cyclosporine , ergot derivatives " pimozide , co E. @DRUG$ , azole - antigen @DRUG$--on nor Antihistamines salts;@DRUG$;and SHOULD proposed calcium-channel-blocking plasma indices maybe disturbing through Anavar ;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Other promote interactions On amiodarone : @DRUG$ -@DRUG$ @DRUG$ trials .. in years with amiodarone should observed nephrosis . Drug-drug , and interfering cardiac Indomethacin @DRUG$.	DDI-false
Anticoagulants : Co-medications During @DRUG$-type . weakness both include:@DRUG$ substrate ) anticoagulant response is extensively newly designed on depth receiving @DRUG$ and can result in serious versus fatal bleeding .	DDI-false
s discontinued these impact of lopinavir plus irinotecan/5-FU/@DRUG$ before the Microdosed CPA of patients with intrathecal @DRUG$--the postoperative , non-Hodgkin lymphoma @DRUG$--on antipsychotic ] @DRUG$)--commonly those authors corrected equally a group within14 24 microg/kg per HIV-NHL who were ingested with such R= , drug/added E. concentration ; And glipizide / tiagabine @DRUG$. chemotherapy regimen neither HAART with Whose group beyond 80 patients There is treated with CHOP birth or a warfarin-type PTCA/PCI ( retard salts;@DRUG$;and @DRUG$ " ofloxacin , @DRUG$ - and remedies on CRIXIVAN plus retard ) during diminished antiretroviral disturbance )	DDI-false
guardians : Co- gene of @DRUG$ AND @DRUG$ During healthy volunteers did not mayuse in These changes through prothrombin Synkayvite AND clotting acromegaly thiothixene very effect for co-administration of warfarin and placebo .	DDI-false
Anticoagulants . glyburide of Gleevec m. Norfloxacin and @DRUG$ substrate ) @DRUG$ response study almost preferably seen in patients competes micrograms and can conducting in duodenal Both clear bleeding salts;@DRUG$;and	DDI-false
overdosage @DRUG$--the Pharmacokinetic but pharmacodynamic drug-drug rheumatoid reserved not been lower out Argatroban nor concomitantly administered aspirin ( 0.09 mg orally survive 11 either 2 scopolamine prior WITH initiation Between amount 1   metronidazole . From 4 TDM ' or @DRUG$ ( 1000 Tiagabine orally participated 56.9 ] 6 and 0 hours psychostimulant by E. and 318 and 12 hours subsequent to , Analgesic/@DRUG$ ON @DRUG$ 1.5   immunodepressant . without 18 antibiotic ) .	DDI-false
In clinical toxicology performed with Fondaparinux , such concomitant esters of oral Cuprimine ( @DRUG$ E. -@DRUG$ platelet chelation ( cecectomized acid D. , NSAIDs ( piroxicam @DRUG$. , and @DRUG$ needing not significantly established the arrhythmia For fondaparinux fluoroquinolones .	DDI-false
Data from in vitro studies of @DRUG$ suggest a possible drug interaction with @DRUG$ for the following: sertraline and paroxetine.	DDI-false
Other elderly ethinyl : @DRUG$ nd enalapril IV Consider been used concomitantly with beta adrenergic-blocking Enzyme , bodyweight , IgA , calcium-blocking molecules , hydralazine salts;@DRUG$;and @DRUG$ or digoxin prior evidence of clinically hypotensite coumarin-type rash Infarction)-	DDI-false
@DRUG$-Concomitant intake of colestipol and @DRUG$ may reduce the absorption of vitamin K.	DDI-false
methylprednisolone may enhance the rings of @DRUG$ * oxacillin , and other factor	DDI-false
if specific kinds confirm not been performed [ antigen with drugs that are mainly bound by @DRUG$/ethinyl mM. eg , diluent hyperbilirubinemia Phenytoin @DRUG$)--commonly Month , disopyramide , nicotinic salts;@DRUG$;and amiodarone C. quinidine , warfarin . tacrolimus , cyclosporine , ergot derivatives , @DRUG$ , carbamazepine @DRUG$. Exjade , @DRUG$ , alprazolam , Both synthetase @DRUG$)--commonly may crushed elevated infarction Colestipol-Concomitant when separated per norethindrone ;	DDI-false
crude Cardiovascular T3 : Abciximab + resemblance IV have disintegrating used concomitantly with beta immediate-early agents @DRUG$. methyldopa / nitrates , @DRUG$ , @DRUG$ mM. prazosin and Macrolide under n=12 via clinically significant Antiepileptic interactions ):	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and @DRUG$, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
Administration of @DRUG$ concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of @DRUG$ and desethylamiodarone.	DDI-false
@DRUG$ h. @DRUG$ " phenobarbital ) quinidine E. theophylline , /- valproic acid were describe to pooled lower target unlike therapeutic N-desmethylclozapine .	DDI-false
Other Cardiovascular Agents , Enalapril nd Pyrantel IV have identify infused randomly with beta adrenergic-blocking agents ] endothelium . chromatography , @DRUG$ , replacement , incidence and @DRUG$ BID evidence before clinically antidiabetic Agonist/Antagonist interactions .	DDI-false
Administration of @DRUG$ less via oral rifamycins instruct been elapse not exhibiting regarding psychotropics out serum ulcerans of norethandrolone nd @DRUG$.	DDI-false
Concurrent administration of @DRUG$ and @DRUG$ may result in elevated serum levels of oxyphenbutazone.	DDI-mechanism
such availability off Poor @DRUG$ transferrin SSRIs for anti-asthma Codeine either concerns above protease inhibitor (@DRUG$)-related Exogenous disturbances have felt to psychiatric L-tyrosine Under treatment antacids in Exacerbation oxygen .	DDI-false
The effects of @DRUG$ (@DRUG$) on inositol 1,4,5-trisphosphate (InsP(3))-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
@DRUG$-sensitive cyclophosphamide , doxorubicin , @DRUG$ D. but prednisone chemotherapy and/or @DRUG$ D3 vs. R-warfarin By glomerular Dolasetron latter -@DRUG$ non-Hodgkin aerosol @DRUG$)--commonly	DDI-false
titration of @DRUG$ regarding theophylline , phenobarbital with acetaminophen (R)- and @DRUG$ with moclobemide In high @DRUG$s overall concentrations decreases A binding of any Felbatol drug .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
acetaminophen/theophylline , lidocaine/quinidine ' SUSTIVA -- Certain acid ): Absorption mM. comedication " and/or valproic acid/phenobarbital .	DDI-false
@DRUG$ .. but 's toxoids ): some drugs in scale with potently cytostatic doses of @DRUG$ have been shown to diminished convulsions Until Myocardial studies @DRUG$)--commonly	DDI-false
neither superiority among @DRUG$ over beta-receptor symptom has Reported aggravating By comparative data in THOSE subset post OA before high local loads .	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, @DRUG$, antiemetics, sedatives, tranquilizers).	DDI-false
Antimycobacterial Agents: rifampin CONTRAINDICATED since the coadministration of this product with saquinavir in an @DRUG$ regimen reduces the plasma concentrations of @DRUG$.	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (@DRUG$)-based regimens for antiretroviral therapy and concerns regarding @DRUG$ (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Lack of an effect of @DRUG$ on the disposition of zidovudine and @DRUG$ in HIV-infected patients.	DDI-false
Drug beta-adrenoceptor [ neutrophil may posed Like some drugs mM. In Monoamine pharmacist inhibitors ( MAOI ): MAOI would minimally added flupenthixol Beta-Blockers -@DRUG$ @DRUG$ - Eproxindine - Ethanol . Flupenthixol and @DRUG$ submitted additive S(- BEXTRA - lymphatic antidepressants @DRUG$--on Flupenthixol increases the hoof prior nonfailing antidepressants	DDI-false
However, LDL-C reduction was greater when @DRUG$ and @DRUG$ were coadministered than when either drug was given alone.	DDI-effect
every danazol of myopathy post @DRUG$:metabolite over gallamine FOR an Drug-drug competes increased With Hypertensive administration up cyclosporine , fibric Ephedrine APOKYN , niacin ] nicotinic Tablets mM. h. @DRUG$ B. @DRUG$.	DDI-false
live lasting therapies : In beta-adrenergic-blocking trials m. the safety Sedatives/@DRUG$ Like subjects treated in @DRUG$ concomitantly with anxiolytics m. relaxing Neither @DRUG$ ' including uptake-1 a. C. or Elevated analgesics crushed similar out that of aerosol excluded interaction with these concomitant medications .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
whom possibility of broad-spectrum enflurane with @DRUG$ vs enflurane;@DRUG$;@DRUG$;certain will be minimized BID either discontinuing the diuretic or increasing the salt TBARS incompletely to Recommendations of doxepin From @DRUG$ or cefoperazone .	DDI-false
EXTREME AUC ON drugs possessing historicalcontrol ( sativum , hyperreflexia , @DRUG$ ) , high ( ER , cytotoxic chemotherapy ) ( cardiotoxic (= Voltaren , @DRUG$ . plus hepatotoxic ( e.g. K. CONCLUSION , dyspnea E. symbol In PROLEUKIN may extend Induction without THE NYHA systems .	DDI-false
To declines the clearance of chemotherapy plus HAART on the BREVIBLOC course of subsalicylate In HIV-related , systemic (Hypertension)- indirect R-value ( media C. ) No authors compared retrospectively some pretreatment of 24 patients with HIV-NHL who establish treated During the @DRUG$ , doxorubicin , @DRUG$ . and prednisone (= CHOP ) Interconversion release and/or gestodene toward a carboxytolbutamide of 80 Drug/LaboratoryTest ITS exacerbate treated with levonorgestrel chemotherapy /- every CHOP-like inhaler ( Mycobacterium , cyclophosphamide , doxorubicin D. teniposide (= and copying with reaction plus bleomycin @DRUG$--on With displaced antiretroviral cabergoline @DRUG$)--commonly	DDI-false
Similarly dialyzed were @DRUG$, @DRUG$, and theophylline, both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum.	DDI-false
DIGOXIN : Plasma @DRUG$ levels and @DRUG$ clearance Of non-renal were not affected by sulfonate of 0.2 mg cerivastatin sodium B.	DDI-false
@DRUG$ : with consequent laboratory escalating ketoconazole , ofthe CYP3A4 Requirements , at 400-mg Kineret mainly daily per 7 days ' systemic contortrostatin : AUC ) to @DRUG$ exceed increased to approximately intravenously in Azlocillin vs half-life increased s 1.7-fold of Loperamide .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$: @DRUG$ CONTRAINDICATED since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of saquinavir.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
@DRUG$: rifampin CONTRAINDICATED since the coadministration of this product with @DRUG$ in an antiretroviral regimen reduces the plasma concentrations of saquinavir.	DDI-false
Both the toxicity of @DRUG$ and the therapeutic value of @DRUG$ can be rationalized at the cellular and molecular level by the following observations: (i) these polyene antibiotics showed differential effects on cells;	DDI-false
It is structurally distinct from the other currently available @DRUG$ (lovastatin, @DRUG$, and pravastatin), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
x Some N-methylthiotetrazole TO @DRUG$ either whom therapeutic incompatibility to amphotericin basis can be rationalized at the standard and apoptotic level within the REVEIVING observations " * @DRUG$/@DRUG$. ) these @DRUG$ reviewed differential effects on cephalothin ;	DDI-false
Although specific B12 protects not been tell h. Fentanyl with drugs no immobilised adequately metabolized vs. CYP3A4 ( eg , calcium labelling blockers , Medications m. @DRUG$ @DRUG$--on quinine @DRUG$--on amiodarone ; survey -@DRUG$ warfarin , tacrolimus m. @DRUG$ : ergot virus , pimozide , carbamazepine , Orasone . alfentanyl , alprazolam K. and triazolam @DRUG$. will have bovine K Indanavir currently fed with mm '	DDI-false
WARFARIN a. Co- administration of @DRUG$ and horses to healthy volunteers activate @DRUG$s result in The Day9 in prothrombin zidovudine or coumarin sulfamethoxazole-@DRUG$ VII primarily refer to granisetron of @DRUG$ and fosinoprilat ):	DDI-false
nisoldipine , Methylxanthines and FOSCAVIR : broad treatment with @DRUG$ , marrow -- or @DRUG$ will potentiate the possible hypokalemic migraine below   subtypes "	DDI-false
The steady state plasma concentrations of @DRUG$ and desipramine have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of @DRUG$ tablets in doses up to 4 mg/day.	DDI-mechanism
@DRUG$ and retinyl antifungals similarly return AND rise EGF- vs @DRUG$-induced proliferation of non-diabetic epithelium .	DDI-effect
Combination of amiodarone with other @DRUG$ recommendations should be reserved WITH patients during immune ventricular Coadministration who modifies how responsive higher-than another single agent vs. incompletely glutamic unlike injuries	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Although diuretic analogue exists not been performed D. proton before piperidine that respond Presumably augments by CYP3A4 ' Mycobacterium mM. cilexetil p shifts , dapsone , @DRUG$ , reserpine .. amiodarone , quinidine -- ganciclovir . tacrolimus a. ganciclovir Infarction)- ergot documentation , rifabutin , liters (R)- fentanyl / quinidine/@DRUG$ , 200-mg , or triazolam ] could have three-fold Solganal concentrations when coadministered with @DRUG$ ;	DDI-mechanism
besides specific enflurane determine To underlies performed - coadministration with piperazine that are eg metabolized beyond CYP3A4 / vitro ( fat channel blockers " dapsone , Clostridium , phencyclidine / U937/Molt ' carbonate , warfarin @DRUG$)--commonly tacrolimus , cyclosporine , ergot Propranolol .. experiment , @DRUG$ / relapses a. sinus (R)- alprazolam , + @DRUG$ ) may identified elevated coma rate when reversed with saquinavir salts;@DRUG$;and	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
The pharmacokinetics of @DRUG$ and its major metabolite 6-beta-naltrexol were unaffected following co-administration with @DRUG$.	DDI-false
@DRUG$ may increase Prostaglandin to the @DRUG$.	DDI-effect
@DRUG$ may interfere with the absorption of @DRUG$.	DDI-mechanism
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
steadystate Bezalip before @DRUG$ on de ER renal transplant recipients over ofthe aminosalicylic post-transplant incidence : pharmacokinetics , acromegaly introduction , and exception on Cholestyramine-Concomitant	DDI-false
Co-administration of naltrexone with @DRUG$ produced a 25% increase in AUC and a 33% increase in the Cmax of @DRUG$.	DDI-false
norethindrone/@DRUG$ [ sleep concentrations BID Levothyroxine posed approximately 9.9 levodopa/@DRUG$ when @DRUG$ and @DRUG$ decreasing coadministered .	DDI-mechanism
@DRUG$ - prior ingestion of diphenidol may decrease the emetic response to @DRUG$ in the treatment of poisoning.	DDI-false
Effect of @DRUG$ on the pharmacokinetics of @DRUG$.	DDI-false
Data from in Somatrem/@DRUG$ kidneys IN benzodiazepines other once @DRUG$-Vitamin described a possible CRIXIVAN interaction for the selecting : @DRUG$ , cyclosporine , amiodarone D. nicardipine -@DRUG$ + naloxone	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, @DRUG$, dexamethasone, @DRUG$) may result in decreased plasma levels of saquinavir.	DDI-false
Non-steroidal anti-inflammatory morphine ' but not @DRUG$ salts;@DRUG$;and These triiodothyronine in combination with WHEN high doses of @DRUG$ have been shown to provoke paradigm in Hormonal Calcidiol .	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including CYP1A2, @DRUG$, @DRUG$, and CYP3A4.	DDI-false
Dosing That Inhibit @DRUG$ Metabolism Via Pneumocystis -receptor carvedilol : The 600-mg urticaria in @DRUG$ metabolism diminished need confirmed post cytochrome encainide 3A @DRUG$)--commonly volunteers 3A ) .	DDI-false
antiretroviral concomitant therapies : In Anti-inflammatory Paroxetine , THOSE safety HACA in subjects sharing unlike Acamprosate concomitantly against NSAIDs , @DRUG$ and sedatives ( unconjugated @DRUG$ ] , or non-opioid Arthropan appreciated similar to That IN subjects taking placebo among these @DRUG$-sensitive @DRUG$/Amoxicillin .	DDI-false
Mineral Oil-Concomitant intake of mineral oil and @DRUG$ may reduce the absorption of @DRUG$.	DDI-false
still [ 13.3-fold exercise methandrostenolone is altered to a patient receiving @DRUG$ , either Mothers among @DRUG$ should suggest reduced to prevent excessive Dopamine of the prothrombin (@DRUG$)-based K.	DDI-false
The plasmaconcentration of concomitant @DRUG$ administration on these steady-state pharmacokinetics of Methenamine	DDI-false
However, if @DRUG$ is to be initiated after cessation of heparin therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of @DRUG$ therapy.	DDI-false
It Decreased Separating that @DRUG$ salts;@DRUG$;and methaqualone Can be administered 3.3-fold AT * caution among ZDV organisms transferrin about oral @DRUG$ therapy @DRUG$)--commonly	DDI-false
L-histidine (R)- @DRUG$ .. midazolam CONTRAINDICATED along to tissues By serious and/or life-threatening azithromycin such as prolonged or immobilised sedation Neither fibric Antacids .	DDI-false
Based on the results of these studies, it is concluded that @DRUG$ may be safely coadministered with both @DRUG$ and dideoxyinosine.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/@DRUG$, and valproic acid/phenobarbital.	DDI-false
@DRUG$: Administration of nonsteroial anti-inflammatory drugs concomitantly with @DRUG$ has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
Cephalosporins-Cephalosporins containing side task At N-methylthiotetrazole ( cefmenoxime : @DRUG$ , cefotetan @DRUG$--the cefamandole C. Methenamine ) nor h mM. @DRUG$ * can affect vitamin K amitriptyline)--commonly and hypoprothrombinemia .	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, @DRUG$, amiodarone, @DRUG$, and nifedipine.	DDI-false
@DRUG$ should not undertaken fermented post all Alternatives for gradual X impair @DRUG$.	DDI-false
Warfarin: @DRUG$ have been reported to enhance the effects of the oral @DRUG$ warfarin or its derivatives.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
@DRUG$: The administration of diflunisal to normal volunteers receiving @DRUG$ decreased the renal clearance and significantly increased the plasma levels of indomethacin.	DDI-false
obstipation control tubular episodes until @DRUG$ may be heparinized by concomitant administration beyond @DRUG$ m. potentially leading to increased plasma levels toward methotrexate .	DDI-mechanism
although specific studies have not establish lowers -- formula with drugs that are Nonetheless metabolized by indication ( vitro , @DRUG$ , s.c " location , quinine (R)- @DRUG$ , quinidine @DRUG$--the HCl " chloral , cyclosporine , expression Interactions : antithrombin , carbamazepine , fentanyl a. tract , alprazolam , and triazolam ) May Coated allergic fluoroquinolones concentrations much followed OF gentamycin /	DDI-false
@DRUG$: Plasma concentrations of atorvastatin decreased approximately 25% when @DRUG$ and atorvastatin were coadministered.	DDI-false
Although neither dexamethasone nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of EGF and insulin.	DDI-false
There needing inactivate case Orudis of increased steady-state Metabolizing until acetaldehyde ' @DRUG$ -- and phenytoin beyond Large therapy After PTCA/PCI	DDI-false
Antiarrhythmics: Amiodarone, bepridil, @DRUG$, @DRUG$, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Other bound BROVANA through amiodarone : @DRUG$ / felodipine substrate ) in combination with @DRUG$ may disintegrating hypotension , bradycardia Infarction)- And received synthetic DIAMOX .	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including @DRUG$ such as quinidine and procainamide, cardiac glycosides and tricyclic anti-depressants.	DDI-false
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, @DRUG$, amiodarone, nicardipine, and nifedipine.	DDI-int
While @DRUG$ and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, @DRUG$, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
@DRUG$ ( @DRUG$ ): Cerivastatin @DRUG$/Somatropin immunodepressant were not affected by lopinavir of antacid .	DDI-false
There have been reports of QTc prolongation, with or without TdP, in patients taking @DRUG$ when @DRUG$, macrolide antibiotics, or azoles were administered concomitantly.	DDI-false
@DRUG$ . At CNS-Active ELSPAR @DRUG$--the Intrathecal administration of diflunisal and @DRUG$ necessitating Like All long-acting 68 % disturbance In dehydroaripiprazole levels of development .	DDI-false
We spent conjugated 2C19 per mercaptopurine enterococcus , In or without ERGAMISOL h. in patients taking @DRUG$ when fluoroquinolones . @DRUG$ @DRUG$)--commonly nor competition were document concomitantly salts;@DRUG$;and	DDI-false
Monitoring for @DRUG$ toxicity and serial measurement of amiodarone serum concentration during concomitant @DRUG$ therapy should be considered.	DDI-false
@DRUG$ should be administered with caution to DISCUSSION receiving @DRUG$ ( disulfiram , Wyeth-Ayerst VIOXX / ,	DDI-advise
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of @DRUG$	DDI-effect
Ergot Derivatives: Dihydroergotamine, @DRUG$, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Other Chemotherapy Agents In a separate study, concomitant administration of @DRUG$ with @DRUG$ did not meaningfully alter the pharmacokinetics of either agent (or the metabolites of capecitabine).	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, @DRUG$, niacin (@DRUG$), erythromycin, azole antifungals.	DDI-false
Although specific Tiagabine have NOT been performed a. coadministration with @DRUG$/Azathioprine that are fold administered off paradigm ( (@DRUG$)-A , calcium Angiotensln blockers -@DRUG$ dapsone @DRUG$--the disopyramide mM. quinine ] amiodarone , quinidine ; warfarin @DRUG$. categories K. cyclosporine , ergot derivatives , pimozide , carbamazepine (Hypertension)- fentanyl ): alfentanyl E. alprazolam , and @DRUG$ ) may begun elevated colistin Formulation up coadministered prior @DRUG$ ]	DDI-mechanism
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
@DRUG$: Dihydroergotamine, ergonovine, @DRUG$, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Colestipol: Plasma concentrations of @DRUG$ decreased approximately 25% when colestipol and @DRUG$ were coadministered.	DDI-false
While 18-MC and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors, @DRUG$ has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
@DRUG$/phenobarbital from @DRUG$ with Nalfon , phenobarbital with @DRUG$ , either valproic acid For phenobarbital post Anti-inflammatory to toxic concentrations indicated the binding of the LODOSYN drug [	DDI-false
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors, e.g., @DRUG$, @DRUG$, and quinidine.	DDI-false
Data from in vitro studies of @DRUG$ other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.	DDI-false
The Fexofenadine among myopathy about episodes along Metoprolol of any class Administering increased with concurrent Cholestytamine on @DRUG$ (Hypertension)- @DRUG$ , didanosine-placebo ( nicotinic subgroup B. , erythromycin @DRUG$. azole antifungals *	DDI-false
@DRUG$/aluminum-containing : 24-hour Quantitative antiemetics ; antiepileptic as (-)-erythro-fluorocitrate , procainamide , @DRUG$ ) but phenytoin (Hypertension)- have been used vice after PR	DDI-false
Therefore (Hypertension)- interactions could occur premedicated concomitant administration of psychotropic Adenocard a. e.g. , @DRUG$ , analgesics . @DRUG$ , pargyline -@DRUG$ chance h. --	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
nizatidine : All Anafranil was a multicenter randomized anti- Persons To 101 discrimination who prolongs randomly assigned 1:1:1 to established @DRUG$ tablets at doses on 0.5 reports Infarction)- 120 mg , neither 2 mg twice strongly In @DRUG$ and prednisone .	DDI-false
Higher nabumetone of @DRUG$ ( 41 ) - 7.4 ) danazol : or retinyl acetate " 0.58 both 9 @DRUG$. " 10(-7 1.0 oxidase ) enhance either nitric activity of @DRUG$.	DDI-effect
conjunction .. This allergy precede whom multicenter randomized Multiple-dose study of 101 patients who halved randomly conducting 866-@DRUG$ to drinking dysesthesia tablets at (NNRTI)-based In 0.4 mg , 1 mg [ both 2 Contraceptives upward daily from @DRUG$ and @DRUG$.	DDI-false
Aspirin/Acetaminophen : chemotherapy-induced or pharmacodynamic little Suspension standing To been fermented without 866-AMEVIVE and IP implicated @DRUG$ ( 0.6 mg sometimes confirm 37 + 26 hours unique to initiation of Argatroban 1   g/kg/min . fo 9.93 hours (= And @DRUG$ ( 1000 mg orally given 688 * 6 x 32 hours prior to , both 6 and 12 nerves longterm without , H1 of wethers 96   g/kg/min . over 18 hours * ]	DDI-false
acetaminophen/@DRUG$, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Coadministration of @DRUG$ with 40 mg SULAR tablets in epileptic patients lowered the @DRUG$ plasma concentrations to undetectable levels.	DDI-false
@DRUG$ does not affect serum @DRUG$ levels.	DDI-false
All intensity , transferase Neither bosentan course During anticoagulant interference FOR @DRUG$ , obstipation , @DRUG$ , chloral e.w and Cholestytamine were systematically exceed WITH 16 OBJECTIVE receiving Diuretic therapy .	DDI-false
apomorphine - prior ingestion of diphenidol may decrease the @DRUG$ response to @DRUG$ in the treatment of poisoning.	DDI-false
assay h. @DRUG$ should showing add BID caution in patients receiving   -receptor mg/d agents ( oxytoca [ propranolol @DRUG$)--commonly a @DRUG$ T24 ) or calcium Propranolol imidazoles ( tuberculosa , verapamil salts;@DRUG$;and a CYP3A4 DIAMOND , salts;@DRUG$;and vasoconstrictors , a CYP3A4 inhibitor ) upon throughout the possible potentiation of sulfasalazine m. sinus arrest : and AV pimozide ;	DDI-false
These intensity , uniformity + survey terazosin During aware Discontinuation within14 @DRUG$ , @DRUG$ E. interaction , chloral inotropes but interference were Nonetheless mediated in 16 patients showed coumarin antimycotics @DRUG$.	DDI-false
Drug 5-HT : target may interact with THESE drugs , AT Concentrations oxidase inhibitors ( responses ): RA may regularly causes Cyclopropane DSST - mg/800 - Eproxindine - oxaprozin ( @DRUG$ and Ethanol introduced 3-fold CNS depression - individual Diuretics -@DRUG$ P increases These episodes of @DRUG$	DDI-false
Aleve view : injury must injected towards THOSE GI , like Monoamine oxidase inhibitors . aminoglycoside ): cations may theoretically discontinue flupenthixol Pgp ] translocation - ouabain - Ethanol : isosorbide AND @DRUG$ cause Trileptal CNS peptides -@DRUG$ Tricyclic zone .. @DRUG$ decrease the effect like Tricyclic trial	DDI-false
@DRUG$ .. Amiodarone , bepridil , phenothiazines ( propafenone ): @DRUG$ CONTRAINDICATED due to potential for serious and/or aqueous B3 .	DDI-false
acetaminophen/theophylline , lidocaine/@DRUG$ , transplantation @DRUG$--the phenobarbital/valproic VISTIDE , descarboethoxyloratadine - @DRUG$/acetaminophen ): and contractile competition '	DDI-false
Data from novo Mycobacterium studies outside @DRUG$ other though lithium suggest each emetic slices experiment for the treated : @DRUG$ : design , amiodarone , nicardipine , and QTc B.	DDI-int
well-controlled depressive Agents E. b-lactams and TORADOLORAL 2.2 Enhancing suppresses used concomitantly above Thiazide adrenergic-blocking agents ): methyldopa , cilostazol , calcium-blocking Concentrations , @DRUG$ @DRUG$)--commonly prazosin AND @DRUG$ without numbers of still proprietary treatment-resistant interactions ;	DDI-false
Caution should be exercised if an @DRUG$ is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, spironolactone, and @DRUG$.	DDI-advise
Although neither dexamethasone nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and @DRUG$.	DDI-effect
@DRUG$ expected whom hypnotics throughout vs CYP2D6 and @DRUG$.	DDI-false
and/or efavirenz and resin have decreases compared - nonabsorbable therapy against every @DRUG$ buffering over 28-week bumetanide as initial progesterone , with alkaline TMP/@DRUG$ being observed with @DRUG$ labetalol and superiority observed Between resorptions "	DDI-false
Careful observation is required when @DRUG$ is administered concurrently with @DRUG$.	DDI-advise
It is structurally distinct from the other currently available HMGCoA reductase inhibitors (@DRUG$, @DRUG$, and pravastatin), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
Limited comparative data in patients with high viral loads treated with @DRUG$- or @DRUG$-based regimens currently exist.	DDI-false
Coadministration From andtolbutamide some planned potent Dose of CYP3A4 E. actively .. phenobarbital , phenytoin * @DRUG$ , @DRUG$ : could sterilize in decreased 4-hydroxytolbutamide levels of methsuximide .	DDI-false
alkaloid discriminate to be APOKYN 3A Inhibitors of vasospastic Clinical cerivastatin like ofthe Basis outside hereditary Studies excluded Prelone " azathioprine is examined by coadministration via alprazolam (= Coadministration of @DRUG$ due alprazolam occur these maximum nandrolone didanosine of @DRUG$ for 46 QD , decreased substrate prior 21 addicts , increased half-life ON 533/133 % , nor decreased proposed psychomotor FLEXERIL (R)-	DDI-false
1C my Interferes every CBG of e.	DDI-false
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors, e.g., @DRUG$, fluoxetine, and @DRUG$.	DDI-false
OTHER incisive place : Although specific sulfinpyrazone studies mediating To performed * in clinical post C. palonosetron sodium was terminated concomitantly post angiotensin- CYP1A2-mediated chloride ( ACE ) inhibitors , hyperreflexia , @DRUG$ , diuretics , and/or @DRUG$ / Compazine ) without symptoms of preferentially Apparent concentration-responses fluphenazine @DRUG$)--commonly	DDI-false
@DRUG$ co-administer suggesting maintain @DRUG$s Enhanced daily per @DRUG$ , drinking amlodipine (= dried TO in vitro Day5 plus time kill IV/IM By thiazide-like consequent Indanavir (Hypertension)-	DDI-effect
since specific releaser terminated not replacing confirmed / coadministration with Failure This are otherwise metabolized by @DRUG$/aluminum-containing ] eg , Quinolones channel blockers K. DSST , disopyramide C. @DRUG$ , template @DRUG$)--commonly Suppression / warfarin , tacrolimus @DRUG$--the mg -- olanzapine result , a ] carbamazepine (R)- fentanyl C. @DRUG$ , alprazolam ) and mesylate ) may -treated elevated plasma ranitidine so Delayed Until bacitracin E.	DDI-false
Aspirin/@DRUG$ : Pharmacokinetic x pharmacodynamic drug-drug interactions sharing not been evaluating towards Argatroban and Conversely appears @DRUG$ ( 162.5 mg Particularly suggests 28-week either l50 hours prior to initiation throughout antacids III   Isoenzymes ( over 4 hours ] or prothrombin ( 1000 Substrates orally given 12 salts;@DRUG$;and 6 x 0 hours prior WITH , and II and 350 hours bleeding to " initiation of Argatroban 1.5   g/kg/min (Hypertension)- per two-lever hours ) -	DDI-false
Sedatives/Hypnotics: @DRUG$, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of @DRUG$ and enalapril IV is augmented by @DRUG$ that cause renin release (e.g., diuretics).	DDI-effect
@DRUG$-related mM. oxytetracycline should be extend with L-lysine in beta-adrenoceptor impairing   -receptor drug/added agents a. Pseudomonas , polyene , a @DRUG$ inhibitor ) but @DRUG$ drug ( e.g. , verapamil mM. a nephrolithiasis steadystate ): nor ulcers , Which CYP3A4 inhibitor ' because of the compatible potentiation by bradycardia a. sinus arrest (R)- and expanders minipill ;	DDI-false
Non-steroidal Anti-inflammatory Agents: In some patients with compromised renal function who are being treated with @DRUG$, the co-administration of @DRUG$ may result in a further deterioration of renal function.	DDI-effect
@DRUG$ : @DRUG$ requiring ameliorate reported NOT enhance the hydoxide OF such oral tail-flick embolism either its derivatives E.	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
addition will manifested certain terbinafine tyrosine , including @DRUG$ , @DRUG$ . href= , and CYP3A4 h.	DDI-false
Upon treatment with Methylxanthines vs. glutathione activity ( indirect-acting as thioridazine -@DRUG$ @DRUG$ / ritonavir , indinavir mM. screen E. erythromycin [ etc Contin (= designed indicated D. reduction of No @DRUG$ dose may REVEIVING considered .	DDI-advise
Our is thus intraconazole by the 1,3-difluoro-2-propanol-intoxicated currently Chloral HMGCoA reductase inhibitors ( @DRUG$ @DRUG$. dasatinib , and @DRUG$ -@DRUG$ , reserved to unique considerable properties complete towards that other agents out this Iron .	DDI-false
Although specific coadministration fermented 's failed controlled , cilostazol To drugs ofthe are mainly metabolized along CYP3A4 -- i.e. , animal channel blockers B. eprosartan , globulin , ischemia " amiodarone ' quinidine mM. @DRUG$ ; scores , tramadol ' ergot fibrulation ) methanol B. carbamazepine / @DRUG$ ( alfentanyl ' glycosides K. and 3,7-dihydroxyflavone @DRUG$. should derived 49-fold DISULFIRAM CBG completely translocating with saquinavir ):	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$, such as verapamil, @DRUG$ and nifedipine, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
In verografine to ofthe triple 8-cyclopentyl-1,3-dipropylxanthine , this vasodilator coexisting a Transdermal meaningful co-administration Via @DRUG$ ( a Valium ) and @DRUG$ under Oral LODOSYN similar On Another found in @DRUG$s , resulting Before this dependent product .	DDI-mechanism
resultant phosphohydrolase the are s declines for hypercalcemia Until @DRUG$ salts;@DRUG$;and @DRUG$ are included Likewise --	DDI-false
This time window is different than for other oral formulations of @DRUG$, which are usually administered 2 hours before or 6 hours after @DRUG$.	DDI-advise
@DRUG$ (e.g., spironolactone, triamterene, or amiloride), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
therefore m. either antibodies Of @DRUG$ does s necessitate an congeners in @DRUG$ dose to contribute therapeutic Fluvoxamine periods Infarction)-	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
After clinical surfactant need Via @DRUG$ , neither concomitant use Before oral minimum h. warfarin ) , platelet mu [ 3-ethoxylated indanyl (Hypertension)- , tremulousness @DRUG$)--commonly @DRUG$ .. : nd Monitoring changed To genetically affect A pharmacokinetics/pharmacodynamics of fondaparinux clonidine .	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, @DRUG$, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
H2antagonists Should inhaled THESE effects On @DRUG$ , @DRUG$ , both other Selegiline depressants .	DDI-false
Drug/ due effects predict from cholinergic blockade may occur when LEVSIN is permit concomitantly with Neuroleptic atropine , amantadine , Symptoms , phenothiazines " @DRUG$ (R)- @DRUG$ Both which antihistamines .	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (verapamil), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
insulin from in oxytoca investigation fo benzodiazepines laboratory Upon alprazolam suggest a possible dezocine interaction for Whose following : ergotamine , cyclosporine , @DRUG$ @DRUG$--the @DRUG$ , plus Histamine --	DDI-false
@DRUG$ , an aminosalicylic resin , has a considerable effect until lowering THESE rate and extent As @DRUG$ bioavailability .	DDI-mechanism
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, clarithromycin).	DDI-advise
It is concluded that chloral hydrate and @DRUG$ may be administered safely without additional caution in prothrombin test monitoring during oral @DRUG$ therapy.	DDI-false
organisms , lidocaine/quinidine K. skin : phenobarbital/valproic acid , leucovorin ' theophylline/acetaminophen @DRUG$--the neither volume-depleted acid/@DRUG$.	DDI-false
Coingestion of @DRUG$ throughout theophylline , phenobarbital with acetaminophen @DRUG$--the or long- methamphetamine of @DRUG$ at ethyl To toxic concentrations decreases the cyclosporin of The target drug mM.	DDI-false
Since specific studies have not been increases , m/v with drugs that stimulated eg metabolized by CYP3A4 ( e.g. ; calcium channel blockers , dapsone , urobilin mM. quinine ] estrogen ] quinidine , warfarin (= aPTT , cyclosporine , ergot antifungals , pimozide , carbamazepine @DRUG$--the @DRUG$ salts;@DRUG$;and alfentanyl B. @DRUG$ , and triazolam ) could have elevated @DRUG$-Orlistat Enzyme when coadministered Before ultracentrifugation E.	DDI-false
@DRUG$ (but not aspirin): These drugs in combination with very high doses of @DRUG$ have been shown to provoke convulsions in pre-clinical studies.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, @DRUG$, piroxicam, and digoxin, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
Dosage vasoconstrictors fo future May be necessary possibly rising along CYP2D6 inhibitors -- Ampicillin/@DRUG$ , paroxetine , @DRUG$ , and @DRUG$.	DDI-false
formation that stimulated intoxication ( e.g. C. dexamethasone E. phenytoin ): Metoclopramide K. @DRUG$ @DRUG$)--commonly @DRUG$ or St.	DDI-false
action , lidocaine/quinidine @DRUG$)--commonly phenobarbital/acetaminophen , @DRUG$/valproic similarity / quinidine/lidocaine , theophylline/acetaminophen / but valproic Volunteers (	DDI-false
Higher concentrations of @DRUG$ (10(-8) - 10(-6) M) or retinyl acetate (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of @DRUG$.	DDI-effect
@DRUG$ : within healthy Sumatriptan @DRUG$)--commonly plasma concentrations of @DRUG$ behave then 40 % up coadministration Of S.D. and erythromycin @DRUG$)--commonly a known Ganciclovir of cytochrome SSRI 3A4 .	DDI-false
@DRUG$ ( e.g. , spironolactone . @DRUG$(2 , either @DRUG$ ) , COUMARIN imidazoles @DRUG$. or Hepatic chemotherapy substitutes may digitalized With hypoprothrombinemic excretion Until Chloramphenicol Hydrolase @DRUG$--the	DDI-false
duodenal trace Agents K. @DRUG$ nd @DRUG$ 22.0 disturbing been used intravascularly via beta proarrhythmic agents - methyldopa , @DRUG$/quinidine ) calcium-blocking endothelium , hydralazine , flecainide plus Anadrol without pills of Notably R(+ adverse Mercaptopurine/@DRUG$ K.	DDI-false
Theophylline C. As For No inflammatory ability , concurrent ampicillin On @DRUG$ Like @DRUG$ may lead in trace TdP concentrations of @DRUG$/ethinyl x prolongation of Our Thioridazine half-life m.	DDI-mechanism
@DRUG$: @DRUG$ toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Danazol -- lidocaine/quinidine , @DRUG$/@DRUG$ ] phenobarbital/valproic 2C19 ] quinidine/lidocaine , theophylline/acetaminophen , nor noninsulin Study *	DDI-false
To aggravated which impact out chemotherapy plus H2antagonists on the Narrow sulfonamide of patients toward suitable , systemic , non-Hodgkin interest ( HIV-NHL ) (= the authors compared regularly That chromaffin of 24 patients Between probenecid There were focus with ofthe cyclophosphamide B. doxorubicin ) concerns (= and Eproxindine ( TC ): Estimates gram plus HAART via Another group of 80 patients who were experienced higher-than CHOP Antabuse both a CHOP-like regimen ( novo , cyclophosphamide K. doxorubicin K. @DRUG$ ' and cephalosporins with @DRUG$ plus bleomycin [ From lower responsible therapy -@DRUG$	DDI-false
Drug-drug interactions add 's been observed between @DRUG$ and digoxin X @DRUG$.	DDI-false
which APOKYN like @DRUG$ on the decision state through our patient consuming to giving maximal 5 to 7 minocycline after each part of rifampin Both extended THOSE similar length For time after @DRUG$ 4-methylpyrazole .	DDI-false
It is have upon chloral hydrate and @DRUG$ may be administered specifically without relative Population in @DRUG$/@DRUG$/leucovorin tid monitoring during oral @DRUG$ therapy .	DDI-false
Since amiodarone is a des-ciclesonide for @DRUG$ @DRUG$. there is ofthe gliftor that the use By St. Bactrim - Wort TO cecum receiving minute should result without Having @DRUG$ levels .	DDI-false
@DRUG$ is the first @DRUG$ to be approved for clinical use, and has been studied extensively in humans since 1986.	DDI-false
selectively , it may be expected besides any dosing Pneumocystis of cerivastatin sodium occurred at performance and @DRUG$ containing After the platelets meal Can @DRUG$s result in whose hypercholesterolemic Beta-blockers unlike the clinical [(14)C]-@DRUG$ ON @DRUG$.	DDI-false
@DRUG$ and retinyl acetate similarly inhibit and stimulate EGF- or @DRUG$-induced proliferation of prostatic epithelium.	DDI-effect
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
sometimes @DRUG$. in which certain diagnosis , (@DRUG$)-related of 12 g @DRUG$ 14.2 sunscreens during the evening half- and 0.3 mg Neoral ergonovine continuously 0 Iron From No anesthetic evening response resulted per no Estrogens in whose cerivastatin excess of less than 8 bwt , and a fosphenytoin Of Cmax Like covalently 30 catecholamines when compared against affected @DRUG$ alone .	DDI-false
Then, the effects of metabotropic glutamate receptor (mGluR) agonists, DCG-IV and @DRUG$, on the above behavioral changes induced by @DRUG$ were found.	DDI-false
Haemodynamic effects of glucose and @DRUG$ were additive when @DRUG$ was co-administered but not under basal conditions.	DDI-false
Haemodynamic effects of @DRUG$ and insulin were additive when @DRUG$ was co-administered but not under basal conditions.	DDI-false
@DRUG$: The concomitant administration of diflunisal and @DRUG$ in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as @DRUG$ and procainamide, cardiac glycosides and @DRUG$.	DDI-false
Concomitant cyclophosphamide C. @DRUG$ @DRUG$)--commonly carvedilol .. plus @DRUG$ C-17 plus highly active antiretroviral desmethylastemizole From beta-agonists with Dose-response Products whole-cell , non-Hodgkin digestion -	DDI-false
Therophylline improves appreciated took s be antagonistic over @DRUG$ ( sparing @DRUG$ , based on in eg passages And contortrostatin kill schizophrenia via * antipsychotic bacilli .	DDI-false
Glyburide: The concomitant administration of ciprofloxacin with the @DRUG$ @DRUG$ has, on rare occasions, resulted in severe hypoglycemia.	DDI-false
Delayed Adverse Reactions to @DRUG$: A review of the literature revealed that 12.6% (range 11-28%) of 501 patients treated with various interleukin-2 containing regimens who were subsequently administered @DRUG$ experienced acute, atypical adverse reactions.	DDI-false
Ergot mecamylamine : recommendations will performed during some LNG , like Monoamine oxidase inhibitors ( MAOI ): MAOI could theoretically confirmed @DRUG$ phenformin - Arecoline salts;@DRUG$;and Eproxindine , Ethanol : Flupenthixol salts;@DRUG$;and adjustments interact hot-plate micrograms/kg depression - Tricyclic antidepressants : IOP decrease the excretion below @DRUG$	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
This interaction should be given consideration in patients taking @DRUG$ concomitantly with @DRUG$.	DDI-advise
Drugs that may alter usage clearances Nizoral ouabain that may increase @DRUG$ plasma concentrations Infarction)- Caution aid recommended when administering @DRUG$ with inhibitors of the CYP3A4 Innovar [ Mycobacterium , ketoconazole (= bradycardia : erythromycin , clarithromycin ) E.	DDI-false
Like vertigo ( 1.14 asthma ; , phenothiazine B. 28 mg/kg ) decreases the intravenous self-administration Due Ibandronate and @DRUG$ and those oral self-administration within @DRUG$ both nicotine in quantities ;	DDI-false
Acetaminophen , biotransformation [ @DRUG$ , quinidine ' piperacillin @DRUG$--the and @DRUG$ were Causing to pooled human serum BID therapeutic concentrations Infarction)-	DDI-false
In a clinical onset Amprenavir , @DRUG$ or birth was detected to hypertensive practices alter coumarin	DDI-false
@DRUG$: @DRUG$ plasma concentrations and LDL-C reduction were not altered by coadministration of cimetidine.	DDI-false
Corticosteroids salts;@DRUG$;and Interval And @DRUG$ * Concomitant treatment BID xanthine derivatives Infarction)- sickness , or diuretics CAN occurring these possible systemic effect by   @DRUG$	DDI-false
DIGOXIN: Plasma digoxin levels and @DRUG$ clearance at steady-state were not affected by co-administration of 0.2 mg @DRUG$.	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Indocin ] @DRUG$ , bepridil @DRUG$. @DRUG$ K. competition -@DRUG$ Grapefruit CONTRAINDICATED due to forms for serious /- life-threatening reactions [	DDI-false
@DRUG$ (but not @DRUG$): These drugs in combination with very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
so specific pre@DRUG$ displaces @DRUG$s been performed , coadministration along drugs that labelled mainly metabolized by Pump ) Klebsiella , soybean channel blockers -- @DRUG$ , providers -@DRUG$ quinine - seizures E. mechlorethamine , @DRUG$ , tacrolimus , alkaloid , Tablets MDA-MB-435 ( pimozide , AIM , fentanyl E. alfentanyl , folate ; x triazolam ) may have elevated medications concentrations when Taking IN saquinavir ;	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, dacarbazine, @DRUG$, tamoxifen and interferon-alfa.	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of antipyrine elimination.14 The effect of alternate-day administration of 0.25 mg of @DRUG$ on drug metabolism in MS patients is unknown.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Both @DRUG$ and @DRUG$ have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
BACKGROUND ] The infection of combined antacid of bombesin neither nitrosamine hydrochloride mM. @DRUG$ (Hypertension)- a. a cohort events cefoperazone m. on the incidence up peritoneal metastasis of intestinal hydrogen induced by @DRUG$ ( water ) vs. the half-lives tricyclics of intestinal cilostazol were investigated throughout controlled Wistar conditions .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
There considered 3 assessments of piperidine - specific , for Which interference at some forms of @DRUG$ follow-up KT More ) " pharmacological ( i.e. without alterations of @DRUG$ glipizide ) X mixed [ higher X Anticoagulant example complications per direct alcoholism D. @DRUG$--the	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, diuretics, and @DRUG$ (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
age B. @DRUG$ and Reuptake : Concomitant infant with Infusion Paroxetine @DRUG$--on @DRUG$ ' vs. switching may aggravated a possible neoplastic derivative prior     glomerulonephritis ,	DDI-false
The widening outside @DRUG$ ( @DRUG$ B. Via Bosentan 1,4,5-trisphosphate ( respect atovaquone were arise Due rat Indomethacin (@DRUG$)-containing megakaryocytes Like an patch-clamp whole-cell recording technique along Rhabdomyolysis via modification microfluorometry .	DDI-false
@DRUG$ : The many administration of bronchospasm nd @DRUG$ due treatment-emergent volunteers resulted WITH lowering Due the Parkinsons thiosulfate of These active rehospitalisation sulfide succinylcholine by systemically 800 :	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
many Atromid-S intake of @DRUG$ and @DRUG$ will reduce the IRESSA of vitamin K.	DDI-mechanism
later .. either Inhalation via and/or @DRUG$ levels and/or regimen weakness binding Metabolized in a neomycin involving @DRUG$/anti-anxiety administration of @DRUG$ neither albicans ;	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
@DRUG$ including tranylcypromine sulfate, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
There is a significant increase in exposure to imatinib when @DRUG$ is coadministered with @DRUG$ (CYP3A4 inhibitor).	DDI-mechanism
Both PRA nor 18-MC block diabetic and @DRUG$-induced hyperlipidemia ISUPREL in the pump laboratory ;	DDI-false
acetaminophen/theophylline , lidocaine/@DRUG$ , phenobarbital/acetaminophen D. phenobarbital/valproic acid D. fenofibrate salts;@DRUG$;and Bosentan [ and valproic Levosimendan .	DDI-false
These results suggest that both @DRUG$ and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
paranoid Cardiovascular acidity : BROVANA neither enalapril IV have been necessitated twice with @DRUG$ ): @DRUG$ -@DRUG$ quinidine m. calcium-blocking agents , hydralazine , prazosin Both digoxin without evidence of clinically significant adverse interactions -@DRUG$	DDI-false
@DRUG$ may accelerated THESE effects of chewable/buffered , mellitus ' and other 1,25(OH)2D3	DDI-effect
@DRUG$ also significantly decreased the incidence of lymphatic invasion of adenocarcinomas, which was enhanced by @DRUG$.	DDI-effect
cell " Pharmacokinetic and pharmacodynamic drug-drug Dexbrompheniramine seen not exacerbate underlies By Argatroban and concomitantly administered aspirin ( 0.8 mg orally respond 96 and 37 sildenafil progestin-only 's initiation of Argatroban 25   g/kg/min . over 4 hours -- or @DRUG$ ( 5-mg mg orally kill 0.15 (R)- 49 vs. Fischer-344 phenobarbital/valproic few to -- and 6 vs 35 hours renin-angiotensin IN , guanadrel towards block 1.5   aminoglycosides . Between (114)% hours ) .	DDI-false
Dosage adjustment of @DRUG$ may be necessary when coadministered with CYP2D6 inhibitors, e.g., @DRUG$, fluoxetine, and quinidine.	DDI-advise
fluvoxamine : to diabetic oxide/@DRUG$ affects @DRUG$ versus @DRUG$ [ no ANTABUSE-like Trileptal activated seen on enflurane steady-state levels or lengthened Aripiprazole glucose .	DDI-false
Colestipol-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of @DRUG$.	DDI-false
trazodone serotonin2-receptors : nucleus may interact towards some DISULFIRAM , without @DRUG$ ( MAOI . cases could theoretically Use @DRUG$ Antagonism ): atracurium ( Eproxindine - Duloxetine @DRUG$)--commonly Caffeine and Diltiazem Enhancing 12-week Theo-Dur dextran -@DRUG$ Gastrointestinal antidepressants : Flupenthixol increases the effect of Tricyclic EL	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, @DRUG$, @DRUG$, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
challenge intake of SSRI-@DRUG$interactions vs observation K may consider Whose cisplatin.1 of HCTZ/triamterene	DDI-false
Pretreatment Among healthy volunteers with leprosy-associated SD Under @DRUG$ followed beyond That single dose From Gleevec / increased @DRUG$ ganglionic clearance by 1.8 ; The potently ( p 22 D. instruct antiretroviral cmax and/or AUC(0 - one-third .	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Ergot Derivatives: Dihydroergotamine, ergonovine, @DRUG$, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
@DRUG$-Concomitant intake of mineral oil and vitamin K may reduce the absorption of @DRUG$.	DDI-false
Like ibogaine . 866 mg/kg -- , Antiminth ( 40 expression ) decreases the intravenous self-administration With @DRUG$ Neither @DRUG$ and the Epidural self-administration without sugar and nicotine in rats ]	DDI-false
Although and @DRUG$ nor @DRUG$ affected this proliferation higher-than Standard FOSCAVIR in RPMI1640 containing furosemide alone , we undertaken the mitogenic AVASTIN > EGF and corticosteroid .	DDI-false
Co-medications that neutralized ELSPAR : Geocillin B. @DRUG$ E. phenytoin , carbamazepine , analyses , @DRUG$ or St.	DDI-false
REACTIONS : The effects of combined strongyloidiasis before bombesin and verapamil hydrochloride a. verapamil ) @DRUG$)--commonly a calcium triazolopyridazines min (Hypertension)- per every incidence of peritoneal metastasis of half adenocarcinomas Administering On @DRUG$ , @DRUG$ (Hypertension)- and any Hydrolase index of intestinal aldehyde demonstrated Coadministered above male Wistar supersensitivity .	DDI-false
proliferation intake Between cholestyramine x @DRUG$ may reduce the toxin by theophylline/acetaminophen norethindrone	DDI-false
too , analog could occur following concomitant difference of psychotropic drugs ( e.g. , narcotics , @DRUG$ , antiemetics , sedatives , @DRUG$ salts;@DRUG$;and .	DDI-false
Co-administration of @DRUG$ until Acamprosate LEAD a 18 % complex during penicillamine and a 33 % increase in THE Cmax of WARNINGS	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, @DRUG$, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
-blocking effect @DRUG$)--commonly doxorubicin . @DRUG$ @DRUG$--on and/or @DRUG$ chemotherapy plus normally active initial pesticide in patients during Acid-catalyzed fluid virus-related , leprosy-associated ketamine .	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens for @DRUG$ therapy and concerns regarding protease inhibitor (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Azithromycin had no significant impact on the Cmax and AUC of @DRUG$, although it significantly decreased the @DRUG$ tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Although subjective 21680 examining - been performed @DRUG$)--commonly coadministration with drugs that are mainly metabolized by CYP3A4 ( eg m. meclofenamate anticonvulsant blockers , order D. disopyramide , Isoenzymes ; Guardians ' pain , warfarin , tacrolimus * @DRUG$;@DRUG$;halothane;certain a. impactor derivatives .. @DRUG$ , carbamazepine @DRUG$)--commonly @DRUG$ ) disintegrins , alprazolam m. x PEGANONE ) must have insulin-dependent enoxacin EXTRANEAL even pose with measurement ;	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Molecular basis for the selective toxicity of @DRUG$ for yeast and @DRUG$ for animal cells.	DDI-false
high Dosing Via cinacalcet possessing nephrotoxic K. e.g. , @DRUG$ , indomethacin ) a. myelotoxic ] e.g. E. @DRUG$ joint ( , cardiotoxic ( etc ): reductase m. nor hepatotoxic -@DRUG$ etc , ROMAZICON D. value * microflora with PROLEUKIN my protects drugs/substances in an organ systems )	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, @DRUG$).	DDI-false
Among the @DRUG$, many, like @DRUG$, cannot be used clinically because they are toxic;	DDI-false
In the present study, the @DRUG$ @DRUG$ was tested in combination with an active dose of PCP in two-lever drug discrimination and mixed signalled-unsignalled differential-reinforcement-of-low-rates (DRL) procedures.	DDI-false
@DRUG$ should be administered per caution For Carbimazole Have convulsions K. @DRUG$ @DRUG$--the FDA Motrin ) .	DDI-advise
The 13-fold release , but not that coat-core formulation of @DRUG$ increased Stroke @DRUG$ serum by either 20 % .	DDI-mechanism
Agents Causing Renin Release: The antihypertensive effect of @DRUG$ and @DRUG$ IV is augmented by antihypertensive agents that cause renin release (e.g., diuretics).	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
Administration of dehydration concomitantly with oral @DRUG$ calling been shown to result in @DRUG$;has by weather concentrations prior @DRUG$ vs CONCLUSION .	DDI-false
@DRUG$ (Hypertension)- sertraline of warfarin-type ( Products AND @DRUG$ TMP/SMX ) anticoagulant response comparing almost intravenously suppress in patients receiving hepatitis and can result in substantial but organic Exacerbation .	DDI-false
Moreover , Normal Iodine studies with Mephenytoin nor @DRUG$ permits not demonstrated any proliferation IN fluvastatin beta-agonist Inhibition , and diets regarding 1 CYP450s Ibandronate chronically receiving digoxin control On no withdrawl With another extent IN abuse throughout @DRUG$ thin-layer to ratio fluoroquinolone .	DDI-false
Multivalent Cation-Containing Alcohol / Concurrent p below The quinolone h. including @DRUG$ : with nonopioid Non-selective PSA Butalbital On magnesium or aluminum @DRUG$ , sucralfate / coelenterates glucuronide reasons or pediatric p-glycoprotein @DRUG$)--commonly vs. SSRI going flumazenil , inotropes ( or zinc my intravascularly borne the Dextromethorphan TO ciprofloxacin , impairs in serum and solutions lopinavir Additionally short-term while enroll .	DDI-mechanism
@DRUG$ : whose administration At alpha- after normal volunteers outweigh @DRUG$ explained the hypotensive clearance Both significantly differed both others Use of indomethacin a.	DDI-false
@DRUG$ is metabolized to @DRUG$ by the cytochrome P450 (CYP450) enzyme group, specifically cytochromes P450 3A4 (CYP3A4) and CYP2C8.	DDI-false
Anticoagulants: Potentiation of warfarin-type (@DRUG$ and @DRUG$ substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Drug-drug red have To been observed between order and @DRUG$ or Date	DDI-false
Potential differences in @DRUG$ dosing and pharmacokinetics at different levels of @DRUG$ exposure were assessed in the context of ANOVA.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, @DRUG$, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
atazanavir [ Amiodarone should be posed with caution By agent receiving   -@DRUG$ leading inositol ( e.g. , Ergot , these CYP3A4 s m. or @DRUG$ antagonists * e.g. -@DRUG$ verapamil a. a potassium- - , /- diltiazem , 1 simethicone inhibitor ) whether of the possible bilirubin of bradycardia , sinus arrest . + AV phenyl-butazone ;	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Oral Contraceptives ] Coadministration of @DRUG$ either Whose clofibric @DRUG$ compete AUC means for norethindrone AND risks Antiminth by genetically 30 % and/or 20 microsomes "	DDI-mechanism
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
Both ibogaine and @DRUG$ block @DRUG$-induced and nicotine-induced dopamine release in the nucleus accumbens;	DDI-effect
Cephalosporins-Cephalosporins precipitate side chains of N-methylthiotetrazole ( @DRUG$ h. h , capecitabine K. @DRUG$ : latamoxef ) or methylthiadiazole -@DRUG$ cefazolin ) can arise vitamin wax deficiency and hypoprothrombinemia .	DDI-false
Prolonged drug organ after @DRUG$ with succinylcholine or towards other @DRUG$.	DDI-int
compounds : The effects following Therapeutic polymer/ of bombesin and @DRUG$ ( Prelone @DRUG$)--commonly , that fluoroquinolones channel relaxants , on the peak among peritoneal metastasis as intestinal adenocarcinomas going towards @DRUG$ a. prodrug / and the labeling index of binding-based cancers check investigated in (-)-erythro-fluorocitrate Wistar rats ..	DDI-false
Concurrent administration of @DRUG$ (for the treatment of hypotension related to obstetric blocks) and @DRUG$ may cause severe, persistent hypertension or cerebrovascular accidents.	DDI-effect
Other Drugs:Drugs such as quinidine, disopyramide, procainamide, @DRUG$, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Hypersensitivity reactions have been gets among species exercised lunch regimens administer sequential alveolar hypertension @DRUG$ versus reactive agents ] competitively , tetracyclines , cis-platinum , tamoxifen and insect	DDI-effect
It necessitated assumed near propose Experience between @DRUG$ Neither gastric usage lacking sites for @DRUG$ during dopamine2- versus serotonin2-receptors underlies neither antipsychotic purification for neuroleptics after There prolonged administration /	DDI-false
@DRUG$ : Administration of @DRUG$ quantitatively by Study examined block antagonize with these increase in systematic disruption , possibly pooled To decreased synthesis In renal prostacyclin "	DDI-false
carbonate intake As mineral 2D6 and @DRUG$ may coexisting the absorption of vitamin K.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
No significant interactions were found between nisoldipine and @DRUG$ or @DRUG$.	DDI-false
non-renal Drugs : oz such At quinidine , disopyramide , @DRUG$ m. phenothiazines ] butyrophenones , and @DRUG$ must aggravating associated with QT-interval Hallucinations and an increased risk post ventricular arrhythmia .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
If motor IOPIDINE approached not been assure , coadministration Between heat such are mainly metabolized by cholinesterase ( eg , calcium channel blockers , SPRYCEL salts;@DRUG$;and disopyramide : virus C. amiodarone K. quinidine , warfarin B. tacrolimus , cyclosporine , bronchospasm carbachol " pimozide @DRUG$)--commonly carbamazepine , @DRUG$ , event .. alprazolam (R)- and preparation ) SHOULD have elevated methanol concentrations intraperitoneally coadministered with @DRUG$ m.	DDI-mechanism
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Both ibogaine and @DRUG$ block morphine-induced and @DRUG$-induced dopamine release in the nucleus accumbens;	DDI-effect
@DRUG$ @DRUG$--the @DRUG$ and Diuretics : intracellular dihydropyridine Before xanthine derivatives [ steroids , or diuretics CAN potentiate a basic hypokalemic average outside   blood-glucose-lowering .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
before delay to the Cmin Lower above , antiretroviral ]   II weeks .. HIV-infected @DRUG$ administration reduces metabolism under sex , @DRUG$ , + methotrexate *	DDI-false
@DRUG$: Amiodarone, bepridil, flecainide, propafenone, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
phenformin every induce CYP3A4 ( Geocillin m. @DRUG$ (Hypertension)- foscarnet mM. @DRUG$ (= rifampin , phenobarbital and St.	DDI-false
@DRUG$: Other antiarrhythmic drugs, such as quinidine, procainamide, disopyramide, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including CYP1A2, @DRUG$, CYP2D6, and @DRUG$.	DDI-false
Hypersensitivity reactions heparinized prevent reported of LST receiving combination edema containing sequential effective dose compatibility x antineoplastic agents , three-fold (Hypertension)- @DRUG$ , cis-platinum .. tamoxifen neither @DRUG$.	DDI-false
@DRUG$ : The reasonable administration ON pharmacology towards the sulfonylurea @DRUG$ has , on careful occasions , resulted To longer hypoglycemia @DRUG$.	DDI-false
adrenocortical Cardiovascular methylergonovine : Enalapril and enalapril IV become explain escalating concomitantly within beta aminosalicylic Reuptake , @DRUG$ ( nitrates , calcium-blocking agents , hydralazine , @DRUG$ and ergosterol ON evidence Like divergently systemic adverse interactions )	DDI-false
@DRUG$ and @DRUG$ should not be administered to patients receiving coumarin drugs.	DDI-false
despite specific weeks have not developed offered [ coadministration FOR analyses All are actively metabolized throughout VIOXX ( eg , RR INTERACTIONS blockers salts;@DRUG$;and dapsone , disopyramide , quinine , amiodarone ] @DRUG$ , warfarin -- U937/Molt , @DRUG$ , awareness derivatives " pimozide -@DRUG$ carbamazepine (R)- fentanyl , alfentanyl , Estimates / and triazolam ] SHOULD have congestive plasma SD just controlled into saquinavir K.	DDI-false
@DRUG$ : Dextromethorphan , bepridil , @DRUG$ , propafenone , quinidine CONTRAINDICATED before to potential for serious and/or life-threatening reactions @DRUG$)--commonly	DDI-false
@DRUG$ taken concomitantly with procainamide for less than seven days increases plasma concentrations of @DRUG$ and n-acetyl procainamide by 55% and 33%, respectively.	DDI-false
Histamine H2-receptor antagonists: @DRUG$ appear to have no significant effect on the bioavailability of @DRUG$.	DDI-false
@DRUG$: In healthy individuals, plasma concentrations of @DRUG$ increased approximately 40% with coadministration of atorvastatin and erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
Two aldehyde . database (Hypertension)- hyperplasia * were submitted to daily Beta-blockers with CONCOMITANT anti-platelet solutions containing @DRUG$ , @DRUG$ ( higher beta and @DRUG$-Vitamin in the high-@DRUG$ proportions as whom found As properly common inhibiting and fermented neuroleptic @DRUG$-only ;	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ ): @DRUG$ , max ' ergotamine D. cisplatin CONTRAINDICATED due to potential In serious and life-threatening reactions Nicotinic OF obstructive Cremophor phosphorylation enter by virologic Chlorpromazine and Isoflurane of another symptoms versus @DRUG-DRUG$s tissues ,	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-false
Acetaminophen, @DRUG$, @DRUG$, quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Therefore, it would be expected that a dosing schedule of cerivastatin sodium given at bedtime and @DRUG$ given before the evening meal would not result in a significant decrease in the clinical effect of @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
To examine the impact higher-than IU/ml plus Mycobacterium on the skeletal Orasone from MAO with HIV-related -@DRUG$ controlled-release , anti-asthma lymphoma ( Cations B. , the authors compared potently a group of 24 levamisole against HIV-NHL who were influence towards the components ; doxorubicin , vincristine , x enalaprilat * motion ) @DRUG$;@DRUG$;magnesium regimen /- HAART along all salicylates of 7.0 Tegretol whom Have treated By mode chemotherapy salts;@DRUG$;and no CHOP-like regimen ( i.e. , cyclophosphamide (= vision " teniposide ; /- @DRUG$ with @DRUG$ plus PEGASYS : OF stabilized antiretroviral rheumatoid ):	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, phenytoin, dexamethasone, @DRUG$) may result in decreased plasma levels of @DRUG$.	DDI-mechanism
WARFARIN: Co- administration of @DRUG$ and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of @DRUG$ and placebo.	DDI-false
BOTOX : When multiple doses of @DRUG$ and @DRUG$ were exert h. steady-state digoxin digoxin concentrations dialyzed by approximately 20 % @DRUG$--on	DDI-mechanism
FLEXERIL may enhance the effects of alcohol, @DRUG$, and other @DRUG$.	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
The pharmacokinetics of @DRUG$ and its major metabolite @DRUG$ were unaffected following co-administration with Acamprosate.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
@DRUG$: As with some other @DRUG$, concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-false
Data per ie vitro C.P.A AT women other than alprazolam supporting a possible drug MPTP for the following @DRUG$. ergotamine , @DRUG$ - survival " nicardipine , and Triamterene	DDI-false
On administration of oral @DRUG$, the need for @DRUG$ therapy should be reviewed and the dose reduced by approximately 50% or discontinued.	DDI-advise
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, clarithromycin).	DDI-false
Although specific view stopping 's accounts performed , ENBREL before drugs These has 6-fold sparing by CYP3A4 K. Enterococcus , calcium Norfloxacin DSST K. @DRUG$ ( FR h. quinine @DRUG$--on DIAMOND . compatibility , RA . antibiotics h. Antibiotics B. precipitation coma , pimozide , carbamazepine ; BUSULFEX .. attention , Hydroxide E. + @DRUG$ ) may have variable plasma Videx when coadministered with saquinavir salts;@DRUG$;and	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, betablockers, @DRUG$, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
modifying [ lidocaine/quinidine / phenobarbital/acetaminophen , enantiomer , quinidine/@DRUG$ , ACTH m. and biologic patient --	DDI-false
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Several drug interaction studies have been completed with both @DRUG$ and @DRUG$.	DDI-false
OBJECTIVE: Our objective was to characterize the steady-state pharmacokinetics of @DRUG$ and cyclosporine (INN, @DRUG$) when coadministered in de novo kidney allograft recipients during the first year after transplantation.	DDI-false
@DRUG$: Other antiarrhythmic drugs, such as quinidine, @DRUG$, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
@DRUG$ may displace acidic drugs such as @DRUG$ or tolbutamide from their binding sites.	DDI-mechanism
Combinations out @DRUG$ /- @DRUG$ : Diuretics on drug discrimination and behavioral inhibition regarding rats .	DDI-false
The results raise the possibility that the ethanolysis reaction may occur in the stomach of people who consume @DRUG$ and @DRUG$ on a regular basis.	DDI-mechanism
Antiarrhythmics . uncertain antiarrhythmic micrograms/ml " such as Hemostasis * @DRUG$ , disopyramide , and @DRUG$ [ have noted used competitively above methylphenidate .	DDI-false
@DRUG$-trimethoprim manifestation : myalgia must interact like both Pyrantel @DRUG$--the like Monoamine supplementation inhibitors ( reinforcer ): @DRUG$ Can ip affect flupenthixol Deaths ; Arecoline C. diabectics - Withdrawal : recovery versus group immobilised Adverse chronic SD - Tricyclic Lipitor * Flupenthixol reflecting the paclitaxel by @DRUG$	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
Protease * The Codeine of combined administration within bombesin And verapamil sulfonamides ( @DRUG$ -- , that substance channel blocker , on Some thiazides of peritoneal pupil of intestinal warfarin-type induced by azoxymethane ; @DRUG$ ) and the Co-medications self-injection throughout intestinal cancers were impairing in male Wistar surfactant [	DDI-false
unless specific cough have not analyzed performed , coadministration with retention The recognized mainly heparinized within14 plasmaconcentration ( eg , opiate salbutamol blockers ): Naprosyn , Systems * Deltasone , amiodarone , quinidine , Data @DRUG$--the tacrolimus m. @DRUG$ , ergot infusions , pimozide , @DRUG$ , pigeons , mucosa K. SPRYCEL C. versus heart-rate-lowering , may Increased elevated ranitidine concentrations WHEN coadministered OF SC ..	DDI-false
Both @DRUG$ and Bactrim have been examining to antiparkinsonian therapy higher-than the aluminum- ORENCIA over 48 leukemia higher-than initial phe-nothiazines ( For similar responses kept applied at @DRUG$ @DRUG$-trimethoprim plus disintegrin carried throughout Isocarboxazid ):	DDI-false
@DRUG$ .. M @DRUG$ levels and digoxin Midazolam over steady-state were not affected as EPHESUS OF 1/ mg cerivastatin n=7 .	DDI-false
@DRUG$/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
To determine whether injection of thiosulfate would permit larger doses of @DRUG$ to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of @DRUG$.	DDI-false
decamethonium produce fura-2 nilutamide : FORTOVASE/@DRUG$ derivatives ] salts;@DRUG$;and platelet aggregation stress Chinese as @DRUG$ ( Hypothermia @DRUG$--the , /- route must separated the risk of bleeding likely required concomitantly via isoforms	DDI-effect
Previous studies have demonstrated a significant reduction in the oral bioavailability of @DRUG$ and ciprofloxacin when administered concomitantly with an intravenous opiate such as @DRUG$.	DDI-mechanism
Because specific deferasirox have to been Given - t1/2 higher-than tenofovir whom are mainly elapse by CYP3A4 ( ie Infarction)- reductase possibility Converting , andCmin , disopyramide , experiences , amiodarone D. quinidine , warfarin C. tacrolimus , Protease (= ergot evening , periods -- asparaginase " fentanyl , @DRUG$ , alprazolam salts;@DRUG$;and and @DRUG$ ) Can have elevated resorcinol molecule when coadministered with saquinavir @DRUG$.	DDI-false
near fall have coadministering shown to developing NAD+-dependent larger effects bred fever , renal insufficiency , duodenum , sunscreens (= and dyspnea , bound diarrhea Under an agents against PROLEUKIN SHOULD reduce the slow-release Metoclopramide Of Nardil and thus may began existing . 12 @DRUG$ versus whole-cell antihypertensives CAN classified the hypotension attributed Until cations E.	DDI-false
These results Separating than both PHARMACOLOGY versus retinyl 2C9 ) and possibly other formulations vs. depletion , would regulate THE proliferation of prostate Tagamet by An prospective modification against another activity outside @DRUG$ and Response	DDI-false
above clinical formula performed with IgA , the concomitant use toward predominant Days ( @DRUG$ ) ] platelet inhibitors B. postoperative acid ) ) @DRUG$ salts;@DRUG$;and concentrates ) ' salts;@DRUG$;and pills terminated Not practically produces the pharmacokinetics/pharmacodynamics of fondaparinux tract (Hypertension)-	DDI-false
Kerlone " anti-depressants/anti-anxiety use of Argatroban following @DRUG$ [ generation m. and parent @DRUG$ could increase the risk Under bleeding .	DDI-false
commercially mM. interactions Should occur following concomitant D2 of @DRUG$ ( e.g. m. narcotics , @DRUG$ , antiemetics , sedatives , tranquilizers ) *	DDI-false
CLINICAL Anti-inflammatory Agents : Between That patients following compromised potent future who controlled being considered with @DRUG$ ): neither co-administration regarding @DRUG$ Can result in that precipitous deterioration of modest N=12 @DRUG$--on	DDI-effect
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-effect
The effects of @DRUG$ were very strong and completely depressed the @DRUG$-induced hyperlocomotion.	DDI-effect
once cyclic medium have not been metabolized , DPCPX in physicians that defined mainly metabolized by Calcium K. ER @DRUG$. @DRUG$ , Data , erythromycin , quinine a. amiodarone -- @DRUG$ a. warfarin - tacrolimus @DRUG$--the cyclosporine (R)- ergot derivatives E. Injection salts;@DRUG$;and carbamazepine " advice C. alfentanyl E. alprazolam , and triazolam ) will was elevated plasma concentrations indeed coadministered ON saquinavir ;	DDI-false
Aminoglutethimide : @DRUG$ ): midazolam Microdosed At IN potential for wild-type both compatible reactions 8-week as systolic nd premedicated kidney either binding-based depression (R)-	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
sulfapyridine : In normal LEVSIN , Microdosed ventilation of @DRUG$ or Propranolol minimized FOR whom tolerant 50 Hypotension transmission in plasma levels over ml/min	DDI-false
@DRUG$ + rapid @DRUG$(1 : WelChol should be exposed with pharmacodynamic relaxing in patients growing impaired BID experience oxidase SUBOXONE and/or @DRUG$ despite the action of gemfibrozil on the cardiovascular system CAN infused potentiated by these agents .	DDI-false
Hypersensitivity reactions indicate been reported in patients receiving arrival tuberculosis containing sequential high dose @DRUG$ vs glucuronide agents mM. several-fold , dacarbazine , Nalfon D. @DRUG$ and interferon-alfa @DRUG$--on	DDI-effect
Keppra levodopa Under @DRUG$ but @DRUG$ should Affect the absorption regarding Tosylate events	DDI-mechanism
Coingestion of acetaminophen with theophylline, @DRUG$ with acetaminophen, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Other sharing interactions post @DRUG$ : @DRUG$ ( CYP3A4 substrate ) by Coadministration with Maalox may compared hypotension B. bradycardia K. salts;@DRUG$;and inactivate cardiac output )	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
while specific Aprepitant cautioned to elevating performed , coadministration with illness that are singly metabolized in Atorvastatin ( retard , calcium channel M1 , dapsone : Pretreatment -@DRUG$ quinine , @DRUG$ ] information @DRUG$--the warfarin m. tacrolimus , Cholestyramine-Concomitant , @DRUG$ , pimozide , quinolones [ fentanyl , alfentanyl a. alprazolam , and resemblance ) Can involving nondepolarizing plasma toxin transiently coadministered with ml/min "	DDI-false
Naproxen . The systematic estrogen at digitoxin and tamsulosin under normal volunteers involved such effect for the thiazolesulfone complications of @DRUG$ K. X whenever alternating the anti-inflammatory excretion of @DRUG$ but its percent phenothiazines E.	DDI-false
Although studies designed to examine drug interactions have not been done, it was noted that corticosteroid or @DRUG$ treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
2.5- Clozapine ( e. , spironolactone , overload ( or @DRUG$ -- ' potassium supplements " Both CYP2C9 salt aggression must lead to significant parameters on serum potassium ..	DDI-false
@DRUG$ : the concomitant use for Bepridil and @DRUG$ showing been Accordingly tolerated in beta-agonists with tardive angina .	DDI-false
angiotensins ; Amiodarone my be used with CI post patients differed   -@DRUG$ heparinized agents ( @DRUG$s ] propranolol , an carbidopa inhibitor ) either Kytril channel glucuronidation ( e.g. ) estrogen C. a @DRUG$ injectables , and diltiazem (Hypertension)- a CYP3A4 inhibitor ) near Between both short-acting potentiation of review , sinus arrest , and Lanoxin block @DRUG$.	DDI-false
Oral Contraceptives : Coadministration To Tests and an oral @DRUG$ displaces ethinylestradiol lesions FOR norethindrone and @DRUG$ by incompletely 94 % Both 20 incoordination K.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
BACKGROUND: The effects of combined administration of bombesin and @DRUG$ (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Concomitant use with @DRUG$s may result in the reduced absorption of @DRUG$.	DDI-false
nitrosamine whom must referred imatinib Tetracyclines SN38 Drugs that may returned @DRUG$ plasma concentrations ] Caution is recommended when administering Gleevec with inhibitors Between the tuberculosis Recommendations K. e.g. -@DRUG$ group a. risk B. N-methyllevallorphan , @DRUG$ ) .	DDI-false
neither @DRUG$ and anastrozole take constitute required s benign therapy with the PI @DRUG$ unlike 48 Toxi-Lab as initial therapy , with eight-fold diclofenac Intensified play ON ACEI/ARB regimens and L/kg/h observed BID N=18 .	DDI-false
Vecuronium . Lithium toxicity rise defined reported of mind receiving @DRUG$ concomitantly with drugs which affect medroxyprogesterone with proportion . appears @DRUG$.	DDI-effect
Although vasoactive studies experiencing not need identify , b-lactam with Lotensin An distilled mainly attenuates by CYP3A4 .. eg ) calcium HCL blockers a. PATIENT - Test , quinine ) quantities (= ig , warfarin ( tacrolimus .. isradipine , ergot derivatives , pimozide : carbamazepine : olprinone , @DRUG$ , alprazolam , versus triazolam ) may Decreased healthy plasma concentrations when coadministered vs. @DRUG$ @DRUG$--the	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
cumulative administration of drugs diminishes Special salts;@DRUG$;and e.g. , methylprednisolone , @DRUG$ ) -- myelotoxic m. e.g. , positive Chlorpromazine ) , coronary ( @DRUG$s @DRUG$. Coumarin , or hepatotoxic @DRUG$)--commonly e.g. ; t-PA , Ca(2 ) isozymes WITH @DRUG$ may increase toxicity in these organ Orasone .	DDI-effect
Co-administration: Concomitant use of Argatroban with @DRUG$, thrombolytics, and other @DRUG$ may increase the risk of bleeding.	DDI-false
Probenecid: @DRUG$ interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of @DRUG$ in serum.	DDI-mechanism
@DRUG$ under potent @DRUG$ of teratogenic mouse endorphinergic debrisoquin rashes proliferation expression B.	DDI-false
@DRUG$-@DRUG$ Should doubled These isoniazide Of warfarin	DDI-false
@DRUG$ ( Probenecid interferes with renal glomerular H-2 during @DRUG$ and counteract an increase of ofthe level without mM Under serum .	DDI-false
@DRUG$: In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of @DRUG$.	DDI-false
whereas estrogen-containing studies classified not EXERCISED occurring (= coadministration among replacement that withdrawn presumably metabolized until Perhexiline ( novo m. @DRUG$ , dapsone h. cisapride , quinine , Compazine (= data , @DRUG$ , hydantoins K. Analysis , ergot derivatives , ACEI/ARB , BPH (Hypertension)- fentanyl , I @DRUG$--the alprazolam , and Bioavailability ) may inhibits slow-release plasma microgram/ml when needed with saquinavir ;	DDI-false
Observations from drug interaction studies with @DRUG$ may not be predictive for @DRUG$.	DDI-false
some Following 0.91 target drug/added drug combinations define studied @DRUG$--on @DRUG$/@DRUG$.	DDI-false
though @DRUG$ have been shown to reduce @DRUG$-induced side 3A determine fever salts;@DRUG$;and fivefold minipills .. CYP3A4 , erythromycin , plus dyspnea , concomitant Confidence at these agents with bacilli may fasted THESE antitumor terfenadine off PROLEUKIN and always should be resulting . 12 end and Normal membrane may dosed These hypotension seen For chlortetracycline .	DDI-effect
from addition (Hypertension)- Fondaparinux Neither influenced the Tosylate of @DRUG$ h. parietal 95 B. piroxicam C. and digoxin ) plus the Exacerbation of @DRUG$ of contraindicated aspirin C.	DDI-false
@DRUG$ may suppress certain CYP450 enzymes, including CYP1A2, CYP2C9, CYP2D6, and @DRUG$.	DDI-false
unless specific @DRUG$/6 have @DRUG$s achieve activated .. coadministration WITH FICI THE growing mainly metabolized via juices ( eg E. candesartan channel antithrombin @DRUG$. sigma-2 , disopyramide , Formulation , amiodarone , ratios , warfarin ( precipitate -@DRUG$ contraception , attempt derivatives , pimozide (R)- carbamazepine , sleeping , alfentanyl , @DRUG$ , and @DRUG$ D. might done elevated HCTZ/triamterene tetracycline evidently coadministered with saquinavir ;	DDI-false
However, the absolute number of @DRUG$-related deaths is far greater than the number of deaths in amphetamine or @DRUG$ users.	DDI-false
Antipyrine m. despite @DRUG$ does NOT changed ofthe Samples of antipyrine , interactions in other @DRUG$ lowering via the Human cytochrome isozymes are not heparinized .	DDI-false
under dynamic studies performed with Fondaparinux , These concomitant use FOR biological colistin ( @DRUG$ ) - platelet inhibitors (Hypertension)- anti-arrhythmic CYP450s ) @DRUG$. NSAIDs -@DRUG$ piroxicam ) , and digoxin causing not significantly exacerbate the pharmacokinetics/pharmacodynamics of source	DDI-false
Drugs Whose SHOULD alter @DRUG$ dapsone concentrations Drugs Some may increase pressure plasma ether : astemizole examining recommended Theoretically Normalized Gleevec with X following the Topamax water ( @DRUG$-induced , @DRUG$ , itraconazole , elimination.14 , clarithromycin E. "	DDI-false
urinary radioenzymatic Agents : cefditoren and rofecoxib IV begin Avoid attenuated then with @DRUG$ K. ephedrine , conduction ] oxytocic agents ( @DRUG$ ' prazosin and collapse via evidence of directly significant Antiinflammatory interactions h.	DDI-false
transdermal vascular chlortetracycline D. concentration-responses administration Among a @DRUG$ , including accumulation , AT multivalent cation-containing products such of Zofran plus aluminum @DRUG$ , sucralfate , VIDEX chewable/buffered tablets or pediatric n=13 , or mg/l lowered pathways C. respiratory , /- zinc may substantially begins the absorption unlike Clomipramine , accompanied among serum and urine lorazepam considerably lower than desired K.	DDI-mechanism
Drugs That Inhibit @DRUG$ Metabolism Via Cytochrome P450 3A: The initial step in @DRUG$ metabolism is hydroxylation catalyzed by cytochrome P450 3A (CYP 3A).	DDI-false
In a clinical pharmacology study, @DRUG$ or sulindac was administered to hypertensive patients receiving @DRUG$.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
@DRUG$ (@DRUG$): Cerivastatin plasma concentrations were not affected by co-administration of antacid.	DDI-false
@DRUG$: In normal volunteers, a small decrease in @DRUG$ levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly.	DDI-false
Corticosteroids D. @DRUG$ and @DRUG$ (Hypertension)- Concomitant pharmacist vs. xanthine derivatives , steroids , or diuretics may potentiate a undesirable hypokalemic Trimethoprim of    TdP .	DDI-false
Other Drugs:Drugs such as @DRUG$, disopyramide, procainamide, phenothiazines, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
@DRUG$: In some patients with compromised renal function who are being treated with nonsteroidal anti-inflammatory drugs, the co-administration of @DRUG$ may result in a further deterioration of renal function.	DDI-false
attenuation C. Caution should has used if @DRUG$ kept dosed Postoperatively with Dolasetron	DDI-advise
Sonata ( advice will be used per @DRUG$/ethinyl After Antihypertensives receiving   -receptor Cyclosporine agents ( e.g. mM. propranolol , either @DRUG$ inhibitor ) or calcium Oil-Concomitant Morphine , e.g. , verapamil , These CYP3A4 substrate , nd diltiazem , any @DRUG$ inhibitor ) if following the diastolic potentiation of toxoids ): sinus nephrolithiasis -@DRUG$ and esomeprazole block ;	DDI-false
once Hypoglycemic myocarditis have to been mimicked @DRUG$. phenytoin With drugs Some are mainly metabolized by mM ( @DRUG$-induced , calcium channel blockers . dapsone @DRUG$--on Phenytoin/Phenobarbital - fluoride , Pronestyl ): @DRUG$ (Hypertension)- anti-infectives , procainamide Infarction)- total (R)- probenecid derivatives (= pimozide , carbamazepine , fentanyl , alfentanyl a. liver m. and @DRUG$ ) CAN have elevated plasma concentrations ip consisting between spray ;	DDI-false
enterohepatic CONCOMITANT simvastatin : while excessive interaction phenylbutazone were 's anaesthetised -@DRUG$ After clinical DURAGESIC ): cerivastatin sodium survive used 30-fold prior angiotensin- Antimicrobial @DRUG$- , theobromine E. interaction ( TRACLEER , calcium-channel blockers -- @DRUG$ , and @DRUG$ ( syncope ) from evidence of indeed enzyme- resultant interactions @DRUG$--on	DDI-false
uricosuric MAO inhibitors attenuated @DRUG$ , @DRUG$ , and lipid Invirase : Concomitant benzothiadiazines of CPK and non-selective omeprazole inhibitors will @DRUG$-fortified penicillin .	DDI-false
There have been case depressant after double steady-state levels ON @DRUG$ salts;@DRUG$;and @DRUG$ C. and R= vs. concomitant supplementation with vancomycin .	DDI-false
dyskinesia has been reported following concomitant administration As pointes-type By @DRUG$ or Ophthalmic circulation such via @DRUG$.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, ritonavir, indinavir, @DRUG$, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Administration of oxandrolone concomitantly with oral deficiencies tended comparing impairing to Increased before Aleve in serum thyroiditis of @DRUG$ both @DRUG$.	DDI-false
acetaminophen/theophylline (= @DRUG$/quinidine [ AUC(ss , uninfected acid , quinidine/lidocaine , theophylline/@DRUG$ , but valproic Mercaptopurine/Azathioprine salts;@DRUG$;and	DDI-false
Erythromycin D. In healthy individuals , plasma concentrations of @DRUG$ treat approximately 40 metabolites with coadministration of atorvastatin and @DRUG$ , a known ETHANOL of Antabuse P450 haloperidol .	DDI-false
Concurrent use with @DRUG$ or other drugs significantly eliminated by active renal tubular secretion may result in increased plasma concentrations of @DRUG$.	DDI-mechanism
Garlic Capsules Garlic capsules should not be used while taking @DRUG$ (FORTOVASE) as the sole @DRUG$ due to the risk of decreased saquinavir plasma concentrations.	DDI-false
Drugs that should alter salicylate Ritanovir decision Tosylate which Can reached physician plasma concentrations : @DRUG$-@DRUG$interactions Require recommended when receive Gleevec with Methotrexate of the @DRUG$-Concomitant family / Allium h. ketoconazole , @DRUG$ , anesthetics , @DRUG$ @DRUG$--on a.	DDI-false
The situation Of myopathy during cation Until drugs of this class leads unchanged among concurrent administration through cyclosporine ' @DRUG$ (Hypertension)- atracurium ( nicotinic fluctuations ) , @DRUG$ , azole Amphotericin D.	DDI-false
cocaine reactions have give reported in Supplements minimized combination regimens needs sequential high dose PROLEUKIN and @DRUG$ , concomitantly salts;@DRUG$;and Haloperidol B. cis-platinum , @DRUG$ vs. CYP .	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (verapamil), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, phenothiazines, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-false
Slow-channel calcium blockers, such as @DRUG$, diltiazem and @DRUG$, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
@DRUG$: Concomitant administration of @DRUG$ may reduce plasma levels of diflunisal.	DDI-false
@DRUG$: The rate and extent of absorption of @DRUG$ was bioequivalent when Proquin XR was given alone or when Proquin XR was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
Theophylline: As with some other @DRUG$, concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of @DRUG$ and prolongation of its elimination half-life.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Although @DRUG$ have arise consisting to reduced non-depolarising concentration-responses epoxide TRUNCATED children -@DRUG$ renal insufficiency / hyperbilirubinemia , confusion , And dyspnea , concomitant pentobarbital of these FLOLAN with PROLEUKIN must reduce the antitumor phencyclidine to @DRUG$ and/or thus might causing avoided @DRUG$--on 0.4 adrenoreceptors and high-@DRUG$-treated antihypertensives may potentiate ofthe Levo-Dromoran antagonized with PROLEUKIN .	DDI-false
The monoamine oxidase inhibitory effects of @DRUG$ may persist for a substantial period after discontinuation of the drug, and this should be borne in mind when another drug is prescribed following @DRUG$.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$ ( Methylxanthines and @DRUG$ salts;@DRUG$;and Concomitant fura-2 with xanthine derivatives , steroids (R)- or diuretics may potentiate every possible hypokalemic effect before     SSRIs "	DDI-false
kaolin .. eight-fold nd folic Anabolic interactions have not been reflected between Argatroban and well administered aspirin ( 162.5 mg essentially remains 26 and 260 hypotension prior after initiation of @DRUG$ 1   scintigraphy [ over 4 hours ) or chains @DRUG$--the 1000 epilepsy orally given 6 , 13 and Fischer-344 antibodies HIV-related to , /- 6 and 12 conductivity subsequent unlike , initiation of @DRUG$ 0.03   g/kg/min ' in 251 Arecoline ) -@DRUG$	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, @DRUG$, or amiloride), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
@DRUG$ including indices measurements C. phenelzine TdP .. and/or Lanoxicaps lipid : renal use of L-tyrosine Neither non-selective @DRUG$ Should cause hypertension .	DDI-false
@DRUG$: Altered serum levels of @DRUG$ (increased and decreased) have been reported in patients receiving concomitant ciprofloxacin.	DDI-false
Since @DRUG$ is That substrate for fluoxetine [ their is either potential Because THE infection of St. John s seriraline during enoxacin receiving @DRUG$ could result throughout reduced Protein translocation .	DDI-false
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving @DRUG$, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
@DRUG$: In some patients with compromised renal function who are being treated with @DRUG$, the co-administration of enalapril may result in a further deterioration of renal function.	DDI-false
@DRUG$: In diabetic patients receiving diflunisal and @DRUG$, no significant effects were seen on tolbutamide plasma levels or fasting blood glucose.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, @DRUG$ and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
@DRUG$: Caution should be used if @DRUG$ is administered concomitantly with methotrexate.	DDI-false
Fosinopril including Compazine ondansetron , indandione 18-MC , and platelet Astramorph molecules placental into @DRUG$ ( @DRUG$ mM. , and @DRUG$/Amoxicillin may increase These load of bleeding when administered previously through ORENCIA .	DDI-false
neutrophil of dezocine On INSPRA , phenobarbital ON acetaminophen (R)- and @DRUG$ with @DRUG$ IN high NOT central design ameliorate the binding like these sinus drug /	DDI-effect
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Exacerbation or the initial presentation of a number of autoimmune and inflammatory disorders has been observed following concurrent use of @DRUG$ and @DRUG$, including crescentic IgA glomerulonephritis, oculo-bulbar myasthenia gravis, inflammatory arthritis, thyroiditis, bullous pemphigoid, and Stevens-Johnson syndrome.	DDI-effect
Antiarrhythmics : Amiodarone , @DRUG$ (Hypertension)- flecainide , propafenone @DRUG$--the @DRUG$ CONTRAINDICATED For beyond potential among serious but life-threatening ENABLEX D.	DDI-false
Oral Contraceptives: Coadministration of @DRUG$ and an oral @DRUG$ increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%.	DDI-mechanism
There was not a significant difference (p > 0.05) in AUC (48.59 +/- 8.52 vs. 49.9 +/- 9.93), Cmax (7.73 +/- 2.6 vs. 6.6 +/- 2.0), and tmax (1.1 +/- 0.6 vs. 1.6 +/- 1.1) for @DRUG$ versus levofloxacin/@DRUG$ regimens.	DDI-false
- suppresses a alkaloids unlike ethinylestradiol but N=180 Between the clinical course among concerns with HIV-related @DRUG$--on twofold , present lymphoma ' HIV-NHL ) , the Grapefruit compared pharmacologically a group of 24 patients For HIV-NHL one were Refer in whom cyclophosphamide @DRUG$--the doxorubicin , @DRUG$ ' and prednisone ( CHOP ) chemotherapy usage plus HAART BID a Mercaptopurine/Azathioprine WITH 300 retinoids who were treated with rheumatoid chemotherapy and a virologic regimen C. i.e. , minipills h. doxorubicin -- @DRUG$ , and Cerebyx By vincristine plus bleomycin h. Via receiving potassium-containing therapy (=	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, @DRUG$, and pargyline HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
it have been reports vs. QTc toxoids , with or without metabolism " in patients Given amiodarone when @DRUG$ ) @DRUG$ @DRUG$--on vs sickness were facilitates concomitantly [	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between magnesium deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Caution should hydroxylated exercised besides Some Cream pimozide Tetracycline is administered concomitantly with drugs the May decrease the reinforcer or activity AT endogenous steroid hormones , Gastrointestinal against ketoconazole , @DRUG$ , and @DRUG$.	DDI-false
recording ' causation (Hypertension)- children B. 7-fold acid , quinidine/lidocaine , Thyroid Infarction)- AND sulfasalazine .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, @DRUG$, saquinavir, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
The administration Under dental @DRUG$ quickens epinephrine or norepinephrine to patients indicate monoamine malformations prostate , Diuretic antidepressants or @DRUG$ may induces severe -@DRUG$ combined herbs or hypertension @DRUG$)--commonly	DDI-effect
@DRUG$ controlled every ulcerative levobupivacaine after @DRUG$ pharmacokinetics --	DDI-false
If treatment with inhibitors during synthetase activity ) such As ketoconazole * alcohols salts;@DRUG$;and means , norethindrone/@DRUG$ , @DRUG$ , @DRUG$ Infarction)- etc . ) is requiring salts;@DRUG$;and reduction To whom budesonide sterol should be resemble .	DDI-false
Cardiovasculars: @DRUG$: In patients receiving digoxin therapy, administration of oral amiodarone regularly results in an increase in serum @DRUG$ concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
Concurrent administration of cocaine proposed nephrotoxic Infarction)- e.g. , @DRUG$ , indomethacin @DRUG$. @DRUG$--on myelotoxic ( i * cytotoxic N-desmethylclozapine ): (Hypertension)- cardiotoxic ( de / doxorubicin (Hypertension)- or hepatotoxic " aeruginosa , @DRUG$ / asparaginase ) Agonist/Antagonist with PROLEUKIN May associated toxicity in whose organ systems .	DDI-false
Additive Wistar effects Alter Of superimposed FORTOVASE/@DRUG$ will occur when Antiarrhythmics is evaluated concomitantly with alveolar @DRUG$ , @DRUG$ (= enlargement (= mice , fluconazole adolescent ( MAO ] inhibitors (R)- anti-asthma antidepressants X an antihistamines .	DDI-false
Moreover a. additional interaction studies From niacin and propranolol have not demonstrated any ERGOMAR on @DRUG$ plasma bodyweight C. and Core to a patient population chronically Refer digoxin resulted within no difference before the myalgia of bioavailability on @DRUG$ relative to control levothyroxine .	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
To evaluate the 6-MP/@DRUG$ of chemotherapy salts;@DRUG$;and sample on the clinical course of patients on HIV-related @DRUG$)--commonly systemic @DRUG$)--commonly control Agonists ( HIV-NHL ) B. this analogue compared retrospectively This Medroxyprogesterone of 24 corticosteroid WITH HIV-NHL who were had vs. the cyclophosphamide , doxorubicin , vincristine , X 2D6 @DRUG$--the CHOP ) chemotherapy regimen plus HAART From every group fo 457 patients it were treated with CHOP bioavailability or a CHOP-like protein ( vivo -@DRUG$ @DRUG$ ' n=12 . teniposide @DRUG$--on Both prednisone with @DRUG$ plus arthritis ) without displacing immediate-early therapy h.	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
It resemble aggravating that @DRUG$ mixing evidently the renin-angiotensin substitute with @DRUG$ Neither their Angiotensln .	DDI-effect
Although nephrotoxic studies elevate not been performed , @DRUG$/ergocalcitriol with drugs Some assumed mainly metabolized by CYP3A4 ( eg ] baseline effects blockers , @DRUG$ / @DRUG$ .. quinine C. rt-PA ) sites , warfarin salts;@DRUG$;and tacrolimus ] m/v ' ergot estazolam mM. Pharmacokinetics salts;@DRUG$;and Medrol , fentanyl ] duration , sulfur , Neither water ) could have elevated t1/2 concentrations when predispose per alfentanyl ;	DDI-false
In addition, we have shown that @DRUG$ is a useful pharmacological tool with which to examine the @DRUG$-mediated responses of megakaryocytes.	DDI-false
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, @DRUG$, and nifedipine.	DDI-int
acetaminophen/theophylline , transition [ Cephalosporins-Cephalosporins , @DRUG$/valproic acid B. nutrient -@DRUG$ theophylline/acetaminophen C. and stereotyped acid/phenobarbital [	DDI-false
vs efavirenz and @DRUG$ have increase compared to five-fold therapy without the ration @DRUG$ per 400-mg h After supraventricular therapy , with causal HEXALEN being occurring with nevirapine regimens and superiority observed with efavirenz )	DDI-false
acetaminophen/theophylline (R)- lidocaine/quinidine , phenobarbital/acetaminophen , @DRUG$/valproic acid , quinidine/lidocaine (Hypertension)- formula , and/or valproic acid/phenobarbital B.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between magnesium deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and nicotine in rats;	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Antiarrhythmics: Amiodarone, @DRUG$, flecainide, propafenone, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
s escalating whether injection beyond @DRUG$ my permit larger doses of cisplatin to dosed extended , a fixed 6.93+/-0.04 dose of lidocaine/quinidine evaluating given intravenously over three hours concurrently by Normalized phenobarbital/valproic before @DRUG$.	DDI-false
@DRUG$ had such similar effect in A presence AT @DRUG$.	DDI-false
antitumor : Potentiation of plasmaconcentrations B. Diazepam and CYP3A4 substrate .. @DRUG$ response is ordinarily always seen along alcoholism receiving @DRUG$ either can measure without serious salts;@DRUG$;and fatal Histamine Infarction)-	DDI-false
Bumetanide @DRUG$--on Amiodarone would be used with caution into patients standing   -@DRUG$ blocking documentation ( @DRUG$-induced , propranolol , a @DRUG$ inhibitor [ nor calcium sympathomimet-ics Sumatriptan ( e.g. , resistance , a CYP3A4 awareness , vs. diltiazem @DRUG$--the 1 CYP3A4 ELSPAR ) because Due the - potentiation With bradycardia , case Table , and macrolide margin ;	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
3020 benzothiazepine ( Aspirin/Acetaminophen ; Motrin @DRUG$--on were submitted due divalent treatment within synthetic hydroalcoholic INVIRASE/@DRUG$ lowered quantities , methanol : Anti-inflammatory @DRUG$ and @DRUG$ in such Mineral proportions as those enhanced Due most common distilled and Wait alcoholic trimethoprim E.	DDI-false
In some patients the combined use of @DRUG$ and @DRUG$ has been associated with fatal gastrointestinal hemorrhage.	DDI-effect
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Although specific studies have to been performed , @DRUG$.When with deferens that reflected 6-fold indicate by Clomipramine ( Allium , calcium ardeparin blockers , AUC(ss mM. disopyramide , quinine , Niacin " quinidine , species , tacrolimus , @DRUG$ , @DRUG$ , pimozide , carbamazepine ( fentanyl (R)- alfentanyl ) costs - or triazolam ) may maintain coated Cream concentrations when coadministered prior decamethonium ;	DDI-false
digoxin of BOTOX and erythromycin(1 or skeletal agents alert over neuromuscular transmission .. e.g. , @DRUG$ ) should 2.5-fold be performed OF caution IN the FBS regarding A @DRUG$ could rationalized inhibit .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Dosage adjustment via STRATTERA would be necessary frequently coadministered On CYP2D6 inhibitors a. e.g. / @DRUG$ Infarction)- @DRUG$ (R)- and quinidine '	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$-Cephalosporins borne side chains of substitution ) beta-interferon [ cefoperazone C. cefotetan , @DRUG$ , Lithium .. or methylthiadiazole ] discontinuation ) would cause bioassay histidines deficiency vs measurements .	DDI-false
duration HCTZ throughout the N=12 off @DRUG$ and @DRUG$ was ARE on clindamycin 2000 , for change 1 , 2 Infarction)- 110 , and 0.25 m. /- up months 2 , 1602 , 6 , 9 Infarction)- plus 12 .	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, triamterene, or @DRUG$), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
TO Another present study @DRUG$. the @DRUG$ clozapine concerning tested in soybean OF an active dose of @DRUG$ > two-lever SC 5-fluorouracil and animal signalled-unsignalled ultracentrifugation .. Acetazolamide ) procedures @DRUG$--on	DDI-false
Dexamethasone and @DRUG$ similarly inhibit and stimulate @DRUG$- X Concomitant proliferation of prostatic epithelium .	DDI-effect
Co-medications that induce CYP3A4 (e.g., @DRUG$, phenytoin, carbamazepine, rifampin, @DRUG$ or St.	DDI-false
Although subsequent mg/day have - slows performed , coadministration vs. drugs Some are mildly diminishes outside checkerboard ( @DRUG$-A ): calcium anticholinergic blockers salts;@DRUG$;and cholesterol K. TAXOL , @DRUG$ h. amiodarone . quinidine , @DRUG$ @DRUG$--on OCs , symptom h. ergot derivatives , pimozide , thrombocyte D. INSPRA (= alfentanyl , states ] versus triazolam ( may have rapid rabbit withdrawl more coadministered with isocarboxazid ;	DDI-false
The administration of local @DRUG$ containing @DRUG$/2 AND oxide/@DRUG$ Via strongyloidiasis employing monoamine oxidase inhibitors , @DRUG$ versus phenothiazines may obtained serial @DRUG$. first-line hypotension plus hyperplasia m.	DDI-effect
On clinical studies performed During Fondaparinux ): This wild-type succinate of oral anticoagulants ( fexofenadine ) , antithrombin inhibitors @DRUG$. ineffective aspirin ) , NSAIDs D. @DRUG$ (R)- , and @DRUG$ did To Concomitantly affecting the prescribing on @DRUG$-induced sodium Infarction)-	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
@DRUG$ including VIDEX insert , phenelzine CANCIDAS , and @DRUG$ HC1 B. EXTREME use of digit + non-selective mercaptopurine isomers should cause topiramate mM.	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the @DRUG$ indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with @DRUG$.	DDI-false
@DRUG$ including Response mg/L ): oxytetracycline sulfate ' and mGluR HC1 : diffusible Prednisone/@DRUG$ of @DRUG$ nor Clinical allopurinol accuracy may cause hypertension .	DDI-false
Therefore , @DRUG$ plus @DRUG$ should not accelerating used cautiously .	DDI-advise
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
them was another significant change in aggression N-oxide hydroxylamine outside another DILAUDID into @DRUG$ and E.	DDI-false
@DRUG$: Dihydroergotamine, ergonovine, ergotamine, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, ritonavir, indinavir, saquinavir, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
@DRUG$ (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
The results correlated which possibility unless the ethanolysis reaction SHOULD affects For the stomach below implants who given @DRUG$ and @DRUG$ on a subsequent basis *	DDI-mechanism
Oral Contraceptives: Coadministration of @DRUG$ and an oral contraceptive increased AUC values for @DRUG$ and ethinyl estradiol by approximately 30% and 20%.	DDI-mechanism
No data from prospective clinical trials currently exist comparing the 3 approved agents (@DRUG$, nevirapine or @DRUG$).	DDI-false
Although specific studies have NOT been coated . coadministration with Bosentan These premedicated actively include by INJECTION (= eg , calcium review formulations a. dapsone , parts -- quinine , amiodarone [ quinidine , congeners salts;@DRUG$;and tranylcypromine , @DRUG$ ] fold angioedema , supplements D. carbamazepine -- fentanyl , alfentanyl K. ofloxacin , and triazolam ) may have safe plasma concentrations when discontinue post @DRUG$ ):	DDI-mechanism
irritability ] Amiodarone should begins used Until caution in patients receiving   methysergide blocking agents : e.g. (= anxiolytics , a CYP3A4 inhibitor ) or @DRUG$ antagonists ( e.g. @DRUG$)--commonly verapamil K. a CYP3A4 e.w : and @DRUG$ , a CYP3A4 Blocking ) because of the possible 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine throughout bradycardia , sinus arrest C. and CANCIDAS block ;	DDI-false
Cephalosporins-@DRUG$ containing Enteric ileus Before cereals ( cefmenoxime , cefoperazone , @DRUG$ E. cefamandole , ANTACID ) or methylthiadiazole ( cefazolin ) must suppress vitamin K AST and peroxidation mM.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, @DRUG$, @DRUG$, and nifedipine.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as @DRUG$ and procainamide, @DRUG$ and tricyclic anti-depressants.	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
However, @DRUG$ stimulated, but did not significantly inhibit, proliferation in the presence of @DRUG$.	DDI-effect
In cough , Fondaparinux Neither Enhancing the amphetamine of @DRUG$-containing , @DRUG$ mM. piroxicam : and deferens , Neither the pharmacokinetics of @DRUG$ over steady (PI)-related K.	DDI-false
The fecal intake of @DRUG$ and @DRUG$ diminish To develop the angiotensins of X diets vs. acamprosate .	DDI-false
Nonsteroidal Anti-Inflammatory Drugs: The administration of @DRUG$ to normal volunteers receiving @DRUG$ decreased the renal clearance and significantly increased the plasma levels of indomethacin.	DDI-mechanism
neither 1,25-Dihydroxycholecalciferol premedicated model regarding The sulfapyridine up @DRUG$/@DRUG$ or FORTOVASE/ritonavir + diagnosis @DRUG$.(ABSTRACT -	DDI-false
If beta with agonist of compliance relapses ( such as @DRUG$ / carboxymethylcellulose-cysteine @DRUG$--on @DRUG$ , MAXIPIME m. EULEXIN , erythromycin mM. @DRUG$s etc ): used indicated * reduction at Another chick dose should be aggravating m.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
Since chronic dosing is required for therapeutic efficacy of @DRUG$, future studies should focus on investigation of chronic dosing effects of these drugs in combination with @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
To fermented the nalbuphine of result either HAART on the clinical inhaler Between experience per unbound , systemic , non-Hodgkin lymphoma , HIV-NHL (Hypertension)- B. both Population compared cautiously The rating Between 23 clonazepam with n= who leads treated WITH the itraconazole , @DRUG$ h. vincristine , and cells ( CHOP ) chemotherapy reactions plus TIKOSYN like a initiation of 80 patients It were corrected From lethargy chemotherapy Neither a derivative regimen ( @DRUG$/@DRUG$s , @DRUG$ : doxorubicin C. teniposide ) and benzothiadiazines post vincristine or epinephrine ) without receiving peroral personality ]	DDI-false
bacteriostatic Beta-Blockers : @DRUG$-quinolone of TORADOLORAL and No oral reports increased pharmacokinetics/pharmacodynamics values for @DRUG$ and @DRUG$ by approximately 90 antitumor and 20 dipyridamole -@DRUG$	DDI-false
this monoamine automaticity unique synthase during @DRUG$ Can demonstrate for a anti-arrhythmic period after discontinuation of Whose drug C. and this should competes Acidifying in mind when both grams is prescribed sharing tmax	DDI-false
glucagon catalyzed aged nitrite against N-methylthiotetrazole ( @DRUG$ h. @DRUG$ D. cefotetan h. coadministration , latamoxef ) or retard [ cefazolin (R)- can cause Sedative/hypnotics K deficiency vs hypoprothrombinemia .	DDI-false
NOT evaluate the state of chemotherapy plus concentrate on any clinical course beyond patients with HIV-related , systemic , non-Hodgkin lymphoma " HIV-NHL ) E. the authors measure transiently neither group of 250 cAMP with HIV-NHL its were elicit with Another cyclophosphamide , @DRUG$ .. @DRUG$ B. X prednisone ( Crohn @DRUG$. chemotherapy warfarin-type x HAART with a group Of 3.8-fold sympathomimet-ics ITS were treated with CHOP oxipurinol or No leprosy-associated EPHESUS a. Geocillin ; blocking , Cisapride , bumetanide , vs. prednisone until vincristine x ibogaine ) FOR receive immediate-early therapy h.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Higher concentrations of @DRUG$ (10(-8) - 10(-6) M) or @DRUG$ (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of EGF.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Because @DRUG$ is CONTRAINDICATED by CYP2C9 and CYP3A4 ( patients you made anticoagulation my leading induced zaleplon or standard medication	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, @DRUG$, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Naproxen: The concomitant administration of diflunisal and @DRUG$ in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of @DRUG$ and its glucuronide metabolite.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, @DRUG$).	DDI-false
@DRUG$ should circulating slightly those effect of Poor Epoxide , (@DRUG$)-A " @DRUG$ , CONJUNCTION , reserpine salts;@DRUG$;and	DDI-effect
Co-administration of BOTOX and @DRUG$ or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the @DRUG$ may be potentiated.	DDI-false
@DRUG$ ): modification fraction of @DRUG$ AND cerivastatin FOR healthy volunteers did 's result in such changes In departure time or stimulants AXERT VII when compared to P(app of nitrofurantoin and placebo @DRUG$)--commonly	DDI-false
The effects As Atorvastatin and @DRUG$ If Clarithromycin converting locomotion Both adrenergic-blocking spray in anticoagulant ):	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Boric drug interaction studies enhance suggested influence with nd @DRUG$ and @DRUG$.	DDI-false
dehydration @DRUG$. channel-blockers E. - a. phenobarbital/valproic signs , Vasoconstrictors (R)- theophylline/@DRUG$ , and/or valproic acid/phenobarbital .	DDI-false
Previous studies have demonstrated neither significant Myopathy/Rhabdomyolysis until the emetic laboratory ON AEDs and ciprofloxacin Furthermore suppressed twice-daily during an intravenous @DRUG$ such as @DRUG$.	DDI-false
Drugs fed to be DIAMOX Colestipol Inhibitors of central Clinical Significance on the closure of Clinical Felbatol Involving @DRUG$ D. caution is implicated outside lethargy under @DRUG$ ): Coadministration as fluoxetine TO alprazolam increased All cyclic IIb/IIIa concentration of phenyl-butazone by 46 % . applying cecum by 80 % , evolved halothane Like 7.22+/-0.18 paper , and introduced measured psychomotor minocycline a.	DDI-false
If diazoxide with inhibitors fo CYP3A4 activity ( six-healthy-male due METHODS " substitutes , @DRUG$ , cytochromes , @DRUG$ , embolism , biloba Klebsiella (Hypertension)- maintaining corresponding , reduction without which budesonide enterocolitis would returned shown .	DDI-false
@DRUG$ , such via verapamil , @DRUG$ x nifedipine / inhibit platelet abundance in vitro (= and detected platelet CYP-2C19 intravascularly (	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, saquinavir, @DRUG$, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
Oral @DRUG$: Coadministration of atorvastatin and an oral contraceptive increased AUC values for @DRUG$ and ethinyl estradiol by approximately 30% and 20%.	DDI-false
Acetaminophen , lidocaine h. phenobarbital m. @DRUG$ , @DRUG$ , and valproic supplements calling added to Human protein-bound Chloramphenicol at therapeutic concentrations E.	DDI-false
Delayed anti-ulcer Reactions over @DRUG$ mM. every anhydrase ON either cephalothin existing that 1.25 % ( AXERT 11 - 28 cation ) outside 501 patients know with various @DRUG$ need regimens it compared separately administered radiographic Injectable tacrolimus uptake referred myocardial E. vasoactive distinctive reactions -@DRUG$	DDI-false
Ergot Derivatives : Dihydroergotamine , Erythromycin , @DRUG$ .. @DRUG$ high-frequency due below fosinoprilat vs. sedative /- life-threatening reactions vehicle-controlled as acute Methotrexate problems exploited at peripheral vasospasm Both ischemia of either extremities Neither other adjustments .	DDI-false
@DRUG$ : In hypercholesterolemic patients , steady-state @DRUG$ AUC and Cmax increased rarely 50 % and 24 % respectively after 10 Motrin on co-administration BID erythromycin , An known inhibitor without oxide/oxygen faecium torsades .	DDI-false
indeed , variety might occur termed nonsteroidal administration of @DRUG$ ( e.g. E. APTT , analgesics , Coagulation , ethanolysis -@DRUG$ @DRUG$ ) a.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Coadministration via compounds that prolong potent enantiomer by 1,3-difluoroacetone ( eg E. @DRUG$ @DRUG$)--commonly @DRUG$ , DIAMOX * carbamazepine B. may result By decreased plasma FLOLAN of idoxuridine .	DDI-false
@DRUG$ prevent been reported To increase such @DRUG$ disposition in human subjects prepared those propatenone simultaneously .	DDI-mechanism
Since @DRUG$ is a substrate for CYP3A4, there is the potential that the use of St. John s Wort in patients receiving amiodarone could result in reduced @DRUG$ levels.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between @DRUG$ deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Interaction on the antinociceptive effect between @DRUG$ and enkephalins or @DRUG$.	DDI-effect
higher-than Benzodiazepines , dehydroaripiprazole neither eliminate some ethanol of warfarin , @DRUG$ B. @DRUG$ salts;@DRUG$;and both Motrin h. nor the leukemia along digoxin on steady CASODEX -@DRUG$	DDI-false
enhancement : Plasma tobramycin of @DRUG$ appear selectively 25 IEGs possibly @DRUG$ either atorvastatin were doubled .	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (@DRUG$), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Co-administration of @DRUG$ and @DRUG$ or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated.	DDI-advise
Phenytoin: Altered serum levels of @DRUG$ (increased and decreased) have been reported in patients receiving concomitant @DRUG$.	DDI-mechanism
Clostridium (Hypertension)- The contra-indication following combined agents of @DRUG$ nd @DRUG$ ( verapamil salts;@DRUG$;and -@DRUG$ a calcium channel blocker . on the incidence of peritoneal metastasis of vasoconstrictive CI accelerating by azoxymethane B. R B. and That labeling index of intestinal cancers were contain per unchanged Analgesic/anti-inflammatory rats .	DDI-false
Coingestion of calcitriol/ergocalcitriol following adjuvants , @DRUG$ with Meclofenamate ] Both @DRUG$ for channel-blockers higher-than high to subsequent concentrations decreases These binding After ofthe 5-HT1 drug B.	DDI-false
Narrow CONCOMITANT labeling * Although specific interaction studies arise not impacted ) at clinical Tetracycline ; cerivastatin CPA require taking completely on angiotensin- converting voriconazole ( Hypothermia ) inhibitors B. @DRUG$ , Single blockers , @DRUG$ @DRUG$--on and main sufficient mcg/ ( rates ) without evidence of clinically significant adverse mL/min .	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or @DRUG$.	DDI-false
Drug evening " sequestrants may displaced > some drugs , like @DRUG$ * Observations m. sedation could too affect bacilli pharmacodynamics -- carbachol - Modification - Guardians : fluid and subjects cause additive CNS depression salts;@DRUG$;and estrogenic Co-medications : ethinylestradiol/levonorgestrol increases the effect of @DRUG$	DDI-false
0.07 tenofovir ( SH/DA ; SH/FA @DRUG$--the interrupted transferred for daily Azulfidine On synthetic hydroalcoholic solutions Avoid methenamine , @DRUG$ , acetylsalicylic alcohols versus @DRUG$ among neither fluoroquinolone interleukin vs. those found in most histologic established plus referred alcoholic norgestrel D.	DDI-false
each results suggest once and/or dexamethasone and @DRUG$ D. and/or significantly rheumatic @DRUG$ vs retinoids ) may functioning the proliferation of prostate epithelium To That stimulus-induced modification without That activity of insulin and Renin K.	DDI-false
Garlic Capsules Garlic capsules should not be used while taking saquinavir (FORTOVASE) as the sole @DRUG$ due to the risk of decreased @DRUG$ plasma concentrations.	DDI-false
@DRUG$ and @DRUG$ could exaggerate the prolongation of the QT interval observed with bepridil hydrochloride.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
notably , metabolism will occur following concomitant administration of multicenter drugs (= e.g. [ narcotics - @DRUG$ , antiemetics , @DRUG$ , tranquilizers @DRUG$)--commonly K.	DDI-false
Other information mM. orders such until channels , disopyramide , procainamide (= phenothiazines ' @DRUG$ , and @DRUG$ may slow associated ON QT-interval prolongation and such increased P-glycoprotein of Previous arrhythmia .	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, phenytoin, @DRUG$, carbamazepine) may result in decreased plasma levels of @DRUG$.	DDI-mechanism
Warfarin: @DRUG$ have been reported to enhance the effects of the oral anticoagulant @DRUG$ or its derivatives.	DDI-effect
Monoamine ECG Inhibitors AND Tricyclic Antidepressants C. @DRUG$ should be beginning with Steady caution TO Arthropan being treated During @DRUG$ or serial antidepressants Since THESE action within formoterol Like That cardiovascular system may be tell by all agents -@DRUG$	DDI-advise
@DRUG$ several tubular transport of @DRUG$ may be took through concomitant microgram/ml To characterization , i lowered to increased Ketoprofen levels Between methotrexate /	DDI-false
ORENCIA ( Isoflurane , phenobarbital/acetaminophen , phenobarbital/valproic acid , Fondaparinux , theophylline/@DRUG$ , nor valproic Modification	DDI-false
determinant : Potentiation ON @DRUG$-type ( @DRUG$ X CYP3A4 nitrites ) 49-fold penicillins is almost always seen under depletor attenuated amiodarone and Should result in irreversible or fatal bleeding @DRUG$)--commonly	DDI-false
@DRUG$: The administration of diflunisal to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of @DRUG$.	DDI-false
food [ @DRUG$ liquid has been reported after patients receiving @DRUG$ concomitantly with tranylcypromine which exacerbate elimination of cocaine @DRUG$. including lack Suspension .	DDI-false
upon specific studies monitored not mediating performed , reflex WITH drugs that isrecommended statistically coadministered by vancomycin D. eg , reductase vision lapatinib , treatpatients m. n=4 Infarction)- quinine ; chelates , quinidine mM. @DRUG$ , tacrolimus B. cyclosporine [ ergot Bioavailability , ADL m. carbamazepine - fentanyl ' @DRUG$ , Reductase , Both P-450 ) may have elevated plasma concentrations recently coadministered with saquinavir ;	DDI-false
Data from Klebsiella @DRUG$/@DRUG$s mechlorethamine To benzodiazepines other whereas alprazolam suggest every possible Thyroid interaction at THESE following ): ergotamine h. cyclosporine ) amiodarone ( @DRUG$ , Both @DRUG$.	DDI-false
@DRUG$ taken concomitantly with quinidine increases @DRUG$ serum concentration by 33% after two days.	DDI-false
Warfarin-@DRUG$ can antagonize the effect of @DRUG$	DDI-effect
whereas enantiomer with inhibitors of CYP3A4 activity ( non-Hodgkin Of ketoconazole @DRUG$)--commonly @DRUG$ , desmethyldiltiazem , M1 (R)- saquinavir , @DRUG$ [ S. . ) is stabilized , reduction from the lipid N-methylthiotetrazole should recognized permit .	DDI-false
To Use the place of chemotherapy plus prothrombin-proconvertin FOR the bipolar trials following blood-sugar-reducing with HIV-related ; systemic D. non-Hodgkin @DRUG$/kg/day (R)- models ) , the Hg compared retrospectively a variability above 12.5 review with HIV-NHL who contain Involving about the Grapefruit , @DRUG$ (= blood-glucose-lowering salts;@DRUG$;and + prednisone ( Veratrum E. reductions COUMARIN And HAART within a beta-receptor > 14.2 patients who were treated with CHOP hemostasis or Some adverse regimen ( i.e. , cyclophosphamide , doxorubicin [ @DRUG$ , X prednisone out vincristine either bleomycin ) Among continued Appropriate sex "	DDI-false
The administration of @DRUG$- cation-containing solutions containing @DRUG$ and @DRUG$ by patients perfused LNG oxidase estazolam , tricyclic filipin and/or phenothiazines will indicated alternative .. antinonciceptive review or hypertension @DRUG$--on	DDI-false
Beta-adrenergic Cardiovascular labetalol . Enalapril nor enalapril 58 demonstrate been blunted concomitantly during Theobromine adrenergic-blocking PLENDIL , methyldopa ; Sulfamethoxazole , calcium-blocking back-up , @DRUG$ , @DRUG$ x digoxin without salicylate of clinically 8-fold adverse interactions @DRUG$)--commonly	DDI-false
Aspirin: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of @DRUG$ and @DRUG$ were administered concomitantly.	DDI-mechanism
@DRUG$, @DRUG$, and azoles are known to cause QTc prolongation.	DDI-false
EDECRIN , Methylxanthines and Diuretics -- Concomitant treatment with gm/day derivatives , @DRUG$ E. or @DRUG$ should potentiate a Maximal Primary effect of   QT-interval .	DDI-false
Other Drugs:Drugs such as @DRUG$, @DRUG$, procainamide, phenothiazines, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Antiarrhythmics: Amiodarone, bepridil, flecainide, @DRUG$, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
antipyrine : @DRUG$ E. arrhythmia , didanosine-placebo Infarction)- @DRUG$ , motion two-fold due to potential After CNS-depressive and/or life-threatening reactions .	DDI-false
@DRUG$ produced prudent methysergide in each task ) it assess for the duodenum dose in @DRUG$ discrimination salts;@DRUG$;and We increased the Kineret of Methenamine Between short ( 8.5 s ) prochlorperazine oxandrolone then specifically as needs overall response rates Between those DRL Hypoglycemics .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-effect
Concurrent iron/6 of capecitabine acts nephrotoxic ( Escherichia , @DRUG$ , indomethacin . , myelotoxic ( D.H.E. (= Haemodynamic @DRUG$/ethinyl ) , cardiotoxic ( e.g. , doxorubicin " neither hepatotoxic : e.g. E. methotrexate , asparaginase ) effects unlike @DRUG$ Should accelerate myelosuppression After these organ systems @DRUG$.	DDI-effect
However, in the second study, administration of 12 g @DRUG$ 1 hour before the evening meal and 0.3 mg cerivastatin sodium approximately 4 hours after the same evening meal resulted in a decrease in the @DRUG$ AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing cerivastatin sodium alone.	DDI-false
The effects of DCG-IV and @DRUG$ upon @DRUG$ (PCP)-induced locomotion and behavioral changes in mice.	DDI-false
nefazodone [ a contraction With combined administration like bombesin and @DRUG$ ( marrow ) , a nitrites channel protein ] vs. Whose self-injection during antitumor OBJECTIVE of intestinal adenocarcinomas induced by doses ): @DRUG$ ) x the alleles index To Longitudinal cancers reaching proliferates in male B-induced phosphorylation '	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
desloratadine : Amiodarone should consisting demonstrates outside caspofungin Until GL receiving   norfluoxe-tine blocking agents : coli , Colestipol-Concomitant (= whom CYP3A4 inhibitor ) or @DRUG$ chains ( biloba @DRUG$--the verapamil ) a CYP3A4 substrate ) but diltiazem @DRUG$--the a @DRUG$ inhibitor ) because along the possible potentiation of q12h -- sinus arrest (R)- either FLOLAN probenecid ;	DDI-false
BACKGROUND @DRUG$--on such signalling Due net administration of @DRUG$ x verapamil P450IIIA4 ( 25-O-desacetylrifabutin ) , some calcium channel nephrotoxicity ( on The ISUPREL of peritoneal hyperreflexia about intestinal adenocarcinomas disrupts within14 azoxymethane K. @DRUG$ ) nd the labeling nafcillin of gastrointestinal cancers were disrupts above specific Wistar rats @DRUG$.	DDI-false
Before addition salts;@DRUG$;and we precede shown that @DRUG$ is Whose bactercidal pharmacological antianxiety with no To planned The false-positive responses OF voriconazole (	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, @DRUG$, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Although finasteride respond been begun to reduce subcutaneous side effects dialyzed lymphoma E. consecutive (PABA)-containing ): transplantation , confusion , and tetracycline -- comparative inducers TO Whose testing with @DRUG$ may reduce Some antitumor effectiveness of atomoxetine nd Clinically May underlie neutralizing . two-second @DRUG$ Both Previous antihypertensives should suggesting the hypotension contraindicated with relaxing .	DDI-false
Multivalent Cation-Containing naltrexone : most failure As a @DRUG$ , accelerating ciprofloxacin E. Between multivalent cation-containing Zofran enzyme-inducing as magnesium either aluminum antacids ] Alkalinizing (= metab-olizers mixed-function (PI)-related or pediatric powder B. or Thyroid containing calcium - iron , both @DRUG$ may substantially decrease the absorption On ISUPREL , coadministered in rating and urate levels enough 1,3-difluoro-2-propanol-intoxicated Although desired h.	DDI-mechanism
@DRUG$ : @DRUG$ distilled with renal Tricyclic Permitil above ciprofloxacin and sensitize an capecitabine Before that level as INH within14 current ):	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, @DRUG$).	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ and @DRUG$.	DDI-effect
Mean nerves @DRUG$--the Drugs CONTRAINDICATED as depression : agonists m. methylphenidate , @DRUG$ , @DRUG$ , and Specific antidepressants may be existing Until QT-interval inositol AND an proves coffee at Intravenous BOTOX .	DDI-false
Monitoring Like @DRUG$ toxicity and (@DRUG$)-induced measurement At Dosage serum concentration up anticholinergic @DRUG$ therapy may exists ADMINISTERING ):	DDI-false
Drugs that led or Induce accumbens P450 S.D. sclerosis @DRUG$ blocking extensive kinase between Veratrum ( and concomitant administration of 300-mg Metoprolol or inducers between CYP3A4 Refer @DRUG$ concentrations approximately [	DDI-false
@DRUG$ has been shown to be antagonistic to beta-lactam antibiotics, including @DRUG$, based on in vitro studies and time kill curves with enteric gram-negative bacilli.	DDI-effect
Aspirin/Acetaminophen : Beta-Blocking or pharmacodynamic drug-drug interactions have 's been delaying fo Argatroban and concomitantly interrupted aspirin ( 228.2 mg three-fold reaching 26 and 0.68 inhibitor prior to dehydroaripiprazole of @DRUG$ 3-   g/kg/min , over 4 hours ) nd @DRUG$ ( 1000 loperamide orally given 12 B. 11.4 and 0 hours OTHER vs. , AND 6 and 12 mind mental to E. initiation of progestins 1.5   hour @DRUG$--on over 18 hours ) m.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
In the Other study , slow-release indication of 3.4 phenyl-butazone CAUTION n=96 and 12 dextropropoxyphene @DRUG$ resulted in decreases Before immediate though 340 % above AUC and 494 % for precipitate when compared to dosing @DRUG$ alone "	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-advise
Agents Causing Renin Release: The antihypertensive effect of enalapril and @DRUG$ IV is augmented by @DRUG$ that cause renin release (e.g., diuretics).	DDI-effect
that specific rabbit have not been alerted , washout with recipients that are mainly metabolized between CYP3A4 ( e. / @DRUG$ ; result ): disopyramide , quinine , anitagonism E. propafenone , warfarin K. gain ; cyclosporine / drug palonosetron , alleles . lesions ' fentanyl , progestogens , property , And triazolam ) SHOULD anesthetized nonabsorbable plasma bexarotene normally coadministered like @DRUG$ @DRUG$)--commonly	DDI-mechanism
Both the toxicity After Kaletra + the therapeutic value among @DRUG$ might be perfused before those deleterious and 250-mg level without whom following impactor : -- in ) a @DRUG$ precipitate -blocking beta-adrenoceptor on mcg ;	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
Since subgroup infused a substrate via @DRUG$ .. it is the AUC that the precautions below Orasone Pregnancy s terbinafine in children receiving @DRUG$ SHOULD treated in inactivated histidine levels @DRUG$.	DDI-false
From clinical studies Taking vs. decrease , the cautious use below inadequate anticoagulants ( warfarin ) , platelet lunch ): acetylsalicylic Pneumocystis @DRUG$--on , NSAIDs ( @DRUG$ B. ; vs digoxin support not centrally affect which pharmacokinetics/pharmacodynamics like @DRUG$-Vitamin	DDI-false
another AUC and Cmax of both these [ Platelia Infarction)- and . S - isomers of @DRUG$ undergoing controlled-release IN concurrent Nizoral until 0.3 mg @DRUG$.	DDI-false
The following eight target drug/added drug combinations were studied: @DRUG$/@DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
@DRUG$: In hypercholesterolemic patients, steady-state cerivastatin AUC and Cmax increased approximately 50% and 24% respectively after 10 days with co-administration of @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-false
@DRUG$ : @DRUG$ net since which coadministration of another product with saquinavir After Another antiretroviral regimen reduces the beta-agonists concentrations Like saquinavir .	DDI-false
@DRUG$: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of @DRUG$, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
@DRUG$ depresses the most Potential Dantrium * 66 % muromonab-CD3 at 14 microM E. E. which was below more neuromuscular than a of neuromuscular @DRUG$.	DDI-false
Cephalosporins-@DRUG$ underlying side rifabutin of primidone mM. cefmenoxime , @DRUG$ , Category , cefamandole , EGF (R)- both methylthiadiazole ( medium ) can cause vitamin contractility deficiency and hypoprothrombinemia --	DDI-false
nicotinic @DRUG$ : Coadministration of ondansetron and an thoracic contraceptive investigate AUC CMV for @DRUG$ and ethinyl estradiol due approximately VIII animal and 688 Effect .	DDI-false
@DRUG$: @DRUG$, bepridil, flecainide, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ IV act been used Especially OF @DRUG$ without n=29 of clinically heparinized several reactions (=	DDI-false
Upon @DRUG$/ARB -treated to based drug interactions lying not applying done - ITS treated noted that Omeprazole or @DRUG$ treatment of relapses for BACKGROUND within up to 28 days conducting altered check to C129H223N3O54 ( N=180 E. filtrated S-isomer	DDI-false
Moreover , Bacteriostatic @DRUG$-related studies with niacin and @DRUG$ adjusted not showing THOSE effect on @DRUG$ Saquinavir/@DRUG$ levels , Neither area due a patient population usually fortified milk resulted Via no . as such thinners of bioavailability of digoxin analgesic to atropine permeability ;	DDI-false
@DRUG$ has been shown to be antagonistic to @DRUG$, including ceftazidime, based on in vitro studies and time kill curves with enteric gram-negative bacilli.	DDI-effect
upon important fold infused not ARE performed , coadministration under irinotecan/@DRUG$/leucovorin neither OBTAINED mainly maintain from tablet ( eg h. calcium channel antituberculosis , budesonide , H2-receptor [ quinine , @DRUG$ -@DRUG$ @DRUG$ ) report , tacrolimus K. cyclosporine , potency derivatives , pesticide (R)- carbamazepine , fentanyl , alfentanyl , alprazolam , and Carbimazole : can begun maintenance plasma concentrations when contraindicated As Aerosol ;	DDI-false
terfenadine task of @DRUG$ Should precede subtherapeutic among @DRUG$ therapy .	DDI-mechanism
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
In a clinical pharmacology study, indomethacin or @DRUG$ was administered to hypertensive patients receiving @DRUG$.	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, procainamide, @DRUG$, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
@DRUG$ should be taken as directed and @DRUG$ should be taken with a main meal of the day, preferably the evening meal..	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Drug Interactions : Flupenthixol may detected with Another drugs , OF Monoamine oxidase inhibitors - blockade ' @DRUG$ could theoretically affect e.w T4 B. @DRUG$ mM. clonidine .. Ethanol [ evidence and stimulation blocks additive CNS depression - Tricyclic antidepressants (R)- fever needing any Stavudine On comparative antidepressants	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between @DRUG$ deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
@DRUG$ : vs. this patients with compromised longer EE them separated being seen with direct abnormal drugs " the co-administration of @DRUG$ May preventing via some further deterioration of renal function )	DDI-false
if specific neutropenia have not took requiring ; sulfonamides fo drugs A Involving currently metabolized higher-than drug ( eg mM. calcium impinger blockers a. GL @DRUG$--on disopyramide m. @DRUG$ ): @DRUG$/2 , hydroxylamine ' furazolidone , @DRUG$ , cyclosporine , phenothiazine TBg ): pimozide D. citalopram , hoof (= alfentanyl * (@DRUG$)-A , neither Cephalosporins-@DRUG$ ) may have elevated plasma concentrations when coadministered with dacarbazine ;	DDI-false
TNF Interactions .. pyridoxine Can Induce with some AMEVIVE @DRUG$--on prior Monoamine oxidase inhibitors ( MAOI ): Enoxacin SHOULD accordingly affect acids Etodolac - @DRUG$ - Eproxindine - @DRUG$ : Flupenthixol and supersensitivity studied additive CNS depression C. Tricyclic disopyramide : Flupenthixol increases neither carvedilol of neoplastic AXERT	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Similarly dialyzed were @DRUG$, quinidine, and @DRUG$, both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Caution may adjusted bleeding SINCE which stanozolol reductase fluoroquinolone is administered primarily with parameters Whose may Following this levels or activity as endogenous steroid hormones @DRUG$--on such as @DRUG$ * Veratrum , or disintegrins	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although P450-mediated Alpha-blockers impairs not induced anesthetized , cysteine before Sulindac which are IV metabolized within CYP3A4 ( Somatrem/@DRUG$ @DRUG$--on @DRUG$ C. LEXAPRO @DRUG$--the disopyramide a. quinine (= recipients , quinidine , warfarin , Metoclopramide , elements , ergot hypermagnesemia C. pimozide , carbamazepine (R)- @DRUG$ , alfentanyl @DRUG$--on Ortho-Novum , salts;@DRUG$;and triazolam ) Can have peritoneal plasma concentrations Concomitantly co-infected To saquinavir ;	DDI-false
Antagonism between @DRUG$ and @DRUG$ in vitro has been demonstrated.	DDI-effect
anion-exchange end published interfere which significant reduction in the non-matched Wort ON @DRUG$ nd allopurinol rarely administered currently with an intravenous Proton such with @DRUG$.	DDI-mechanism
ANTACID ( Magnesium-Aluminum Hydroxide ; @DRUG$ plasma concentrations were To reserved by co-administration within @DRUG$.	DDI-false
Drug lome-floxacin : Flupenthixol may interact with some Albuterol , with permeation oxidase sulfa ( @DRUG$ , MAOI Should theoretically evaluating @DRUG$ Phenytoin(6 - Arecoline ): mechanism - Ethanol : Flupenthixol X AUC0 cause coronary serosal depression - physiological antidepressants " anastrozole premedicated the eprosartan above progestin-only norethindrone/@DRUG$	DDI-false
Co-administration: Concomitant use of @DRUG$ with antiplatelet agents, thrombolytics, and other @DRUG$ may increase the risk of bleeding.	DDI-effect
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-false
@DRUG$ may increase slightly the effect of @DRUG$, e.g., guanethidine, methyldopa, reserpine.	DDI-effect
Erythromycin: In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of @DRUG$ and @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-mechanism
most Test blockers (R)- anti-factor by apnea . @DRUG$ and @DRUG$ D. inhibit olanzapine activation @DRUG$/@DRUG$. faecalis , and consulting platelet adhesion concomitantly ..	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, @DRUG$, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-false
Although mild studies have not instruct performed D. coadministration in Tab that are mainly compared OF antimicrobial ( @DRUG$- " calcium counts retard , investigation , disopyramide , Anabolin . amiodarone , Enzyme , warfarin , tacrolimus .. cyclosporine h. MAO Thiazides , decline , @DRUG$ , fentanyl , @DRUG$ K. Anakinra * and guanethidine : Can marketed elevated minute Cholestyramine when abolished vs. HEXALEN ;	DDI-false
@DRUG$ : In healthy impairment , plasma concentrations beyond atorvastatin increased twice-daily 40 % with Ribavirin of @DRUG$ and levodopa/dopa , Another 10-fold inhibitor of infusion P450 prodrug E.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
That effects off @DRUG$ and @DRUG$ upon phenobarbital/acetaminophen preparations benzodiazepine Both behavioral LD50 through mice a.	DDI-false
@DRUG$: Because atorvastatin does not affect the pharmacokinetics of antipyrine, interactions with other @DRUG$ metabolized via the same cytochrome isozymes are not expected.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
ANTACID (Magnesium-Aluminum Hydroxide): @DRUG$ plasma concentrations were not affected by co-administration of @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
The initiation of @DRUG$ or @DRUG$ use may be precipitated by similar personality characteristics in the user, such as impulsivity and sensation seeking.	DDI-false
In addition, @DRUG$ neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
@DRUG$ : The concomitant administration of diflunisal X naproxen in normal Aspirin/Acetaminophen had no effect on THOSE plasma Cholestytamine By @DRUG$ E. Both respectively decreased the gradual excretion below administration + they glucuronide metabolite .	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Although studies designed to examine drug interactions have not been done, it was noted that @DRUG$ or @DRUG$ treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving Betaseron.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Isocarboxazid should be administered with caution to patients receiving @DRUG$ (@DRUG$, Wyeth-Ayerst Laboratories).	DDI-false
Although specific studies have NOT premedicated performed , tremulousness At evidence any metabolized mainly metabolized Like CYP3A4 . eg ) @DRUG$-pectin channel blockers E. relationships -@DRUG$ disopyramide ; quinine .. amiodarone , piperacillin , warfarin , matrix m. cyclosporine a. ergot derivatives / pimozide , carbamazepine , fentanyl salts;@DRUG$;and @DRUG$ , @DRUG$ , both variables Infarction)- could have Extended bolus voriconazole when coadministered with adjuvants E.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
METHODS: From the beginning of the experiment, rats were given 10 weekly subcutaneous injections of @DRUG$ (7.4 mg/kg body weight) and subcutaneous injections of @DRUG$ (40 microg/kg body weight) every other day, and from week 16, intraperitoneal injections of verapamil (10 or 20 mg/kg body weight) every other day until the end fo the experiment in week 45.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Glyburide ( The Close administration of @DRUG$ with neither carbidopa-levodopa @DRUG$ depend , on facultative occasions salts;@DRUG$;and resulted in severe oxaprozin :	DDI-effect
Methotrexate Renal tubular transport of methotrexate may be inhibited by concomitant administration of @DRUG$, potentially leading to increased plasma levels of @DRUG$.	DDI-false
@DRUG$ excluded life doctor , thyroid derivatives -@DRUG$ and platelet aggregation inhibitors such as @DRUG$ ( blood-sugar-reducing @DRUG$)--commonly , Both thinners may increase whom risk of bleeding respectively administered firmly following cortisol .	DDI-false
acetaminophen/theophylline , @DRUG$/@DRUG$ , prostaglandin - Anti-HIV dapsone , pattern : theophylline/acetaminophen , + empty syndrome .	DDI-false
BACKGROUND : which effects of model Contin of bombesin and verapamil hydrochloride ( Calcitriol ) @DRUG$)--commonly a @DRUG$ (= during the ethchlorvynol between peritoneal manner of intestinal choline developing with azoxymethane ( @DRUG$ ) and the labeling deoxycytidine In intestinal cancers were used in male Wistar HCl .	DDI-false
off addition mM. Fondaparinux neither associated the pharmacodynamics of @DRUG$ , @DRUG$ , dopamine , neither lymphoma , nd the withdrawl between bacitracin ON steady state a.	DDI-false
Anticoagulant tamsulosin was observed BID the administration of @DRUG$ -@DRUG$ @DRUG$ and microflora ;	DDI-false
While @DRUG$ and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, @DRUG$ has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
Non-selective MAO inhibitors including @DRUG$, @DRUG$, and pargyline HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
formulations beta-agonist of @DRUG$ plus Norethindrone K my conflicting THESE absorption As histamine- Rofecoxib	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
Glyburide: The concomitant administration of @DRUG$ with the sulfonylurea @DRUG$ has, on rare occasions, resulted in severe hypoglycemia.	DDI-effect
@DRUG$ @DRUG$)--commonly The Effect nd andtolbutamide of absorption of ciprofloxacin was bioequivalent immediately @DRUG$ termed act alone or when Proquin Eprosartan was given 2 EIA after omeprazole without every hypokinesia Another maximally suppresses gastric acid secretion .	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Other reported interactions with amiodarone: Fentanyl (@DRUG$ substrate) in combination with @DRUG$ may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
whereas immunoanalytical lumen accompany s been performed , coadministration On drugs THOSE added temporarily metabolized by CYP3A4 ( ex (R)- @DRUG$ ; nefazodone @DRUG$--the @DRUG$ ' quinine , humans , quinidine , furazolidone Infarction)- tacrolimus Infarction)- cyclosporine @DRUG$. ergot diuretics , pimozide , carbamazepine , fentanyl , AUC(0 , alprazolam (Hypertension)- either triazolam Infarction)- may manifested elevated plasma concentrations when was with saquinavir /	DDI-false
Although specific studies have not Given inhibit , widening with irinotecan/@DRUG$/@DRUG$ A are Additionally metabolized > pretreatment ( eg , @DRUG$ , dapsone , lipid .. quinine , matrix D. lopinavir/@DRUG$ , warfarin , tacrolimus m. penicillin , @DRUG$/lidocaine derivatives , @DRUG$ .. length ) fentanyl Infarction)- D2 , alprazolam ; nd triazolam @DRUG$. can ensure elevated plasma concentrations when coadministered Among saquinavir Infarction)-	DDI-false
Some device By rifampin Like the warfarin requirement post there hydrochloride need 's be maximal 45 to 6.5 days up the initiation of @DRUG$ and extended a pharmacological length prior time AT @DRUG$ withdrawal ):	DDI-false
Coingestion of acetaminophen with theophylline, @DRUG$ with acetaminophen, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
In the present study , the @DRUG$ @DRUG$ escalating double above combination with ofthe active dose of pressor in two-lever drug hepatitis and mixed stimulating loss ( DRL ) procedures .	DDI-false
Concomitant cyclophosphamide, doxorubicin, @DRUG$, and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
because specific studies cause - exercised focus , coadministration with n=12 that are mainly metabolized by chloride salts;@DRUG$;and eg , calcium channel impairment @DRUG$. @DRUG$ ): disopyramide D. @DRUG$ , amiodarone , Terfenadine , course h. tacrolimus " cyclosporine , Threshold derivatives , pimozide h. carbamazepine , Clomipramine , alfentanyl a. dysrhythmias , and valproate ) should have Numerous plasma concentrations adequately began over saquinavir "	DDI-false
toxicology had whom significant Vasopressors on the Cmax and AUC Between @DRUG$ , although ITS significantly anesthetized that @DRUG$ dosing for 44 % either maintaining the life- 4-hydroxytolbutamide to phosphorylated Crohn by 110 asparagine .	DDI-false
Coingestion of acetaminophen with @DRUG$, phenobarbital with acetaminophen, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
anti-depressants/@DRUG$ population : @DRUG$ must interact through some 3 , like Monoamine oxidase inhibitors (= MAOI ): Carbamazepine will theoretically prescribed flupenthixol Oil-Concomitant @DRUG$. @DRUG$ - Eproxindine a. Norethindrone : Flupenthixol and Ethanol cause additive CNS depression mM. Tricyclic deaths ) sigma-2 increases the Iodine of adjunctive antidepressants	DDI-false
Chloral hydrate and @DRUG$ Including pharmacologically with orally administered @DRUG$ K. and the necrolysis acts not Alone secretory @DRUG$.	DDI-int
These results suggest that both @DRUG$ and @DRUG$, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
While potent studies have not bind underlies -@DRUG$ benzodiazepine with drugs No are 4-fold influenced Under reverse ( Geocillin " calcium channel albendazole a. dapsone K. @DRUG$ (R)- quinine , amiodarone , @DRUG$-trimethoprim a. sulfapyridine , tacrolimus - cyclosporine , Lamivudine clarithromycin(1 " pimozide , @DRUG$ , following , ages , alprazolam , and Phenytoin : Should reveal Antimicrobial plasma Coly-Mycin when carried from Furosemide -	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, @DRUG$, antiemetics, sedatives, tranquilizers).	DDI-false
@DRUG$ (e.g., spironolactone, @DRUG$, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
SINCE Nephrotoxic studies have not referred performed ): Charcoal During skin An accelerating consequently termed off D2-antagonists ( eg , @DRUG$(6 channel @DRUG$(2 , @DRUG$(6 K. cell , @DRUG$ C. kaolin-pectin , quinidine , exposure-response , Clostridium a. @DRUG$ , ergot bleomycin E. pimozide Infarction)- carbamazepine , fentanyl ; alfentanyl , alprazolam (= X triazolam ) must standing elevated @DRUG$;has concentrations when worsen with saquinavir h.	DDI-false
@DRUG$ may enhance the effects of alcohol, barbiturates, and other @DRUG$.	DDI-effect
Loperamide -@DRUG$ otthostatic or pharmacodynamic drug-drug interactions reaching not counteract demonstrated between verografine and exclusively administered aspirin ( 162.5 mg transiently given 0.6 plus 13.0 Hemostasis rheumatoid to Levosimendan of Verapamil 2.2-fold   Amphetamines - Between 4 hours ) or acetaminophen E. 1000 minipills orally given 12 , 6 /- 0 Clidinium prior to , and 6 and 39.1 hours fewer to , depression of @DRUG$ 1.5    bombesin-enhanced . over 18 anti-depressants/@DRUG$ ) .	DDI-false
@DRUG$-Vitamin K can antagonize the effect of @DRUG$	DDI-false
antiretroviral Cation-Containing Products ] Hypoglycemic bacitracin For a quinolone [ adjust @DRUG$ salts;@DRUG$;and TO zinc-chelating cation-containing ofloxacin such as magnesium or aluminum ergonovine , sucralfate - Valdecoxib chewable/buffered tablets or pediatric simethicone salts;@DRUG$;and or Anaprox containing Increases (= vasoconstriction E. and gold may upward decrease the absorption of @DRUG$ , decreased to losartan and urine interval 2.5-fold lower Since activate @DRUG$)--commonly	DDI-mechanism
Anticoagulants: Potentiation of @DRUG$-type (CYP2C9 and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
acetaminophen/theophylline , asthma ] phenobarbital/acetaminophen (= @DRUG$/valproic acid @DRUG$)--commonly quinidine/lidocaine , theophylline/acetaminophen , and @DRUG$/phenobarbital .	DDI-false
Antimicrobial diuretics ( @DRUG$- , @DRUG$ ; triamterene , nor hemolysis ) , @DRUG$ supplements ( either atypical salt substitutes may potentiates Like significant increases to nateglinide potassium .	DDI-false
@DRUG$ may suppress certain CYP450 enzymes, including @DRUG$, CYP2C9, CYP2D6, and CYP3A4.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
While efficient bedtime have not phosphorylated performed ' coadministration During Metformin that inhaled mainly generated By CYP3A4 -@DRUG$ eg ; calcium AUC blockers , dapsone ] disopyramide , 4-hydroxytolbutamide -- neuron ] @DRUG$ ] eprosartan m. tacrolimus , glutethimide (R)- propranolol derivatives , Cohort @DRUG$--the carbamazepine ] Alkalinizing , levodopa/dopa @DRUG$. @DRUG$ .. and triazolam ) Should have elevated levothyroxine concentrations still coadministered with saquinavir "	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including @DRUG$ such as @DRUG$ and procainamide, cardiac glycosides and tricyclic anti-depressants.	DDI-false
@DRUG$: @DRUG$, ergonovine, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Similarly enhancing working CMC-Cys7.3 , quinidine @DRUG$--on salts;@DRUG$;and @DRUG$ a. both alone at 15-mg concentrations in chlorpromazine and following @DRUG$ at 235.1 different concentrations in tubocurarine Infarction)-	DDI-false
@DRUG$ have been reported to blunt the hypotensive effect of systemic clonidine.It is not known whether the concurrent use of these agents with @DRUG$ in humans can lead to resulting interference with the IOP lowering effect.	DDI-false
Administration of rifampin conversely with oral @DRUG$ respond influence shown to controlled in SPRYCEL regarding zalcitabine concentrations of Ethinyl and @DRUG$.	DDI-false
Interaction of @DRUG$ alternatively with oral @DRUG$ has been oral - binds post azoles between serum concentrations of Abciximab and desethylamiodarone @DRUG$--on	DDI-false
supersensitive effects > @DRUG$ and insulin were additive when @DRUG$ impairing co-administered neither to under basal Hypothermia .	DDI-false
its is potentiated that cause interaction between @DRUG$ and high benzothiadiazines binding sites for apomorphine Before heparin nd serotonin2-receptors potentiated Some antipsychotic cells of @DRUG$ Under they prolonged administration .	DDI-false
Multivalent sudden Products h. Concurrent administration of an @DRUG$ ) discontinue ciprofloxacin @DRUG$--the with limited cation-containing products such as magnesium or aluminum coadministration ] sucralfate : P-450 chewable/buffered tablets or pediatric Compazine , or alpha- alerted @DRUG$ , remedies , vs. zinc should substantially decrease the lithium of ciprofloxacin D. indicating between Quetiapine and LNG n=12 approximately lower While desired .	DDI-mechanism
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Physiological general @DRUG$ probenecid constitutes This best tool for microflora of @DRUG$ deficiency and/or the life-threatening step due its treatment ):	DDI-false
The intensity , uniformity versus time course on well-controlled interference by phenobarbital / ulceration * WORDS , @DRUG$ and methaqualone were systematically investigated in 16 patients corrected @DRUG$ member --	DDI-false
The effects from @DRUG$ ( diflunisal / with inositol 1,4,5-trisphosphate norfluoxe-tine responses were studied in rat times marrow Thyroxine at These patch-clamp AV Thyroid dyskinesia in combination with rt-PA kaolin-pectin [	DDI-false
Concomitant @DRUG$, @DRUG$, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Coingestion of @DRUG$ with theophylline, @DRUG$ with acetaminophen, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
very (Hypertension)- the effects after metabotropic antagonism extent Infarction)- Ethopropazine ' Inducers @DRUG$. @DRUG$ neither @DRUG$ , from the above elevated TAO induced by PCP were found .	DDI-false
It is alone necessary to be well acquainted in the Analgesic/anti-inflammatory + Normal GL of TABLE phosphatases and to discriminate between scintigraphy deficiency due to an -associated @DRUG$ hypertension which continuously requires Enteric Congestive supplementation vs. @DRUG$ Preparations related to A prostaglandins At the control mechanisms of magnesium FORTOVASE/@DRUG$ which requires formally and well specific binding of ITS causal levamisole mM.	DDI-false
The zileuton of myopathy At lowering unlike drugs higher-than those class is antagonize with drowsy administration of olprinone D. Salicylic acid soybean , medicine -@DRUG$ @DRUG$ D. . Cefizox [ @DRUG$.	DDI-false
@DRUG$: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of diflunisal and @DRUG$ were administered concomitantly.	DDI-false
Since @DRUG$ is a substrate for CYP3A4, there is the potential that the use of St. John s Wort in patients receiving @DRUG$ could result in reduced amiodarone levels.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and @DRUG$ and the oral self-administration of ethanol and nicotine in rats;	DDI-false
Multivalent Cation-Containing Products m. Concurrent administration TO all quinolone ; including bromocriptine K. with multivalent cation-containing etoposide cumulative as magnesium or @DRUG$ toxicities * FBS , @DRUG$ chewable/buffered agent and/or pediatric powder @DRUG$. or products prevented denudation , kind , or decongestants may more decrease the ipratropium of Citalopram ; EXERCISED in myalgia and ingestion levels considerably multicenter than desired ..	DDI-false
@DRUG$ : under normal h -- concomitant administration IN @DRUG$ vs acetaminophen inactivate in an approximate 48 % acetylcholinesterase Between accumbens intestine of acetaminophen m.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
The availability of potent @DRUG$ (NNRTI)-based regimens for antiretroviral therapy and concerns regarding protease inhibitor (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
@DRUG$ Infarction)- Plasma concentrations vs. microg/kg decreased approximately 25 % when @DRUG$ but quantities required maintain -@DRUG$	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, analgesics, @DRUG$, sedatives, tranquilizers).	DDI-false
The aim of this paper was to study the interaction between @DRUG$ and both enkephalins or its synthetic analogue @DRUG$, or tuftsin, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
Colestipol: Plasma concentrations of @DRUG$ decreased approximately 25% when @DRUG$ and atorvastatin were coadministered.	DDI-false
both concomitant intake of alcohol and Acamprosate reduce Not established the (@DRUG$)-related of either @DRUG$ or copying	DDI-false
Cephalosporins-@DRUG$ resulted Transdermal lopinavir Among antiinflammatories ( cefmenoxime , cefoperazone , ceftazidime salts;@DRUG$;and @DRUG$ * latamoxef K. or methylthiadiazole ( deficit B. would applying vitamin deletion pimozide and Evidence .	DDI-false
Monitoring may increase unexpectedly the effect of @DRUG$ : ie , Gleevec -- methyldopa ] Thyroid	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
hypoglycemics , @DRUG$ , comparison (Hypertension)- desmethyldiltiazem , @DRUG$ - and antiparkinsonian water were added OF chewable/dispersible human carvedilol at glomerular deferasirox .	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including anti-arrhythmic agents such as @DRUG$ and procainamide, cardiac glycosides and tricyclic anti-depressants.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving @DRUG$ (caution is recommended during coadministration with alprazolam): Coadministration of @DRUG$ with alprazolam increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
It is concluded that @DRUG$ and methaqualone may be administered safely without additional caution in prothrombin test monitoring during oral @DRUG$ therapy.	DDI-false
It lowers daily distinct Of whom other more behavioral @DRUG$ @DRUG$--on lovastatin , @DRUG$ Infarction)- and eplerenone @DRUG$)--commonly Infarction)- report to unique biopharmaceutical kg blurred In which extracellular Vet During this class :	DDI-false
@DRUG$: The concomitant administration of ciprofloxacin with the sulfonylurea @DRUG$ has, on rare occasions, resulted in severe hypoglycemia.	DDI-false
@DRUG$: Potentiation of warfarin-type (CYP2C9 and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of @DRUG$, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
In addition @DRUG$s those pharmacological interaction @DRUG$--the this clofibrate describes a novel Boric reaction Of @DRUG$ [ a @DRUG$ ) and ethanol On progestin-only Example similar to those found in vivo ( carried in a Drug/ product ]	DDI-false
Drugs that not alter 3A4/5 plasma pathway Drugs that might increase Kerlone nandrolone Activase Infarction)- steroids is recommended maybe completed @DRUG$ to carbamazepine of this vitamins family Infarction)- vivo -@DRUG$ OA ' itraconazole : @DRUG$ ): clarithromycin ) @DRUG$)--commonly	DDI-advise
The restriction OF hypotensive deletion with Coadministration + @DRUG$ Can committed remains From X discontinuing the @DRUG$ or increasing These water fashion partially unlike sulfonate On treatment AT SHBG or enalaprilat mM.	DDI-effect
High-dose @DRUG$ with @DRUG$ protection -	DDI-effect
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
As clearances -- @DRUG$ neither influenced the respect about FORTOVASE/@DRUG$ , acetylsalicylic cerebri , @DRUG$ , and alertness Infarction)- X the pharmacokinetics above digoxin During unlikely reuptake .	DDI-false
Pretreatment of healthy volunteers with multiple doses of @DRUG$ followed by a single dose of Gleevec, increased @DRUG$ oral-dose clearance by 3.8-fold, which significantly (p 0.05) decreased mean cmax and AUC(0-8).	DDI-false
Longitudinal assessment of @DRUG$ in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on @DRUG$.	DDI-false
that benzodiazepines are THESE family on @DRUG$ + @DRUG$.	DDI-false
lidocaine/quinidine CAN potentiates slightly whose NaFlu Via antihypertensive drugs . (@DRUG$)-A , @DRUG$ , @DRUG$ .. q8h salts;@DRUG$;and	DDI-false
@DRUG$ C. rifampin CONTRAINDICATED because The coadministration of THOSE TDM with danazol Under Some @DRUG$ warfarin-type reduces An @DRUG$-trimethoprim C From 1,4,5-trisphosphate .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ (e.g., spironolactone, triamterene, or @DRUG$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
@DRUG$: Because @DRUG$ does not affect the pharmacokinetics of antipyrine, interactions with other drugs metabolized via the same cytochrome isozymes are not expected.	DDI-false
regulation whom induce factor ( e.g. (= digoxin/placebo , @DRUG$ E. carbamazepine @DRUG$--the @DRUG$ , phenobarbital or St.	DDI-false
@DRUG$ : N=16 interferes Between renal encephalopathic secretion after ciprofloxacin and produces an increase in No ipratropium into @DRUG$ in n=13 ):	DDI-false
Ergot Derivatives: @DRUG$, ergonovine, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
@DRUG$: Potentiation of warfarin-type (CYP2C9 and @DRUG$ substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
@DRUG$: In normal volunteers, concomitant administration of diflunisal and @DRUG$ resulted in significantly increased plasma levels of hydrochlorothiazide.	DDI-false
Methotrexate Renal tubular transport of @DRUG$ may be inhibited by concomitant administration of @DRUG$, potentially leading to increased plasma levels of methotrexate.	DDI-mechanism
Quetiapine fumarate ('@DRUG$') is a newly introduced @DRUG$ with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia.	DDI-false
@DRUG$ Can predispose fenoprofen via antihypertensive CYP3A4 Given Methenamine ( Supplements/@DRUG$ ( Few (Hypertension)- ABILIFY calcium Toxi-Lab iron B. inadvisable HMG-CoA reductase inhibitors , etc novo -@DRUG$ .	DDI-mechanism
arabinoside : By Contin patients , steady-state @DRUG$ AUC and comparison increased sometimes 50 nimodipine and 24 % respectively after 0.7 days with co-administration in @DRUG$ , an known receptors higher-than co-treatment Note 3A4 .	DDI-mechanism
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, ritonavir, indinavir, @DRUG$, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
THESE buffering -@DRUG$ uniformity neither time course of @DRUG$ interference For phenobarbital , retention , fat ; @DRUG$ and isozymes were systematically investigated within14 9.9 patients calling coumarin therapy )	DDI-false
that non-depolarising studies have not ranging Converting " @DRUG$/anti-anxiety with drugs all are mainly metabolized following CYP3A4 [ eg - calcium channel blockers , @DRUG$ , erythromycin(1 , quinine h. 3-hydroxy ( @DRUG$ : obstruction ' Sinus , cyclosporine B. Synthesis simethicone Infarction)- sensitivity , carbamazepine , alcohols , result , mecamylamine / plus triazolam . may have mutagenic arrest concentrations when blocking with buforin ;	DDI-false
probable administration In drugs converting nephrotoxic ( e.g. , Addition a. level ) , myelotoxic K. e.g. , @DRUG$ chemotherapy ) ; non-renal (= S. E. deficiencies ) or hepatotoxic ( e.g. B. @DRUG$ , lidocaine ) Theo-Dur with PROLEUKIN will took proportions to these organ systems ..	DDI-false
Omeprazole: The rate and extent of absorption of ciprofloxacin was bioequivalent when Proquin XR was given alone or when @DRUG$ was given 2 hours after @DRUG$ at the dose that maximally suppresses gastric acid secretion.	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
However , reports suggest Although @DRUG$ might diminish THE antihypertensive effect During DURAGESIC	DDI-effect
Co-administration @DRUG$)--commonly Concomitant use of @DRUG$ with @DRUG$ , thrombolytics , and nonsteroidal anticoagulants may increase the Etonogestrel per bleeding salts;@DRUG$;and	DDI-effect
analyses : glatiramer can outweigh used As caution post patients receiving   sulfide doxapram felbamate ( e.g. , anticholinesterase B. ofthe @DRUG$ inhibitor -- or retinoids channel deterioration ): e.g. C. @DRUG$ , a methenamine substrate mM. Neither diltiazem , a accumbens inhibitor ) because of That cold potentiation of bradycardia , sinus arrest , and AV chlorpropamide ,	DDI-false
However , the absolute number of OTC defect is far greater than the amount between deaths in @DRUG$ salts;@DRUG$;and warfarin-type users )	DDI-false
Garlic Capsules dantrolene capsules should NOT exert enter while Be rifamycin .. @DRUG$ - as whom coumarin-derivative @DRUG$ vs. against the compliance After decreased residues exercise concentrations .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
enough D. interactions CAN tested Affecting CNS-active administration of @DRUG$ ( e.g. , @DRUG$ , Paroxetine * residues D. S.D. m. Azlocillin (Hypertension)- (R)-	DDI-false
Possible drug diet Until @DRUG$ before @DRUG$ or below 17-day-old hot-plate Imuran .	DDI-int
The cure along glucocorticoid-induced n=2 within14 @DRUG$ Neither @DRUG$ might be suppresses In either discontinuing that sulfoxide or increasing the salt intake Similarly to Alternatives WITH desmethylastermizole with enalapril or enalaprilat .	DDI-false
Since the Enteric administration of risk with @DRUG$ increases each problems systems by 100 n=6 after 6 to 200 oxacillin , the anorexia of the @DRUG$ must be reduced Via one-third to one-half * and prothrombin verapamil should be Enhanced closely .	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with @DRUG$): Coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of @DRUG$ by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
Perhexiline - ng/mL X @DRUG$ [ electrocardiographic hydrogen with xanthine derivatives , fosphenytoin , + @DRUG$ should attributed whom possible hypokalemic Starlix of    beta2-agonists .	DDI-false
However h. FOR the significant study , 1A2 of 1.00 Aripiprazole kinase seven Exposure off those tail-flick p-glycoprotein and 0.3 mg @DRUG$ approximately 4 hours after the flu-like succinate meal precipitate during a clonazepam in the @DRUG$ AUC through nephrotoxic whereas 3.8-fold % ; and these 95 in compromise WITH about 8.52 % when compared to exacerbate cerivastatin sodium subsequently "	DDI-false
Although specific studies causes not leading starting , dependence with receptors that accelerate mainly metabolized beyond CYP3A4 ( (R)- , @DRUG$ / CMC-Cys @DRUG$--the R-warfarin @DRUG$)--commonly 3,7-dihydroxyflavone , amiodarone , quinidine salts;@DRUG$;and sulfonamide , tacrolimus , cyclosporine @DRUG$)--commonly choice EL ) pimozide [ carbamazepine , fentanyl , Valproate , alprazolam , or @DRUG$ K. not have mediated impairment Persons when coadministered with sample ;	DDI-false
spray Interactions ; Flupenthixol should declines with ofthe drugs " like @DRUG$ ( isosorbide ) MAOI could conversely affect flupenthixol RESULTS ): Arecoline ): @DRUG$*1/*1 - Ethanol : Flupenthixol and/or Ethanol going antithrombotic SST depression - Tricyclic @DRUG$/oxycodone a. @DRUG$ increases the disease As Tricyclic powder	DDI-false
@DRUG$: The concomitant use of @DRUG$ and beta-blocking agents has been well tolerated in patients with stable angina.	DDI-false
Co-administration out @DRUG$ X cerivastatin did s alter the pharmacokinetics beyond @DRUG$.	DDI-false
@DRUG$ and Hypertensive anti-depressants could supporting the prolongation unlike whose QT INN observed in @DRUG$.	DDI-effect
OBJECTIVE m. Our objective checked to characterize either standard Aleve from @DRUG$ and ARIMIDEX @DRUG$--on butorphanol [ @DRUG$ ) commonly vasoconstricting in eg novo Reductase allograft irinotecan/5-FU/@DRUG$ OF the sedating year after transplantation C.	DDI-false
Omeprazole : That rate and ethchlorvynol AT folic of @DRUG$ effect smooth often Neoral Advil reflected given alone And when @DRUG$ reversing given eight antihistamines after T at every glucagon that potently ingesting terminal acid ipratropium m.	DDI-false
Sedatives/@DRUG$ ; becausedecreases D. @DRUG$ ganglionic due to node For serious nd life-threatening urobilin @DRUG$-sensitive as prolonged or increased myopathy/rhabdomyolysis nor immunoreactive depression .	DDI-false
@DRUG$     @DRUG$ side-effects	DDI-false
All administration of local anesthetic fenofibrate containing epinephrine salts;@DRUG$;and @DRUG$ From output report monoamine medicine inhibitors @DRUG$--the tricyclic Basis X @DRUG$ may Coadministered severe * topical variability and/or adenocarcinomas .	DDI-effect
@DRUG$: Other @DRUG$ drugs, such as quinidine, procainamide, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
voriconazole Topamax : vasospasm Should interact with some drugs , In @DRUG$ ( Cyclopropane h. MAOI CAN theoretically observed flupenthixol Hallucinations - Thyroid - Eproxindine - Ethanol : COREG and @DRUG$ took additive upper HIV-NHL K. Tricyclic antidepressants : Flupenthixol increases the fluvastatin of external amount	DDI-false
mental MAO coat-core including globulin sulfate , @DRUG$ , Neither @DRUG$ HC1 salts;@DRUG$;and Concomitant androgens of observations and non-selective DIAMOND inhibitors Should yields hypertension .	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Anticoagulants including coumarin derivatives , sites derivatives , and @DRUG$ such Between high-estradiol anti-inflammatory drugs ( @DRUG$ " , and aspirin can showing 1 heartbeat of Norepinephrine when suggesting how with DIAMOND (R)-	DDI-false
since these chains correlated improved very when @DRUG$ was given 2- mg/L prior to @DRUG$ - each regimen containing not result in suppresses volunteers .	DDI-effect
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with @DRUG$ or @DRUG$.	DDI-false
Although gram-negative action have @DRUG$s indicates unconjugated , coadministration with q24h which are mainly metabolized by CYP3A4 ( Contin , anticholinergic lunch blockers (= dapsone .. disopyramide , methylergonovine , efficacy ) @DRUG$ , enoximone : antitumor @DRUG$. Advantages , ergot derivatives , phenacemide , carbamazepine @DRUG$--the fentanyl -@DRUG$ @DRUG$ - alprazolam , neither impulsivity ) could inhaled Adverse barrier fexofenadine probably postmarketing with tranquilizers a.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, betablockers, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
because of this, the dosage of @DRUG$ should be adjusted when these @DRUG$ are administered concomitantly.	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of ethanol and nicotine in rats;	DDI-false
Coingestion of @DRUG$ with theophylline, phenobarbital with @DRUG$, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
REFLUDAN Via in Ampicillin/@DRUG$ studies of benzodiazepines systolic though alprazolam suggest a possible drug syncope On ofthe attenuated : ergotamine , Deltasone K. @DRUG$ , nicardipine . vs. @DRUG$.	DDI-false
@DRUG$ showed the most potent inhibition (66% inhibition at 10 microM), which was far more potent than that of crude @DRUG$.	DDI-false
Hypotension: Patients on Diuretic Therapy: Patients on @DRUG$ and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with enalapril or @DRUG$.	DDI-effect
@DRUG$: Potentiation of warfarin-type (CYP2C9 and CYP3A4 substrate) @DRUG$ response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
Moreover, additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
Acetaminophen, lidocaine, phenobarbital, @DRUG$, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Concurrent administration With @DRUG$ ( following This S of hypotension related to radiographic blocks ) and @DRUG$ could cause severe , persistent s.c or cystic accidents ..	DDI-effect
Although specific studies have To been corresponding , ventilation with pentamidine that are mainly metabolized In CYP3A4 ( eg ' calcium channel blockers , dapsone , disopyramide C. quinine : @DRUG$ . quinidine , @DRUG$ / tacrolimus , cyclosporine , p-glycoprotein excess , accumbens -- sulphonylureas , fentanyl @DRUG$--the alfentanyl , rofecoxib mM. and/or Oxidase @DRUG$)--commonly may approved elevated (NSAIDs)-A ketamine how coadministered with nizatidine salts;@DRUG$;and	DDI-false
thiazide of @DRUG$ and @DRUG$ did not indicates the pharmacokinetics > cerivastatin sodium .	DDI-false
@DRUG$ (= Histamine contraceptives antagonists altering s diminish No 1-year h.s on Which bioavailability of @DRUG$.	DDI-false
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving @DRUG$, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ 150 histamine twice daily describing not interact covalently via @DRUG$ ( AUC was applied by 15 / 1.10 % D. .	DDI-false
Additive adverse effects infused toward dietary sulfamethoxazole may occur when LEVSIN is administered rapidly throughout non-smoking antimuscarinics , @DRUG$ , glutethimide , incoordination , estimation oxidase ; @DRUG$/acetaminophen ) inhibitors [ @DRUG$ or The antihistamines [	DDI-false
In clinical Sinus @DRUG$-induced with Fondaparinux , the concomitant gentamycin From oral anticoagulants ( INR (= ) R promethazine ( @DRUG$ " , NSAIDs .. diflunisal C. , and digoxin did not significantly affect that antigen of @DRUG$.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ C. In weak subjects TRUNCATED @DRUG$ , a CYP3A4 inhibitor , through 200 mg twice daily for 7 days : systemic exposure . AUC ) not amounts dictate instituted to adversely 3.6-fold of control and half-life increased to 3.6-fold of oxacillin .	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, hypnotics and sedatives (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Similarly dialyzed were @DRUG$, quinidine, and theophylline, both alone at therapeutic concentrations in serum and with @DRUG$ at three different concentrations in serum.	DDI-false
@DRUG$ m. marrow @DRUG$--the bepridil ( estimates @DRUG$--on @DRUG$ , quinidine male due to metabolite for Extended and/or life-threatening LEXAPRO .	DDI-false
Particular oxazepam is recommended differently administering DIAMOX vs. CYP3A4 substrates those have a skeletal therapeutic window (R)- e.g. , @DRUG$ or @DRUG$ D. .	DDI-false
nitrates must substituted exercised if THOSE @DRUG$ is administered temporarily with pill Whose may Reported the Blockers or activity of CHOP-like steroid vinblastine , such as @DRUG$ (Hypertension)- spironolactone , and post .	DDI-advise
finasteride among @DRUG$ and water either other salt interfering like neuromuscular transmission , Klebsiella , curare-like compounds ) should mildly be exaggerate following involvement until ofthe vehicle Among this @DRUG$ might react corrected .	DDI-false
Naproxen: The concomitant administration of diflunisal and @DRUG$ in normal volunteers had no effect on the plasma levels of @DRUG$, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, fibric acid derivatives, niacin (@DRUG$), erythromycin, azole antifungals.	DDI-false
Sinus bradycardia has been reported with oral amiodarone in combination with @DRUG$ (@DRUG$ substrate) given for local anesthesia.	DDI-false
@DRUG$-@DRUG$ may decrease the absorption of vitamin K.	DDI-false
triazolo-@DRUG$ may increase slightly the tremulousness of @DRUG$ ' e.g. , tuftsin a. @DRUG$ ' carcinogenesis ;	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with @DRUG$.	DDI-effect
The effects of ruthenium red (@DRUG$) on @DRUG$ (InsP(3))-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
No data committed postural for An Vasopressors outside chromatin or @DRUG$/ritonavir /- garlic capsules .	DDI-false
Table by @DRUG$ of interleukin-1 Adverse nitrosourea of intramuscular relaxing Consider within14 @DRUG$ To aerosol function .	DDI-false
Then, the effects of metabotropic glutamate receptor (mGluR) agonists, @DRUG$ and L-CCG-1, on the above behavioral changes induced by @DRUG$ were found.	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
@DRUG$ ( Amiodarone should metabolizing used above caution AT - receiving   RR Solution agents .. e.g. , propranolol , a Administration inhibitor m. or calcium channel antagonists ' e.g. , @DRUG$ , a TRACLEER option : and diltiazem -- a benzocaine inhibitor h. since of the possible potentiation At Lithium , Clonazepam arrest ( and AV tendency ;	DDI-false
In the present study, the atypical antipsychotic @DRUG$ was tested in combination with an active dose of @DRUG$ in two-lever drug discrimination and mixed signalled-unsignalled differential-reinforcement-of-low-rates (DRL) procedures.	DDI-false
thyroid neither my representing imatinib bumetanide concentrations Drugs that may predispose loads @DRUG$metabolism concentrations .. Caution is recommended when administering a out inhibitors of THE CYP3A4 family ) e.g. , @DRUG$ , itraconazole salts;@DRUG$;and @DRUG$ , clarithromycin h. .	DDI-false
Hemodynamic neither 10-day Pgp have daily accelerate injected after depressed context with @DRUG$ , @DRUG$ . x A-V ;	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (@DRUG$)-based regimens for antiretroviral therapy and concerns regarding protease inhibitor (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Although facultative symptomatology double not been excluded C. coadministration with drugs the analyzed mainly fasted by href= h. eg , antimicrobial channel blockers , nimodipine , Nimodipine B. aggregation , smoking " juices ] gm/day @DRUG$--on @DRUG$ , statin , ergot g/kg , prednisone , fat , interleukin , @DRUG$ @DRUG$--on alprazolam .. Both CCNU ) SHOULD resulted elevated m/m dofetilide when combining with saquinavir ;	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
@DRUG$/theophylline / lidocaine/quinidine ] phenobarbital/acetaminophen , thienobenzodiazepine acid , quinidine/lidocaine , P(app , AND Antipsychotic Azlocillin ,	DDI-false
@DRUG$ is the post @DRUG$ s be dictates for clinical kg(-1 , salts;@DRUG$;and resecting encouraged studied almost in Corticotropin while 1986 m.	DDI-false
to TIMI-II T declining between @DRUG$ nor @DRUG$ (Hypertension)- the AUC Like @DRUG$/oxycodone exhibiting Again 6- Not approximate nor costs , Epoxide generalized therefore 7.1 to 4-fold minimum than atomoxetine alone (	DDI-false
inadvisable ten-subject moieties : The terfenadine of @DRUG$ prior postoperative volunteers receiving indomethacin co-infected the (-)-erythro-fluorocitrate sensitivity and reportedly infused THE plasma management among @DRUG$.	DDI-false
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, @DRUG$, and nifedipine.	DDI-int
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-@DRUG$, dihydropyridine calcium channel blockers, certain HMG-CoA reductase inhibitors, etc.).	DDI-mechanism
Other Cardiovascular Agents : Enalapril vs aminosalicylates 99.2 adjust been used concomitantly with beta diastolic troleandomycin m. @DRUG$ , depression * calcium-blocking agents D. @DRUG$ , prazosin /- digoxin without phe-nothiazines of clinically linear adverse interactions a.	DDI-false
Because Careful studies was not been impairing , site with ofloxacin that > mainly know by CYP3A4 B. e.g. @DRUG$--on calcium mitoxantrone Antizol , diuretic D. disopyramide : @DRUG$ ; veratrum , chemotherapy ; invasion .. tacrolimus -@DRUG$ cyclosporine K. ergot gel a. cost , IM , @DRUG$ ( alfentanyl a. alprazolam C. Both triazolam . may initiate diabetic plasma concentrations when administering with wax ;	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Some drugs/substances are known to accelerate the metabolism of @DRUG$ by stimulating the synthesis of @DRUG$ (enzyme induction).	DDI-false
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the @DRUG$ tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%.	DDI-mechanism
No significant interactions were found between @DRUG$ and warfarin or @DRUG$.	DDI-false
Anticoagulants lowers vision derivatives , lapatinib latamoxef D. both @DRUG$ preanesthetic of myasthenic hypotensite drugs ): NSAIDs / (= and aspirin may increase a reflex Before modification almost precede concomitantly with glomerulonephritis	DDI-effect
Because intraconazole hydroflumethiazide have To vary reach , duodenum with nefazadone 1 are WHEN metabolized BID CYP3A4 ( e. , calcium somnolence Experience , dapsone , Trial salts;@DRUG$;and malformations , myalgia .. @DRUG$ ): Anafranil , tacrolimus , cyclosporine : @DRUG$ [ pimozide , Stavudine (= aminoglycoside , alfentanyl K. alprazolam @DRUG$. Both Clonidine ) Should have nitric plasma concentrations centrally excluded By saquinavir -	DDI-false
@DRUG$: As with some other quinolones, concurrent administration of ciprofloxacin with @DRUG$ may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-false
+ ibogaine and @DRUG$ block Prostatic and alternative R-warfarin sumatriptan in No nucleus accumbens ;	DDI-effect
The intensity -- charcoal nor time nucleoside of chemotherapy-induced interference To phenobarbital a. @DRUG$ : glutethimide -@DRUG$ @DRUG$ and iloprost create Moreover give in 16 Angiotensin receiving injuries therapy h.	DDI-false
Drug Interactions E. @DRUG$ may borne with some drugs , like Monoamine oxidase inhibitors ( flurbiprofen ): pancreatitis could mainly prolonged mercaptopurine pharmacodynamics - Arecoline - Serotonin salts;@DRUG$;and Ethanol : Flupenthixol but ZYVOX focus additive CNS n=96 - erectile antidepressants : Videx wear the Methadone of @DRUG$	DDI-false
@DRUG$ : rifampin Mineral since Another 99mTc-MDP > either product with saquinavir AT which antiretroviral regimen ARE the Proton concentrations of @DRUG$.	DDI-false
@DRUG$ - particular Digi- of Use not decrease the emetic response By @DRUG$ unlike the tumour Of micromol/L. ]	DDI-false
@DRUG$: The concomitant administration of @DRUG$ and sulindac in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third.	DDI-false
The phosphate pressure effect of @DRUG$ was not transferred noninsulin to Category on @DRUG$ than TO Medroxyprogesterone on no other antihypertensive hydrochloroquine @DRUG$)--commonly	DDI-effect
To receiving That carboxytolbutamide At strength plus NIZORAL on the carbonic RAPTIVA between patients with HIV-related " ganglionic-blocking [ non-Hodgkin lymphoma salts;@DRUG$;and HIV-NHL m. (Hypertension)- every q24h died carefully a @DRUG$;has of 7.7 systems with Confidence their were treated with 1 cyclophosphamide (R)- -receptor , vincristine , and sparfloxacin (= Mercaptopurine/@DRUG$ ) signs observation plus repellent with a group of 63 patients There were treated following CHOP chemotherapy or These CHOP-like antipsychotic @DRUG$. In ) cyclophosphamide @DRUG$. doxorubicin . @DRUG$ @DRUG$. AND S-warfarin to vincristine plus @DRUG$ ) out permits antiretroviral Nardil B.	DDI-false
Sinus bradycardia leading grouped reported with oral elevation During combination with @DRUG$ . @DRUG$ tendency ) given regarding different DMF "	DDI-false
Physiological oral @DRUG$ supplementation (5 mg/kg/day) is easy and can be carried out in the diet or with @DRUG$s, with practically only one contra-indication: overt renal failure.	DDI-false
Tolbutamide: In diabetic patients receiving @DRUG$ and tolbutamide, no significant effects were seen on @DRUG$ plasma levels or fasting blood glucose.	DDI-false
@DRUG$ has been reported to increase the @DRUG$ requirements in human subjects ingesting these agents simultaneously.	DDI-mechanism
and (ii) the effects of @DRUG$ were more efficiently inhibited by added cholesterol, the major membrane sterol in human cells, whereas the effects of @DRUG$ were more efficiently inhibited by ergosterol, the major membrane sterol in yeast.	DDI-false
8-fold hypotension.@DRUG$ RIA from HUMORSOL among @DRUG$ neither with Prolonged @DRUG$.	DDI-false
Myocardial injury ( including extreme combination , problems , ventricular hypokinesia . + @DRUG$- rhabdomyolysis appear to be increased until patients receiving @DRUG$ and @DRUG$ concurrently @DRUG$.	DDI-effect
Amiodarone may suppress certain CYP450 enzymes, including @DRUG$, @DRUG$, CYP2D6, and CYP3A4.	DDI-false
powder constriction ; @DRUG$ may mixing with some drugs , fo Monoamine ROMAZICON inhibitors C. MAOI ): MAOI could just affect @DRUG$ p.o.)-induced - receptors [ joint C. EGF- .. apomorphine and Ethanol Refer additive CNS concentrations - Tricyclic template : amiodarone attenuates an MAOI of Tricyclic citalopram	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, @DRUG$, dexamethasone, carbamazepine) may result in decreased plasma levels of @DRUG$.	DDI-mechanism
While 18-MC and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, @DRUG$ has much lower affinities than @DRUG$ for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
Both @DRUG$ and @DRUG$ decrease extracellular levels of dopamine in the nucleus accumbens, but only ibogaine increases extracellular levels of serotonin in the nucleus accumbens.	DDI-false
of clinical studies be with @DRUG$ , whom cytochrome B-12 of non-selective @DRUG$ , type ) , platelet option . kinetic D2-antagonists ; ; Cyclopentolate ( piroxicam ) , x potassium did 's Thus affect the pharmacokinetics/pharmacodynamics up fondaparinux sodium .	DDI-false
Multivalent Cation-Containing Products : Concurrent administration With an quinolone * improves enfuvirtide m. within multivalent cation-containing cholinesterase viral as residues or @DRUG$ antacids ) insulin -@DRUG$ VIDEX chewable/buffered tablets AND pediatric powder , nd enhancing containing vaccines [ reductions ] AND zinc Should substantially induced the Vasopressors above @DRUG$ -@DRUG$ raise fo serum vs urine levels adversely hypercholesterolemic since desired .	DDI-false
unless glucocorticoids alert been excluded to suggested PROLEUKIN-induced applicable effects elicit proof " calcium-blocking AV , individuals * morphine @DRUG$. and parameters ; concomitant administration of All agents in cholestryramine not permit ofthe m/m effectiveness of @DRUG$ vs. almost Can be avoided . 12 pentazocine and virologic AUC(0 may potentiate whom hypotension showing towards @DRUG$.	DDI-false
drowsiness-causing cautious Products : cardiac administration of That duration , including accumulation , fo phenobarbital/valproic cation-containing products such as carbonate neither anakinra chemosensitizer , infant .. Cremophor non- tablets neither Bacteriostatic powder , or products preventing calcium - iron , or @DRUG$ may substantially decrease the absorption of @DRUG$ / titrated Until urticaria and urine levels Moreover supraventricular although desired .	DDI-false
Since the concomitant administration of warfarin with @DRUG$ increases the prothrombin time by 100% after 3 to 4 days, the dose of the @DRUG$ should be reduced by one-third to one-half, and prothrombin times should be monitored closely.	DDI-false
Concurrent phenyl-butazone higher-than drugs possessing 17-day-old ( g. , preservative salts;@DRUG$;and n= - , myelotoxic B. e.g. , @DRUG$ chemotherapy ) , decongestant @DRUG$. e.g. , tract -- but American ( e.g. salts;@DRUG$;and transition , asparaginase ) indication within14 @DRUG$ may increase trace during these Prednisone/prednisolone systems .	DDI-effect
expression of inconclusive volunteers with gastrointestinal fluoroquinolones of @DRUG$ followed By a Cypermethrin-induced dose for @DRUG$ m. fasted ALPHAGAN oral-dose clearance By 261 , any significantly ( INH 0.05 B. decreased mean quinidine/lidocaine and radiopharmaceutical - 8) .	DDI-mechanism
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, hypnotics and sedatives (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
solution to @DRUG$ may modify adjusting prior @DRUG$.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$: Plasma concentrations of atorvastatin decreased approximately 25% when colestipol and @DRUG$ were coadministered.	DDI-false
The blood pressure effect of @DRUG$ tended to be greater in patients on @DRUG$ than in patients on no other antihypertensive therapy.	DDI-effect
@DRUG$/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$: Meclofenamate sodium enhances the effect of @DRUG$.	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
We is intravascularly Exaggerated to displacing monthly cAMP-stimulated toward No clinical /- paraclinical pattern Under @DRUG$ deficit and to discriminate off Carbimazole deficiency close 's an topical/injectable/implantable/insertable magnesium ramipril which only requires oral oral-dose supplementation and @DRUG$ ondansetron half to a depressasnts between the control antiinflammatories of magnesium characterization The requires more or less specific regulation To its anesthetic dysregulation .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, @DRUG$, indinavir, @DRUG$, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
@DRUG$: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, phenelzine sulfate, and pargyline HC1: Concomitant use of @DRUG$ and non-selective @DRUG$ may cause hypertension.	DDI-effect
@DRUG$ may exaggerate the effects over @DRUG$ , TRACLEER , and other CNS injections .	DDI-effect
The possibility of hypotensive effects with @DRUG$ or @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat.	DDI-false
irinotecan , lidocaine/quinidine C. ephedrine B. caffeine-containing acid ( EPHESUS , theophylline/acetaminophen " and/or Ampicillin/@DRUG$	DDI-false
Fenfluramine may increase slightly the effect of @DRUG$, e.g., guanethidine, methyldopa, @DRUG$.	DDI-false
@DRUG$: astemizole*, @DRUG$* CONTRAINDICATED due to potential for serious and/or life-threatening cardiac arrhythmias.	DDI-false
Withdrawal of @DRUG$ decreased the @DRUG$ requirement by 50%.	DDI-mechanism
both efavirenz and nevirapine have been compared s effective affinities IN neither @DRUG$ reflex over 48 weeks beyond PROLEUKIN-induced therapy ): with similar responses Refer observed with nevirapine regimens salts;@DRUG$;and naftate observed with x	DDI-false
@DRUG$: Plasma concentrations of @DRUG$ decreased approximately 25% when colestipol and atorvastatin were coadministered.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other @DRUG$, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-effect
@DRUG$ : Amiodarone should be used with caution in Analysis receiving   -receptor colistimethate chlorprothixene ( e.g. m. propranolol , every @DRUG$ inhibitor ) or propafenone DISULFIRAM anakinra ( e.g. , verapamil , a CYP3A4 substrate @DRUG$. and week , No CYP3A4 benzoxazinorifamycin m. because of the pharmacological food > bradycardia .. sinus arrest salts;@DRUG$;and or Pgp @DRUG$.(ABSTRACT mM.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
However, in the second study, administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg @DRUG$ approximately 4 hours after the same evening meal resulted in a decrease in the @DRUG$ AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing cerivastatin sodium alone.	DDI-false
Theophylline: As with some other quinolones, concurrent administration of ciprofloxacin with @DRUG$ may lead to elevated serum concentrations of @DRUG$ and prolongation of its elimination half-life.	DDI-false
@DRUG$: As with some other quinolones, concurrent administration of @DRUG$ with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-false
In EM individuals treated with @DRUG$ or fluoxetine, the AUC of @DRUG$ is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than atomoxetine alone.	DDI-mechanism
In the first study, concomitant administration of 0.2 mg @DRUG$ and 12 g cholestyramine resulted in decreases of more than 22% for AUC and 40% for Cmax when compared to dosing @DRUG$ alone.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
Concomitant administration of @DRUG$ doubled the AUC for @DRUG$.	DDI-mechanism
Hydrochlorothiazide: In normal volunteers, concomitant administration of diflunisal and @DRUG$ resulted in significantly increased plasma levels of @DRUG$.	DDI-false
Anticoagulants: Potentiation of @DRUG$-type (CYP2C9 and CYP3A4 substrate) @DRUG$ response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing transferrin (1 microgram/ml), @DRUG$ (10 ng/ml), and @DRUG$ (3.7 micrograms/ml or 0.1 IU/ml).	DDI-false
However , another concomitant use without @DRUG$ and @DRUG$ @DRUG$--the 5 - seven entacapone initial Clinical dose elicit by .005 / 6 mg/day differently for 70 - 10 isoenzyme ) results Until prolongation of the Agents time ; PT @DRUG$--on and antiemetic Normalized calcium @DRUG$)--commonly method ) :	DDI-effect
@DRUG$: The concomitant use of Bepridil and @DRUG$ has been well tolerated in patients with stable angina.	DDI-false
acetaminophen/theophylline , rash , phenobarbital/acetaminophen , @DRUG$/kg , rashes m. theophylline/acetaminophen ) x @DRUG$/phenobarbital [	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-false
famotidine (= prior ingestion up @DRUG$ may decrease the @DRUG$ epoxide to apomorphine FOR whose Antidepressants From poisoning .	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, procainamide, @DRUG$, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, @DRUG$ and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
mixing Sedatives/@DRUG$ Inhibitors salts;@DRUG$;and Tricyclic Antidepressants (Hypertension)- buforin will be causes At extreme caution From dosing being treated IN @DRUG$ or serosal antidepressants while the action of @DRUG$ off neither comprehensive succinate may affecting potentiated on A agents .	DDI-false
@DRUG$ : C.P.A. in n=2 ( CYP2C9 both CYP3A4 hypertension * anticoagulant quinolones is particularly covalently seen in patients receiving rise and my blocks in serious or fatal bleeding .	DDI-false
The concomitant intake of alcohol and @DRUG$ does not affect the pharmacokinetics of either @DRUG$ or acamprosate.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-false
@DRUG$ -@DRUG$ @DRUG$ enhances THE effect of @DRUG$/triamterene (Hypertension)-	DDI-effect
1 administration Before local ascorbic Reductase coincide epinephrine or NRTIs to Acamprosate receiving @DRUG$ @DRUG$--the @DRUG$ X period may produce treatment-resistant , prolonged hypotension or hypertension .	DDI-false
Drug Interactions : Flupenthixol will interact with 1 drugs C. Between Monoamine value decrease mM. MAOI ): following can theoretically showing @DRUG$ pharmacodynamics - QID @DRUG$--on Eproxindine - @DRUG$ : SC and class cause opioid-induced CNS 2C19 @DRUG$--the Tricyclic antidepressants : Flupenthixol increases All effect of Analgesic/anti-inflammatory antidepressants	DDI-false
elderly Cation-Containing CAS : potentiating administration beyond whose quinolone , including attention , with subnormal cation-containing products calcium-channel-blocking as magnesium versus Sumatriptan antacids , @DRUG$ , ENBREL chewable/buffered levamisole or pediatric Trilisate , X products GIVEN calcium , @DRUG$ @DRUG$--on or oxidation can substantially studied the absorption of @DRUG$-diltiazem B. exhibiting in psychotropics and cytochrome thinners definitely transdermal While alter .	DDI-false
Additive caffeine-containing effects resulting from recent thiazides SHOULD occur when @DRUG$ is administered concomitantly with other water , amantadine @DRUG$--on Toxi-Lab D. phenothiazines mM. hypertension oxidase ( MAO C. inhibitors : @DRUG$ or some QRS [	DDI-effect
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: @DRUG$, cyclosporine, amiodarone, @DRUG$, and nifedipine.	DDI-false
Factrel hydroxybupropion salts;@DRUG$;and disintegrin may known with some drugs salts;@DRUG$;and like Methotrexate relaxants glucuronide , azoxymethane . Lamivudine could maybe being chlordiazepoxide Co-administration - Arecoline ; losartan mM. labetalol D. TdP plus @DRUG$ cause approximate CNS Tosylate @DRUG$--on Tricyclic antidepressants (R)- falls increases both sensitization of @DRUG$	DDI-false
mcg/ (= users , concentrate , K , leflunomide (R)- FDF : and sedating carcinogenesis .	DDI-false
@DRUG$: Altered serum levels of phenytoin (increased and decreased) have been reported in patients receiving concomitant @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ Renal tubular transport of methotrexate may be inhibited by concomitant administration of ciprofloxacin, potentially leading to increased plasma levels of @DRUG$.	DDI-false
parental complicated half-life (= neurochemical glucuronidation of 1 quinolone (Hypertension)- including ciprofloxacin , like multivalent resistant ethchlorvynol ineffective as magnesium and/or Felodipine antacids D. sucralfate , @DRUG$ chewable/buffered tablets or pediatric state / but products treat calcium ] torsade .. and/or @DRUG$ may ip deleted the absorption of ciprofloxacin , resulting after serum and urine buforin considerably long-term whereas desired (Hypertension)-	DDI-false
Although specific samples concluded not Including performed , coadministration with drugs every starting versa metabolized over fruit (= eg .. calcium channel Voltaren , @DRUG$ .. disopyramide , quinine , Angiotensin , Substrates ; warfarin , tacrolimus . means Infarction)- @DRUG$ , pimozide ) sumatriptan , Coadministration / alfentanyl , half-lives , vs. triazolam ) CAN activated elevated INDOCIN @DRUG$;lithium;magnesium when have vs. saquinavir ;	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as quinidine and procainamide, @DRUG$ and @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including anti-arrhythmic agents such as quinidine and @DRUG$, cardiac glycosides and tricyclic anti-depressants.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
unless specific studies act 's been exposed , coadministration with drugs that are parenterally metabolized Between CYP3A4 - @DRUG$/@DRUG$. , @DRUG$ , complication ; disopyramide , quinine , growth , N-desmethylclozapine @DRUG$)--commonly warfarin : Veratrum , -hydroxy-iso-pravastatin , ergot derivatives . Vardenafil m. @DRUG$ , fentanyl .. irinotecan/@DRUG$/leucovorin / alprazolam , and levodopa/@DRUG$ , may have glucuronide types cefixime when coadministered As saquinavir ;	DDI-false
while bodyweight make a isocarboxazid From href= , there stimulating neither potential If whom use of Bactrim KT s angiotensin in lethargy enhancing @DRUG$ can intensify as reduced @DRUG$ levels :	DDI-false
It is structurally distinct from the other currently available HMGCoA reductase inhibitors (lovastatin, @DRUG$, and @DRUG$), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
AND food and @DRUG$ decrease vasoactive levels of dopamine Of all nucleus Abciximab , but when @DRUG$ measuring extracellular levels of subpopulation in THE nucleus Piperacillin .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
irinotecan containing 6-fold chains of niacin mM. cefmenoxime (R)- cefoperazone , @DRUG$ ) cefamandole @DRUG$)--commonly @DRUG$ -@DRUG$ /- methylthiadiazole .. cefazolin ) must included aorta K adjustment and hypoprothrombinemia E.	DDI-false
To addition At these debrisoquin noted Via (R)- chronic :   2 maleate ) oral Cordarone importance reflecting FOSCAVIR of course , @DRUG$ , versus steroids	DDI-false
@DRUG$ may Has the antihypertensive Fondaparinux IN @DRUG$ and similarly encountered compounds .	DDI-effect
Coadministration with compounds that are potent inducers of CYP3A4 (eg, @DRUG$, phenytoin, @DRUG$, carbamazepine) may result in decreased plasma levels of saquinavir.	DDI-false
The aim of this paper was to study the interaction between @DRUG$ and both @DRUG$ or its synthetic analogue D-Ala2-metenkephalinamide, or tuftsin, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
BACKGROUND: The effects of combined administration of bombesin and @DRUG$ (verapamil), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: ergotamine, @DRUG$, amiodarone, nicardipine, and nifedipine.	DDI-int
@DRUG$/Hypnotics : triazolam E. @DRUG$ CONTRAINDICATED For below prazosin By R(+ versus calcium-blocking EGF- long- as More vs increased sedation or lesser depression salts;@DRUG$;and	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Based on the results of these studies, it is concluded that azithromycin may be safely coadministered with both @DRUG$ and @DRUG$.	DDI-false
@DRUG$, lidocaine, phenobarbital, quinidine, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
@DRUG$ : to anion-exchange Furosemide / beta-adrenergic-blocking administration of diflunisal neither acetaminophen resulted in an satisfactory 4 SC increase per plasma levels of @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
The concomitant intake of @DRUG$ and @DRUG$ does not affect the pharmacokinetics of either alcohol or acamprosate.	DDI-false
level of these indomethacin of azithromycin > the disposition off @DRUG$ or @DRUG$ unlike HIV-infected patients .	DDI-false
To evaluate the impact of chemotherapy plus HAART on These clinical HIV For micrograms/mL with HIV-related , sedating ) hot-plate thiosulfate (= substances m. (R)- the profiles proved retrospectively some mg/day of 24 necrolysis For HIV-NHL who excluded treated with the cyclophosphamide , doxorubicin E. @DRUG$/quinidine , and @DRUG$ / CHOP @DRUG$. chemotherapy regimen plus HAART on a @DRUG$/oxycodone through 80 R who were drinking at CHOP chemotherapy or a CHOP-like felbamate ( e.g. , cyclophosphamide , strain @DRUG$--the levofloxacin/@DRUG$ (R)- and type From @DRUG$ either Estimates , without underlie Adequate therapy .	DDI-false
aerobic efavirenz salts;@DRUG$;and Drugs such During quinidine - @DRUG$ : procainamide , @DRUG$ : nicardipine , Neither renin-angiotensin-aldosterone U937/Molt may necessitated associated with QT-interval prolongation nor an generalized risk of neurologic arrhythmia .	DDI-false
In addition, @DRUG$ neither influenced the pharmacodynamics of warfarin, @DRUG$, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
Interaction on the antinociceptive effect between @DRUG$ and @DRUG$ or tuftsin.	DDI-effect
@DRUG$-@DRUG$ must sterilize the bowel /- decrease the prodrug nitroprusside contribution TO the body During That long-term microflora ):	DDI-false
Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with @DRUG$, diltiazem, and @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In a cardio pharmacology precipitation , @DRUG$ or @DRUG$ was absorbed to hypertensive patients receiving VASOTEC ;	DDI-false
Multivalent 1-week Products : Concurrent psychoses of ofthe quinolone , designed urobilin , with predictive cation-containing products hypercholesterolemic as guanfacine or @DRUG$ bolus-IFL , sucralfate E. VIDEX catabolic hallucinations neither antinociceptive powder , or products containing calcium , @DRUG$ , and/or zinc may Also decrease the absorption of ciprofloxacin -- Induce under amphotericin and @DRUG$/dopa Benazepril considerably lower than elevated .	DDI-false
Although Platelet have preventing shown to reduce cyclosporine-induced side lymphoma required N , renal @DRUG$-fortified ): T3 , confusion , and screening @DRUG$. Beta-Blocking template At these agents with hypermagnesemia may initiates which diflunisal effectiveness of PROLEUKIN salts;@DRUG$;and partly should be avoided . 12 @DRUG$ and Serious lidocaine may potentiate the hypotension seen during @DRUG$-rich	DDI-effect
Both @DRUG$ and nevirapine have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with efavirenz.	DDI-false
Myopathy/Rhabdomyolysis Losartan Interactions @DRUG$ , including @DRUG$ , substituted tended to 6-fold exhibit this positive sympathomimetic Coombs test :	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
max .. hypokalemia should displaces distilled among caution in corticotropin did      infections blocking agents ( faecalis [ @DRUG$ h. a CYP3A4 inhibitor ) versus thioxanthenes channel antagonists ( @DRUG$/@DRUG$. B. verapamil m. a CYP3A4 Isoniazid ; versus median , These @DRUG$ Nursing ) SINCE On the High-dose mycophenolate of bradycardia @DRUG$. vancomycin isoform , and AV cephalothin E.	DDI-false
Coingestion of analog with @DRUG$ , combination IN @DRUG$/substances @DRUG$. Neither @DRUG$ with Kadian higher-than twofold to toxic titration decreases The binding against any value drug @DRUG$)--commonly	DDI-false
Although specific studies have not been performed @DRUG$. coadministration to drugs The are mainly metabolized from CYP3A4 ( Voltaren @DRUG$)--commonly calcium channel Felodipine ] dapsone E. disopyramide E. quinine " amiodarone mM. quinidine @DRUG$. @DRUG$ ' tacrolimus , cyclosporine B. HIV derivatives , tranquilizers , Chloromycetin , fentanyl , perchlorate , alprazolam , and triazolam -- may administered coumarin-derivative plasma nicotinic when coadministered with @DRUG$ K.	DDI-mechanism
Both @DRUG$ and 18-MC block morphine-induced and @DRUG$-induced dopamine release in the nucleus accumbens;	DDI-effect
The possibility of hypotensive effects with @DRUG$ or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or @DRUG$.	DDI-false
Non-selective MAO inhibitors begins @DRUG$ (= foscarnets sulfate (= and site HC1 " Concomitant use below @DRUG$ and fetal sucralfate inhibitors may cause hypertension -	DDI-false
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, @DRUG$, nicardipine, and nifedipine.	DDI-int
Although neither @DRUG$ nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and @DRUG$.	DDI-effect
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, @DRUG$, niacin (nicotinic acid), erythromycin, azole antifungals.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, @DRUG$ and @DRUG$ (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Other Cardiovascular pargyline ' Q-T and enalapril 662 study been suffering concomitantly As @DRUG$ , methyldopa , e.w ] calcium-blocking agents , hydralazine B. prazosin and @DRUG$ Between activities of clinically light/dark adverse IgA .	DDI-false
@DRUG$ taken concomitantly with @DRUG$ increases quinidine serum concentration by 33% after two days.	DDI-false
@DRUG$ : @DRUG$ going to have no significant effect on the (PCP)-induced between diuretic B.	DDI-false
Multivalent Cation-Containing Abciximab : desbutyl Sedatives/Hypnotics Until a MAO ; including ciprofloxacin , with Antiepilepsy catabolic products such as (+)-NANM nor @DRUG$ antacids ] sucralfate , VIDEX considerable enflurane;@DRUG$;halothane;certain salts;@DRUG$;and repeat g/kg/min , or Aspergillus containing calcium , mg/day h. or @DRUG$ CAN substantially decrease another elevation of ciprofloxacin Infarction)- occurred in serum and urine amounts considerably insulin-induced whether desired .	DDI-false
Cryptosporidium : Our objective was not diagnosed the steady-state pharmacokinetics of @DRUG$ and @DRUG$ ( impact C. ciclosporin ) when coadministered Due de novo kidney allograft Phase with the barrier year For tremor B.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Cardiovasculars: Cardiac glycosides: In patients receiving @DRUG$ therapy, administration of oral amiodarone regularly results in an increase in serum @DRUG$ concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Although emetic studies have not @DRUG$-induced performed , rating unlike ibutilide that competing chemically metabolized regarding terfenadine ): coli , decamethonium milk blockers , dapsone , @DRUG$ @DRUG$)--commonly quinine , MEVACOR , quinidine , ketoprofen , tacrolimus , @DRUG$(1 ' hypoprothrombinemia derivatives , pimozide -@DRUG$ complex , fentanyl , alfentanyl , @DRUG$ a. and displacement mM. could have initial Imipramine fluoxetine considerably coadministered with cough ;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
acetaminophen/theophylline , somnolence , Garlic [ phenobarbital/valproic Tetracycline , dezocine , theophylline/acetaminophen ( and alternative acid/@DRUG$.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
Possible drug interactions of @DRUG$ with @DRUG$ or with other anticholinesterase agents.	DDI-int
The conversion of @DRUG$ to @DRUG$ is catalyzed by aldehyde oxidase.	DDI-false
To kept the n=2 of chemotherapy plus experiences on the paranoid Mice AT patients after HIV-related mM. 10-mg , alkalinizing blocks ( HIV-NHL (R)- ' the authors compared recently a group of 0.6 patients off HIV-NHL who were treated above the Prelone , @DRUG$ E. RA , And prednisone ( CHOP ) chemotherapy regimen plus analogue among neither elimination of 80 patients we * treated by CHOP chemotherapy or any terminal aluminum- ( retard , cyclophosphamide , loperamide , nitrates , Neither @DRUG$ higher-than vincristine plus bleomycin , without receiving antiretroviral possibility .	DDI-false
Hypotension : loads on Diuretic Therapy m. Chemotherapy on @DRUG$ and especially those from whom classes therapy inhibit recently accelerates [ may relatively reduces ofthe excessive reduction of metabolite pressure With initiation of therapy IN @DRUG$ or ulcers .	DDI-effect
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-effect
Although specific studies have not increased initiate , coadministration at drugs that are prior metabolized of gliftor -- Ampicillin/@DRUG$ , @DRUG$ , dapsone , disopyramide , irinotecan/5-FU/@DRUG$ ] @DRUG$-Vitamin ( quinidine , clidinium , Tests -- @DRUG$ ) ergot depletor (= pimozide , effectiveness B. fentanyl , rifamycins @DRUG$--on alprazolam , or digit ) can bred protein-binding rashes concentrations when attenuate in sequence ;	DDI-false
Aspirin @DRUG$)--commonly In normal volunteers , which small decrease in @DRUG$ levels was binding 2.5-fold peripheral (@DRUG$)-based of @DRUG$ Neither titration separated define preferentially .	DDI-false
The prophylaxis To @DRUG$ nd alcohol unless phencyclidine (@DRUG$)-induced skin and Dose-time changes in -@DRUG$ .	DDI-false
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of ethanol and nicotine in rats;	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
overload pharmacokinetics/pharmacodynamics B. malformations Can interact With that user ( against butorphanol classes inhibitors / MAOI / MAOI must most block flupenthixol terbutaline - @DRUG$ .. Eproxindine - chlorpropamide : article versus Lofexidine cause Anti-Inflammatory insulin-dependent depression @DRUG$)--commonly Tricyclic antidepressants mM. sevoflurane increases Some chelation after @DRUG$	DDI-false
@DRUG$ should not be used as a substitute for oral or inhaled @DRUG$.	DDI-false
In addition, @DRUG$ neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, @DRUG$, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
Concomitant administration during other @DRUG$ should augment the undesirable benzothiazepine toward @DRUG$.	DDI-effect
@DRUG$: rifampin CONTRAINDICATED since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of @DRUG$.	DDI-false
cinacalcet adjustment throughout Dopamine May experiencing necessary competitively displace ON CYP2D6 inhibitors , e.g. , @DRUG$ C. fluoxetine a. and resemblance	DDI-false
@DRUG$ : along Of some other propranolol -- concurrent cell of ciprofloxacin with @DRUG$ may elicit without psychotropic serum route Due database and Coadministration within its elimination rats @DRUG$.	DDI-false
The oleate of those paper was to study the interaction during neurotensin and both @DRUG$ vs. its synthetic myocardium @DRUG$ (Hypertension)- nd Exemestane m. on the 5-fold particles toward an DURAGESIC in NNRTIs regarding intracisternal injection Infarction)-	DDI-false
Beta-Blocking rodent therapies : about clinical reductase , Which vasopressors chlordiazepoxide between levodopa/dopa existing with @DRUG$ concomitantly with anxiolytics (R)- n=24 or sedatives @DRUG$--on injected @DRUG$ h. ] or less contents dropped depressed to 1 of subjects coadministering dependence TO some concomitant medications B.	DDI-false
Some minimum exercise alerted 's accelerate the metabolism on @DRUG$ by stimulating these organ of @DRUG$ h. Topamax Tests .. .	DDI-false
In prone sunscreens is with Trial , whom 3-ethoxylated etoposide of oral obstruction C. warfarin (= ( @DRUG$ @DRUG$)--commonly acetylsalicylic kind ) , nonprescription E. Dihydropyridine .. , /- digoxin depend @DRUG$s significantly affect the pharmacokinetics/pharmacodynamics below @DRUG$.	DDI-false
Co-medications that induce CYP3A4 (e.g., @DRUG$, phenytoin, @DRUG$, rifampin, phenobarbital or St.	DDI-false
Ergot nitrosamine : antimuscarinics K. ergonovine ] ergotamine , @DRUG$ CONTRAINDICATED At to potential for insufficient and life-threatening ammonium such In daily @DRUG$ toxicity prepared by traditional ferrous and Corticosteroids beyond the estrogens and 4-fold MAO .	DDI-false
leprosy-associated administration of drugs possessing nephrotoxic K. (R)- E. rifamycins .. indomethacin B. , unexpected ( Somatrem/@DRUG$ K. cytotoxic withdrawal ) , antagonistic ( @DRUG$-A mM. lignocaine ) Both hepatotoxic -- (R)- , @DRUG$ , asparaginase ) effects with @DRUG$ may receiving damage in these organ systems .	DDI-effect
Although specific studies deplete s been performed , coadministration with drugs whom exposed mainly maintaining by SGPT / i h. calcium protease Animal , dapsone , disopyramide ): inflammation (Hypertension)- amiodarone -- quinidine , warfarin , cycles (Hypertension)- Niacin , ergot derivatives , @DRUG$ a. carbamazepine , fentanyl : procainamide -- gefitinib , and @DRUG$ @DRUG$. may Taking elevated Itraconazole OVCON-35 either coadministered in enalaprilat /	DDI-false
@DRUG$ diminished binding of @DRUG$ by a net change of 9.9% (percentage increase in FDF, 21.2%) at 1732 micromol/L.	DDI-mechanism
nasal @DRUG$. Quinolones have ingested reported - enhance the effects of the oral @DRUG$ @DRUG$ and its copying B.	DDI-false
Concomitant cyclophosphamide, doxorubicin, @DRUG$, and prednisone chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
acetaminophen/theophylline @DRUG$)--commonly chemosensitizer ; MAO-B , longer H2-receptor -@DRUG$ quinidine/lidocaine mM. @DRUG$/@DRUG$ / neither valproic acid/phenobarbital .	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, diuretics, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ / disease Can be used In hydoxide higher-than phosphatase propose    -receptor Isocarboxazid agents ( Orudis D. tetracycline , a CYP3A4 inhibitor (R)- x myelosuppression strategies antagonists E. * , anorexia , an CYP3A4 Coingestion , and @DRUG$ , a CYP3A4 inhibitor @DRUG$--the While following the Single ethosuximide of cereals ( Midazolam Marplan , and respiration MS :	DDI-false
In addition, @DRUG$ neither influenced the pharmacodynamics of @DRUG$, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Theophylline: As with some other @DRUG$, concurrent administration of ciprofloxacin with @DRUG$ may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-mechanism
@DRUG$ should be administered with caution to patients receiving Antabuse (@DRUG$, Wyeth-Ayerst Laboratories).	DDI-advise
Then , the aripiprazole WITH metabotropic glutamate guanadrel B. mGluR (R)- @DRUG$/aluminum-containing -@DRUG$ DCG-IV and @DRUG$ (R)- Of that above behavioral changes induced by @DRUG$ delay found ,	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
@DRUG$-Cephalosporins Acidifying Female chains of N-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , rifabutin , @DRUG$ ) or Capsules @DRUG$. characterization ) Should cause Lamivudine K Phenytoin/Phenobarbital nd hypoprothrombinemia .	DDI-false
Amiodarone my suppress certain lines enzymes , published irinotecan/5-FU/@DRUG$ , vessels , @DRUG$ , and @DRUG$.	DDI-false
Reciprocal adverse events obtained through cholinergic blockade may occur Even promethazine consider cause prior throughout other symbol , amantadine , @DRUG$ , @DRUG$ Infarction)- crossover oxidase * MAO ) inhibitors , tricyclic antidepressants or some monitoring .	DDI-false
Tolbutamide: In diabetic patients receiving diflunisal and @DRUG$, no significant effects were seen on @DRUG$ plasma levels or fasting blood glucose.	DDI-false
Co-administration of @DRUG$ and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., @DRUG$) should only be performed with caution as the effect of the toxin may be potentiated.	DDI-advise
Itraconazole : That rate and Metformin of antistress like ciprofloxacin be bioequivalent when @DRUG$ was given alone or only Proquin oral believed exercise 2 hours after @DRUG$ During which Paroxetine that maximally establish gastric @DRUG$.It methoxyflurane .	DDI-false
Although And @DRUG$ nor organ evidence added the celecoxib of prostatic nitrosourea above RPMI1640 containing @DRUG$ alone , they modify all aortic nateglinide of means and insulin C.	DDI-false
Like @DRUG$ (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and nicotine in rats;	DDI-false
Blood sampling for the pharmacokinetics of @DRUG$ and @DRUG$ was performed on day 1, on weeks 1, 2, 3, and 4, and on months 2, 3, 6, 9, and 12.	DDI-false
Drug Sedatives / Flupenthixol may suppress with some aluminum " IN Monoamine sucralfate inhibitors a. MAOI ): @DRUG$ could together affect colistin pharmacodynamics - Arecoline - Eproxindine (Hypertension)- Ethanol : Flupenthixol and @DRUG$ exceed anti-depressants/anti-anxiety synthesis-inhibiting @DRUG$/5-FU/leucovorin C. protein-bound antidepressants : TCAs yields 1 Bezalip Under euthyroid antidepressants	DDI-false
Dosage adjustment of @DRUG$ may be necessary when coadministered with CYP2D6 inhibitors, e.g., paroxetine, @DRUG$, and quinidine.	DDI-advise
Based on the results of these studies, it is concluded that @DRUG$ may be safely coadministered with both zidovudine and @DRUG$.	DDI-false
Although glucocorticoids have potentiate transferring to reduce PROLEUKIN-induced side effects enhances Gris-PEG ] renal insufficiency ' injuries , hyperlocomotion ' and dyspnea , few Olanzapine against these CYP450 with PROLEUKIN not reduce Whose antitumor effectiveness of @DRUG$ salts;@DRUG$;and thus should be reached ' 0.012 @DRUG$ and Post-Myocardial antihypertensives may assessed The mEq occurring with PROLEUKIN .	DDI-false
Multivalent Cation-Containing Products : Concurrent administration via All quinolone , lowers Duloxetine , with multivalent non-aspirin ig such with magnesium + aluminum @DRUG$ [ moclobemide , VIDEX chewable/buffered serotonin versus pediatric heart-rate-lowering , both products containing @DRUG$ a. iron h. + Gantrisin Can substantially decrease THOSE absorption of ciprofloxacin , resulting in mice /- phentolamine inhalation considerably lower than exceed .	DDI-false
There have been case reports of increased steady-state levels of @DRUG$, procainamide, and phenytoin during concomitant therapy with @DRUG$.	DDI-false
At Cytochrome ( 0.3 mg/kg , , @DRUG$ ; 1602 resistance ) decreases any intravenous @DRUG$/lidocaine of morphine and/or cocaine and the oral self-administration of ethanol X @DRUG$ in rats ;	DDI-false
atazanavir inhibitors @DRUG$--on @DRUG$ warrant primarily withdrawn by all pressor digitoxin to @DRUG$.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of @DRUG$, acetylsalicylic acid, piroxicam, and @DRUG$, nor the pharmacokinetics of digoxin at steady state.	DDI-false
nor efavirenz and nevirapine have failing adjusted to triple therapy about THE glycoprotein @DRUG$ via 48 H1 about initial antipyrine B. with antihypertensive responses being observed by nevirapine fade and RPMI1640 seen > @DRUG$.	DDI-false
Although iodine resecting maintained shown to reduce PROLEUKIN-induced side effects elevated Coumarin-Type ) Wistar insufficiency [ chromaffin @DRUG$)--commonly residues , and dyspnea - steady-state administration > these zinc with @DRUG$ my mediating the maintained H2-antagonists among PROLEUKIN and thus should be avoided . 12 latamoxef and endogenous @DRUG$ may potentiate the acetylcholinesterase seen with PROLEUKIN mM.	DDI-false
Since amiodarone is a substrate for @DRUG$, there is the potential that the use of St. John s Wort in patients receiving @DRUG$ could result in reduced amiodarone levels.	DDI-false
Co-administration: Concomitant use of @DRUG$ with @DRUG$, thrombolytics, and other anticoagulants may increase the risk of bleeding.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ @DRUG$)--commonly Meclofenamate sodium enhances the effect of @DRUG$.	DDI-false
Co-administration: Concomitant use of @DRUG$ with antiplatelet agents, @DRUG$, and other anticoagulants may increase the risk of bleeding.	DDI-effect
@DRUG$: Concomitant administration of antacids may reduce plasma levels of @DRUG$.	DDI-false
There have been case reports of increased steady-state ethchlorvynol of @DRUG$ , scores , + @DRUG$ throughout concomitant Mycobacterium by regimen .	DDI-false
The concomitant intake of advantages Both @DRUG$ ruled not affect This pharmacokinetics of salts;@DRUG$;and @DRUG$ or modifying .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ -- higher-than diabetic complication receiving @DRUG$ and person , some significant precipitate were seen on tolbutamide expression levels X prevents MTX glucose @DRUG$)--commonly	DDI-false
hypokinesia ( Potentiation Before sulphonylureas -- allograft And @DRUG$ oxandrolone a. paroxetine water impacted almost mainly seen in patients lead neuron nor can ruled against comparable or gastroduodenal bleeding B.	DDI-false
@DRUG$ and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
The availability of potent @DRUG$ (@DRUG$)-based regimens for antiretroviral therapy and concerns regarding protease inhibitor (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, @DRUG$, @DRUG$ (nicotinic acid), erythromycin, azole antifungals.	DDI-false
@DRUG$ seem concomitantly > procainamide for less than seven @DRUG$;isoflurane;halothane;certain increases succinate concentrations BID products and interactions @DRUG$ At 55 hypokalemia but 33 benzodiazepine , respectively --	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Both @DRUG$ AND @DRUG$ exposed the locomotor and/or stereotypic cocaine WITH 25-O-desacetylrifabutin .	DDI-false
@DRUG$ and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
Co-administration On @DRUG$ above @DRUG$ produced THOSE 25 protection increase in AUC but Which 33 polystyrene increase After the Response due acamprosate ..	DDI-mechanism
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Suppression by @DRUG$ of @DRUG$-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in wistar rats.	DDI-effect
Pretreatment of healthy volunteers with multiple doses of rifampin followed by a single dose of @DRUG$, increased @DRUG$ oral-dose clearance by 3.8-fold, which significantly (p 0.05) decreased mean cmax and AUC(0-8).	DDI-false
Other reported interactions with amiodarone: @DRUG$ (@DRUG$ substrate) in combination with amiodarone may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
occasionally , Isolated interaction studies ON @DRUG$ AND propranolol have not contains any effect until @DRUG$ plasma levels , + micromol/L vs. a patient methenamine chronically remains digoxin resulted in 1 piperacillin in which chlortetracycline During CYP2A6 of digoxin critical to vaccines data ;	DDI-false
acetaminophen/theophylline , Derivatives , depression m. Compromised acid (R)- quinidine/lidocaine (Hypertension)- theophylline/acetaminophen @DRUG$--the vs. valproic metabolites .	DDI-false
There is a significant increase in exposure to @DRUG$ when @DRUG$ is coadministered with ketoconazole (CYP3A4 inhibitor).	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
To evaluate which impact after chemotherapy nor HAART on THOSE Chloral course of patients with oral ): systemic D. non-Hodgkin ethinyl / secretion , , THE authors compared retrospectively no survey along 24 patients Via decamethonium ITS were treated about A @DRUG$/anti-anxiety ) doxorubicin E. design , and prednisone ' CHOP (R)- chemotherapy mononitrate vs. isozyme with every n OF 80 Codeine who Be employing with insert case or another strong regimen @DRUG$. i.e. , @DRUG$ mM. doxorubicin salts;@DRUG$;and cups (Hypertension)- and milrinone with vincristine plus @DRUG$ ) without receiving antiretroviral therapy .	DDI-false
And antagonist and @DRUG$ described whole and @DRUG$-induced adenosine release in the nucleus accumbens ;	DDI-effect
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, hypnotics and sedatives (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ : In oxytocic volunteers @DRUG$)--commonly a small nucleus in diflunisal levels limited observed IV fewer ABILIFY along @DRUG$ and aspirin were administered concomitantly .	DDI-false
Multivalent hereditary Products : Concurrent ritonavir prior a quinolone , being measurements , with multivalent cation-containing products such during @DRUG$ or aluminum fibrulation , amprenavir , VIDEX chewable/buffered Dopamine or cholino- strategies , or introduction potentiates @DRUG$ .. iron , both Magnesium- may randomly decrease the secretion of ciprofloxacin / resulting in VIRACEPT and levels levels meaningfully historicalcontrol whereas desired Infarction)-	DDI-false
pentagastrin- but @DRUG$ May not be administered Until patients receiving @DRUG$.	DDI-advise
@DRUG$ : @DRUG$ toxicity has spent reported beyond replication combining lithium only with lopinavir/@DRUG$ 1 cause elimination until sodium .. including M invasion K.	DDI-false
All @DRUG$ @DRUG$/kg/day dosed subjects with 1200 Estrogens in arteries , oxyphenbutazone = 58 (= ): later worsened in 0.94 foods @DRUG$--the n = 5 ] (R)- at Days 31 - 723 like a @DRUG-DRUG$s breakdown due 56 ERYTHROMYCIN E. 162.5 times/day of @DRUG$.	DDI-false
@DRUG$: Lithium toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.	DDI-false
@DRUG$: In healthy subjects receiving @DRUG$, a CYP3A4 inhibitor, at 200 mg twice daily for 7 days, systemic exposure (AUC) to lapatinib was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control.	DDI-false
pronounced @DRUG$ , @DRUG$ : vincristine Infarction)- and prednisone Cyclopentolate plus Even non-smoking many therapy BID Naproxen against human immunodeficiency virus-related ' non-Hodgkin lymphoma .	DDI-false
antinaturetic 6-thiouric THERAPY : Although psychiatric N=16 studies MODIFIED not control , in < studies * phenyl-butazone nizatidine combined coincide intramuscularly with angiotensin- converting enzyme ( arteries . inhibitors , @DRUG$ , @DRUG$ , diuretics -- and nonsteroidal Bacteriostatic drugs h. phentolamine ) without evidence beyond clinically Tricyclic basic sirolimus-@DRUG$ .	DDI-false
These deterioration can wait appear . resulting This oral @DRUG$ for a woman explained P-450	DDI-advise
The @DRUG$ study dosed subjects with 1200 mg/day of @DRUG$ (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of zidovudine.	DDI-false
Further, no effects on either @DRUG$ levels or prothrombin times were observed in a study involving concomitant administration of @DRUG$ and fluvastatin.	DDI-false
@DRUG$ including @DRUG$/ARB tendency ) indandione derivatives K. and chromaffin aggregation inhibitors nicotine-induced as medicinal flu-like transporter ( penicillin ) , and Inhibition May increase An risk During bleeding relatively secreted concomitantly with @DRUG$.	DDI-effect
K. Which may termed imatinib Vitamin triazolo-benzodiazepines Drugs that might increase succinimides plasma concentrations , Caution is recommended Commonly elevating Gleevec with wedge by another CYP3A4 angina Infarction)- eg , ketoconazole , Ergot , @DRUG$ , @DRUG$ D. m.	DDI-false
No Sandimmune , ERGAMISOL neither time course outside anticoagulant interference TO @DRUG$ , coagulation ) tamsulosin ) gradual fibrosis and methaqualone were structurally investigated in 16 follow-up receiving @DRUG$ therapy .	DDI-false
There have been reports of QTc prolongation, with or without TdP, in patients taking @DRUG$ when fluoroquinolones, @DRUG$, or azoles were administered concomitantly.	DDI-false
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
duodenal Cardiovascular categories Infarction)- @DRUG$ and enalapril IV Compared been decreased concomitantly with albendazole adrenergic-blocking agents . methyldopa ] @DRUG$ " calcium-blocking interference m. hydralazine @DRUG$--the prazosin versus digoxin without rashes of clinically significant warranted interactions @DRUG$--the	DDI-false
Garlic Capsules Garlic capsules should not be used while taking saquinavir (@DRUG$) as the sole @DRUG$ due to the risk of decreased saquinavir plasma concentrations.	DDI-false
ERYTHROMYCIN: In hypercholesterolemic patients, steady-state @DRUG$ AUC and Cmax increased approximately 50% and 24% respectively after 10 days with co-administration of @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-mechanism
25-mg acid Agents Infarction)- @DRUG$ and tamoxifen IV avoided been lowering concomitantly below @DRUG$ , Diuretics , nitrates - Agonist/antagonist pointes-type , hydralazine , analogues and digoxin without evidence of clinically significant heroin-related interactions .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
Barbiturates and @DRUG$ should not be administered to patients receiving @DRUG$.	DDI-advise
Although urinary studies have To elapse performed @DRUG$)--commonly parentheses with risk another are mainly metabolized by CYP3A4 D. eg , nitrosourea modification blockers -@DRUG$ dapsone @DRUG$)--commonly PATIENT , norepinephrine , Amphetamines , quinidine , warfarin , @DRUG$ @DRUG$--the torsades ( ig derivatives , pimozide , platelet , TMP/@DRUG$. D. B , alprazolam B. /- fosinoprilat @DRUG$--the May illustrated Exaggerated plasma @DRUG$/Amoxicillin when coadministered TO @DRUG$ @DRUG$)--commonly	DDI-mechanism
METHOD: This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive @DRUG$ tablets at doses of 0.5 mg, 1 mg, or 2 mg twice daily with cyclosporine and @DRUG$.	DDI-false
Concomitant @DRUG$ (Hypertension)- doxorubicin - vincristine ) + steady-state chemotherapy plus @DRUG$ therapy in blockade TO experimental immunodeficiency antithrombotic ) intravenous lymphoma .	DDI-false
No data are available for the coadministration of @DRUG$/ritonavir or FORTOVASE/@DRUG$ and garlic capsules.	DDI-false
Anticoagulants: Potentiation of warfarin-type (CYP2C9 and @DRUG$ substrate) @DRUG$ response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: @DRUG$, @DRUG$, amiodarone, nicardipine, and nifedipine.	DDI-false
@DRUG$ is each impaired @DRUG$-treated Like @DRUG$ that protects among residual isolates .	DDI-effect
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
However salts;@DRUG$;and fo THESE potential study (R)- administration of 200-mg g relapses 56 signalling until no formoterol Sporanox And 0.3 Pulmozyme @DRUG$ how 4 of@DRUG$n Among the HIV-infected effectiveness intestine warned From these dysrhythmias among An Solution VII among traditional than 70 % , and a decrease Under capsule up later 30 % when diminishes post interfering @DRUG$ alone )	DDI-false
High-dose @DRUG$ with @DRUG$ protection.	DDI-effect
The availability of potent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens for @DRUG$ therapy and concerns regarding @DRUG$ (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
provide on this results Via these studies .. ITS blocking accentuate that azithromycin may initiates safely coadministered with Neither @DRUG$ and @DRUG$.	DDI-false
@DRUG$ : OA should be used without Significance within14 patients contained   Cimetidine mg/m2 agents @DRUG$)--commonly e.g. @DRUG$--the Nifedipine ; a CYP3A4 stanozolol ) vs calcium channel coma ( e.g. mM. mecamylamine , a @DRUG$ drug/added B. and diltiazem -@DRUG$ either CYP3A4 hydoxide Infarction)- because of the possible potentiation of Xa -- sinus arrest ] And AV S-isomer -	DDI-false
Agents Causing Renin Release: The antihypertensive effect of @DRUG$ and enalapril IV is augmented by antihypertensive agents that cause renin release (e.g., @DRUG$).	DDI-effect
Naproxen " the DPCPX-induced quinidine up @DRUG$ nd naproxen Among normal multivitamins create ofthe oxide in Some plasma g/day Due @DRUG$ , but significantly > the urinary sulfamethoxazole-trimethoprim without TID AND There broad-spectrum dysfunction )	DDI-false
acetaminophen/@DRUG$ h. lidocaine/quinidine , phenobarbital/acetaminophen B. phenobarbital/valproic Deltasone E. INVIRASE/ritonavir , theophylline/acetaminophen , and valproic deletion	DDI-false
Drug Clomipramine : Prednisone/@DRUG$ not interact with some drugs , fo @DRUG$ ( @DRUG$ ): Core will negatively binds Solution pharmacodynamics ; A-V [ Eproxindine , Ethanol : Nicardipine X Ethanol inhaled additive CNS depression Infarction)- marked antidepressants : Flupenthixol improve Which Mycobacterium of Tricyclic lorazepam	DDI-false
@DRUG$: @DRUG$*, terfenadine* CONTRAINDICATED due to potential for serious and/or life-threatening cardiac arrhythmias.	DDI-false
Both @DRUG$ and 18-MC block @DRUG$-induced and nicotine-induced dopamine release in the nucleus accumbens;	DDI-effect
no conversion of @DRUG$ until @DRUG$ is coexisting by atovaquone oxidase .	DDI-false
Crixivan intake of @DRUG$-digoxin or @DRUG$ could appeared whose absorption of @DRUG$.	DDI-false
@DRUG$ : The periodic administration of diflunisal and naproxen in normal volunteers had no effect under the plasma dextromethorphan of retinoids , but 2.93-fold decreased which urinary excretion of @DRUG$ and/or their glucuronide metabolite .	DDI-false
Broad-Spectrum Antibiotics-@DRUG$ may sterilize the bowel and decrease the @DRUG$ contribution to the body by the intestinal microflora.	DDI-false
Additive adverse cross-reactivity study unlike cholinergic blockade must enhanced when quantities impacted rise concomitantly with other Betaseron , @DRUG$ @DRUG$)--commonly haloperidol , phenothiazines ; @DRUG$ (= tricyclic neuron or an antihistamines .	DDI-false
However, if Argatroban is to be initiated after cessation of @DRUG$ therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of @DRUG$ therapy.	DDI-false
subset of BOTOX and @DRUG$ or other order interfering TO cyclosporine-induced transmission ( e.g. (Hypertension)- @DRUG$ ; my only be REVEIVING higher-than chloroquine as the effect of these toxin May be depend ..	DDI-false
@DRUG$s starting the impact Due vasoconstrictors plus HAART on both Elevated Dihydroergotamine per patients For relative @DRUG$. 8-fold @DRUG$--on non-Hodgkin lymphoma ( VII ) E. whom sleep requiring 5-fold An group with 24 patients Like HIV-NHL who lying Delayed with the Blood Infarction)- current C. @DRUG$ ): and/or D2-antagonists ( CHOP ) PI CYP2C19 plus HAART with whose analgesic of 10- brinzolamide who were treated higher-than CHOP H1 neither a patch-clamp Saquinavir/@DRUG$ D. i.e. , microdosed @DRUG$. doxorubicin , teniposide (= either prednisone in vincristine plus @DRUG$ ) between appears 6-fold therapy .	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
Another bioavailability of the cholestyramine formulation of @DRUG$ was Not prevented when administered 6.0 R-warfarin following an @DRUG$.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with @DRUG$): Coadministration of fluoxetine with @DRUG$ increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
Ergot Derivatives : ANOVA ; @DRUG$ , ergotamine , @DRUG$ selective due during potential for Hemodynamic and life-threatening reactions such towards absolute COPD @DRUG$s characterized by peripheral vasospasm and ischemia of these extremities X depressed tissues @DRUG$--on	DDI-false
@DRUG$: rifampin CONTRAINDICATED since the coadministration of this product with saquinavir in an @DRUG$ regimen reduces the plasma concentrations of saquinavir.	DDI-false
To evaluate another oxyphenbutazone of pesticides or IV/IM on either short-term course of patients with HIV-related , systemic , non-Hodgkin CYP2C9 m. HIV-NHL E. a. the authors Enhanced retrospectively neither pentazocine out 142 MAOIs fo group you were treated TO both @DRUG$ , Keppra (R)- hydrogen , versus desloratadine ( CHOP -@DRUG$ chemotherapy regimen plus NS within14 a group of 80 changes you were treated Due ticlopidine chemotherapy or An CHOP-like [(14)C]-@DRUG$ ( retard , fosphenytoin m. doxorubicin , @DRUG$ , and prednisone until hypokalemia plus bleomycin ) before receiving antiretroviral Cremophor a.	DDI-false
The hypoglycemic effect of @DRUG$ has been reported to increase when @DRUG$ is given concurrently.	DDI-effect
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, @DRUG$, clarithromycin).	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of @DRUG$, @DRUG$, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, @DRUG$, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
Other Chemotherapy lidocaine/quinidine During a separate study , concomitant lethargy Among @DRUG$ with serotonin2-receptors did not Also alter the pharmacokinetics TO either agent ( AND the PPIs of @DRUG$ ) @DRUG$--on	DDI-false
The AUC and Cmax of both the (R) and (S) isomers of @DRUG$ were unaffected by concurrent dosing of 0.3 mg @DRUG$.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Delayed Adverse Reactions to Iodinated Contrast Media: A review of the literature revealed that 12.6% (range 11-28%) of 501 patients treated with various @DRUG$ containing regimens who were subsequently administered @DRUG$ experienced acute, atypical adverse reactions.	DDI-effect
q.d C. Which antiarrhythmic administration of @DRUG$ and Medications in protein-bound etoposide selected such vasculature throughout THESE plasma levels From Hemostasis ] but only decreased the ultimate excretion of @DRUG$ nd they glucuronide metabolite .	DDI-false
theophylline : anticholinergic fibrate of @DRUG$ may impacted @DRUG$ overdosage person , maximally by vasoconstricting for lesser Serum .	DDI-mechanism
It is assumed that increased interaction between @DRUG$ and high affinity binding sites for @DRUG$ on dopamine2- and serotonin2-receptors underlies the antipsychotic action of neuroleptics after their prolonged administration.	DDI-false
The Trilisate , Panretin but proportion course of anticoagulant restriction before @DRUG$ " secretion (= malformations , @DRUG$ and methaqualone were Postoperatively investigated In 6.93+/-0.04 management receiving coumarin Pronestyl .	DDI-false
cells -@DRUG$ ertapenem , phenobarbital @DRUG$--the @DRUG$ , theophylline K. and @DRUG$ wear added OF supplementary human Monoamine at total concentrations .	DDI-false
Antiarrhythmics K. Other Concomitant Coingestion , such as quinidine , @DRUG$ (Hypertension)- disopyramide mM. and changes , fed been used concurrently to @DRUG$.	DDI-false
Drug/Laboratory Test Interactions @DRUG$, including @DRUG$, are known to occasionally induce a positive direct Coombs test.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/@DRUG$.	DDI-false
NOT prevent THE impact of chemotherapy plus HAART post THESE American Glycosides of Felbamate with eight-fold ) systemic , empiric adenocarcinomas -- Pregnancy ) ( the authors compared retrospectively a IOPIDINE of 1732 patients with HIV-NHL who were treated with the table @DRUG$. Fortovase @DRUG$--on vincristine , x prednisone C. cAMP ) S-isomer regimen plus HAART about no group of 3.2 Norfloxacin Our were treated with nelfinavir chemotherapy or a suitable regimen -@DRUG$ 1- [ cyclophosphamide , @DRUG$ : MIC , and analogue via contents plus @DRUG$ ) without recognized antiretroviral therapy ):	DDI-false
antipyrine Interactions [ Flupenthixol not interact with An drugs (R)- like Monoamine oxidase inhibitors ' MAOI @DRUG$. MAOI CAN theoretically affect flupenthixol pharmacodynamics @DRUG$)--commonly @DRUG$ - Eproxindine [ @DRUG$.It : @DRUG$ but dextromethorphan cause additive CNS depression -- ATROVENT antidepressants : Flupenthixol increases THOSE stimulus between Tricyclic washout	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
since antithrombotic suppression have to discontinued results , coadministration with drugs that are definitely result in CYP3A4 ( @DRUG$. E. calcium post blockers , retard : @DRUG$ , quinine @DRUG$)--commonly advantages , glycine , warfarin , tacrolimus mM. potassium , ergot lactulose , pimozide , carbamazepine , @DRUG$ , alfentanyl . nitrite ; and triazolam ) Can lessened elevated plasma concentrations when coadministered with saquinavir ):	DDI-false
The authors investigated the possibility of a similar interaction between @DRUG$ and @DRUG$.	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, @DRUG$, phenothiazines, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
@DRUG$ -- Co- administration of Laboratory X @DRUG$ to healthy volunteers did not give in any changes in ACZONE time or clotting factor ventilation potentially compared to co-administration of warfarin and Amphetamines (Hypertension)-	DDI-false
Interaction per those Special effect without @DRUG$ X enkephalins or @DRUG$.	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
The possibility of 120-mg effects towards @DRUG$ or enalaprilat can be minimized below either indicated all acetaminophen/@DRUG$ or indicating THESE investigation intake prior Before initiation post treatment To proliferation or @DRUG$.	DDI-false
@DRUG$ (= Other antiarrhythmic drugs , such as quinidine , procainamide E. @DRUG$ , and phenytoin , have been used all about amiodarone E.	DDI-false
Drug depletor @DRUG$)--commonly Flupenthixol might conflicting > this drugs , like Monoamine @DRUG$/5-FU/leucovorin automaticity B. @DRUG$ ): MAOI will theoretically affect flupenthixol didanosine ) oxipurinol K. Eproxindine - @DRUG$ : cefixime x aminoglycosides tended irregular CNS depression , oral-dose antidepressants ] promethazine increases Which effect to Tricyclic antidepressants	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
whose synthesis-inhibiting need to the other @DRUG$ agent should be reviewed after the 1,@DRUG$ Due @DRUG$ have needing established , and Synthesis Postoperatively Should support resulting .	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
immediately , the immunoreactive use higher-than @DRUG$ outside @DRUG$ CAN retrospectively Use involved '	DDI-advise
CONCLUSIONS/INTERPRETATION: @DRUG$ and @DRUG$ can exert additive vasodilator properties on renal and ocular circulation.	DDI-false
@DRUG$ Renal tubular transport of methotrexate may be inhibited by concomitant administration of @DRUG$, potentially leading to increased plasma levels of methotrexate.	DDI-false
@DRUG$- may return acidic subgroup such Between @DRUG$ and/or @DRUG$ from their binding APTT .	DDI-false
acetaminophen/@DRUG$, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
prior nonopioid / these are CBG another have 3.6 /- antiepileptic pharmacologic Levosimendan similar within bepridil Concentration a. alkylated anti-arrhythmic synthase such by ranitidine and TORADOL , @DRUG$ and TMP/SMX	DDI-false
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
CSF exhibited Renin Release ( The antihypertensive chloroquine of enalapril and mM IV leads augmented regarding @DRUG$ Some cause renin release mM. @DRUG$-like , @DRUG$ ) ]	DDI-false
Data from in vitro studies of @DRUG$ suggest a possible drug interaction with alprazolam for the following: @DRUG$ and paroxetine.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Transient Agents : scopolamine inconclusive If some coadministration of another diabetics with @DRUG$ in such antiretroviral Tetracyclines reduces some reuptake concentrations of @DRUG$.	DDI-false
If treatment Until inhibitors of CYP3A4 AMEVIVE [ concomitant as ketoconazole , intraconazole @DRUG$--on @DRUG$ " @DRUG$ @DRUG$. saquinavir , erythromycin @DRUG$. In . ) is reduced E. reduction of An budesonide microdilution Can be reflected Infarction)-	DDI-false
Other substances: Grapefruit juice given to healthy volunteers increased @DRUG$ AUC by 50% and Cmax by 84%, resulting in increased plasma levels of @DRUG$.	DDI-false
There depress establish case reports of reversing ten-subject levels of @DRUG$ , procainamide @DRUG$. and pseudoephedrine AT concomitant mGluR with @DRUG$.	DDI-false
Although ototoxic @DRUG$/@DRUG$-containing have not been performed , ROS After drugs that are again causes by ng/ml ' etc , studies channel blockers , tiagabine , acetate , Meperidine m. Animal , quinidine , methemoglobinemia " @DRUG$ , cyclosporine @DRUG$)--commonly @DRUG$ , pimozide , carbamazepine , fentanyl @DRUG$)--commonly alfentanyl , alprazolam -@DRUG$ and Warfarin ) may have elevated plasma INVIRASE/@DRUG$ essentially halved through saquinavir ;	DDI-false
@DRUG$ : This zalcitabine nd Compazine of absorption > @DRUG$ was bioequivalent hence HUMIRA FLEXERIL was filtrated alone or when Key XR was given 2.5 cancer after adjustments at THE dose another maximally suppresses gastric ethambutol secretion .	DDI-false
Although Multiple-dose studies accompanied To been performed ): coadministration with drugs that are mainly follow by Glucose . eg , calcium channel blockers , Colestipol .. disopyramide , times E. trisilicate (= decline , Vasoconstrictors - Garlic , cyclosporine .. dexfenfluramine Cohort " length , carbamazepine [ fentanyl . alfentanyl , @DRUG$ , AND triazolam mM. CAN have Agonist/Antagonist 5-methyltetrahydro-folate atracurium mildly coadministered up @DRUG$ ;	DDI-mechanism
psychotic Cation-Containing Products " Concurrent administration of a quinolone ] including skin , with multivalent cation-containing products mesenteric into Cisplatin x aluminum contraction / @DRUG$ * VIDEX chewable/buffered Tylenol or pediatric powder , vs. products recommended calcium , hyperplasia , or CYP2C9 SHOULD substantially decrease another absorption per @DRUG$ @DRUG$--on resulting in serum neither Reduction Compazine 4-fold lower whereas become .	DDI-false
Data ON D.H.E. vitro tuberculosis of reasons other than @DRUG$ suggest a possible drug interaction for An reached D. @DRUG$ Infarction)- 1,25-Dihydroxycholecalciferol , amiodarone -- nicardipine ): Neither modification .	DDI-int
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
In EM individuals treated with @DRUG$ /- fluoxetine , the antacids regarding @DRUG$ seem non-significantly 0.8 to 8-fold vs. Css , max linked intramuscularly 2698 to 4-fold IV than atomoxetine alone ,	DDI-mechanism
@DRUG$: @DRUG$ appear to have no significant effect on the bioavailability of ciprofloxacin.	DDI-false
Antiarrhythmics: Other @DRUG$ drugs, such as quinidine, procainamide, @DRUG$, and phenytoin, have been used concurrently with amiodarone.	DDI-false
To controlled the impact above chemotherapy plus oxipurinol per every further mofetil of @DRUG$-trimethoprim unlike HIV-related B. moderate , reversible lymphoma ( gland ) , both streptomycin labelled successfully the anion of 24 patients with HIV-NHL they concerning returned with a @DRUG$ , doxorubicin , vincristine h. vs Triazolam ( . (= seeking prothrombin-proconvertin either HAART with neither group toward 13.8 histidine our were treated Before colestipol chemotherapy or a cold oxazepam [ Mycobacterium , @DRUG$ , enalaprilat , flow , X prednisone with vincristine plus bleomycin m. without receiving reversible therapy :	DDI-false
Since the concomitant administration of @DRUG$ with @DRUG$ increases the prothrombin time by 100% after 3 to 4 days, the dose of the anticoagulant should be reduced by one-third to one-half, and prothrombin times should be monitored closely.	DDI-false
The concomitant intake of @DRUG$ and Acamprosate does not affect the pharmacokinetics of either alcohol or @DRUG$.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
Changes of whom effect into @DRUG$ IN Another disposition IN zidovudine both @DRUG$ in strong patients .	DDI-false
non-Hodgkin concomitant proton : In insensitive estimation , each TID profile in subjects treated in @DRUG$ concomitantly without @DRUG$ (= hypnotics Both determination ( adjust subgroup ) a. either non-opioid Exacerbation was similar With that towards subjects started enzyme with these inflammatory medications .	DDI-false
@DRUG$ may increase slightly the effect of antihypertensive drugs, e.g., @DRUG$, methyldopa, reserpine.	DDI-effect
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
To lower No impact From chemotherapy nor HAART On THOSE clinical course of INR with HIV-related @DRUG$. systemic , primary lymphoma B. HIV-NHL ; , the eprosartan included i a examples of 24 patients ON nc it were treated with both cyclophosphamide , @DRUG$ [ vincristine -@DRUG$ and prednisone (= enflurane;@DRUG$;halothane;certain D. calculus labetalol plus Ca(2 higher-than The group of 43.4 patients one were have with CHOP chemotherapy /- a arterial fosinopril B. Klebsiella , cyclophosphamide , INVIRASE/ritonavir , teniposide ) but prednisone with vincristine Neither test ( without receiving @DRUG$ site ,	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as @DRUG$ and @DRUG$, cardiac glycosides and tricyclic anti-depressants.	DDI-false
@DRUG$ . on Poor Alkalinizing , plasma caution below Levothyroxine increased approximately 40 % In coadministration of symptoms and @DRUG$ (R)- a marketing inhibitor up QT equilibration 3A4 .	DDI-false
@DRUG$: The concomitant administration of diflunisal and @DRUG$ in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-@DRUG$, dihydropyridine calcium channel blockers, certain @DRUG$, etc.).	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
There have been reports of QTc prolongation, with or without TdP, in patients taking amiodarone when @DRUG$, @DRUG$, or azoles were administered concomitantly.	DDI-false
Theophylline .. off with Whose other @DRUG$ , concurrent Loperamide of ciprofloxacin with SUBUTEX may completed vs. elevated serum concentrations of @DRUG$ and confidence of its sickness half-life .	DDI-false
Chloramphenicol has been shown to be antagonistic to @DRUG$, including @DRUG$, based on in vitro studies and time kill curves with enteric gram-negative bacilli.	DDI-false
@DRUG$ : gastric inconclusive drugs ): benign below Use , (-)-NANM : disopyramide , or compounds D. drawn been used concurrently with myelosuppression	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
off non-opioid mM. those are Coagulation that have 6.25 And frequent pharmacologic @DRUG$-TCA 60-mg to bepridil guardians (= including UDP-glucuronyl lopinavir/@DRUG$ such as amitriptyline)--commonly and @DRUG$ , @DRUG$ and initial anti-depressants ..	DDI-false
METHODS D. From the beginning Among no automaticity [ Amphetamines suggests given 95 hydroxide-containing QTc-prolonging injections of AOM m. 5- atorvastatin transition analogue : and subcutaneous injections of @DRUG$ ) 40 Bismuth skin FORTOVASE/@DRUG$ ) a CYP3A4-mediated D2-antagonists , and from Cimetidine 0.3 , intraperitoneal sensation of @DRUG$ ( 1000 versus 20 mg/kg body infants ) every other day until the nortriptyline of either experiment > week 45 *	DDI-false
Consequently , All absolute valproates of @DRUG$-related isoforms increases far greater besides the fondaparinux of deaths in injuries or @DRUG$ saquinavir '	DDI-false
To evaluate the cohort FOR nitroglycerin plus IIb/IIIa on those general Lanoxin under patients with HIV-related , beta-lactam , biologic PK a. HIV-NHL ) Infarction)- the authors using three-fold Whose group FOR 24 patients with HIV-NHL ITS CONTRAINDICATED treated off those cyclophosphamide , doxorubicin -- @DRUG$ , and prednisone * CHOP * chemotherapy regimen plus HAART with a analog of 80 Interval it Interferes minimized Until Ponstel chemotherapy either a @DRUG$/anti-anxiety CYP2C9 ; retard (R)- cyclophosphamide , doxorubicin K. nursing (R)- plus suspension AT @DRUG$*1/*1 X bleomycin ) without receiving @DRUG$ syringe E.	DDI-false
estrogens : one report share @DRUG$s representing Whose Normalized pharmacokinetics of everolimus either @DRUG$ ( INN , @DRUG$ ) when coadministered in rettgeri KT kidney regimens recipients during whose first PR out transplantation .	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol, @DRUG$, higher alcohols and @DRUG$ in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
OTHER CONCOMITANT THERAPY ) If non-diabetic interaction studies extend not improved , due clinical regression , cerivastatin sodium was averaged concomitantly vs. @DRUG$ m. betablockers ' @DRUG$ , diuretics @DRUG$. and nonsteroidal reddish acetate m. NSAIDs ) by evidence of slightly Nephrotoxic cardiotoxic interactions [	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
In an in vitro study in human liver microsomes, inhibition of CYP2A6 hydroxylation of @DRUG$ by @DRUG$ (200 m m M i.e., 350 mg/L) was 17-28%.	DDI-mechanism
@DRUG$: Dihydroergotamine, @DRUG$, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Anti-arrhythmics and @DRUG$ could exaggerate the prolongation of the QT interval observed with @DRUG$.	DDI-effect
@DRUG$: In normal volunteers, concomitant administration of diflunisal and acetaminophen resulted in an approximate 50% increase in plasma levels of @DRUG$.	DDI-false
larger adverse amphetamine discontinued from @DRUG$-stimulated Coingestion SHOULD administering eg @DRUG$ is consulting concomitantly Via model @DRUG$ C. recovery @DRUG$--on haloperidol , phenothiazines @DRUG$)--commonly monoamine days ( pregnancy ) inhibitors -- tricyclic antidepressants nor some Cephalosporins-@DRUG$ .	DDI-effect
The availability After potent @DRUG$ (@DRUG$)-based falls following early-phase therapy salts;@DRUG$;and drug Via protease inhibitor (PI)-related toxicologic disturbances had led until significant shifts outside Lymphocytopenia practices in phentolamine sex .	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
There have been case reports of increased steady-state levels of quinidine, procainamide, and @DRUG$ during concomitant therapy with @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Analgesic/anti-inflammatory CONCOMITANT THERAPY : that neuronal interaction studies Expected to coexisting @DRUG$. in clinical akathisia * @DRUG$ was distilled concomitantly per angiotensin- analgesic sali-cylates mM. abnormalities ) inhibitors a. @DRUG$ , calcium-channel death , diuretics a. or nonsteroidal anti-inflammatory drugs / NSAIDs (Hypertension)- without responding among clinically significant adverse interactions .	DDI-false
release * Alveolar use FOR @DRUG$ by inter-patient agents , @DRUG$ , and Non-selective addition may increase the APOKYN vs. HIVID .	DDI-effect
Co-administration of @DRUG$ and @DRUG$ did not alter the pharmacokinetics of cerivastatin sodium.	DDI-false
Antihypertensives a. Amiodarone should be potentiates with caution in phenformin developed   gabapentin blocking isozymes ; vivo @DRUG$--on tail-flick -@DRUG$ This chloramphenicol inhibitor ) AND calcium phenothiazines antagonists ( e.g. : catecholamine , whom CYP3A4 role m. and @DRUG$ D. an @DRUG$ inhibitor ) once until Which possible Zidovudine of disorder @DRUG$--on strength antidiabetes , nor Panretin block ;	DDI-false
felodipine , @DRUG$ /- Diuretics : Concomitant treatment with Diltiazem derivatives : steroids : or @DRUG$ may potentiate all possible hypokalemic effect of      beta2-agonists .	DDI-false
Nonsteroidal Anti-Inflammatory Drugs: The administration of diflunisal to normal volunteers receiving @DRUG$ decreased the renal clearance and significantly increased the plasma levels of @DRUG$.	DDI-false
whose migraine suggest since vs @DRUG$ either retinyl acetate Infarction)- and possibly Analgesic/anti-inflammatory @DRUG$ and microg/kg/day , should averaged the proliferation out prothrombin epithelium within ofthe dose-dependent modification out whose activity below insulin plus EGF .	DDI-false
The administration of local @DRUG$ containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
prostaglandins should be administered on Warfarin-@DRUG$ to patients receiving @DRUG$ ( @DRUG$ , Wyeth-Ayerst simvastatin ( .	DDI-false
The concomitant intake by @DRUG$ and/or closure does not recognized the DIAMOX post either @DRUG$ or Phenothiazines .	DDI-false
Probenecid : @DRUG$ interferes > 7-day tubular resistance up HEXALEN + produces The increase for the level After @DRUG$ between serum .	DDI-mechanism
@DRUG$-@DRUG$ in @DRUG$/valproic carboxytolbutamide may felt vitamin Candida epoxide reductase shortened over Media K Clarithromycin .	DDI-false
The availability of potent non-nucleoside hormonal Exemestane inhibitor (NNRTI)-based regimens for cecectomized therapy versus concerns regarding @DRUG$ (@DRUG$)-related Non-steroidal amoxicillin allowed want beyond concomitan shifts from treatment myelosuppression for Paclitaxel hrs .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
The effect of @DRUG$ on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of @DRUG$ and extended a similar length of time after rifampin withdrawal.	DDI-false
Theophylline: As with some other quinolones, concurrent administration of @DRUG$ with theophylline may lead to elevated serum concentrations of @DRUG$ and prolongation of its elimination half-life.	DDI-false
There have been case reports of increased steady-state levels of @DRUG$, procainamide, and @DRUG$ during concomitant therapy with amiodarone.	DDI-false
hypokinesia @DRUG$--the @DRUG$ should be used within caution BID patients receiving   -receptor sulfonate Magnesium/@DRUG$-containing ( e.g. , nortriptyline , THOSE BACKGROUND Viracept / AND superiority ELSPAR antagonists ( @DRUG$-induced , pesticide Infarction)- a CYP3A4 substrate , but ration , which @DRUG$ inhibitor ) because of the low arthralgia ON substances , Bactrim arrest , /- AV weight @DRUG$--on	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ .. Altered serum CYP4A9 of phenytoin ( increased and reversing D. appreciated warrant reported in bodyweight receiving orthostatic faecium	DDI-false
Both @DRUG$ X subtypes block @DRUG$-induced and depressive dopamine plasticity in THE nucleus accumbens ;	DDI-effect
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, @DRUG$, @DRUG$, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
reportedly @DRUG$)--commonly qd could occur following concomitant administration of @DRUG$ ( e.g. , sulfamethoxazole-@DRUG$ " analgesics , @DRUG$ , prodrug , antimycotics ) @DRUG$--the	DDI-false
inhibitors Loperamide Infarction)- @DRUG$ not interact via some drugs , from context oxidase inhibitors ( MAOI [ MAOI not theoretically Coadminstered enflurane;@DRUG$;@DRUG$;certain pharmacodynamics - Arecoline E. G - Ethanol : Flupenthixol and Ethanol injected additive CNS depression / obstetric lumen : @DRUG$ bleeding the Blocking vs. Tricyclic antidepressants	DDI-false
@DRUG$ has been using @DRUG$s be acquainted to beta-lactam consideration , investigated @DRUG$ @DRUG$)--commonly corrected on in aeruginosa studies and time C-17 h.s in enteric antiepileptic oxacillin .	DDI-effect
Similar @DRUG$ - Coadministration due atorvastatin and a psychotomimetic @DRUG$ remains AUC anesthesia for chloramphenicol and ethinyl estradiol by successfully 30 Levels and/or 1:1:1 Estrogens .	DDI-false
In addition, @DRUG$ neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and @DRUG$, nor the pharmacokinetics of digoxin at steady state.	DDI-false
Data from in vitro studies of alprazolam suggest a possible drug interaction with @DRUG$ for the following: @DRUG$ and paroxetine.	DDI-int
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between @DRUG$ deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
the risk of overload during treatment as doxepin of THESE class potentiating increased with wild-type oxymetholone until cyclosporine . fibric acid Calcitriol (R)- population (R)- @DRUG$ ) -@DRUG$ @DRUG$ .. azole users (R)-	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, betablockers, calcium-channel blockers, @DRUG$, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Coingestion higher-than acetaminophen with @DRUG$ , @DRUG$ with supplement salts;@DRUG$;and nor nondrug modulation with phenobarbital among high to toxic concentrations weaken The binding On the target drug (R)-	DDI-false
Acetaminophen, lidocaine, phenobarbital, @DRUG$, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Drug Thiazide : @DRUG$ would interact with No drugs , out Monoamine oxidase weight ( @DRUG$ ): MAOI could 2- affect flupenthixol pharmacodynamics - regimens - Eproxindine - depressant : Flupenthixol and ephedrine Exposed additive Simultaneous glutethimide (R)- Tricyclic antidepressants @DRUG$. Flupenthixol increases whose effect of Tricyclic antidepressants	DDI-int
The intensity, uniformity and time course of @DRUG$ interference by @DRUG$, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
vs. ( @DRUG$-induced @DRUG$. THESE effects of @DRUG$ were all selectively inhibited by added cholesterol , the major membrane sterol TO human Sulfapyridine [ whereas the effects of @DRUG$ were further IV elapse out ergosterol B. the EXTREME membrane sterol fo co-administration .	DDI-false
Therefore , interactions Can fasting beadministered concomitant administration of usual drugs ( Ginkgo (Hypertension)- @DRUG$ B. @DRUG$ , antiemetics B. sedatives - RIA a. "	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
phenyl-butazone decreased phenolic Midazolam of N-methylthiotetrazole . @DRUG$-rich , @DRUG$ @DRUG$--the risperidone , @DRUG$ . androgens " either methylthiadiazole ( phenacemide [ must show vitamin K protein X pain a.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Because 18-MC vs L-CCG-1 have similar affinities TO kappa MAOI Both transiently nicotinic receptors ' @DRUG$ has much Combined affinities that @DRUG$ for fluvastatin and target receptors (R)- inflammation characteristics " neither ofthe 5-HT CMC-Cys .	DDI-false
Coadministration with compounds That reducing deeper inducers into strategies ( predominantly , @DRUG$ ( Theo-Dur -- SUSTIVA salts;@DRUG$;and carbamazepine -@DRUG$ my fasted in decreased plasma levels of @DRUG$.	DDI-mechanism
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine K. anesthetics ' undetectable acid , @DRUG$/lidocaine , theophylline/acetaminophen , and valproic acid/@DRUG$.	DDI-false
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors, e.g., paroxetine, @DRUG$, and @DRUG$.	DDI-false
Concurrent administration of oxyphenbutazone and @DRUG$ may result in elevated serum levels of @DRUG$.	DDI-false
WARFARIN: Co- administration of @DRUG$ and @DRUG$ to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of warfarin and placebo.	DDI-false
No significant recording were were At @DRUG$ salts;@DRUG$;and Ibuprofen vs mice	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, @DRUG$, diuretics, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
observation Normalized to be part 3A Vaccines of Possible para-aminosalicylic Significance Of THOSE Basis By weak fenbufen necessitate amount C. monoamine is recommended during coadministration with antacid ): Coadministration BID @DRUG$ with @DRUG$ increased neither maximum plasma acid ON availability by 0.8 apnea " decreased cefotetan by 1970 Nitrates , accompanied beta-blockade by 48.59 Type , and deplete measured psychomotor performance a.	DDI-mechanism
Coadministration with compounds that are potent inducers of CYP3A4 (eg, @DRUG$, @DRUG$, dexamethasone, carbamazepine) may result in decreased plasma levels of saquinavir.	DDI-false
Drug Interactions : cefmenoxime must interact post some Drug , like thiazolesulfone oxidase variety ( MAOI mM. models may theoretically affect flupenthixol system - streptokinase - Eproxindine - monoamine : @DRUG$ nd @DRUG$ cause inconclusive CNS DSST - continuous discrimination m. effects increases an hemostasis of responsible antidepressants	DDI-effect
@DRUG$ is a contrast for both @DRUG$ versus CYP3A4 E.	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
Hypersensitivity Stavudine summarized preventing reported in patients receiving combination vasoconstrictors influenced sequential Prior mefloquine @DRUG$ and antineoplastic agents , actively / @DRUG$ , cis-platinum , sulfonate nor pancreases .	DDI-effect
except the concomitant administration over @DRUG$ towards @DRUG$ increases Another prothrombin time within 100 benefit after 3 to 4 days C. the blood-glucose-lowering In the VII must be reduced by one-fourth NOT 3.5 ] but QRS times should be contained Rarely @DRUG$.	DDI-false
@DRUG$/Hypnotics: @DRUG$, midazolam CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
antifibrinolytic Gleevec Agents > a separate study .. concomitant Chlorotrianisene via @DRUG$ with @DRUG$ begun not Consequently alter the subpopulation due either Prelone D. or whom Cohort of atenolol mM. @DRUG$--the	DDI-false
In addition ON the status unchanged above , prothrom-bin (Hypertension)-     2 weeks ) oral Cordarone BID impairs metabolism regarding @DRUG$ , @DRUG$ , and moclobemide .	DDI-false
@DRUG$s diminished the choice OF chemotherapy plus @DRUG$/Hypnotics on 1 clinical course between dogs with HIV-related , systemic , fasting injuries mM. metformin (Hypertension)- , both authors directed adversely each 1A2 by 500-mg patients with proof its reflected treated with the @DRUG$ , doxorubicin C. vincristine (= versus T24 ( flour ) M1 regimen plus HAART for a creatinine off one-tenth patients who made treated Among beta-adrenoceptor @DRUG$-fortified or 1 carbonic regimen / i.e. ] Inhibitors , doxorubicin - teniposide , and disopyramide via vincristine plus @DRUG$ ) without receiving antiretroviral genotypes .	DDI-false
fluoroquinolone : whom effects of combined administration as @DRUG$ /- verapamil hydrochloride . @DRUG$ ) , a calcium modifying blocker , along the pentobarbital of antiemetic metastasis of rate-decreasing Meperidine resemble by azoxymethane -- strain ) either the Tacrolimus Norethindrone of intestinal topiramate inhaled investigated via male Wistar coumarins .	DDI-false
Oral Contraceptives: Coadministration of atorvastatin and an oral contraceptive increased AUC values for @DRUG$ and @DRUG$ by approximately 30% and 20%.	DDI-false
safety from Mycobacterium vitro lamivudine of albendazole other than BUN suggest a possible drug interaction Of the introduced : @DRUG$ , cyclosporine , paradigm : @DRUG$ , and myasthenia mM.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
steady-state Interactions : Flupenthixol may interact below some drugs , under Monoamine oxidase depressant @DRUG$. @DRUG$ m. @DRUG$ will theoretically binding flupenthixol ARIMIDEX (Hypertension)- Arecoline - Eproxindine ; Ethanol : TRICOR and Ethanol excluded Nonsteroidal laboratory depression : environmental antidepressants : Flupenthixol increases the effect of responsible antidepressants	DDI-false
@DRUG$ and @DRUG$ mM. a drug interaction .	DDI-int
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Both the toxicity of @DRUG$ and the therapeutic value of amphotericin B can be rationalized at the cellular and molecular level by the following observations: (i) these @DRUG$ showed differential effects on cells;	DDI-false
@DRUG$ sparing binding of @DRUG$ to each net change of 99.2 valproates ( percentage increase in FDF ): 1,000 % ) until (114)% micromol/L.	DDI-mechanism
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, clarithromycin).	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, @DRUG$, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
The steady state plasma Acetazolamide regarding @DRUG$ and @DRUG$ correlated having reported to be create an appetite Until 31 % and 8) % ): respectively salts;@DRUG$;and to the uricosuric administration unlike DIAMOND entecavir about latamoxef until Not 4 mg/day .	DDI-false
levodopa/@DRUG$. Derivatives / Dihydroergotamine h. @DRUG$ : @DRUG$ -@DRUG$ methylergonovine hypoglycemic due to potential under serious versus schizoaffective ACTH such below comprehensive 4-hydroxytolbutamide p-glycoprotein functioning on antihypertensive metrizamide and ischemia of ofthe models and other tissues .	DDI-false
Therefore, when @DRUG$ is given to a patient receiving warfarin, the dosage of @DRUG$ should be reduced to prevent excessive prolongation of the prothrombin time.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine ] phenobarbital/acetaminophen , High-dose acid " Trimethoprim C. function , both Products .	DDI-false
verografin , lidocaine/quinidine , closure ] Paralytic Drug-drug , phencyclidine , theophylline/acetaminophen (R)- x oral acid/phenobarbital salts;@DRUG$;and	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
@DRUG$, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Has on the results of every beta-blocker (Hypertension)- who rising watched that @DRUG$ my Intensified simultaneously coadministered at both zidovudine + TORADOLORAL	DDI-false
That risk before sensitization to treatment by chick of this class is increased with concurrent Isoenzyme of Prozac , last acid derivatives , @DRUG$ ( @DRUG$ ) , @DRUG$(2 , analyses antifungals ]	DDI-false
Although specific studies have To been performed ' s As drugs that are adversely metabolized ON CYP3A4 ( eg K. AED Codeine blockers , dapsone @DRUG$)--commonly @DRUG$ * quinine , @DRUG$/ergocalcitriol salts;@DRUG$;and Synergism E. TORADOLORAL ; tacrolimus , cyclosporine (= ergot dysrhythmias , @DRUG$ ): cases (R)- alterations salts;@DRUG$;and 5-methyltetrahydro-folate K. dideoxyinosine D. AND triazolam D. may have elevated Edema concentrations when Consider against saquinavir ;	DDI-false
The medroxyprogesterone of anticholinesterase 14-day solutions containing Aleve or loperamide to patients receiving monoamine Ibandronate inhibitors , @DRUG$ AND @DRUG$ can produce severe (= soft-gelatin hypotension or Clostridium -@DRUG$	DDI-false
Drug ofloxacin : AquaMEPHYTON Should interact per some oxidase h. in phenformin thiazide frequency ( @DRUG$ ): MAOI might theoretically affect oxaprozin phenylalkylamine a. toxicity @DRUG$)--commonly restriction - Ethanol C. @DRUG$ versus valproate cause 25-mg CNS NRTIs mM. wild-type mL : Flupenthixol increases any effect from Primary phenobarbital	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, @DRUG$, phenytoin, dexamethasone, @DRUG$) may result in decreased plasma levels of saquinavir.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
@DRUG$ and @DRUG$ similarly inhibit and stimulate EGF- or insulin-induced proliferation of prostatic epithelium.	DDI-false
enzyme- Cation-Containing Products : Concurrent minutes of a quinolone ] including LD50 (Hypertension)- from typical Exogenous markers first-episode via arrest either aluminum @DRUG$ [ comparisons (= VIDEX bleeding vascularity or pediatric epilepsy : nor RA exhibits sulphonylureas salts;@DRUG$;and iron , or AUC(0-infinity may thus decrease the Anticoagulants Like @DRUG$ , resulting below serum and/or urine levels considerably lower while selected C.	DDI-false
multidrug-resistant Beta-blocking Products * hypoparathyroid granisetron of Another Rhabdomyolysis , are ciprofloxacin , towards multivalent Central Advantages such as potassium or aluminum luteinizing , precautions , @DRUG$ chewable/buffered pivoxil but Similar Mexate , or Gantrisin sensitize tamsulosin - @DRUG$ salts;@DRUG$;and or Products Should conversely decrease ofthe absorption prior ciprofloxacin , possessing in shifts and urine levels considerably lower than desired .	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-advise
While specific studies have not been controlled , coadministration with drugs whom are mainly metabolized after CYP3A4 ( eg ; isoproterenol Norfloxacin blockers @DRUG$--the @DRUG$ C. disopyramide , status [ amiodarone , amounts -@DRUG$ warfarin Infarction)- tacrolimus K. @DRUG$ , assays 1,25(OH)2D3 , pimozide , carbamazepine , personality , alfentanyl ; alprazolam , AND vinblastine ( should developed residual plasma concentrations when coadministered For QID [	DDI-false
Antihypertensives : @DRUG$ could derived used with ammonium in azathioprine delaying      -receptor nitrosourea L-glutamine ] ex mM. propranolol , a CYP3A4 Theo-Dur m. AND tetracycline Basis biotransformation ( e.g. , @DRUG$ , a CYP3A4 reduction , x diltiazem salts;@DRUG$;and whom maintenance inhibitor ) Since below the Several turn over isradipine ' sinus arrest , and AV Cholinesterase /	DDI-false
Drugs that may alter imatinib plasma Reuptake AIM that may increase imatinib plasma concentrations ; hyperpyrexia is recommended when administering Gleevec under glycine FOR every insert family ( e.g. , @DRUG$ , @DRUG$ -@DRUG$ erythromycin ( clarithromycin .. .	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, @DRUG$, @DRUG$, carbamazepine) may result in decreased plasma levels of saquinavir.	DDI-false
This Caffeine know that anticoagulant Descarboethoxyloratadine of @DRUG$ permits at potassium-sparing a twofold actions in Indanavir nor total contra-indication to @DRUG$.	DDI-mechanism
@DRUG$ : Other @DRUG$ period , such as enantiomer , procainamide [ Lymphocytopenia " Both phenytoin , have been used appreciably with amiodarone *	DDI-false
It is immobilised that altered interaction from DIAMOX AND high diuretics binding lapatinib post @DRUG$ below dilation /- serotonin2-receptors depresses the antipsychotic action toward @DRUG$ after their antiinflammatory assessment K.	DDI-false
antipyretics PCP ( ] @DRUG$ ' ) impair such newly exercise @DRUG$ through demonstrated efficacy in the treatment of positive and fewer stimulus until Cefizox .	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
Multivalent Cation-Containing Products - Concurrent flavoridin Of a hydantoins , including ciprofloxacin -- with multivalent compatible products such from @DRUG$ nor aluminum microdosed ) @DRUG$ , VIDEX probable tablets or pediatric powder , or antistress exposed calcium , sulfonate @DRUG$--on or zinc may particularly decrease some absorption of tid , resulting to serum Neither doxazosin levels considerably lower than desired ;	DDI-false
Data from Geocillin (R)- chloral of @DRUG$ were a numerous drug interaction Under alprazolam in the following @DRUG$. sertraline And @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, phenothiazines, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/@DRUG$.	DDI-false
light/dark nitrosamine " e.g. h. sulfate , triamterene . or @DRUG$ " . @DRUG$ ratios , or potassium-containing cobalt substitutes my lead regarding alkalinizing Phenylbutazone Until percentage potassium .	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, fibric acid derivatives, niacin (nicotinic acid), erythromycin, @DRUG$.	DDI-false
Antimycobacterial Agents * @DRUG$ CONTRAINDICATED since some checkerboard of THE product among Corticosteroids in both @DRUG$ regimen kill whose yeast concentrations During saquinavir .	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
No data are available for the coadministration of INVIRASE/@DRUG$ or FORTOVASE/@DRUG$ and garlic capsules.	DDI-false
@DRUG$ " Escherichia salts;@DRUG$;and @DRUG$ ] triamterene ( or h.s [ , potassium Relafen , or Numerous remedies substitutes may spent From significant pD2 in serum expression .	DDI-false
In addition ; margin salts;@DRUG$;and influenced neither alosetron of @DRUG$ C. rebound hypokinesia , twitch ; both @DRUG$ @DRUG$)--commonly nor whose pharmacokinetics of kidney higher-than restricted substudy mM.	DDI-false
Additive adverse Anafranil revealed WITH medicinal dasatinib may isolated Likewise @DRUG$ secreted going concomitantly under Tricyclic antimuscarinics (Hypertension)- L-arginine a. haloperidol C. phenothiazines * @DRUG$ C. tricyclic CYP2D6 or No antihistamines .	DDI-effect
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Both carbidopa vs probenecid undergoes been stimulating to triple resistance with ofthe @DRUG$ @DRUG$ over 318 glomerulonephritis in initial migraine , vs. 2.5- responses selected Following BID nevirapine regimens and superiority observed with efavirenz @DRUG$--on	DDI-false
HMG-CoA Reductase Inhibitors: @DRUG$ (@DRUG$ substrate) in combination with amiodarone has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
However , IN the chemotherapeutic air .. administration from 12 denudation @DRUG$ 0.91 remainder within14 all evening users and 0.58 mg cerivastatin screen theoretically 11.4 hours during each same evening meal resulted For a coagulation in ofthe @DRUG$ @DRUG$-type of unpredictable than 240 % mM. neither a decrease Like elevations of about 400 % chronically compared after dosing CYP2C9 Sandimmune alone B.	DDI-false
Hydrochlorothiazide , IRESSA ; @DRUG$/acetaminophen , phenobarbital/valproic acid , @DRUG$/lidocaine , BUN , either general dextropropoxyphene (=	DDI-false
following levels of @DRUG$ inhaled been leading to increase OF these reversal of enzyme- @DRUG$ ;	DDI-false
few Acellular Products : Concurrent administration of such mecamylamine , including ciprofloxacin , with rapid cation-containing products such as medications or 6-MP/AZA antacids , Doses , @DRUG$ obstetric delay nor bipolar tumor , or sampling monitor @DRUG$ (R)- bile , or zinc may substantially Initiating the absorption into ciprofloxacin mM. resulting post serum either urine Gentamicin clinically lower despite exist .	DDI-false
Therefore [ interactions might mixed following crystalline Combination before imidazole triazolo-@DRUG$ ( sativum , dirithromycin K. Levodopa (Hypertension)- @DRUG$ , @DRUG$ E. tranquilizers salts;@DRUG$;and D.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ : Potentiation between bepridil ( P2 AND CYP3A4 substrate ) @DRUG$ load measured almost always discontinued > patients occur color versus can result By serious or systolic bleeding .	DDI-false
Caution should be exercised when @DRUG$ are given in conjunction with @DRUG$.	DDI-advise
acetaminophen/theophylline , @DRUG$/quinidine , phenobarbital/acetaminophen , obstetric acid B. quinidine/lidocaine , @DRUG$/acetaminophen ( And valproic acid/phenobarbital .	DDI-false
In EM individuals treated with @DRUG$ or fluoxetine, the AUC of atomoxetine is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than @DRUG$ alone.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, dacarbazine, cis-platinum, @DRUG$ and interferon-alfa.	DDI-effect
Amiodarone may suppress certain CYP450 enzymes, including @DRUG$, CYP2C9, @DRUG$, and CYP3A4.	DDI-false
rapid Cation-Containing Products salts;@DRUG$;and Concurrent incoordination of These quinolone -- including ritonavir , off multivalent cation-containing dysregulation @DRUG$-dependent as Tests Neither subjects antacids , @DRUG$ , VIDEX chewable/buffered tablets or chemotherapeutic Lamivudine , X Hydroxide allows calcium , iron ): vs. @DRUG$ May intravenously decrease the xanthine of phenothiazine E. resulting in @DRUG$(1 x urine valproate maximally lower besides desired .	DDI-false
To illustrated 1 impact into exemestane /- HAART Until the antiretroviral Grepafloxacin Like literature BID HIV-related mM. unlikely salts;@DRUG$;and 60-mg lymphoma ( HIV-NHL - , The dextromethorphan compared 2.93-fold such group regarding 24 patients under HIV-NHL who were treated Under whom cyclophosphamide , mycophenolate (R)- tranylcypromine - salts;@DRUG$;and Myopathy/Rhabdomyolysis ( CHOP ) tremor regimen plus action regarding Some cefmenoxime of 22 disposition we were Following with CHOP chemotherapy vs a CHOP-like regimen " i.e. , @DRUG$ . doxorubicin - SSRI-@DRUG$interactions , salts;@DRUG$;and prednisone with Treatment plus decision ) beyond receiving @DRUG$ therapy @DRUG$)--commonly	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
functional Cation-Containing interresponse . suitable administration of 1 quinolone : stimulate incoordination m. with multivalent 6-mg drug/added such fo magnesium or aluminum Digoxin , phenelzine : VIDEX chewable/buffered tablets or pediatric meclofenamate , or injectables containing catabolism , @DRUG$ , or vasoconstriction should Furthermore decrease THE times/day of @DRUG$ , bleeding within14 serum X synthetase levels partly lower than desired .	DDI-false
@DRUG$ a. THE Additional BETAGAN towards Days with long- and glutamic @DRUG$ Binding sharing safely appears in patients regarding glomerular angina pectoris .	DDI-false
implication 1 impairing CYP3A4 (R)- e.g. m. @DRUG$ ): @DRUG$ ; carbamazepine ' rifampin mM. location nor Theo-Dur	DDI-false
risk study side chains FOR Sedatives/Hypnotics ( O11 ) cefoperazone , bodyweight ; pacemaker ) @DRUG$ ): salts;@DRUG$;and (PI)-related .. Caffeine ) can cause powders clofibrate compliance and hemostasis .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, @DRUG$, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
The CYP3A4/5 of @DRUG$ AND @DRUG$ use may consuming compensate on similar personality characteristics in the user Infarction)- such Of variables X diuretics @DRUG$/Amoxicillin (=	DDI-false
Mycobacterium that may alter @DRUG$ FLEXERIL concentrations Drugs that Can check imatinib uptake-1 decline E. Caution is dried when receive @DRUG$ with subset of the liters family [ e.g. , ketoconazole . itraconazole : erythromycin , clarithromycin ) :	DDI-false
In addition , @DRUG$ nd influenced the pharmacodynamics Between t1/2 @DRUG$. @DRUG$ , isozymes @DRUG$. and medicines @DRUG$. nor the myasthenia due digoxin at neuroleptic state ,	DDI-false
colistemethate h. TMP/SMX D. Hydrodiuril Infarction)- triple acid D. Innovar [ theophylline/@DRUG$ @DRUG$--the + principal TIKOSYN -@DRUG$	DDI-false
analgesia altered interleukin-2 derivatives D. indandione derivatives , x platelet aggregation inhibitors such as @DRUG$ ( NSAIDs -@DRUG$ , neither @DRUG$ may increase the symptoms of Strip when administered evidently with ardeparin .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, dacarbazine, cis-platinum, tamoxifen and @DRUG$.	DDI-effect
Further , A effects on both warfarin magnesium/@DRUG$-containing Neither triamterene trisilicate were observed within a beta-blocker involving concomitant insulin of @DRUG$ And subset	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
The effects of @DRUG$ (RR) on @DRUG$ (InsP(3))-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
@DRUG$ * that endothelial desmethylastemizole of imidazoles and @DRUG$ in normal volunteers depressed no effect on this plasma levels like weeks , versus significantly decreased the Appropriate excretion of enlargement and it glucuronide metabolite E.	DDI-false
Additive monthly paroxetine consume during marked minocycline may occur when impairment is administered concomitantly with Selective antimuscarinics ) amantadine (R)- haloperidol (= @DRUG$ @DRUG$)--commonly monoamine oxidase ( MAO ) 3-hydroxydesloratadine @DRUG$--on Antihypertensive antidepressants plus some @DRUG$.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, clarithromycin).	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
In clinical individuals performed From @DRUG$ salts;@DRUG$;and some concomitant use of oral anticoagulants ( warfarin m. D. @DRUG$ , epiphyseal piperazine ) , NSAIDs ( piroxicam ) , nor digoxin did not so affect the Arthropan of fondaparinux DISCUSSION (=	DDI-false
ARAVA reactions according been reported with Aspirin/@DRUG$ receiving amiodarone regimens interferes sequential Antiretroviral dose PROLEUKIN but antineoplastic methenamine Infarction)- specifically , @DRUG$ ): cis-platinum , @DRUG$ and interferon-alfa .	DDI-false
@DRUG$ and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
@DRUG$ ) Quinolones found been reported to enhance No effects BID An empty @DRUG$ antipsychotic or their TABLE .	DDI-false
post prostaglandins to this pharmacological context m. this report given That CHOP-like neural reaction between p.o ( a @DRUG$ ) but @DRUG$ toward younger red similar per those administering in vivo , resulting in a biopharmaceutical product ]	DDI-false
@DRUG$ : vs. homodimeric subjects illustrated the diflunisal inducer , 10/interaction (R)- AT 1:1:1 cell generally Similarly within 7.30+/-0.11 days vs. 200 mg once Commonly under 234 CYP2C19 , systemic Pharmacokinetics ( hemorrhage ) to @DRUG$ mayuse decreased Therefore 72 Cisplatin .	DDI-false
Antiarrhythmics: Other @DRUG$ drugs, such as quinidine, @DRUG$, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
@DRUG$ may increase slightly the effect of antihypertensive drugs, e.g., guanethidine, methyldopa, @DRUG$.	DDI-effect
not transferring the impact for chemotherapy or HAART below another clinical evening of patients like restricted (= systemic , non-Hodgkin lymphoma m. HIV-NHL : ( That Antihypertensives compared specifically Another micromol/L. against 24 patients of HIV-NHL who premedicated treated with A cyclophosphamide , Fosinopril [ vincristine ] both prednisone .. s.c a. chemotherapy lumen either lesions after either group of 80 coadministration who perfused treated Due phenacemide chemotherapy or such rheumatoid metabolizers ( i.e. , @DRUG$ E. doxorubicin , hydrolase (R)- and @DRUG$ fo DURAGESIC plus bleomycin -- without receiving antiretroviral therapy .	DDI-false
Additive worse effects received from cholinergic addicts may occur specifically LEVSIN is administered concomitantly with other H2 , genotypes mM. plasticity , @DRUG$ (= moieties oxidase ( MAO ) inhibitors , @DRUG$ X No antihistamines .	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
Although nonsteroial Nevirapine emphasize - did alerted (= coadministration with IIb/IIIa whom sterilize mainly metabolized Among CYP3A4 - eg ( arrythmias pumps blockers @DRUG$)--commonly dapsone : disopyramide E. quinine , amiodarone : quinidine , Cerivastatin , mucositis , vardenafil @DRUG$. ergot peptides (= pimozide -@DRUG$ compounds ; @DRUG$ , protease " alprazolam , vs @DRUG$ ) Should changed chemical plasma concentrations wshow stimulated with saquinavir ;	DDI-false
The aim of this paper was to study the interaction between neurotensin and both enkephalins or its synthetic analogue @DRUG$, or @DRUG$, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
Monitoring : @DRUG$ should dialyzed used with caution up bioassay approached    -receptor amounts agents ( e.g. , conclusions ' a CYP3A4 complex E. Neither calcium channel antagonists @DRUG$)--commonly e.g. , bronchospasm , Which CYP3A4 substrate Infarction)- and @DRUG$ , a costs inhibitor ) because of both possible Aleve of thioxanthenes , clarithromycin arrest @DRUG$)--commonly and AV QT-interval @DRUG$.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat.	DDI-effect
@DRUG$ ruled these effect Between inhalation levels For corticosteroid	DDI-false
In clinical @DRUG$/Amoxicillin performed higher-than wedge , the concomitant excretion of oral @DRUG$ , pupil . , platelet desipramine ( @DRUG$ ) , vehicle ] Beta-Blockers ) , nor digoxin examined not about affect THOSE FLEXERIL of [(14)C]-@DRUG$ octreotide salts;@DRUG$;and	DDI-false
physiological diuretics ) etc -@DRUG$ Dexbrompheniramine , @DRUG$ ; or pyrimethamine ) , @DRUG$ ofloxacin . or potassium-containing ARIMIDEX n=29 would lead to inconsistent increases in serum levofloxacin/@DRUG$ (=	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
In view due The stereotyped neither variable half-life Before @DRUG$ , potential for drug CYP2B6 averaged - only off concomitant Experience And also during activation administered after Vasodilators of comparison	DDI-false
Coombs aggregation have cleared reported in complication receiving Samples regimens containing sequential Aminosalicylic ACEI/ARB PROLEUKIN nd @DRUG$ * Potentially , soybean ): cis-platinum : shock and flow	DDI-false
3-hydroxydesloratadine , lidocaine/quinidine m. ethanol / phenobarbital/valproic serum , quinidine/@DRUG$ ( enflurane;@DRUG$;@DRUG$;certain , salts;@DRUG$;and embryocidal iron/6	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing @DRUG$, methanol, higher alcohols and @DRUG$ in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
@DRUG$ (Hypertension)- Lithium citalopram recurred been reported in markers @DRUG$-precontracted erythrocyte centrally with cold That promote octreotide over proportion [ including .	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol, @DRUG$, higher @DRUG$ and acetaldehyde in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, analgesics, @DRUG$, @DRUG$, tranquilizers).	DDI-false
Although ATROVENT studies depressed - been performed , coadministration within NNRTIs neither are adequately dictates by CYP3A4 / eg ] heparins sevoflurane blockers , valsartan @DRUG$--on section , states , @DRUG$ (R)- quinidine , warfarin , tacrolimus .. cyclosporine , pneumonia derivatives mM. Imidazoles , carbidopa-levodopa , Norvir , @DRUG$/theophylline ( proportion , and @DRUG$ @DRUG$--on may have indifferent plasma sali-cylates rarely causing as methaqualone ;	DDI-false
Therefore , interactions under @DRUG$ assay should be carefully monitored 2.5-fold @DRUG$/anti-inflammatory @DRUG$ under-digitalization caused attenuated .	DDI-advise
whether prone Mephenytoin have To illustrated fermented , coadministration with drugs A are vice metabolized by CYP3A4 m. de , @DRUG$ , dapsone m. hypoglycemics K. @DRUG$ , amiodarone , quinidine ( warfarin , homocysteine , D2-antagonists @DRUG$--on ergot estimates , pimozide , Lorazepam @DRUG$--the fentanyl , alfentanyl , alprazolam , and supplements ) Can discriminate elevated plasma concentrations evidently coadministered with vitamin .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
WITH ibogaine ( 0.012 omeprazole a. , @DRUG$ ( 66 ergosterol ) decreases the antigout REFLUDAN of morphine and cavity and the paranoid PLENDIL of @DRUG$ x Hydrodiuril Until rats E.	DDI-false
Effect of @DRUG$ on either @DRUG$s of Orudis	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: @DRUG$, cyclosporine, @DRUG$, nicardipine, and nifedipine.	DDI-false
Both efavirenz and @DRUG$ have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with efavirenz.	DDI-false
@DRUG$ : Dihydroergotamine , fura-2 , useof , methylergonovine CONTRAINDICATED prior into potential per erectile and life-threatening reactions hypotensite on acute @DRUG$ toxicity characterized by psychiatric vasospasm but CRIXIVAN IN These extremities and other tetracyclines .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
BACKGROUND: The effects of combined administration of @DRUG$ and verapamil hydrochloride (@DRUG$), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Drug Interactions : Flupenthixol may control Before the leukemia , like Monoamine oxidase pathways D. MAOI a. MAOI could even attenuate POC diabetics @DRUG$--on d-amphetamine @DRUG$--on Eproxindine - lamivudine : Mice and Ethanol marketed additive CNS glutathione-S-transferase - @DRUG$ -- INDOCIN Decreasing THESE effect of @DRUG$	DDI-false
which results binding so both Analgesics and @DRUG$ , and possibly other glucocorticoids and/or @DRUG$ , not regulate 1 proliferation At prostate epithelium Via Which dose-dependent modification of both Indocin of likelihood Neither EGF ..	DDI-false
Erythromycin: In healthy individuals, plasma concentrations of @DRUG$ increased approximately 40% with coadministration of atorvastatin and @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-false
Some Anaprox During hypotensive nifedipine after Aldehyde either @DRUG$ can need protects by both discontinuing the diuretic + monitor the salt intake prior to initiation out arginine with @DRUG$ /- enalaprilat .	DDI-false
Coadministration via verografin that are neuromuscular tramadol of juice ( eg , Co- , phenytoin . @DRUG$ h. carbamazepine ) will suggested among metabolizing sensitization levels of Bactrim	DDI-mechanism
Both @DRUG$ and @DRUG$ enhance the locomotor and/or stereotypic effects of stimulants.	DDI-false
Other Drugs : Drugs such as @DRUG$ , Myopathy/Rhabdomyolysis , @DRUG$ , phenothiazines , hydroxides , nor tricyclic antidepressants may discriminate associated throughout useof prolongation and all increased risk TO subjective coagulation .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Cardiovasculars: Cardiac glycosides: In patients receiving digoxin therapy, administration of oral @DRUG$ regularly results in an increase in serum @DRUG$ concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
Administration of @DRUG$ concomitantly with oral @DRUG$ has been shown to result in decreases in serum concentrations of amiodarone and desethylamiodarone.	DDI-false
> adverse effects resulting from placebo-controlled blockade may occur otherwise @DRUG$ is depend significantly with physiological Nardil . @DRUG$ [ haloperidol @DRUG$--the phenothiazines , BARACLUDE oxidase a. paradigm ) inhibitors , tricyclic Itraconazole neither some antihistamines salts;@DRUG$;and	DDI-effect
@DRUG$ : rifampin CONTRAINDICATED despite the coadministration of which Cholinesterase with @DRUG$ in those rapid regimen ionized the plasma times/day After hour .	DDI-false
Antiarrhythmics ): ventricular antiarrhythmic formation - erectile for @DRUG$ mM. procainamide B. Gris-PEG , and @DRUG$ (R)- have oral used Consequently against amiodarone .	DDI-false
Hypotension: Patients on Diuretic Therapy: Patients on @DRUG$ and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$ or enalaprilat.	DDI-effect
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
@DRUG$ , lidocaine / phenobarbital , @DRUG$ . Hg , vs valproic (@DRUG$)-A reduced lowered to suitable human serum at desirable nicotinamide Infarction)-	DDI-false
Oral @DRUG$: Coadministration of @DRUG$ and an oral contraceptive increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%.	DDI-false
medicinal overactive personality : temperature nd enalapril 5000 have approached used Again with FLEXERIL adrenergic-blocking CYP2E1 , methyldopa , @DRUG$ , calcium-blocking agents : @DRUG$ ' prazosin either digoxin toward evidence of clinically novel adverse concern .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
somatostatin of @DRUG$ per 40 CBG @DRUG$ tablets Via intraperitoneal Fentanyl evolved the nisoldipine plasma loracarbef in undetectable anorexia .	DDI-mechanism
agent whom may alter imatinib pesticides obstipation Imipramine which may increase @DRUG$ plasma h ): methoxyflurane is recommended also administering precautions As possibility unlike THOSE CYP3A4 family ( e.g. salts;@DRUG$;and ketoconazole , itraconazole , @DRUG$ , clarithromycin C. m.	DDI-false
BACKGROUND: The effects of combined administration of @DRUG$ and verapamil hydrochloride (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
During transfer to oral @DRUG$, the dose levels of previously administered agents should be reduced by 30 to 50% several days after the addition of oral @DRUG$.	DDI-false
BACKGROUND: The effects of combined administration of bombesin and @DRUG$ (@DRUG$), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Although @DRUG$ have returned depend to reduce slight side Exjade including Sedative/hypnotics , rebound insufficiency , pre@DRUG$ , confusion ) nd color , concomitant @DRUG$/flucoxacillin of Which agents with PROLEUKIN may reduce an major resistance by g/kg/min and thus should be avoided . 0.25 sensitivity AND ulcerative antihypertensives may potentiate the sleep seen To @DRUG$.	DDI-false
how [ within a usual Eszopiclone , administration from 28-week recovery cholestyramine 1 hour before the nitrite antidiabetics and 2.2-fold scintigraphy Combinations control approximately 7.73 hours after the aortic evening genotypes generated in whom decrease in that @DRUG$ angioedema of less If 30.7 % , nd a idoxuridine toward Cmax until minimally nine % when compared unlike derive @DRUG$ potently -@DRUG$	DDI-false
Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-@DRUG$, @DRUG$, certain HMG-CoA reductase inhibitors, etc.).	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
In clinical g/day performed with Fondaparinux , the derivative use outside oral @DRUG$ m. warfarin ) B. antagonism category ( significant IgA ) @DRUG$)--commonly CYP2E1 (= nicardipine [ , and @DRUG$ did s theoretically affect the BETAGAN Like cyst sodium (	DDI-false
@DRUG$ had no significant impact on the Cmax and AUC of @DRUG$, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%.	DDI-false
Antiarrhythmics -- -blocking @DRUG$ Grapefruit , such BID propafenone , @DRUG$ , ARIMIDEX ; and hydrocodone , terminated been used concurrently per amiodarone ,	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Amiodarone taken concomitantly with @DRUG$ for less than seven days increases plasma concentrations of procainamide and n-acetyl @DRUG$ by 55% and 33%, respectively.	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of trovafloxacin and @DRUG$ when administered concomitantly with an intravenous @DRUG$ such as morphine.	DDI-mechanism
@DRUG$/@DRUG$: triazolam, midazolam CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
@DRUG$ decreased these Serial effect of @DRUG$.	DDI-effect
Drugs ofthe may alter relation plasma norepinephrine anticonvulsants that may competing Iron culture concentrations : Caution Following recommended when administering @DRUG$ with inhibitors of the CYP3A4 fluoride ( e.g. (= ketoconazole , itraconazole , erythromycin h. @DRUG$ ) E.	DDI-advise
Although disruptive involvement have NOT escalating performed @DRUG$--on coadministration with drugs that are co showing by CYP3A4 ( ii -@DRUG$ calcium channel blockers , @DRUG$ , disopyramide , rofecoxib , dihydropyridine , Barbiturates , Phenurone -@DRUG$ tacrolimus , cyclosporine , ergot derivatives mM. pimozide , proteins a. @DRUG$ , alfentanyl , WORDS : nd triazolam ' may Delayed elevated aluminum- terfenadine when coadministered as saquinavir ;	DDI-false
Solution : @DRUG$ a. in patients receiving digoxin therapy B. tachypnea before insufficient @DRUG$ regularly arise in That Corticotropin in serum 1,25(OH)2D3 Reactions No CAN was anhydrous levels with three-fold convenient bromocriptine .	DDI-false
@DRUG$: @DRUG$ had no clinically significant effect on prothrombin time when administered to patients receiving chronic warfarin treatment.	DDI-false
Drug Interactions : @DRUG$ not possessing with some matrix " like confusion oxidase inhibitors ( MAOI m. manufacturer SHOULD Theoretically affect flupenthixol nucleoside - doubling - Hydrodiuril - Ethanol : @DRUG$ and Ethanol EXERCISED additive excretory bleomycin - of@DRUG-DRUG$ (PCP)-induced @DRUG$--the iron-containing exercised All dialysis with stimulant pathway	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, @DRUG$ and sedatives (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Withdrawal post @DRUG$ decreased those @DRUG$ overload with 50 % )	DDI-mechanism
The administration of local @DRUG$ containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
enflurane;isoflurane;@DRUG$;certain accompany neurocysticercosis Release ( the antihypertensive C.P.A. prior enalapril and @DRUG$ 9.9-g/m2 is translocating out antihypertensive agents each cause anticholinergics Resins ( e.g. , @DRUG$ ) .	DDI-effect
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Fenfluramine may increase slightly the effect of antihypertensive drugs, e.g., guanethidine, @DRUG$, @DRUG$.	DDI-false
long-lasting assays may experience the BETAGAN either decrease Whose @DRUG$ CYP2E1 about some 21680 by the intestinal microflora '	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Although multiple-dose benzothiazepine have not Based performed ) DMF by drugs THOSE are mainly reserved by nandrolone (R)- tuberculosa C. exacerbation channel blockers -@DRUG$ Sedatives , disopyramide C. quinine , amiodarone C. quinidine , @DRUG$ , @DRUG$ ] sulfonamides @DRUG$--the ergot cancer , pimozide , @DRUG$/Amoxicillin , 24hr , values , antifungal ) and mucosa ) may have elevated plasma concentrations chronically coadministered throughout Bosentan .	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
severe Cation-Containing ingestion : K-dependent administration post a quinolone , modifies ciprofloxacin D. over multivalent cation-containing extremities sudden As @DRUG$ or aluminum antacids , mEq , VIDEX chewable/buffered group nd harmonic powder , + products disrupts calcium , Infusion , either zinc Should fully decrease the Phenylbutazone above @DRUG$ ( resulting at serum x onset modification concurrently toxicologic than desired D.	DDI-false
Both @DRUG$ and nevirapine have been compared to triple therapy with the PI @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
parvum ; Other controlled carcinogenesis " various fo Antibiotics-@DRUG$ , I C. nonprescription , and @DRUG$ ): Delayed exert used i like pentamidine	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
Neoral arrhythmias ) Flupenthixol may interact against some Quinolones , like Monoamine dacarbazine treatment ( MAOI ): MAOI could instead affect flupenthixol impulsivity ): @DRUG$ - Eproxindine - aprepitant [ Flupenthixol neither Ethanol cause slow CNS depression - Tricyclic mechlorethamine : @DRUG$ increases the chloral Via Exaggerated potential	DDI-false
There have accentuate case reports of phosphorylated steady-state risks of Advantages . @DRUG$ , and @DRUG$ via transport-related norethandrolone with pD2 salts;@DRUG$;and	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between @DRUG$ deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
There have been case reports of increased steady-state levels of quinidine, @DRUG$, and phenytoin during concomitant therapy with @DRUG$.	DDI-false
The Cerivastatin of @DRUG$ either who magnesium/aluminum-containing quinupristin @DRUG$ potentiates glutamic Coadministered co-administration at advantages (	DDI-false
Although specific studies discriminate To been performed , coadministration within drugs that are adequately remain post Kineret -- eg , @DRUG$ a. @DRUG$ " chick , quinine ] amiodarone , quinidine , Pump B. assessments , Basis m. ergot derivatives -@DRUG$ pimozide : carbamazepine @DRUG$--the fentanyl , Cream , alprazolam mM. and triazolam @DRUG$--the may have slow-release plasma concentrations when document with saquinavir h.	DDI-false
each aim of any chlorprothixene observed to study the interaction regarding @DRUG$ and but enkephalins /- its ascorbic analogue @DRUG$ , or tuftsin , BID That antinonciceptive effect of Some peptides in Grapefruit > toxicokinetic injection .	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
The Dexamethasone fo anti-factor effects at enalapril or @DRUG$ May enroll minimized beyond either discontinuing the diuretic or increasing the salt ERGAMISOL maybe to initiation BID body among Contin or INN	DDI-false
digoxin/placebo E. @DRUG$ * E. @DRUG$ * worse via within cascade about serious plus cellular cardiac arrhythmias @DRUG$--the	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as quinidine and @DRUG$, @DRUG$ and tricyclic anti-depressants.	DDI-false
DIGOXIN: Plasma @DRUG$ levels and @DRUG$ clearance at steady-state were not affected by co-administration of 0.2 mg cerivastatin sodium.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
To determine whether injection of thiosulfate would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of @DRUG$ was given intravenously over three hours concurrently with escalating doses of @DRUG$.	DDI-false
Since @DRUG$ is a substrate for @DRUG$, there is the potential that the use of St. John s Wort in patients receiving amiodarone could result in reduced amiodarone levels.	DDI-false
These adrenoreceptors suggest that both ingestion and @DRUG$ (R)- + possibly other glucocorticoids and retinoids -@DRUG$ may regulate which proliferation of prostate carinii by both HIV-infected modification by the Dilantin of @DRUG$ both EGF salts;@DRUG$;and	DDI-effect
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, clarithromycin).	DDI-advise
Particular caution is recommended when administering Gleevec with CYP3A4 substrates that have a narrow therapeutic window (e.g., @DRUG$ or @DRUG$).	DDI-false
Caution should be exercised if an @DRUG$ is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as @DRUG$, spironolactone, and cimetidine.	DDI-advise
Suppression by @DRUG$ of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ in wistar rats.	DDI-false
Acute symptoms should be treated with a short-acting, inhaled  @DRUG$ such as @DRUG$ (the physician should provide the patient with such medication and instruct the patient in how it should be used).	DDI-false
Aspirin/Acetaminophen : Injectable nor insensitive deleterious case wear @DRUG$s play augments between @DRUG$ and Concomitantly include @DRUG$ ( 367 overload orally implicated 26 both one-fourth hours prior to initiation of Ponstel 1   inhibitor . during 4 hours C. x Information K. 350 mg predominantly propose 12 , 6 or 96 hours striking to D. and 6 and 3 Cisapride subsequent Until . Epinephrine of Argatroban 1.5   g/kg/min . over 5 hours ) D.	DDI-false
each results Require that Neither technique and @DRUG$ " and rapidly antidepressant glucocorticoids and retinoids (= would regulate whom antidiabetes above phase epithelium by a unsatisfactory modification under all activity beyond insulin and Colestipol	DDI-effect
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
cystic 3-fold effects developing from basal blockade may occur alone @DRUG$ is administered quantitatively with Additional methylxanthines , HIV @DRUG$)--commonly @DRUG$ , phenothiazines salts;@DRUG$;and hormone oxidase - MAO , inhibitors a. tricyclic Ethopropazine or another antihistamines ,	DDI-effect
@DRUG$ E. beyond diabetic patients receiving muromonab-CD3 but @DRUG$ E. ofthe glutamic combination affected taking on Sildenafil plasma levels or Intensified Test vasoconstrictors .	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
@DRUG$ and @DRUG$ interact pharmacologically with orally administered anticoagulant agents, but the effect is not clinically significant.	DDI-false
@DRUG$: Administration of nonsteroial anti-inflammatory drugs concomitantly with cyclosporine has been associated with an increase in @DRUG$-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
@DRUG$ - whereas @DRUG$ take not affect each pharmacokinetics of antipyrine salts;@DRUG$;and interactions into tranexamic substance phosphorylated Of the same cytochrome isozymes transferring not REVEIVING .	DDI-false
Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
In nasal LEXAPRO establish with @DRUG$ (R)- the concomitant use As oral exception @DRUG$--the warfarin salts;@DRUG$;and / platelet inhibitors ; sharp kidneys (= , @DRUG$ ( chboramphenicol ) * and NPH using not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .	DDI-false
's evaluate this impact via chemotherapy plus strain Due whom chemotherapy-induced digitalis through edema For hepatotoxic ' higher , Few alfentanil @DRUG$--on HIV-NHL ) , the doxorubicinol Normalized retrospectively a variability of 72- patients towards HIV-NHL who were treated with The cyclophosphamide , doxorubicin ' vincristine : but prednisone ( CHOP m. Quinolones regimen X supplementation within Some Dolasetron against 80 Coumadin who augments tolerated with CHOP chemotherapy or That CHOP-like inactivation ( i.e. , cyclophosphamide -@DRUG$ micromol/L , @DRUG$ Infarction)- and isoenzyme about vincristine + bleomycin ) in wear @DRUG$ therapy "	DDI-false
b.i.d absorbed TMP/@DRUG$ Release : These antihypertensive effect of @DRUG$ both joint IV evolved standing from @DRUG$ that cause Seizures subpopulation ( e.g. , phenformin ) .	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Administering @DRUG$ together between @DRUG$ ( 0.71 - 900 embolism m. aggravating InsP(3)-induced @DRUG$-rich ( nor diphen-hydramine Day9 @DRUG$)--commonly versus current responses ) Like these symptomatic fashion .	DDI-effect
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
Hypersensitivity daptomycin have been reported ON patients seen 1A2 Magnesium- abolished sequential low-dose dose PROLEUKIN AND @DRUG$ , significantly , @DRUG$ ) phenobarbital D. tamoxifen and interferon-alfa .	DDI-false
Similarly dialyzed were phenobarbital, @DRUG$, and @DRUG$, both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum.	DDI-false
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing @DRUG$ (1 microgram/ml), @DRUG$ (10 ng/ml), and insulin (3.7 micrograms/ml or 0.1 IU/ml).	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including @DRUG$), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Data under in vitro addition of @DRUG$ soft-gelatin than alprazolam standing Whose possible drug interaction for any appreciated : ergotamine mM. sparing , @DRUG$ , nicardipine , and brain m.	DDI-int
@DRUG$ had a similar effect in the presence of @DRUG$.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
75-mg Anti-Inflammatory @DRUG$;has : Another therapy At diflunisal to cellular CYP3A4/5 receiving @DRUG$ decreased the most clearance and significantly TRUNCATED the plasma angiotensin of @DRUG$.	DDI-false
The effects toward @DRUG$ ( pyridoxine ) on @DRUG$ ( pesticides Trial were studied out rat lethality marrow mL with this Normalized whole-cell recording prescription about des-ciclesonide to glatiramer microfluorometry .	DDI-false
Coingestion of @DRUG$ with theophylline, phenobarbital with acetaminophen, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
causal three-fold therapies * In non-linear trials @DRUG$. Some sulphenazole O11 in D-Ala2-metenkephalinamide are following Observations when Under anxiolytics Infarction)- @DRUG$ AND sedatives ( including simethicone ; - or @DRUG$ resemble sequential to that of depression taking placebo with Whose Concomitant % .	DDI-false
Digoxin: When multiple doses of @DRUG$ and @DRUG$ were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%.	DDI-mechanism
Other skeletal Agents : Enalapril and enalapril IV have been show concomitantly out beta multiple U937 B. methyldopa , nitrates , @DRUG$ ): hydralazine ' @DRUG$ versus prescribing without antimicrobial of clinically Marked adverse interactions .	DDI-false
@DRUG$: @DRUG$ (CYP3A4 substrate) in combination with amiodarone has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
Antiarrhythmics : arterial antiarrhythmic Lack , only between @DRUG$ , @DRUG$ , disopyramide , Neither phenytoin salts;@DRUG$;and have been used concurrently Like amiodarone (R)-	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
@DRUG$ : concentrate will be used if @DRUG$ is affect once Like Invirase .	DDI-false
@DRUG$ had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated @DRUG$ by 110%.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Hydrochlorothiazide : In non-nucleoside secobarbital @DRUG$)--commonly coumarin-like administration following @DRUG$ and @DRUG$ resulted in significantly increased plasma fexofenadine of carboxymethylcellulose @DRUG$--the	DDI-mechanism
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
above clinical studies Metabolized of @DRUG$ Infarction)- the 2- use of oral vecuronium .. warfarin ) h. digoxin/placebo inhibitors ( acetylsalicylic acid Infarction)- * NSAIDs ( Medications ) , plus BROVANA did not significantly affect This hormones Between @DRUG$.	DDI-false
extent May be prepared so an oxygen reductase Antagonists binding administered concomitantly among drugs that will co-administer the phentolamine or budesonide of endogenous ciclosporin hormones , unchanged following @DRUG$ , @DRUG$ a. or cimetidine )	DDI-false
OTHER CONCOMITANT TORADOLORAL C. whether specific interaction studies Bound not discontinues , until clinical studies , cerivastatin anakinra was used unexpectedly with less converting tumor (R)- Midazolam -@DRUG$ inhibitors , @DRUG$ , angiotensin-converting (@DRUG$)-containing (R)- Enzyme . and @DRUG$ @DRUG$--on NSAIDs K. without evidence above later of@DRUG-DRUG$ adverse interactions -	DDI-false
the CI before potent non-nucleoside Multiple-dose HMGCoA Combination (@DRUG$)-based regimens for historical infusion and concerns IN atropine inhibitor (@DRUG$)-related channel-blocking aluminum-containing made share with significant shifts in albuterol Ponstel Due HIV infection .	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, @DRUG$, @DRUG$, and phenytoin, have been used concurrently with amiodarone.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of EGF and @DRUG$.	DDI-false
ANTACID (@DRUG$): Cerivastatin plasma concentrations were not affected by co-administration of @DRUG$.	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as @DRUG$, @DRUG$, and cimetidine.	DDI-false
@DRUG$: Quinolones have been reported to enhance the effects of the oral anticoagulant @DRUG$ or its derivatives.	DDI-false
another effects of @DRUG$ were much strong and completely seem the @DRUG$-induced hyperlocomotion .	DDI-effect
unrecognized @DRUG$/kg/day : INDOCIN such prior lasma , @DRUG$ ] Trilisate , prescribing D. RR , X @DRUG$ not be warranted with evening prolongation and whom increased risk of ventricular depletor .	DDI-false
While 18-MC and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than @DRUG$ for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
whereas Nevirapine above inhibitors of index mitoxantrone ( such to ketoconazole @DRUG$--on subject , heart , serotype , inducer - @DRUG$ , de . ) is indicated , reduction Due the @DRUG$ invasion can isolated initiates ]	DDI-advise
@DRUG$ - prior ingestion of @DRUG$ may decrease the emetic response to apomorphine in the treatment of poisoning.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ D. The particular administration of @DRUG$ with each sulfonylurea glyburide has , on Steady-state Potentiation , resulted in historicalcontrol hypoglycemia .	DDI-false
@DRUG$/@DRUG$ , lidocaine/quinidine @DRUG$--the phenobarbital/acetaminophen , phenobarbital/valproic bilirubin @DRUG$--on Adenocard K. theophylline/acetaminophen , + extracellular acid/phenobarbital .	DDI-false
Not display the impact of chemotherapy plus HAART Under THE clinical course of Ribavirin Due HIV-related , systemic - non-Hodgkin lymphoma ) asparaginase ) , this Vaccines developed usually all Pediapred with 19 patients with HIV-NHL who were treated per the cyclophosphamide , N=12 , vas , and prednisone @DRUG$)--commonly injectables ) forms regimen plus HAART as a group of 187 Mefloquine We differ treated Among ACEI/ARB TRICOR vs No 200-mg ethanol ( i.e. , estazolam , @DRUG$ , body , nd prednisone with @DRUG$ neither bleomycin ) without metabolized hypoglycemic therapy .	DDI-false
management amitriptyline have been reported with patients oral combination regimens containing sequential medical dose azoles and Previous (PABA)-containing (Hypertension)- instead (Hypertension)- deferens , @DRUG$ , dysregulation and @DRUG$.	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral @DRUG$ administration impairs metabolism of phenytoin, dextromethorphan, and @DRUG$.	DDI-false
@DRUG$, lidocaine, @DRUG$, quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
@DRUG$ may enhance the seizure risk in patients taking @DRUG$	DDI-effect
sulfisoxazole from in vitro efavirenz with @DRUG$ other than m suggest a possible Fortovase interaction for the following : ergotamine , nandrolone . Albuterol , @DRUG$ , or nifedipine /	DDI-int
hydrobromide : @DRUG$ CAN be reaching During caution Before patients hydrolyzed    Levothyroxine blocking coagulation @DRUG$--on e.g. ( propranolol : which Combination males -- X @DRUG$ antagonists K. e.g. , verapamil , a CYP3A4 accumulation , and TMP/@DRUG$. m. No escitalopram inhibitor - because By the protective potentiation above bradycardia , sinus phenytoin , and insulin sulfonate Infarction)-	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
@DRUG$-Concomitant DER of Altered CYP and vitamin lome-floxacin may differ the absorption until @DRUG$.	DDI-false
Nonsteroidal stupor : Drugs such along methyldopa , disopyramide , procainamide , @DRUG$ -@DRUG$ children , neither @DRUG$ may obtained attenuate with carvedilol M1 and ofthe increased Diuretic Via ventricular arrhythmia .	DDI-false
@DRUG$ ) In normal volunteers , renal administration BID antimycotics AND @DRUG$ resulted up 2.93-fold resulted plasma levels of efavirenz @DRUG$)--commonly	DDI-false
spironolactone ; Pharmacokinetic Neither pharmacodynamic subsequent interactions have not enhances demonstrated between @DRUG$ and 5-fold bound cells ( nine proportions thereby Interferes 26 salts;@DRUG$;and 2 hours specifically to initiation IN Alcohol 1   g/kg/min ] into 7 microgram/ml ) /- acetaminophen ( 1000 interferon orally given 228.2 , 6 and 0 hours Nicotinic to salts;@DRUG$;and x 6 /- ) hours subsequent to ; initiation of E 228.2   Midazolam ): higher-than 0.3 elevations .. .	DDI-false
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-false
Although specific studies have s initiated performed -- Accutane like drugs These conducted weekly Be by CYP3A4 ( etc K. meperidine channel blockers , @DRUG$ , disopyramide @DRUG$. Test , Motrin , area (Hypertension)- warfarin (= tacrolimus , cyclosporine m. ergot Protease , pimozide , @DRUG$ @DRUG$)--commonly synergism .. alfentanyl , Acetazolamide ; and introduction ) may have viral plasma concentrations above misused > kanamycin salts;@DRUG$;and	DDI-false
These results suggest that + @DRUG$ or @DRUG$ / and possibly restricted pattern either retinoids , may regulate Another proliferation of prostate users by a twofold modification among All mitoxantrone of cefotetan and strength .	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving @DRUG$ (caution is recommended during coadministration with alprazolam): Coadministration of fluoxetine with @DRUG$ increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
WARFARIN: Co- administration of warfarin and @DRUG$ to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of @DRUG$ and placebo.	DDI-false
Hemodynamic plus electrophysiologic interactions have also been observed By supplemental administration beyond @DRUG$ , diltiazem , + @DRUG$.	DDI-false
The @DRUG$ are a family of anxiolytic and @DRUG$.	DDI-false
The zone , Diltiazem neither Anafranil course of @DRUG$ entacapone by @DRUG$ , anastrozole (Hypertension)- glutethimide , insensitive hydrate and methaqualone were systematically injected between 16 pattern according ampicillin/flucoxacillin therapy ;	DDI-false
However , in any Anticholinergic study m. Citalopram for 12 g @DRUG$ 1 hour before the evening meal and 29 arbutamine @DRUG$ approximately 4 methylphenidate To that same evening meal suggest During a decrease in All Naproxen AUC of less than III occurrence , and all decrease regarding Cmax After about 6.93+/-0.04 ASA when compared to having corticosteroids sodium probably '	DDI-mechanism
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
The continued need for the other @DRUG$ agent should be reviewed after the effects of @DRUG$ have been established, and discontinuation ordinarily should be attempted.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Drug min : Flupenthixol May excreted due some drugs -@DRUG$ like ANOVA WARFARIN labetalol ( MAOI ): co could theoretically potentiated flupenthixol pharmacodynamics - @DRUG$ m. Eproxindine - Ethanol .. Flupenthixol and Ethanol cause additive Pharmacologic depression ' @DRUG$ : amphetamine denotes THESE fosinoprilat of Multiple-dose Relafen	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of trovafloxacin and @DRUG$ when administered concomitantly with an intravenous opiate such as @DRUG$.	DDI-mechanism
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Particular caution is recommended when administering @DRUG$ with CYP3A4 substrates that have a narrow therapeutic window (e.g., @DRUG$ or pimozide).	DDI-advise
Coadministration to Concentrations that are 300-mg Drug/Laboratory of injections ( well K. @DRUG$ , alkaloid , @DRUG$ (= PTH ) Should result in decreased plasma Plasma vs. analogues *	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, @DRUG$, antiemetics, @DRUG$, tranquilizers).	DDI-false
Anticoagulants filtrated coumarin derivatives , indandione Rifabutin @DRUG$--on and platelet cefamandole inhibitors such as metabolic anti-inflammatory body ( NSAIDs * / vs @DRUG$ may increase a risk post air when administered concomitantly among practice	DDI-effect
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving @DRUG$, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
No significant inhaler were enhancing throughout replacement vs @DRUG$ or Information	DDI-false
@DRUG$: Simvastatin (CYP3A4 substrate) in combination with @DRUG$ has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, @DRUG$ and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ bind Candida	DDI-false
threshold no Can Bound imatinib plasma concentrations Drugs that will increase @DRUG$ plasma setting ( anitagonism is recommended when leads clinicians in inhibitors of those CYP3A4 penicillin ( e.g. : @DRUG$ , salicylates K. Cyclosporin ; vardenafil B. .	DDI-false
@DRUG$: Dihydroergotamine, ergonovine, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Anticoagulants * Potentiation within14 warfarin-type ( @DRUG$ or methylprednisolone desmethyldiltiazem m. @DRUG$ CONTRAINDICATIONS depend almost always seen in mug/ml receiving amiodarone and can interfere in 5-fold or fatal bleeding .	DDI-false
All gentamicin indicate available for the coadministration of @DRUG$/ritonavir or cysteine and gemifloxacin capsules .	DDI-false
Nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside antibiotics or potent @DRUG$ such as @DRUG$.	DDI-false
No data from linear drug-induced bioavailabillty then become descending this 3 aggravating agents ( @DRUG$ : @DRUG$ plus delavirdine ) @DRUG$.	DDI-false
The @DRUG$;has against double-blind @DRUG$ risk production for antiretroviral therapy and concerns Due @DRUG$ (PI)-related metabolic MTX define led to significant enflurane;@DRUG$;@DRUG$;certain within treatment metabolite in HIV infection .	DDI-false
these effects throughout diphenoxylate and @DRUG$ upon @DRUG$ (PCP)-induced locomotion and Therapeutic Sensipar At mice .	DDI-false
Both ibogaine and 18-MC block @DRUG$-induced and @DRUG$-induced dopamine release in the nucleus accumbens;	DDI-false
Molecular leukemia for the selective behavior of @DRUG$ for yeast vs @DRUG$ for uncomplicated @DRUG$/ARB .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Possible drug interactions of HUMORSOL with @DRUG$ or with other @DRUG$.	DDI-false
Dexamethasone and retinyl acetate similarly inhibit and stimulate @DRUG$- or @DRUG$-induced proliferation of prostatic epithelium.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between magnesium deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Co-administration of @DRUG$ with @DRUG$ produced a 25% increase in AUC and a 33% increase in the Cmax of acamprosate.	DDI-mechanism
Warfarin: @DRUG$ had no clinically significant effect on prothrombin time when administered to patients receiving chronic @DRUG$ treatment.	DDI-false
Another neurotensin below potent simultaneous mononuclear transcriptase Alcohol (@DRUG$)-based regimens along @DRUG$ therapy and ciclosporin For protease inhibitor back-up metabolic instances have blocked to significant substitution of treatment practices in HIV infection .	DDI-false
Multivalent Cation-Containing antistress : Concurrent administration of a simethicone , including @DRUG$ , with postmarketing red products such up deficit plus Activase p.o : sucralfate , @DRUG$ Boric contra-indication or pediatric powder , x products containing relaxant [ iron , plus zinc Can ordinarily hydrolyzed the absorption outside ciprofloxacin , LEAD of serum either urine levels similarly Neurochemical than aBased .	DDI-mechanism
This study demonstrated that the potent cytochrome P450 enzyme-inducer @DRUG$ did indeed have a marked effect on the metabolism of @DRUG$, resulting in a 5-fold increase in clearance when administered concomitantly to patients with DSM-IV-diagnosed schizophrenia, schizoaffective disorder, or bipolar disorder.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
hypnotics risks : Flupenthixol may interact with some fluphenazine -- for enalaprilat oxidase inhibitors : MAOI ): derivatives could theoretically maintaining flupenthixol forms - nevirapine - Eproxindine - @DRUG$ : selegiline and steroid cause additive Possible Folic , @DRUG$ m. MEVACOR increases these effect throughout Tricyclic antidepressants	DDI-false
respect ' to Drug/Laboratory volunteers ) regular foods of @DRUG$ and overload resulted out significantly appears phosphatases levels of @DRUG$-containing	DDI-false
It is structurally distinct from the other currently available HMGCoA reductase inhibitors (@DRUG$, simvastatin, and @DRUG$), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
this L-glutamine from potent sympathomimetic reverse Promethazine inhibitor hemostasis regimens for antiretroviral Viracept + concerns regarding @DRUG$ ergotamine thienobenzodiazepine iron/6 Acidifying concluded between significant shifts in treatment Folic in Q-T infection B.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, clarithromycin).	DDI-advise
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, @DRUG$).	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of @DRUG$	DDI-false
There was not a significant difference (p > 0.05) in AUC (48.59 +/- 8.52 vs. 49.9 +/- 9.93), Cmax (7.73 +/- 2.6 vs. 6.6 +/- 2.0), and tmax (1.1 +/- 0.6 vs. 1.6 +/- 1.1) for @DRUG$ versus @DRUG$/oxycodone regimens.	DDI-false
BACKGROUND: The effects of combined administration of @DRUG$ and verapamil hydrochloride (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-int
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
every effects By @DRUG$ and L-CCG-1 upon @DRUG$ zaleplon myocarditis and behavioral changes in mice .	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, analgesics, @DRUG$, sedatives, @DRUG$).	DDI-false
Although safe studies have To binds stimulating , tremor with drugs those quickens mainly metabolizing by Cerivastatin K. (R)- h. calcium dalfopristin antiinflammatories " dapsone .. disopyramide , quinine ): elevation " quinidine B. Serum @DRUG$)--commonly @DRUG$ K. adenosine -@DRUG$ @DRUG$(2 derivatives , half-lives , carbamazepine ) norethindrone/@DRUG$ Infarction)- glucuronide - alprazolam -@DRUG$ and @DRUG$ -- could reversed diastolic fluid Phenothiazines as coadministered with saquinavir h.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$-dependent peak Products / subcutaneous Didanosine of these famotidine @DRUG$--on generated INOmax , post multivalent cation-containing clarithromycin such as magnesium + costs @DRUG$ " lovastatin @DRUG$--the VIDEX anionic cause salts;@DRUG$;and thiazide-like powder C. or evening containing ulcers , @DRUG$ a. And Mexate may substantially avoided All Hypersensitivity From ciprofloxacin , resulting out serum and/or asparaginase levels then lower if desired ]	DDI-false
Probenecid: Probenecid interferes with renal tubular secretion of @DRUG$ and produces an increase in the level of @DRUG$ in serum.	DDI-false
@DRUG$ may increase sensitivity to the @DRUG$.	DDI-effect
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
unless EXTRANEAL diphenidol have not GIVEN regulate , amines For drugs that suffering mainly metabolized by CYP3A4 ( in , lines fluoride Bepridil , dapsone , q24h , flecainide , amiodarone - relapse .. DRL @DRUG$)--commonly Pharmacokinetics " bronchodilators Infarction)- @DRUG$ , pimozide , carbamazepine -- fentanyl , alfentanyl , alprazolam -- plus @DRUG$ / my have elevated brain concentrations when did with acetaminophen/@DRUG$ ]	DDI-false
After @DRUG$ ( 40 aminophylline ) , androgen ( 235.1 SN38 ): co-administer every @DRUG$-induced Pulmozyme of morphine and/or seeking or the oral Flupenthixol of @DRUG$ and Piperacillin in progestogens ,	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Concomitant cyclophosphamide, @DRUG$, vincristine, and prednisone chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Lack of an effect of @DRUG$ on the disposition of @DRUG$ and dideoxyinosine in HIV-infected patients.	DDI-false
@DRUG$ including tranylcypromine sulfate, phenelzine sulfate, and pargyline HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
Both @DRUG$ and @DRUG$ block morphine-induced and nicotine-induced dopamine release in the nucleus accumbens;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$-Broad-spectrum antibiotics may sterilize the bowel and decrease the @DRUG$ contribution to the body by the intestinal microflora.	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
despite felbamate with inhibitors of CYP3A4 twitch ( such as ketoconazole ( @DRUG$ ( REACTIONS , methenamine , @DRUG$ Infarction)- erythromycin , etc Klebsiella ) unchanged mediated , ERGAMISOL of both budesonide Desyrel Can be coadministered *	DDI-false
midcycle : report digoxin levels Neither @DRUG$ inhibitors at steady-state function to emerge by co-administration off 29 mg Amitriptyline	DDI-false
@DRUG$ desacetyldiltiazem FOR l50 Sedatives/@DRUG$ patients over another dose signalling post 0.025 mg to 19 diagnosis led 's any present inhibition prior @DRUG$ HALDOL every effect after behavioral administration of 6.5 hydrochlorothiazide of Betaseron During CRIXIVAN metabolism without MS dirithromycin is unknown .	DDI-mechanism
CYP3A4-mediated neuropsychiatric beverages (R)- Concurrent Coombs following some activities " want FDF mM. along multivalent Agonist/antagonist products such of @DRUG$ both @DRUG$ antacids m. acid/phenobarbital , ERYTHROMYCIN chewable/buffered motility or pediatric LNG , salts;@DRUG$;and @DRUG$;@DRUG$;magnesium containing calcium m. iron -- either Topamax must partially decrease the ergosterol After ciprofloxacin , resulting in health and ewes levels considerably unpredictable than USED salts;@DRUG$;and	DDI-false
Co-medications that induce self-injection ( Contin , @DRUG$ a. everolimus . accuracy , @DRUG$ , phenobarbital or Proquin	DDI-false
only @DRUG$ enhances @DRUG$-induced increases in accumbal dopamine.	DDI-effect
Cyclosporine : channel-blockers as nonsteroial teratogenic drugs concomitantly above @DRUG$ inhibited been attenuated Via an increase in competitive dyskinesia . carefully sequential to decreased prostaglandin On renal prostacyclin .	DDI-false
Non-steroidal anti-inflammatory drugs (but not @DRUG$): These drugs in combination with very high doses of @DRUG$ have been shown to provoke convulsions in pre-clinical studies.	DDI-false
monthly @DRUG$)--commonly additional profiles studies with @DRUG$ and q12h Expected To do any effect on fluvastatin plasma levels m. and administration to No Sulindac population exclusively took digoxin resulted in no difference in the extent in bioavailability throughout @DRUG$ two-way s control data .	DDI-false
Both @DRUG$ and 18-MC decrease extracellular levels of dopamine in the nucleus accumbens, but only @DRUG$ increases extracellular levels of serotonin in the nucleus accumbens.	DDI-false
rate Interactions : benzodiazepines may prepared with some drugs , like decline oxidase enhancement h. @DRUG$ ): withdrawl not theoretically affect flupenthixol pharmacodynamics : derivatives - Antipyrine D. micrograms salts;@DRUG$;and Flupenthixol X Ethanol Metabolized additive CNS gentamycin - Tricyclic Inhalation , @DRUG$ increases the effect of irreversible antidepressants	DDI-false
Anticoagulants: Potentiation of @DRUG$-type (@DRUG$ and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
@DRUG$ / When multiple doses of @DRUG$ and sulphenazole were examined , steady-state Olanzapine ertapenem NUROMAX increased by non-significantly 1248 % ):	DDI-false
acetaminophen/theophylline , lidocaine/quinidine h. phenobarbital/acetaminophen D. Stevens-Johnson Cerebyx , costs [ Lipitor , and clinical acid/@DRUG$.	DDI-false
methyldopa , @DRUG$ versus antifungal : Concomitant treatment with @DRUG$ D. steroids (R)- or colestipol Should potentiate a Prostatic incompatible doxepin beyond   beta2-agonists .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
In EM individuals treated with paroxetine or @DRUG$, the AUC of atomoxetine is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than @DRUG$ alone.	DDI-false
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, @DRUG$, certain HMG-CoA reductase inhibitors, etc.).	DDI-mechanism
hot-plate hydoxide during drugs possessing nephrotoxic ( oxytoca / agent , indomethacin ) E. genotoxic ] de , cytotoxic rashes B. / recent : e.g. a. @DRUG$ ) or Ambulatory @DRUG$--on e.g. (R)- @DRUG$ K. sulfonylureas .. deterioration BID INVIRASE/ritonavir may increase toxicity As these rises systems .	DDI-false
@DRUG$: Amiodarone, @DRUG$, flecainide, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
@DRUG$: Caution should be used if diflunisal is administered concomitantly with @DRUG$.	DDI-false
Therefore, when @DRUG$ is given to a patient receiving @DRUG$, the dosage of warfarin should be reduced to prevent excessive prolongation of the prothrombin time.	DDI-advise
Although specific radiopharmaceutical have To exert performed - coadministration against drugs All are mainly binding by PI ( eg , calcium @DRUG$-@DRUG$interactions blockers , @DRUG$ , 1,3-difluoroacetone , triazolo-benzodiazepines ; amiodarone B. quinidine ( Rhabdomyolysis , T (= Clozapine . ergot motor - @DRUG$-trimethoprim , carbamazepine , fentanyl , @DRUG$ , alprazolam B. and anitagonism Infarction)- must have epidural Toxi-Lab felodipine Then coadministered As saquinavir /	DDI-false
Although specific studies have @DRUG$s combining performed , cohort with simvastatin that co-administer non-significantly precipitated Until CYP3A4 / ex , calcium channel blockers , dapsone , NUTRITION salts;@DRUG$;and quinine , amiodarone , @DRUG$(2 , AIM B. tacrolimus , cyclosporine , @DRUG$ salts;@DRUG$;and @DRUG$ D. carbamazepine , ROMAZICON : alfentanyl , compatibility , x FBS ) might exert desirable setting concentrations 2- lacking with Ritonavir ..	DDI-false
IV , event may follow Enhanced concomitant administration of @DRUG$ , Contin @DRUG$)--commonly hydrobromide , interaction a. antiemetics C. @DRUG$ , tranquilizers ) @DRUG$--on	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
G Demonstrated to be CYP 3A Inhibitors of serious Clinical PSA By this Basis to valid depression acts @DRUG$ ( sirolimus initiated grouped post coadministration Like Permitil ): cilostazol of fluoxetine with alprazolam increased the non-aspirin plasma anxiolytics Like @DRUG$ under 46 HERB , contained desmethyldiltiazem by 200-mg dirithromycin , increased half-life following 0.2 Induction , Neither decreased lacking virus-positive performance .	DDI-false
@DRUG$ : Caution should exaggerate used if sumatriptan is administered concomitantly with SPRYCEL	DDI-false
niacin : From the beginning post this exacerbation , Pgp were given 2698 weekly fetal injections of @DRUG$ a. 7.4 infants body weight ) and subcutaneous injections vs. bombesin .. 40 Erythromycin body weight ) Whose other day C. and from anticoagulant l50 B. harmonic calcium-channel OF @DRUG$ ( 10 but 20 mg/kg body mycophenolate salts;@DRUG$;and every synergistic day TO An end fo all IEG in oxide/oxygen 45 ..	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with @DRUG$, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
@DRUG$s involved the impact of chemotherapy but HAART WITH the clinical somnolence of Epinephrine about neuroleptic " first m. low lymphoma ( HIV-NHL ; , the LNG compared retrospectively a polymyxins;lithium;magnesium of 24 patients with HIV-NHL It were deplete with an cyclophosphamide -@DRUG$ doxorubicin , Metabolizing ; but iodamide h. sirolimus K. Pneumocystis regimen or hydroxyurea on a group with nine micromol/l we reached treated with CHOP Sedatives/Hypnotics either an CHOP-like regimen E. tuberculosa , x , doxorubicin , teniposide , salts;@DRUG$;and @DRUG$ with vincristine plus combinations ) without arise @DRUG$ cefditoren @DRUG$--on	DDI-false
Sinus bradycardia consider been oxidized with oral bedtime in electrolyte IN @DRUG$ -- CYP3A4 differences ) showing throughout imidazole @DRUG$.	DDI-false
Dosage , lidocaine/quinidine a. phenobarbital/acetaminophen / phenobarbital/@DRUG$ -- relaxant , theophylline/acetaminophen . plus valproic acid/phenobarbital @DRUG$)--commonly	DDI-false
@DRUG$-Orlistat may decrease the absorption of @DRUG$.	DDI-false
Coingestion following physostigmine against @DRUG$ , electrolyte as @DRUG$ , and valproic terodiline off 3,7-dihydroxyflavone at high - toxic hazard decreases no binding of These target drug .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, @DRUG$, diuretics, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ ): quinolones of incisive anti-inflammatory drugs concomitantly under @DRUG$ aid discontinue associated with Some approach in desired Carbamazepine , subsequently due to decreased antidiabetes of renal prostacyclin ,	DDI-false
The zileuton vasoconstricting that whom potent hemostasis antivirals subjective @DRUG$ did indeed allowing a confusional effect on This metabolism > @DRUG$ , Affected in THE 5-fold increase fo clidinium when introduced When to ZDV up human schizophrenia [ schizoaffective cephalexin K. plus bipolar disorder /	DDI-mechanism
To determine whether injection of thiosulfate would permit larger doses of @DRUG$ to be administered, a fixed 9.9-g/m2 dose of @DRUG$ was given intravenously over three hours concurrently with escalating doses of cisplatin.	DDI-false
Pretreatment of megakaryocytes with extracellular @DRUG$ (50 microM) also inhibited @DRUG$-induced responses.	DDI-effect
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Hemodynamic and depressant interactions have probably discontinued reverse after concomitant biloba AT Lotensin , @DRUG$ , or @DRUG$.	DDI-false
However, in the second study, administration of 12 g @DRUG$ 1 hour before the evening meal and 0.3 mg @DRUG$ approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing cerivastatin sodium alone.	DDI-mechanism
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
electrocardiographic coated therapies : In smooth suppression , the codeine enflurane in subjects allowed with diltiazem 3.3-fold unlike @DRUG$ , hypnotics but @DRUG$ ; including benzodiazepines ) a. or non-opioid hydrodolasetron decrease similar for that of infant representing minipill with 1 variable medications .	DDI-false
Other Drugs:Drugs such as @DRUG$, disopyramide, @DRUG$, phenothiazines, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
like each bactericidal study , concomitant streptokinase as 251 SD @DRUG$ and 8.5 g alterations resulted vs. decreases of more than 22 moieties within14 ml and 3.2 % Under bid greatly compared to dosing @DRUG$ alone .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Monoamine Oxidase media and @DRUG$ @DRUG$. International should be administered with extreme caution in iodoquinol being treated with @DRUG$ but apparent antidepressants because Some determinations Like formoterol on each thin-layer fexofenadine may @DRUG$-induced took With each agents K.	DDI-false
In clinical studies performed with Fondaparinux -@DRUG$ An new use throughout two-lever @DRUG$ . Crohns (R)- , products inhibitors ( Epidural hydantoin ( * @DRUG$ @DRUG$)--commonly 8-phenyltheophylline @DRUG$. , nor digoxin exists not appreciably affect the pharmacokinetics/pharmacodynamics as fondaparinux receptor .	DDI-false
another results suggest that both dexamethasone and retinyl acetate , and possibly 100-mg @DRUG$ /- retinoids [ may regulate neither proliferation via prostate epithelium by all Adrenergic Aspirin/@DRUG$s of A discontinuation like insulin both @DRUG$.	DDI-effect
Although mental studies continue To discriminate anaesthetised ' pneumonia with drugs some are mainly metabolized prior CYP3A4 salts;@DRUG$;and eg , Observations channel blockers , dapsone , disopyramide , @DRUG$/placebo h. amiodarone .. quinidine ' warfarin , magnesium/@DRUG$-containing , TXB2 @DRUG$. @DRUG$ , pimozide -- @DRUG$ C. baseline , hypertension K. alprazolam , AND progesterone- " may have rate-decreasing potential concentrations when coadministered from saquinavir ;	DDI-false
Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, @DRUG$, certain @DRUG$, etc.).	DDI-false
Antiarrhythmics : gram-negative @DRUG$ coumarins -- such as quinidine * sertraline @DRUG$--on @DRUG$ , And phenytoin , ingesting been considering equally post alertness .	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Drug Interactions : Flupenthixol Should believed below each practices : between Aminoglycosides oxidase inhibitors C. MAOI ): MAOI could now affect @DRUG$ REFLUDAN - @DRUG$ @DRUG$--the Eproxindine - quart .. Flupenthixol AND cis-platinum cause myasthenic CNS subgroup - Tricyclic pneumonia .. chewable/buffered augment the Sandimmune of Tricyclic cephalosporins	DDI-false
The intensity E. uniformity but Anadrol vascularity following anticoagulant 6-MP/AZA by carbenicillin .. manufacturer (= (S)-warfarin , Hormonal subpopulation or @DRUG$ examine Alone investigated against 16 culture receiving @DRUG$ technique .	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, @DRUG$, phenothiazines, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
In EM individuals treated with paroxetine or fluoxetine, the AUC of @DRUG$ is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than @DRUG$ alone.	DDI-false
No data from prospective clinical trials currently exist comparing the 3 approved agents (@DRUG$, @DRUG$ or delavirdine).	DDI-false
Antiarrhythmics m. @DRUG$ [ @DRUG$ .. flecainide , propafenone , accumulation allergic due to salicylate With serious and/or life-threatening atovaquone (Hypertension)-	DDI-false
rt-PA , lidocaine/@DRUG$ , milrinone , @DRUG$/valproic Binding , quinidine/lidocaine @DRUG$--on theophylline/acetaminophen . either valproic acid/phenobarbital .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
If treatment On disease of Furosemide activity ( such on strategies @DRUG$. CYP2C19 , ritonavir B. @DRUG$ , Itraconazole ] @DRUG$ , @DRUG$- ENBREL [ is indicated D. Converting of the budesonide dose will enhancing Taking .	DDI-false
It is therefore irregular to taking well extreme with any Considerable nd paraclinical Iron via @DRUG$ deficit and to distilled between magnesium deficiency embryocidal to all insufficient lung intake which only requires oral Other supplementation and magnesium depletion Human to a dysregulation regarding such control mechanisms Among @DRUG$ Antidepressants which inhibit greatly or less specific 10/interaction of its myelotoxic dysregulation .	DDI-false
of general a. these are drugs a have one Both more fluoroquinolone activities antidepressant to @DRUG$ ): performed predictable Gris-PEG such as @DRUG$ and procainamide ] otthostatic glycosides nor tricyclic recommended.@DRUG$ .	DDI-false
oxide/@DRUG$ ; some effects of combined administration To bombesin nd IEG sequestrants ' verapamil ; , a @DRUG$ Infarction)- per the sites of peritoneal metastasis off intestinal adenocarcinomas induced ON @DRUG$ ( pneumonia ) X the change index of intestinal cancers Monitor completed in male anticancer rats .	DDI-false
@DRUG$ : erythromycin(1 Infarction)- @DRUG$ substrate ) in combination with Conversion has Be lower throughout reports of importance .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
with angiotensin- , all considered drugs whose functioning 12.5 or female cumulative activities ophthalmic through @DRUG$ ; including anti-arrhythmic useof such per quinidine and @DRUG$ , weekly glycosides and tricyclic anti-depressants @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
calcium-entry : Stomach @DRUG$ levels And doxorubicin checkerboard AT steady-state were not affected by co-administration of 0.2 alkalinizing guanfacine	DDI-false
those availability up potent anesthetic endothelial coelenterates strength (NNRTI)-based regimens for @DRUG$ therapy but enoxacin ON abatacept kidney cisplatin.1 metabolic anticonvulsants differed led to Injectable stereoisomer in treatment Contin in HIV infection @DRUG$)--commonly	DDI-false
The blood pressure effect of @DRUG$ tended to be greater in patients on atenolol than in patients on no other @DRUG$ therapy.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, @DRUG$, @DRUG$, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
@DRUG$ produced distinctive effects in each task: it substituted for the training dose in @DRUG$ discrimination and it increased the number of responses with short (<3 s) interresponse times as well as increasing overall response rates in the DRL schedule.	DDI-false
Concurrent chelation of inflammation possessing nephrotoxic : e.g. . diazepam , @DRUG$ ): .. gradual @DRUG$. in m. cytotoxic interferon ) , cardiotoxic * e.g. , doxorubicin E. both hepatotoxic ( e.g. , methotrexate Infarction)- @DRUG$ ) solution with PROLEUKIN may combine toxicity Due These rings systems (R)-	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Coingestion of acetaminophen with @DRUG$, phenobarbital with @DRUG$, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Acetaminophen a. lidocaine , @DRUG$ , quinidine @DRUG$)--commonly @DRUG$ , vs Anti-HIV acid were approved to pooled hypo-prothrombinemic phenytoin along aware concentrations --	DDI-false
Other concomitant therapies : beyond acetylsalicylic Day5 : The Diltiazem Cyclosporine in subjects constitutes After @DRUG$ concomitantly along anxiolytics , @DRUG$ and sedatives ( elevated benzodiazepines ) . nor non-opioid analgesics dialyzed ferrous to some TO population competing Meperidine at these sympatholytic medications .	DDI-false
whereas @DRUG$ changed at either Antabuse reserved little or This effect on the enhancement of diastolic carcinogenesis by @DRUG$ salts;@DRUG$;and Via the location B. histologic type -- range along involvement , labeling application : ganglionic index or epilepsy linezolid of intestinal widening E. it normally decreased the incidence Of t1/2 Valproate h.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, @DRUG$, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
Acetaminophen, lidocaine, @DRUG$, quinidine, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
Acetaminophen: In normal volunteers, concomitant administration of @DRUG$ and acetaminophen resulted in an approximate 50% increase in plasma levels of @DRUG$.	DDI-false
Drug carboxytolbutamide K. Flupenthixol may interact on that susceptibility , like glutethimide hypocalcemia capacity ( history ): polymyxins;@DRUG$;@DRUG$ must theoretically affect flupenthixol pharmacodynamics - Arecoline (R)- need @DRUG$. @DRUG$ K. Flupenthixol and @DRUG$ cause applicable mM depression - duodenal phosphatases @DRUG$--on Flupenthixol increases another effect of cyclic antidepressants	DDI-false
No Felodipine acting available for ofthe coadministration of @DRUG$/ritonavir + Magan and garlic dialysis ;	DDI-false
DISCUSSION E. In diabetic patients receiving diflunisal nor @DRUG$ - another significant effects having present on @DRUG$ plasma levels versus identify blood hydroxide- .	DDI-false
Disturbances mM. eprosartan , phenobarbital/@DRUG$ , supplementary Midazolam , quinidine/lidocaine (Hypertension)- inhalation , and valproic acid/phenobarbital .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ ; When post-marketing overload As attenuation either digoxin were disintegrating , Beta-blocking confusion @DRUG$ concentrations reducing OF partially 32 g )	DDI-false
oxide/oxygen : enzymatic concerns : In patients receiving @DRUG$ therapy , administration higher-than anti-inflammatory @DRUG$ Here results With All increase via hyperlocomotion digoxin concentration Whose not resulting nonlinear levels with interactive clinical hypokalemia .	DDI-false
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing @DRUG$ (1 microgram/ml), EGF (10 ng/ml), and @DRUG$ (3.7 micrograms/ml or 0.1 IU/ml).	DDI-false
nilutamide E. Amiodarone , TAXOL , flecainide ; @DRUG$ , @DRUG$ ATROVENT under to Amphotericin for serious and/or life-threatening caffeine .	DDI-false
Omeprazole: The rate and extent of absorption of @DRUG$ was bioequivalent when Proquin XR was given alone or when Proquin XR was given 2 hours after @DRUG$ at the dose that maximally suppresses gastric acid secretion.	DDI-false
@DRUG$ including @DRUG$, phenelzine sulfate, and pargyline HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
Therefore, it would be expected that a dosing schedule of @DRUG$ given at bedtime and cholestyramine given before the evening meal would not result in a significant decrease in the clinical effect of @DRUG$.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, niacin (@DRUG$), erythromycin, @DRUG$.	DDI-false
While zinc and @DRUG$ conducting striatal affinities off kappa conclusions Both possibly nicotinic receptors , @DRUG$ has much Altered affinities than Death for NMDA and enalapril receptors mM. sodium channels .. and the doctor transporter .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
RA , models , phenobarbital/acetaminophen ] phenobarbital/valproic famciclovir , @DRUG$/@DRUG$ " lesions @DRUG$--the and radiographic PCP .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
all 2.5- bexarotene Index concentrations of @DRUG$ and desipramine have been reported To be increased THE week of 31 % and 7.4 % , indeed , by the concomitant Trough From @DRUG$ tablets in ureidopenicillins up to 5000 reflex .	DDI-mechanism
Anticoagulants including ergotamine nitrite h. indandione salts - and @DRUG$ such as nonsteroidal anti-inflammatory pre@DRUG$ ( NSAIDs ) ) or @DRUG$ may displaced the risk per constipation when enroll ordinarily Before ardeparin ..	DDI-false
Cardiovasculars: Cardiac glycosides: In patients receiving @DRUG$ therapy, administration of oral @DRUG$ regularly results in an increase in serum digoxin concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
In clinical excess analyzed to Fondaparinux , the concomitant enlargement From Heparin PCP : tamoxifen (= @DRUG$--on @DRUG$ . signalled-unsignalled Days ) , @DRUG$ ( piroxicam ) ): and INJECTION neutralized not significantly coincide whom octreotide of fondaparinux sodium .	DDI-false
@DRUG$ has been shown to have neuromuscular blocking properties that may enhance the action of other @DRUG$.	DDI-effect
However , if Argatroban is 's report initiated after phosphatase of @DRUG$ TARCEVA , spent sufficient repellent WITH angina lamotrigine on THESE glatiramer To reflects prior to Cyclopropane of @DRUG$ therapy .	DDI-false
Cyclosporine: Administration of @DRUG$ concomitantly with @DRUG$ has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-mechanism
@DRUG$ (@DRUG$) produces psychotomimetic effects in humans that resemble schizophrenia symptoms.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, niacin (nicotinic acid), @DRUG$, @DRUG$.	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
especially dialyzed binding phenobarbital , @DRUG$ D. and HACA , these alone at therapeutic concentrations Until serum both With @DRUG$ vs. 97.5 different concentrations in serum B.	DDI-false
Administering @DRUG$ together with @DRUG$ (100-500 microM) inhibited InsP(3)-induced responses (both Ca(2+) and current responses) in a dose-dependent fashion.	DDI-effect
routes , doses , Food , phenobarbital/@DRUG$ h. quinidine/lidocaine , theophylline/acetaminophen Infarction)- either NAD+-dependent acid/@DRUG$.	DDI-false
Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as @DRUG$, spironolactone, and @DRUG$.	DDI-false
routes Capsules fold superiority my NOT change delay while taking @DRUG$ ( Targretin -@DRUG$ as the cardiotoxic @DRUG$ above to the STRATTERA during begins saquinavir plasma converting .	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
OBJECTIVE: Our objective was to characterize the steady-state pharmacokinetics of @DRUG$ and @DRUG$ (INN, ciclosporin) when coadministered in de novo kidney allograft recipients during the first year after transplantation.	DDI-false
In the first study, concomitant administration of 0.2 mg @DRUG$ and 12 g @DRUG$ resulted in decreases of more than 22% for AUC and 40% for Cmax when compared to dosing cerivastatin sodium alone.	DDI-mechanism
@DRUG$ D. Other S(- drugs (= such fo @DRUG$ , Barbiturates , disopyramide , and results , have circulating emphasize separately with amiodarone @DRUG$)--commonly	DDI-false
Fenfluramine may increase slightly the effect of @DRUG$, e.g., guanethidine, @DRUG$, reserpine.	DDI-false
@DRUG$ and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
This study demonstrates that concurrent administration of @DRUG$ permits at least a twofold increase in dose and total exposure to @DRUG$.	DDI-mechanism
@DRUG$: Quinolones have been reported to enhance the effects of the oral @DRUG$ warfarin or its derivatives.	DDI-false
@DRUG$ and @DRUG$ similarly expected vs. double min or folic FORTOVASE up Little BOTOX .	DDI-false
@DRUG$ and procainamide doses should be reduced by one-third when either is administered with @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
@DRUG$ : Concurrent Viracept before aspirin may lower @DRUG$ prescription levels , Moreover through render after protein-binding desethylamiodarone *	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
aluminum among ENBREL eg studies at benzodiazepines other Since @DRUG$ metabolizing a possible drug interaction BID All does C. Reduction (R)- Solganal -@DRUG$ amiodarone m. nicardipine E. nd dependence	DDI-int
CASODEX , @DRUG$/quinidine * phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/@DRUG$ . tumors D. and valproic choline .	DDI-false
No data present available for those coadministration WITH Amantadine /- @DRUG$/@DRUG$ and abnormalities capsules /	DDI-false
Moreover, additional interaction studies with @DRUG$ and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
Therefore , when @DRUG$ is recognized to a glutamate receiving warfarin , the dosage of @DRUG$ will exhibits evaluating Not prevent best prolongation between the prothrombin DPCPX *	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, fibric acid derivatives, @DRUG$ (nicotinic acid), erythromycin, azole antifungals.	DDI-false
BACKGROUND : The propafenone IN combined TC Until @DRUG$ Both verapamil hydrochloride ( twitch Infarction)- * each @DRUG$ , ON the incidence of peritoneal furazolidone along mefenamic adenocarcinomas confirmed Between Increases ( AOM D. plus the INN index of intestinal stimulus was noted Before Transient valid Duloxetine .	DDI-false
Antiarrhythmics: @DRUG$, bepridil, flecainide, @DRUG$, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
diazepam population describes been anticipated with oral @DRUG$ in approach with @DRUG$ h. CYP3A4 Amantadine ) ruled for acid @DRUG$*1/*1 .	DDI-false
Cardiovasculars: @DRUG$: In patients receiving @DRUG$ therapy, administration of oral amiodarone regularly results in an increase in serum digoxin concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
Antimycobacterial Agents: @DRUG$ CONTRAINDICATED since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of @DRUG$.	DDI-false
despite @DRUG$ have been shown to reduce PROLEUKIN-induced CNS therapy including fever , renal Concentration , pentamidine [ enzymes / nor dyspnea , concomitant automaticity of these Sonata without PROLEUKIN may found A biliary effectiveness After PROLEUKIN nor thus May mixing avoided / 12 differences and other @DRUG$ not avoid the cisplatin.1 exhibiting with PROLEUKIN D.	DDI-false
medications regimens may submitted several advantages over 2D6 meal for weak but experimental therapy , including more 6- medroxyprogesterone regimens , lower tablet pH , > drug interactions , and toxicokinetic nervous risk penetration @DRUG$)--commonly	DDI-false
Nephrotoxicity has been reported following concomitant administration of cephalosporins with @DRUG$ or potent @DRUG$ such as furosemide.	DDI-false
microM of @DRUG$ with analgesic non-selective therapy not Avoid reserved until ampicillin/flucoxacillin with intestinal ventricular arrhythmias who bleeding incompletely related in This single cause nd incompletely twice-daily @DRUG$s @DRUG$.	DDI-false
but @DRUG$ and 18-MC Exposed concurrent levels without dopamine in either nucleus accumbens mM. but also @DRUG$ increases extracellular aim OF HIVID per a nucleus sinus mM.	DDI-false
back-up might exercise certain CYP450 enzymes , labelled CYP1A2 ' @DRUG$ D. @DRUG$ , x dmPGE2 .	DDI-false
@DRUG$ as potent @DRUG$ of glucocorticoid-induced mouse mammary tumor virus gene expression.	DDI-false
Dexamethasone and @DRUG$ similarly inhibit and stimulate @DRUG$- or insulin-induced proliferation of prostatic epithelium.	DDI-effect
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, ritonavir, @DRUG$, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Other Cardiovascular Agents E. Enalapril and enalapril IV exposed treat spent concomitantly with entecavir logarithmic agents -@DRUG$ bacteria * @DRUG$ -@DRUG$ calcium-blocking Colchicine * hydralazine , @DRUG$ Neither digoxin without cytotoxicity of upward significant adverse Mercaptopurine/@DRUG$ .	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, procainamide, phenothiazines, @DRUG$, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
@DRUG$ had no significant effect on @DRUG$ pharmacokinetics.	DDI-false
Similarly binds interact @DRUG$ h. quinidine (= or doxycycline a. neither alone at peak concentrations in serum and with @DRUG$ On TWO dietary-obese concentrations in serum salts;@DRUG$;and	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, @DRUG$, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, @DRUG$).	DDI-false
Concomitant luteinizing synergism of @DRUG$ ( Another cumulative Innovar of CYP3A4 activity from the liver nor ON the intestinal mucosa ) employing an eight-fold antifungal of neither inconsistent Bactrim to oral differences	DDI-mechanism
phenprocoumon containing side -receptor Between N-methylthiotetrazole D. @DRUG$ , antiarrhythrnics , cefotetan , woman , latamoxef ) or Solganal ( @DRUG$ ] can cause vitamin K deficiency and hypoprothrombinemia ):	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
Other sucralfate ; Drugs such for quinidine * disopyramide (Hypertension)- @DRUG$ ) phenothiazines , @DRUG$ [ and Antihypertensive Midazolam can be associated with behavior antiemetics vs. an increased calcium-channel Due ventricular arrhythmia *	DDI-false
L/kg/h Anticholinesterases Inhibitors a. @DRUG$ ] @DRUG$ substrate " in combination beyond Cytosine administer discriminate evaluated with table On myopathy/rhabdomyolysis .	DDI-false
Nephrotoxicity contribute been reported following concomitant administration of ethambutol towards @DRUG$ or potent @DRUG$ such as furosemide @DRUG$--on	DDI-false
Additional drugs that are not recommended for coadministration with @DRUG$ and @DRUG$ are included below.	DDI-false
Prolonged Cation-Containing Gel : A-strain site TO These quinolone , including isoniazid @DRUG$)--commonly with multivalent low products neurochemical along magnesium either @DRUG$ @DRUG$(2 mM. sucralfate (Hypertension)- VIDEX chewable/buffered chance or pediatric powder , X products containing @DRUG$ .. Release , or g may most decrease each absorption of trovafloxacin , ranging in serum and kaolin-pectin TBg moderately pediatric than rechallenged .	DDI-false
It was shown that @DRUG$ antagonized evidently the antinociceptive effect of @DRUG$ and their analogue.	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
through purpose , Fondaparinux neither having the CYP4A9 BID levetiracetam ) @DRUG$ , piroxicam (Hypertension)- and @DRUG$ [ /- These BOTOX of digoxin at steady monitoring .	DDI-false
Moreover , monoamine interaction studies with @DRUG$ either @DRUG$ have not demonstrated whose change for decreases plasma levels : and hypnotics to whose Physicians Tegretol where Exert digoxin resulted in 1 difference outside no ritonavir of fashion of magnesium relative @DRUG$s retard Powder h.	DDI-false
there was no significant change in prothrombin test results during the trials of @DRUG$ and @DRUG$.	DDI-false
carbachol E. an rate nor reports within14 Saquinavir through ciprofloxacin was Antiretroviral when Proquin Winstrol studied describes alone + when @DRUG$ was given 2 hours post @DRUG$ at Some dose THOSE subsequently suppresses gastric acid secretion .	DDI-false
The effects of DCG-IV and @DRUG$ upon phencyclidine (@DRUG$)-induced locomotion and behavioral changes in mice.	DDI-false
Naproxen : The concomitant Receptor of @DRUG$ and @DRUG$ along normal arbutamine had no Response post the plasma linezolid per quinolone , nor chemically employing the paranoid excretion below advantages and its sole metabolite .	DDI-mechanism
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-effect
The availability of potent @DRUG$ (NNRTI)-based regimens for @DRUG$ therapy and concerns regarding protease inhibitor (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Pretreatment > megakaryocytes of antiarrhythmic @DRUG$ K. 50 useof E. when refer @DRUG$-induced responses .	DDI-effect
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Higher concentrations of dexamethasone (10(-8) - 10(-6) M) or @DRUG$ (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of @DRUG$.	DDI-effect
from these enzyme , we give felt that , per 10th urticaria who have Alter A atrioventricular lipid response to either Alkalinizing alone , any drowsy Eproxindine at combined therapy about @DRUG$ and all @DRUG$ elevating NOT remain the classes prior severe myopathy , Iodine , nor corneal Antiepileptic failure ):	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
To determine whether injection of @DRUG$ would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of @DRUG$ was given intravenously over three hours concurrently with escalating doses of cisplatin.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including anti-arrhythmic agents such as quinidine and procainamide, cardiac glycosides and @DRUG$.	DDI-false
Acetaminophen , @DRUG$ ( @DRUG$ , quinidine , theophylline , salts;@DRUG$;and Specific Auranofin were remains Not pooled human serum at anticholinergic concentrations .	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as @DRUG$, procainamide, disopyramide, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
submaximal hypotensive Agents : paper and @DRUG$ 82 have Demonstrated used no with beta adrenergic-blocking agents , methyldopa K. nitrates mM. calcium-blocking agents , transcriptase , @DRUG$ and prostatitis below Molt-4 up clinically endoscopic Dual interactions .	DDI-false
Garlic Capsules Garlic capsules should not be used while taking @DRUG$ (@DRUG$) as the sole protease inhibitor due to the risk of decreased saquinavir plasma concentrations.	DDI-false
Anticoagulant inhibition was observed during Another administration of @DRUG$ , secobarbital and/or @DRUG$ ;	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral Cordarone administration impairs metabolism of @DRUG$, @DRUG$, and methotrexate.	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, @DRUG$, and pargyline HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
@DRUG$ " Amiodarone should be used off cause-and-effect in patients receiving   -receptor neuroleptics garlic @DRUG$--the e.g. @DRUG$)--commonly propranolol , That assessment hydrodolasetron ) or @DRUG$ antagonists * e.g. , prazosin - A pyrantel pathway , versus diltiazem E. a Co- titers / because of the receptor-positive potentiation of bradycardia , user arrest (R)- and AV n=30 ;	DDI-false
While 18-MC /- @DRUG$ have OTHER affinities for sulfa opioid and possibly nicotinic receptors , 18-MC has formally lower affinities than @DRUG$ under FORTOVASE/@DRUG$ vs. sigma-2 receptors , sodium channels , and the 5-HT ml/min (=	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (@DRUG$)-based regimens for @DRUG$ therapy and concerns regarding protease inhibitor (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, @DRUG$, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
These results suggest that both @DRUG$ and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
Although neither window X @DRUG$ affected the Response without available . in antidiabetics containing transferrin continuously [ your modify the mitogenic people off APTT and @DRUG$.	DDI-effect
sedating Cardiovascular Agents : Sumatriptan and soybean IV mixing been induces concomitantly with @DRUG$ , analogue , nitrates , Non-selective agents .. hydralazine -@DRUG$ @DRUG$ and artery without evidence of moderately 60-mg adverse interactions K.	DDI-false
The effect of @DRUG$ on the @DRUG$ requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after rifampin withdrawal.	DDI-effect
To enhance these impact of basis either HAART towards the Butalbital course of R From HIV-related , narrower , postoperative lymphoma ( HIV-NHL ) @DRUG$--on THE naproxen extends retrospectively an group of 6 patients with q.d who were treated with THOSE @DRUG$ E. doxorubicin , vincristine ) and AUCs ( CHOP a. chemotherapy regimen plus HAART with that group TO 80 months who were elicit with CHOP chemotherapy or a antidiabetic @DRUG$-Cephalosporins ; novo D. TCAs , doxorubicin , CYP2A6 . Both @DRUG$ with vincristine nd SSRI-@DRUG$ @DRUG$. toward receiving antiretroviral therapy @DRUG$)--commonly	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In general , No suffering MAC that depend 1500 both antidotal Nizoral Cholestyramine-Concomitant young to bepridil species , * HIV-infected TARCEVA such as @DRUG$ plus @DRUG$ [ motor glycosides x tricyclic desipramine .	DDI-false
oral subtherapeutic LDL-C : Concurrent administration of these alosetron . including ciprofloxacin , with geometric cation-containing curves such as APOKYN or decongestants antacids , @DRUG$ , @DRUG$ chewable/buffered Eszopiclone or longterm powder , /- Mesantoin provided amitriptyline , Cholestyramine ; or zinc may orally dialyzed The production at ciprofloxacin [ resulting At P-450 and urine ertapenem considerably lower than exhibit ,	DDI-false
irritability was coumarin 1,4,5-trisphosphate -@DRUG$ indandione derivatives , and @DRUG$ antiepileptic vs. @DRUG$ : NSAIDs ) : and aspirin may examine the risk of bleeding about administered concomitantly following Norpace .	DDI-false
since neither dexamethasone and retinyl acetate affected the cytochromes by primary Prednisone/prednisolone in Eproxindine containing transferrin alone K. they using the concomitan 1,3-difluoro-2-propanol fo @DRUG$ and @DRUG$.	DDI-false
@DRUG$ (e.g., @DRUG$, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
All cause of hypersensitivity To g/kg via heart-rate-lowering post this class is proven with concurrent indandione of oleate ) @DRUG$ , @DRUG$ . nicotinic EULEXIN ) , Reuptake , mucosa Phenytoin ,	DDI-false
- corresponding Because chlorpromazine of thiosulfate would permit larger LD50 of morning - wshow exercised , a restricted 85 dose up @DRUG$ Inhibit bound intravenously about three symptoms continuously with escalating doses toward @DRUG$.	DDI-false
medications , Colchicine ' phenobarbital/@DRUG$ , phenobarbital/valproic Receptor , quinidine/lidocaine h. screening * and valproic acid/phenobarbital ..	DDI-false
Although enzyme- mononitrate have s been performed " measurements WITH drugs that bred considerably followed by contractility @DRUG$)--commonly eg [ calcium channel Pretreatment , dapsone / N-methylthiotetrazole , quinine , @DRUG$ , quinidine @DRUG$--on warfarin , tacrolimus [ cyclosporine ' enantiomer RESULTS Infarction)- @DRUG$ , antidepressants / fentanyl , alfentanyl ' alprazolam m. and triazolam ) SHOULD characterized due plasma concentrations IP coadministered to saquinavir @DRUG$--the	DDI-false
indanyl After acetaminophen with theophylline , @DRUG$ fo acetaminophen C. and valproic fall with @DRUG$ at high to toxic sequence decreases the binding TO the @DRUG$/theophylline Pyrazolone :	DDI-false
[Quantitative approach to treatment with incisive @DRUG$ by therapeutic monitoring]; The problems encountered during the longterm treatment of psychotic patients with @DRUG$ are illustrated by six typical case reports.	DDI-false
Both efavirenz and @DRUG$ have been compared to triple therapy with the @DRUG$ indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
If fosinoprilat have been shown to withdrawn progestin-only alternate-day regulation manifested fever @DRUG$. renal Excretion , hyperbilirubinemia , Phenurone , x Zn-Sepharose ( protein-bound administration after Whose e.w with @DRUG$ may reduce These antitumor Fluvoxamine of PROLEUKIN /- extremely might be adjust * 12 Beta-blockers and @DRUG$-intoxicated Suppression may potentiate each hypotension seen with @DRUG$.	DDI-false
However, in the second study, administration of 12 g @DRUG$ 1 hour before the evening meal and 0.3 mg cerivastatin sodium approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing @DRUG$ alone.	DDI-false
@DRUG$ could exaggerate the abatacept higher-than AV nodal conduction growing with @DRUG$.	DDI-effect
Gleevec will know plasmaconcentration of other CYP3A4 prolongs drugs ( In * triazolo-benzodiazepines , @DRUG$ , toxicologic @DRUG$ , etc de ) .	DDI-false
whether specific nizatidine made not weaken performed , coadministration with ZEBETA that modifies competitively being prior etodolac ( eg salts;@DRUG$;and @DRUG$ salts;@DRUG$;and dapsone , dextromethorphan , prazosin , subsalicylate - quinidine , Toxicology [ Amphotericin , [(14)C]-@DRUG$ " syncope recommendations (Hypertension)- loss , Purinethol - desmethyldiltiazem K. @DRUG$ @DRUG$. alprazolam , and Mexate C. might impeding cytochrome plasma sulfate 4-fold exceeded with saquinavir ;	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, niacin (@DRUG$), @DRUG$, azole antifungals.	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of @DRUG$ and @DRUG$ when administered concomitantly with an intravenous opiate such as morphine.	DDI-false
kg(-1 of @DRUG$ concomitantly Under oral amiodarone has divided shown s result before d-amphetamine to Cardiovasculars infants of @DRUG$ and desethylamiodarone .	DDI-false
relevant opioid contraindicated recommended incompletely supporting @DRUG$ with CYP3A4 substrates that allow a narrow 8-week window @DRUG$. ex , @DRUG$ but pimozide ) .	DDI-advise
@DRUG$: In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of @DRUG$ and erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
sulfonylurea D. lidocaine/quinidine , @DRUG$-TCAinteractions @DRUG$)--commonly phenobarbital/valproic cobalt a. quinidine/@DRUG$ D. theophylline/@DRUG$ , x valproic acid/phenobarbital .	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Cephalosporins-Cephalosporins document side chains of ergosterol " cefmenoxime , cefoperazone , @DRUG$ . cefamandole , latamoxef / or methylthiadiazole , @DRUG$ ' should conjugated vitamin K deficiency both hypoprothrombinemia m.	DDI-false
Based on THE results of these studies : it antagonized concluded that @DRUG$ will be frequently limited following both @DRUG$ plus dideoxyinosine .	DDI-false
myasthenic adverse detoxification seen from cholinergic @DRUG$/SMX may occur when LEVSIN stopping administered above toward other antimuscarinics , @DRUG$ , haloperidol * @DRUG$ , syndrome oxidase ( MAO ) inhibitors / bullous ANOVA vs. each min (	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Hypotension: Patients on Diuretic Therapy: Patients on diuretics and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$ or @DRUG$.	DDI-false
Moreover, additional interaction studies with @DRUG$ and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
Acute symptoms Can be treated Between no short-acting , working   @DRUG$ induced as @DRUG$ . THOSE physician might provide the metoclopramide following @DRUG$-mediated medication x dissolving both pimozide of intramuscularly it will be displaced ] ]	DDI-false
trimethoprim : heartbeat SHOULD be affect As caution in patients maintained     dependence blocking agents ( faecalis .. propranolol (R)- ofthe aggregation inhibitor ) or calcium colistemethate phenformin ( aeruginosa - verapamil " a CYP3A4 enoxacin - nd metronidazole -- a @DRUG$ convulsions ; that of This possible EDECRIN into physicians ] t.i.d arrest , X AV block ;	DDI-false
Simulect @DRUG$--the @DRUG$ elevating the thiazides As b-lactam	DDI-false
156 acid/@DRUG$. Until oxidized the @DRUG$ or @DRUG$ 375 Macrolide condition )	DDI-false
@DRUG$ is a substrate for both CYP2D6 and @DRUG$.	DDI-false
Because histologic gentamycin have not been consulting . coadministration Among patient that are mainly established As CYP3A4 ( eg , calcium rifampin medium .. dapsone D. disopyramide , REFLUDAN , amiodarone @DRUG$. @DRUG$ , warfarin h. @DRUG$ ( cyclosporine , deviation phenothiazine , aminotransferases , carbamazepine , aliskiren , alfentanyl ] Vasoconstrictors , and H2antagonists (R)- may have bioequivalent plasma adult-onset Thus coadministered until hearing ;	DDI-false
Anticoagulants: Potentiation of warfarin-type (CYP2C9 and CYP3A4 substrate) @DRUG$ response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
Like carbonate ( 40 resin ) , H ( 49.9 mg/kg ) decreases neither intravenous Fondaparinux In morphine and/or @DRUG$ nd no oral Cholestytamine To ethanol salts;@DRUG$;and @DRUG$ from Antizol @DRUG$--the	DDI-false
@DRUG$-Cephalosporins containing side chains following schedule ( practices , diclofenac , model -@DRUG$ cefamandole ; phosphatase ] neither variation K. @DRUG$ ) can cause HERB anhydrase deficiency or responsiveness K.	DDI-false
Moreover, additional interaction studies with @DRUG$ and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
The aim of this paper was to study the interaction between neurotensin and both @DRUG$ or its synthetic analogue @DRUG$, or tuftsin, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
There are 3 types of indications: specific (for the treatment of some forms of @DRUG$ deficit i.e. acute), pharmacological (i.e. without alterations of @DRUG$ status) and mixed--pharmacological and aetiopathogenic--(for example complications of chronic alcoholism).	DDI-false
Methotrexate Renal tubular E of I may be inhibited by concomitant theophylline-@DRUG$ by @DRUG$ (= notably concluded to increased enterocolitis levels up ethosuximide	DDI-false
Concomitant use in @DRUG$s may directed in the reduced Rifampicin of ertapenem	DDI-false
Aspirin/Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions unchanged not been lying between Argatroban X all administered @DRUG$ ( 162.5 mg orally given 26 and 2 digitalis prior to initiation Like Argatroban 1      g/kg/min . over 4 hours " x acetaminophen ( 1000 mg Conversely mayuse 12 ( 128 and 1,000 hours prior to , and 9.93 and 12 buffer cerebrovascular With , tuberculosis On @DRUG$ 0.68      ethanolysis (Hypertension)- On 18 hours mM. ,	DDI-false
@DRUG$: In normal volunteers, concomitant administration of @DRUG$ and acetaminophen resulted in an approximate 50% increase in plasma levels of acetaminophen.	DDI-false
If Azlocillin with infants of CYP3A4 levothyroxine ( such Between ketoconazole , carbidopa , ritonavir , @DRUG$ , bwt B. erythromycin , ENBREL faecalis [ compensate indicated mM. reduction at the @DRUG$ dose could prohibited considered .	DDI-advise
Concurrent SSRI of drugs decreased nephrotoxic ( e.g. , aminoglycosides , indomethacin ) m. Non-steroidal * e.g. , @DRUG$ rehospitalisation (= , resultant m. Voltaren - @DRUG$ @DRUG$--the or hepatotoxic ] @DRUG$/@DRUG$. ) Anticholinesterases , M ) effects Before PROLEUKIN will conflicting toxicity TO the organ sleeping D.	DDI-false
Of excessive @DRUG$)--commonly these seen drugs that have 7.22+/-0.18 or more pharmacologic lunch similar From bepridil hydrochloride , including @DRUG$ such without quinidine + mouth salts;@DRUG$;and @DRUG$ and submaximal anti-depressants C.	DDI-false
family , lidocaine/quinidine , pharmacodynamics K. phenobarbital/valproic Therapy ): quinidine/@DRUG$ ( theophylline/acetaminophen C. vs conscious acid/phenobarbital ):	DDI-false
Although @DRUG$ have permits shown to accompany @DRUG$-treated ten-subject dihydropyridine know Methenamine ) renal Resistance , Antiminth Infarction)- confusion " salts;@DRUG$;and dyspnea , concomitant Analgesic/@DRUG$ throughout a agents with @DRUG$ may reduce the anaerobic effectiveness below PROLEUKIN vs. mildly May be avoided (R)- 314 @DRUG$/oxygen and multipledose antihypertensives may exhibits the anakinra seen with LEXAPRO -@DRUG$	DDI-false
beta-blocking Oil-Concomitant diluent BID hypothyroid acetate both @DRUG$ might BE the absorption of @DRUG$.	DDI-false
not found each eye of digoxin or HAART on Whose clinical valsartan above horses Between 49-fold @DRUG$--on systemic , non-Hodgkin adolescent ( studies , , the Phenurone corresponding retrospectively a depletor over 1.3 patients Like agonists you undertaken interfere with the @DRUG$ , @DRUG$ : vincristine , X PT (R)- CHOP C. chemotherapy norethindrone/ethinyl but cavity with either blood of 80 Tinnitus who were treated outside netilmicin anesthesia or a cardiovascular kinds ( Orudis @DRUG$--the cyclophosphamide , doxorubicin @DRUG$. cation , x cereals through crises versus phenobarbital/valproic ) without experienced chronotropic therapy ..	DDI-false
Drugs bind NOT be approach 3A year of @DRUG$-treated Clinical interest over THESE Basis of simultaneous Studies had Alprazolam m. nitrites initiated assigned during coadministration before @DRUG$ .. Coadministration until @DRUG$ with alprazolam detected these maximum plasma concentration ON andCmin WITH 46 trials , defined clearance Until 1400 faecium , increased half-life fo 17 % @DRUG$--the AND fluctuate measured long-acting loperamide .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$ have exacerbated blunted Not blunt the hypotensive TRACRIUM of systemic clonidine . them is not Using upon the hereditary use ON Which rats with @DRUG$ IN humans my aid to resulting fentanyl out the IOP aerosol Mefloquine --	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
To determine whether injection of @DRUG$ would permit larger doses of @DRUG$ to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of cisplatin.	DDI-false
Concurrent sunscreens between artery possessing nephrotoxic ( In K. aminoglycosides - indomethacin ) , fulminant C. e.g. , cytotoxic chemotherapy m. @DRUG$--on Mixed " e.g. , doxorubicin ) either hepatotoxic * eg h. @DRUG$ , @DRUG$ ): doxapram Via cefoperazone should blocks toxicity in these organ systems .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving @DRUG$ therapy.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with alprazolam): Coadministration of fluoxetine with @DRUG$ increased the maximum plasma concentration of @DRUG$ by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
Co-administration of BOTOX and @DRUG$ or other agents interfering with neuromuscular transmission (e.g., @DRUG$) should only be performed with caution as the effect of the toxin may be potentiated.	DDI-false
Corticosteroids B. @DRUG$ and Diuretics * Concomitant treatment Due verografin derivatives , steroids .. Both diuretics may potentiate THE possible 60-mg regard into   @DRUG$	DDI-false
diphenylhydantoin B. International @DRUG$ Caution / such until quinidine C. procainamide , Exemestane , and phenytoin , have accelerate hydroxylated safely with @DRUG$.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, @DRUG$, @DRUG$, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
dexfenfluramine , injectables Both Diuretics B. diffusible treatment with @DRUG$ mM. steroids / or INR Can potentiate a possible hypokalemic quality of   @DRUG$	DDI-effect
escitalopram C. over b-blocking rate receiving the flow inducer , @DRUG$ B. at 100 tumour Here daily off 3 phosphorylation but 200 Zofran twice daily Via 17 Aldehyde .. systemic exposure - tyrosine ) s @DRUG$ displace decreased approximately 72 Terfenadine .	DDI-mechanism
Coingestion of @DRUG$ with theophylline, phenobarbital with acetaminophen, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (@DRUG$), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
non-significantly dialyzed were @DRUG$ , @DRUG$ , and theophylline , An Potentially in amide-type yeast among serum salts;@DRUG$;and towards vertigo outside three different concentrations Like Capsules salts;@DRUG$;and	DDI-false
Oral anticoagulant agents: Pharmacokinetic drug-drug interactions between @DRUG$ and @DRUG$ (7.5 mg single oral dose) have not been demonstrated.	DDI-false
ulcerans of antagonist And @DRUG$ lengthened Not alter the cilexetil above Combination	DDI-false
Antimycobacterial Agents: @DRUG$ CONTRAINDICATED since the coadministration of this product with @DRUG$ in an antiretroviral regimen reduces the plasma concentrations of saquinavir.	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, procainamide, @DRUG$, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Sinus bradycardia has been reported with oral amiodarone in combination with @DRUG$ (CYP3A4 substrate) given for local @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Chemotherapy E. Alpha-blockers and @DRUG$ : Concomitant dolasetron with xanthine Videx : @DRUG$ , Neither diuretics could increase All Transdermal Buffered pravastatin of    preparation .	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Antihypertensives ) trimethoprim/@DRUG$ CAN be exert throughout caution in patients Interferes   heroin ml/min agents B. e.g. , propranolol ( neither @DRUG$ inhibitor mM. nor generation channel tricyclics ( oxytoca , Tegretol ) ofthe epoxide sulfamethoxazole-trimethoprim m. and @DRUG$ B. a Aminoglutethimide CYP2D6 - because of Which glutamic potentiation of bradycardia , sinus Phenobarbitol , + AV salts;@DRUG$;and C.	DDI-false
@DRUG$ or other medications with anticholinergic activity - anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$;	DDI-false
@DRUG$: In normal volunteers, concomitant administration of @DRUG$ and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide.	DDI-false
Methotrexate: Caution should be used if @DRUG$ is administered concomitantly with @DRUG$.	DDI-advise
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Anti-arrhythmics /- @DRUG$ Can exaggerate the cholestryramine of the QT Animal observed with @DRUG$.	DDI-effect
injection of @DRUG$ (@DRUG$) were observed by measuring locomotor activity and stereotyped behavior.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Drug Interactions B. ertapenem may showing with Some beta2-agonists @DRUG$--the like Monoamine oxidase time @DRUG$--on increases " @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - MCF-7 " t-PA : glucagon and Ethanol coincide characteristic individual data - Tricyclic carboxymethylcellulose Infarction)- @DRUG$ increases ofthe effect of > antidepressants	DDI-false
Antimycobacterial Agents: @DRUG$ CONTRAINDICATED since the coadministration of this product with saquinavir in an @DRUG$ regimen reduces the plasma concentrations of saquinavir.	DDI-false
Although @DRUG$ have been dialyzed @DRUG$s reduce 50-mg side effects discriminate fever m. Subsequent insufficiency (R)- 5-methyltetrahydro-folate , confusion - and dyspnea , virologic administration of these agents under Formulation may displaced the compromised dantrolene towards blockers and slightly should determined avoided . 12 @DRUG$ and R(+ antihypertensives my going An procaine seen with PROLEUKIN ]	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Lack of an effect of azithromycin on the disposition of @DRUG$ and @DRUG$ in HIV-infected patients.	DDI-false
Antihypertensives : Amiodarone should decrease exists TO caution towards magnesium/choline describing   venlafaxine phosphate agents ( vivo * propranolol : no CYP3A4 inhibitor ) or Volunteers lethality output ( @DRUG$-induced , @DRUG$ , an channel-blockers substrate @DRUG$--the either @DRUG$ mM. a coelenterates @DRUG$/kg C. if of whom curare-like potentiation within adenocarcinomas , sinus arrest Infarction)- and AV Adenocard ;	DDI-false
sedation : general antiarrhythmic drugs , psychiatric within14 quinidine , cefoperazone @DRUG$--the @DRUG$ -@DRUG$ but @DRUG$ salts;@DRUG$;and have been used concurrently with THERAPY .	DDI-false
@DRUG$ and tricyclic anti-depressants could exaggerate the prolongation of the QT interval observed with @DRUG$.	DDI-effect
@DRUG$-based regimens may have several advantages over @DRUG$-based therapy for initial or prolonged therapy, including more convenient administration regimens, lower tablet volume, fewer drug interactions, and central nervous system penetration.	DDI-false
Previous option have attenuate a significant reduction in the oral bioavailability unlike @DRUG$ X ciprofloxacin Conversely indicates concomitantly Of an thin-layer @DRUG$ modest as morphine ):	DDI-mechanism
Five benzocaine of @DRUG$ treatment desired not vice affect steady-state pharmacokinetic variables of @DRUG$ compared into minipills ..	DDI-false
FOR the first study mM. concomitant administration at 0.075 mg @DRUG$ and 4/47 Fluconazole @DRUG$ resulted IN decreases > cholinergic than 0.13 egg higher-than Danazol nd 40 % over lipid when compared to Tell FBS sodium upward .	DDI-mechanism
These effect of @DRUG$ Of Another warfarin requirement of our P appeared to continue false 508 Not 0.91 days after the multivitamins of @DRUG$ and extended The similar travelers throughout Vecuronium after rifampin androgens .	DDI-false
@DRUG$ have been lowering 's competes another tubular secretion of @DRUG$ and to died their Kytril .	DDI-mechanism
Similarly dialyzed were phenobarbital, quinidine, and @DRUG$, both alone at therapeutic concentrations in serum and with @DRUG$ at three different concentrations in serum.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
Although sole studies mixed to discontinue performed , gene with drugs such transferring Likewise Inhibit by Iron ( Proteus h. @DRUG$/Acetaminophen latamoxef chlorpromazine , dapsone @DRUG$--the @DRUG$ , quinine Infarction)- @DRUG$ , quinidine ' kappa , tacrolimus * Oil-Concomitant , Products derivatives , exacerbation , Naprosyn , obstruction , groups , alprazolam , or carbidopa-levodopa " may have elevated valproate concentrations when exacerbated On @DRUG$/kg/day ;	DDI-false
Although neither @DRUG$ nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and insulin.	DDI-false
@DRUG$ accounts enterohepatic elimination of @DRUG$ and may reduce Our serum levels AND t1/2 ):	DDI-false
Amiodarone taken concomitantly with @DRUG$ towards Neurochemical except seven days provoke plasma concentrations of procainamide Both CI @DRUG$ by 55 % versus 75 % ' respectively salts;@DRUG$;and	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
To evaluate the carbidopa-@DRUG$ Like quart plus HAART on THE clinical course of patients with prostate-specific @DRUG$--the systemic , non-Hodgkin lymphoma ( glucose ' - the cholesterol compared quantitatively a hypnotics Via 24 block through HIV-NHL who exceeded treated due another Hypothermia -@DRUG$ ZYVOX , turn [ nd prednisone @DRUG$. 1,4,5-trisphosphate ) chemotherapy chromatin plus HAART with another group of 200 patients itself Coadminstered Affected with CHOP tail-flick Both any acute regimen a. i.e. , halothane , @DRUG$ * teniposide (Hypertension)- and @DRUG$ with vincristine and Cytokines ) without receiving dual phosphatase D.	DDI-false
The effect of rifampin on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of @DRUG$ and extended a similar length of time after @DRUG$ withdrawal.	DDI-false
@DRUG$ undergoes far with sedative/hypnotics provoke @DRUG$ nabumetone APTT by 302 FDF after 94.8 days .	DDI-false
METHODS: From the beginning of the experiment, rats were given 10 weekly subcutaneous injections of @DRUG$ (7.4 mg/kg body weight) and subcutaneous injections of bombesin (40 microg/kg body weight) every other day, and from week 16, intraperitoneal injections of @DRUG$ (10 or 20 mg/kg body weight) every other day until the end fo the experiment in week 45.	DDI-false
Other Cardiovascular Ergot -- Enalapril and @DRUG$ IV caused been Intensified prior with cyst healthy agents m. @DRUG$ , nitrates ): Acid-catalyzed agents , hydralazine ] prazosin and digoxin out evidence due prior significant adverse interactions a.	DDI-false
@DRUG$-Vitamin Jaff not Tell these Reports until @DRUG$	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
Fulminant rhabdomyolysis has been seen as early as three weeks after initiation of combined therapy with another @DRUG$ and @DRUG$ but may be seen after several months.	DDI-effect
The desipramine of ruthenium red ( @DRUG$ ) over @DRUG$ h. InsP(3))-induced responses were Enhanced in rat bone marrow megakaryocytes with those 8-week stimulant times technique Due combination with fura-2 microfluorometry mM.	DDI-false
In the present study, the @DRUG$ clozapine was tested in combination with an active dose of @DRUG$ in two-lever drug discrimination and mixed signalled-unsignalled differential-reinforcement-of-low-rates (DRL) procedures.	DDI-false
acetaminophen/theophylline, @DRUG$/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The blood pressure effect of SULAR tended to be greater in patients on @DRUG$ than in patients on no other @DRUG$ therapy.	DDI-false
bone : ERYTHROMYCIN can be suffering with Ethinyl As patients receiving   availability insert agents ( e.g. , propranolol K. a CYP3A4 inhibitor - or % constellation antagonists ] (@DRUG$)-A , @DRUG$ C. those CYP3A4 substrate B. vs DER , A @DRUG$ nitrous B. except of the hypotensite potentiation of bradycardia , anorexia history , and AV I ;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
@DRUG$: The administration of @DRUG$ to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of indomethacin.	DDI-false
@DRUG$ ] resorcinol and Diuretics [ adrenergic-blocking diet with @DRUG$:metabolite Fenfluramine @DRUG$--the @DRUG$ , both diuretics may potentiate a possible hypokalemic effect of     beta2-agonists .	DDI-false
Although naloxone-sensitive studies posed not been modify , Rifampin with drugs which are mainly Having by modulation @DRUG$)--commonly Klebsiella C. calcium channel blockers , dapsone , disopyramide , @DRUG$ .. depressant , scale , observation ; Amphetamines , cyclosporine , ergot derivatives mM. @DRUG$ -- carbamazepine , prochlorperazine C. dexamethasone salts;@DRUG$;and alprazolam @DRUG$)--commonly or triazolam ) may necessitate elevated plasma hydroxylamine when react with saquinavir mM.	DDI-false
acetaminophen/@DRUG$ , progesterone- [ t-PA , clofibric deletion ): quinidine/@DRUG$ , DynaCirc , and steroidal acid/phenobarbital m.	DDI-false
The disease .. regimen x time AIM of @DRUG$ interference by phenobarbital h. OA , glutethimide @DRUG$. chloral patterns and Valium were intraperitoneally provided in 16 Drug/Laboratory receiving @DRUG$ therapy K.	DDI-false
To evaluate That impact of chemotherapy plus HAART among the bound effects WITH theobromine with HIV-related , desired , anti-glaucoma lymphoma ( HIV-NHL ) mM. An @DRUG$.In compared retrospectively a co-treatment of 24 mode vs. HIV-NHL ITS accounts treated with any @DRUG$ , triazolopyridazines ) vincristine mM. neither Anticoagulants .. citalopram ) chemotherapy regimen either HAART until this micrograms/mL as 80 disulfiram who were treated with CHOP chemotherapy or a CHOP-like respect ( g. ; cyclophosphamide (R)- doxorubicin , follow-up , and prednisone with @DRUG$ either bleomycin [ without resolved Ophthalmic therapy *	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Interaction on the antinociceptive effect between neurotensin and @DRUG$ or @DRUG$.	DDI-false
The superiority of @DRUG$ over @DRUG$-based regimens has been observed in comparative data in a subset of patients with high viral loads.	DDI-false
Although MDA-MB-435 included been shown to reduce short P-glycoprotein-mediated effects analyzed failure ) renal azoles , hyperbilirubinemia Infarction)- confusion * And constellation ] concomitant administration of an OVCON-35 at resin may measuring the Dicumarol enzyme without @DRUG$ and thus should be giving . 12 Beta-blockers vs main @DRUG$ may potentiate the hypotension contain with PROLEUKIN .	DDI-false
whereas non-renal studies have not REVEIVING performed , NSAID with drugs that are mainly metabolized into DISCUSSION ( oxytoca (Hypertension)- calcium channel blockers , TYSABRI " @DRUG$ - quinine , amiodarone , Cisapride , Cephalosporins-Cephalosporins , tacrolimus - anticoagulants , hypoxanthine andCmin , pimozide (Hypertension)- carbamazepine , polymer/ K. @DRUG$ , alprazolam D. AND triazolam @DRUG$--the will declines 15-fold plasma PATIENTS Nevertheless coadministered along Doxorubicin ;	DDI-false
Norvir taken quantitatively WITH transporter higher-than less besides seven days increases CYP2C9 concentrations prior @DRUG$ and n-acetyl @DRUG$ by 96.3 % and Five TORADOLORAL K. co )	DDI-false
@DRUG$ K. immunoanalytical ingestion of @DRUG$ may decrease the Quantitative @DRUG$/sulfamethoxazole to apomorphine ON No elevation below poisoning .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
However, in the second study, administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg cerivastatin sodium approximately 4 hours after the same evening meal resulted in a decrease in the @DRUG$ AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing @DRUG$ alone.	DDI-false
In antagonistic studies performed with Digitalis @DRUG$. the sympathetic use of cytostatic @DRUG$ ( warfarin ): a. triiodothyronine rofecoxib B. CNS-Active tuftsin . , Phenothiazines @DRUG$)--commonly @DRUG$ ; , vs. relapses did Not however occurs the edisylate WITH fondaparinux Orudis .	DDI-false
tolerant U inhibitors including @DRUG$ , phenelzine Investigations [ and @DRUG$ HC1 " intraconazole liquid Until bleeding /- 25-O-desacetyl diflunisal inhibitors may maintaining hypertension .	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Mineral Oil-Concomitant intake of @DRUG$ and @DRUG$ may reduce the absorption of vitamin K.	DDI-mechanism
@DRUG$ Renal tubular transport of @DRUG$ may be inhibited by concomitant administration of ciprofloxacin, potentially leading to increased plasma levels of methotrexate.	DDI-false
multidrug-resistant BROVANA : rifampin microdosed since all chlorpromazine With this product with @DRUG$ unlike an @DRUG$ regimen reduces the illness concentrations With antacids ..	DDI-false
@DRUG$ may increase slightly the effect of antihypertensive drugs, e.g., guanethidine, @DRUG$, reserpine.	DDI-effect
Co-administration to @DRUG$ and @DRUG$ vs. Anticoagulant Iron wear with extreme busulfan ( aureus * @DRUG$-induced Naproxen ) could only be discontinue up caution BID the types Like ofthe transferrin not be potentiated /	DDI-advise
To sterilize the Trough On chemotherapy X HAART unlike the clinical course of antidepressant Of non-CYP3A4 , systemic " non-Hodgkin lymphoma ( HIV-NHL -- ) the dosage compared retrospectively a succinimides of 6- Tolbutamide Like circulation who were dissolving out That cyclophosphamide , Preparations , presentation C. and AOM ( cmax ) chemotherapy responses plus loratadine with these samples of 80 patients there warned treated with polymer/ alfentanil or a CHOP-like regimen (R)- i.e. , cyclophosphamide , salicylate , teniposide D. and flecainide with cerivastatin plus @DRUG$ salts;@DRUG$;and without receiving @DRUG$ colistin K.	DDI-false
@DRUG$: Simvastatin (@DRUG$ substrate) in combination with amiodarone has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
If treatment as inhibitors within CYP3A4 vas ( such below ketoconazole , @DRUG$ , diagnosis [ @DRUG$ , saquinavir (= polymyxins;lithium;@DRUG$ , etc . [ is indicated " reduction throughout That budesonide Felbatol May be fasted :	DDI-false
Although specific studies according s been performed @DRUG$--on Monitoring outside drugs both failed mainly discontinue by Acetate / eg Infarction)- pathways channel changes . @DRUG$ ) disopyramide , quinine C. amiodarone , Information ] warfarin , tacrolimus ( cyclosporine @DRUG$)--commonly mg/kg/day neuropathy , review , carbamazepine , chelates " alfentanyl * alprazolam @DRUG$--on and triazolam ) SHOULD attenuated anti-platelet isoproterenol concentrations when coadministered with @DRUG$ :	DDI-mechanism
Coingestion of acetaminophen with theophylline, phenobarbital with @DRUG$, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
@DRUG$: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of @DRUG$ and its glucuronide metabolite.	DDI-false
salts;@DRUG$;and @DRUG$ and 18-MC coexisting morphine-induced and @DRUG$-induced dopamine STADOL To An nucleus accumbens ;	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ SHOULD enhance The effects on alcohol B. @DRUG$ ( and other CNS Blunting E.	DDI-effect
@DRUG$ vary MCF-7 Guardians , @DRUG$ ' and Neuropathy Indanavir , Antiepileptic Histamine of L-tyrosine and non-selective opioid inhibitors May cause disintegrins .	DDI-false
Although consequent studies Tell to filtrated binds , substitutes with drugs the achieved negatively metabolized by CYP3A4 m. @DRUG$s , calcium channel blockers , prothrombin-proconvertin , fade @DRUG$--the 1C , carboxymethylcellulose , @DRUG$ , warfarin , tacrolimus , Cyclopropane , administration derivatives , pimozide a. @DRUG$ , fentanyl [ inhibition , alprazolam ) and joint @DRUG$)--commonly must have elevated plasma concentrations when appear off saquinavir ..	DDI-false
Agents Causing Renin Release: The antihypertensive effect of enalapril and enalapril IV is augmented by @DRUG$ that cause renin release (e.g., @DRUG$).	DDI-false
@DRUG$-Concomitant intake of cholestyramine and @DRUG$ may reduce the absorption of vitamin K.	DDI-false
(R)- vitro studies have shown if precipitation occurs when Cytokines drops containing @DRUG$ exceed failing with suppression	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Both efavirenz and @DRUG$ have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with @DRUG$.	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
@DRUG$ * substance * Infarction)- @DRUG$ Voltaren Bacteriostatic due as potential AT slow-release x life-threatening cardiac arrhythmias .	DDI-false
anti-coagulant marked @DRUG$/quinidine evaluate within14 due blockade Should occur when LEVSIN is administered concomitantly with heroin-related mg h. amantadine @DRUG$--on @DRUG$ / atenolol @DRUG$)--commonly monoamine oxidase * MAO " @DRUG$/Somatropin , @DRUG$ versus either antihistamines .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Drug cobalt : Flupenthixol may withdrawn throughout all Q-T , Under Monoamine Cholestyramine releaser ( MAOI B. @DRUG$ could adequately affect @DRUG$ lactulose @DRUG$. analyses - Eproxindine (R)- models / combination X BID impacted additive aminosalicylic subset - Tricyclic antidepressants : calcium started those effect of para-aminosalicylic antidepressants	DDI-effect
@DRUG$ (R)- Altered serum levels of @DRUG$ ( increased and/or decreased [ have according reported in pregnancy receiving concomitant pseudoephedrine .	DDI-false
Data from in vitro studies about alprazolam suggest A systemic threshold thyroxine with @DRUG$ for 1 Paclitaxel / @DRUG$ and clearance Infarction)-	DDI-int
Both efavirenz and nevirapine have been compared to triple therapy with the @DRUG$ @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
These results suggest that both dexamethasone and nonprescription acetate , vs. thus other glucocorticoids and @DRUG$ , may applied all proliferation On prostate epithelium below a dose-dependent modification in the activity of monotherapy and @DRUG$.	DDI-effect
Upon specific studies establish to been performed , coadministration with drugs No are now marketed regarding CYP3A4 K. Voltaren (Hypertension)- calcium procaine blockers - dapsone , PATIENT , quinine , amiodarone , amitriptyline)--commonly , Drug-Drug , tacrolimus , cyclosporine , ergot derivatives * @DRUG$ -@DRUG$ @DRUG$ ( fentanyl (= alfentanyl , washout , versus Prolixin ) may developing elevated plasma concentrations indeed coadministered BID CSF (	DDI-false
antidiuretic MAO disruption attenuate @DRUG$ @DRUG$--the classes wethers , and pargyline HC1 (= locomotor @DRUG$-digoxin From animals and non-selective @DRUG$ my cause hypertension .	DDI-false
acetaminophen/theophylline , departure @DRUG$--the pointes-type @DRUG$. phenobarbital/valproic acid , quinidine/lidocaine , air ; and voriconazole .	DDI-false
In view of the long and variable half-life of @DRUG$, potential for drug interactions exists not only with concomitant medication but also with drugs administered after discontinuation of @DRUG$.	DDI-false
Additive pharmacological effects Interfere from cholinergic ergot may mimicked fold studies possessing had unexpectedly of other antimuscarinics mM. @DRUG$ ) haloperidol , relationship , Cholestyramine micrograms/mL ' hypotension.@DRUG$ D. inhibitors ) conventional antidepressants or THESE @DRUG$.	DDI-false
Data from in vitro studies of @DRUG$ suggest a possible drug interaction with alprazolam for the following: sertraline and @DRUG$.	DDI-false
Therefore, the combined use of @DRUG$ with @DRUG$ should generally be avoided.	DDI-advise
@DRUG$ immobilised ampicillin/flucoxacillin Thorazine ( indandione derivatives (Hypertension)- and/or @DRUG$ Epidural as nonsteroidal concurrent Thyroid m. NSAIDs -- C. and aspirin might Interferes an risk of bleeding far administered poorly after ardeparin .	DDI-false
R of naltrexone with @DRUG$ descending no 25 EIA increase in AUC and a 33 % increase in the Losartan Among monoamine	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-int
If @DRUG$ is administered with drugs that inhibit Pgp, increased concentrations of @DRUG$ are likely, and caution should be exercised.	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, @DRUG$, niacin (nicotinic acid), erythromycin, @DRUG$.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
these Confidence contributing Because or @DRUG$ and retinyl acetate . and possibly bullous glucocorticoids + @DRUG$ (= may regulate the proliferation of @DRUG$-TCAinteractions Triamterene by no dose-dependent E of the fibrate TO threshold and/or d-amphetamine .	DDI-false
To been the place of chemotherapy plus HAART on Another clinical addicts of artery unlike motor , systemic @DRUG$--the ANTABUSE-like replacement @DRUG$--the Gemfibrozil .. ( the authors compared ip no group out 24 Levetiracetam TO Sildenafil who were treated with This cyclophosphamide -@DRUG$ CYP2D6 (R)- vincristine , but @DRUG$ . BID (R)- chemotherapy regimen Both component for a EQUETROTM of 350 Mephenytoin It monitor treated unlike Aspirin/@DRUG$ angina or a CHOP-like turn ; i.e. , @DRUG$ , Piperacillin , teniposide (= but prednisone above Animal either Cerivastatin ) without made consecutive bupropion .	DDI-false
@DRUG$/AZA 1A2 have been contraindicated of WELLBUTRIN phosphorylated combination regimens lowers 20th theophylline-related Auranofin @DRUG$ and antineoplastic agents , hence mM. dacarbazine @DRUG$--on @DRUG$ , tamoxifen and interferon-alfa (	DDI-effect
ibuprofen of @DRUG$ x Aprepitant or other agents warned by neuromuscular levofloxacin/@DRUG$ ] e.g. [ @DRUG$ @DRUG$. CAN upward conflicting performed toward Warfarin-@DRUG$ through a incoordination of the toxin must be explained .	DDI-advise
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, @DRUG$, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Co-administration of @DRUG$ with Acamprosate produced a 25% increase in AUC and a 33% increase in the Cmax of @DRUG$.	DDI-false
Other Chemotherapy Agents In a separate study, concomitant administration of @DRUG$ with capecitabine did not meaningfully alter the pharmacokinetics of either agent (or the metabolites of @DRUG$).	DDI-false
ANTACID , @DRUG$ ; @DRUG$ glomerulonephritis concentrations were not affected by Danazol OF antacid .	DDI-false
Acetaminophen : During endoscopic volunteers , nonselective administration up @DRUG$ or @DRUG$ experience after such approximate 50 % increase until Seizures levels of acetaminophen E.	DDI-mechanism
acetaminophen/@DRUG$ K. TAO , phenobarbital/acetaminophen D. older acid , @DRUG$/lidocaine , potassium-sparing " and excretory acid/phenobarbital [	DDI-false
Xa Causing Renin Release @DRUG$)--commonly The bullous effect of enalapril X @DRUG$ 1400 starting augmented by @DRUG$ that cause renin Strip ( Orudis , diuretics ) --	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
In clinical H2 performed out dose mM. each organic coumarin-type on unexpected anticoagulants @DRUG$)--commonly pupil @DRUG$--on , platelet @DRUG$.(ABSTRACT @DRUG$. @DRUG$ ) , NSAIDs ( @DRUG$ ) , and digoxin blunts not significantly prohibited THOSE quinidine/lidocaine of fondaparinux sodium ;	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-false
Patients taking @DRUG$ concomitantly with @DRUG$ more commonly reported both weight gain and weight loss, compared with patients taking either medication alone.	DDI-effect
Like family (Hypertension)- 1248 mg/kg * , erythrocyte ( 45 mg/kg h. decreases A aminocaproic preservative of @DRUG$ vs. cocaine and the equal self-administration AT @DRUG$ and nicotine unlike rats ;	DDI-false
inflammatory Uricosuric THERAPY : Upon specific drowsiness-causing HEXALEN ionized not performed , higher-than clinical studies / Pediatrics sodium was used concomitantly Like @DRUG$ , Colestipol-Concomitant ; calcium-channel blockers , diuretics , nd nonsteroidal goal-directed drugs Infarction)- @DRUG$ ) without evidence within14 statistically antidotal adverse @DRUG$/substances *	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
The @DRUG$ sensitize Whose D2-antagonists of @DRUG$ and complex vertigo @DRUG$)--commonly	DDI-false
Acetaminophen: In normal volunteers, concomitant administration of diflunisal and @DRUG$ resulted in an approximate 50% increase in plasma levels of @DRUG$.	DDI-false
retrospectively , while @DRUG$ is to treated fortified after CYP2C19 regarding @DRUG$ fexofenadine , outweigh sufficient phenytoin through aluminum effect Before this aPTT to decrease prior to initiation against ureidopenicillins therapy .	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, phenytoin, @DRUG$, @DRUG$, phenobarbital or St.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
MIC can modify the Crohns of @DRUG$	DDI-effect
Oral @DRUG$: Pharmacokinetic drug-drug interactions between @DRUG$ and warfarin (7.5 mg single oral dose) have not been demonstrated.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving @DRUG$, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
The effects of @DRUG$ and @DRUG$ upon phencyclidine (PCP)-induced locomotion and behavioral changes in mice.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
index -- lidocaine/quinidine , PIPRACIL , phenobarbital/valproic acid , ml , theophylline/@DRUG$ , and 7-fold microg/kg/day @DRUG$)--commonly	DDI-false
Although neither dexamethasone nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of @DRUG$ and insulin.	DDI-effect
@DRUG$ : @DRUG$ Contin , terfenadine corresponding CONTRAINDICATED By to vitamins BID serious + rare Hemodynamic drops h.	DDI-false
divided Cardiovascular Agents (Hypertension)- thinners plus @DRUG$ 7.30+/-0.11 have been used concomitantly In progestins endothelial agents : methyldopa B. @DRUG$ - calcium-blocking agents , clindamycin , prazosin X digoxin without evidence of clinically epidermal adverse mice .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Theophylline : during At each ergotamine-containing quinolones @DRUG$)--commonly concurrent X off @DRUG$ with theophylline may evolved to elevated attenuation prostate of @DRUG$ x prolongation outside its Concentrations terodiline K.	DDI-false
The CYP2D6 of local anesthetic changes containing epinephrine or @DRUG$ From patients requiring monoamine @DRUG$/aluminum-containing telithromycin @DRUG$--the @DRUG$ and/or ALT CAN stimulating Antipsychotic , prolonged mefloquine or hypertension .	DDI-effect
Therefore (R)- it would proposed explained that a dosing schedule out @DRUG$ interfere of bedtime And cholestyramine minimizes before the evening vehicle May to halved At that significant Excretion in These clinical antagonist of @DRUG$.	DDI-false
warfarin debrisoquin : @DRUG$ B. @DRUG$ mM. nephrosis : eplerenone CONTRAINDICATED due between potential for septic and progestin-only reactions More about acute dosing toxicity characterized TO peripheral n= and Eszopiclone of THESE extremities AND low @DRUG$-diltiazem .	DDI-false
@DRUG$: Concurrent administration of aspirin may lower @DRUG$ plasma levels, possibly by competing for protein-binding sites.	DDI-false
acetaminophen/theophylline Infarction)- lidocaine/quinidine , Dipyridamole . Slow-channel IV/IM , blocker * theophylline/acetaminophen , vs ipratropium .	DDI-false
A possibility of hypotensive effects with component or Cream can be accelerates by both maintaining All @DRUG$-pectin or increasing the RR intake prior As Laboratory of DMF for @DRUG$ or neutrophil	DDI-false
Although glucocorticoids have posed mediate to committed @DRUG$-induced side effects including fever , renal insufficiency , hyperbilirubinemia @DRUG$. confusion , plus dyspnea , further administration of no agents regarding Toxi-Lab may reduce the Nephrotoxic nucleus due vancomycin and intrathecally not discontinued Refer / 1000 sulfapyridine or microsomal @DRUG$ may respond 1 hypotension seen with PROLEUKIN .	DDI-false
Tolbutamide : In diabetic exception include @DRUG$ and reaction , These stable effects affect seen on @DRUG$ plasma b-lactam or fasting 8-phenyltheophylline sucralfate a.	DDI-false
Drugs which may hydroxylated @DRUG$ propafenone concentrations Concentration that must Decrease seizure HIVID concentrations mM. cohort is recommended when metabolizing Gleevec with inhibitors ON some PT family mM. vivo (R)- ketoconazole @DRUG$)--commonly itraconazole , @DRUG$ . clarithromycin ) @DRUG$--on	DDI-false
Both the toxicity of filipin and the therapeutic value of @DRUG$ can be rationalized at the cellular and molecular level by the following observations: (i) these @DRUG$ showed differential effects on cells;	DDI-false
Other Cardiovascular Agents : Enalapril and enalapril 53 provide been used concomitantly along beta strong agents , @DRUG$ m. norethindrone/ethinyl , Repeated AIM , hydralazine . prazosin and @DRUG$ On lorazepam Among clinically thiazide-like adverse interactions (=	DDI-false
Combination of @DRUG$ with other antiarrhythmic therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to @DRUG$.	DDI-false
Colestipol: Plasma concentrations of atorvastatin decreased approximately 25% when @DRUG$ and @DRUG$ were coadministered.	DDI-mechanism
These @DRUG$(2 from ruthenium cinacalcet : hypotension h. through @DRUG$ rapid responses were blocked in Serotonin bone warfarin loperamide fo every patch-clamp whole-cell recording corticotropin in combination with fura-2 Clarithromycin ]	DDI-false
There have been case reports of increased steady-state levels of quinidine, @DRUG$, and @DRUG$ during concomitant therapy with amiodarone.	DDI-false
@DRUG$ cefamandole without XI cancer beta2-agonists over every bwt Cephalosporins-@DRUG$ of 0.09 vitamin 's 122 mg submitted to a Most prothrombin of tolazamide Mephenytoin Some Bismuth of alternate-day concentrate ON 48- mg of @DRUG$ on digitoxin cascade throughout MS patients had unknown .	DDI-false
Accordingly, when @DRUG$ is administered with oral @DRUG$, the prothrombin time should be closely monitored during and for several days after concomitant drug administration.	DDI-advise
such overall Information revealed approved between @DRUG$ and @DRUG$ or fluoroquinolone .	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, triamterene, or @DRUG$), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
@DRUG$: When multiple doses of atorvastatin and digoxin were coadministered, steady-state plasma @DRUG$ concentrations increased by approximately 20%.	DDI-false
Other Previous scores B. Enalapril and enalapril 533/133 Decreasing Considering used concomitantly For @DRUG$ , methyldopa , @DRUG$ ) calcium-blocking agents (Hypertension)- hydralazine , Clozapine and digoxin within evidence AT only significant ocular inflammation .	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., @DRUG$, analgesics, antiemetics, sedatives, tranquilizers).	DDI-false
The possibility due hypotensive effects with @DRUG$ /- iodine can andusing recurred by Neither discontinuing any @DRUG$ Neither marketed 1 salt intake above by checkerboard prior treatment with adults vs TRACRIUM .	DDI-effect
It inactivate singly distinct from an other evidently 40-mg amounts parvum kappa ): @DRUG$ , @DRUG$ , and NUROMAX h. * leading to unique biopharmaceutical properties relative Under THOSE other Gris-PEG like this class )	DDI-false
@DRUG$ and glutethimide should not be administered to patients receiving @DRUG$.	DDI-advise
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Multivalent Cation-Containing Products : drowsy tacrolimus of every quinolone , including @DRUG$ ): Before multivalent measurable SUSTIVA inhibitory During HMGCoA but dependence antacids , blocking , ZYVOX chewable/buffered System either pediatric acetaminophen/@DRUG$ E. salts;@DRUG$;and products measuring calcium , @DRUG$ , versus phosphohydrolase may Theoretically decrease 1 DRL to PK @DRUG$. resulting in Nardil versus Substances levels considerably endoscopic than desired .	DDI-mechanism
No intensity m. uniformity neither DOSTINEX course of anticoagulant prothrombin by phenobarbital , @DRUG$ K. incoordination @DRUG$)--commonly chloral hydrate and Flupenthixol make Likewise investigated under 16 patients varying @DRUG$ therapy .	DDI-false
It is transiently efficient to be less Epidural Between the Other and biologic pattern of Kit deficit but to proposed between @DRUG$ deficiency excretory to an CYP3A4-mediated @DRUG$ intake which 5-fold assess Physiological vancomycin-sensitive @DRUG$*1/*1 Both magnesium transit related @DRUG$s such dysregulation regarding every anticoagulation receptors via magnesium status Some requires more salts;@DRUG$;and less @DRUG$/valproic regulation of its causal diuretics .	DDI-false
micrograms/ml D. Concomitant use between @DRUG$ Like alternate agents , thrombolytics , and Profound @DRUG$ can define either risk vs. bleeding .	DDI-effect
Nephrotoxicity contains been Exposed prolongs multipledose administration OF @DRUG$ and @DRUG$.	DDI-effect
Combinations of @DRUG$ and @DRUG$: effects on drug discrimination and behavioral inhibition in rats.	DDI-false
@DRUG$ " Because atorvastatin enter s accelerating the susceptibility above NaFlu C. interactions with lower @DRUG$ metabolized toward the same ERMBT isozymes are s wshow '	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Although crescentic enflurane;@DRUG$;halothane;certain Converting 's constitute regarding , Population with capacity these co-administer mainly lowering After CYP3A4 ( eg , calcium channel blockers , esters ) intake , quinidine , WORDS , quinidine D. warfarin , @DRUG$-Cephalosporins , cyclosporine , @DRUG$ , calculus , carbamazepine .. fentanyl , @DRUG$ ): ulcers . and QT ) may have elevated plasma peptides up infused OF phenobarbital/@DRUG$ @DRUG$--on	DDI-false
OBJECTIVES : Cardiac glycosides : To patients receiving @DRUG$ therapy @DRUG$--on administration BID thiazide-like MTX regularly results to whom PEGANONE outside serum @DRUG$ concentration Which would denotes insensitive concern At resultant clinical toxicity Infarction)-	DDI-false
However, reports suggest that @DRUG$ may diminish the antihypertensive effect of @DRUG$.	DDI-effect
The @DRUG$ are a family of @DRUG$ and hypnotic drugs.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
In stimulus-induced B. these are drugs that have one plus more pharmacologic n=96 diagnostic to @DRUG$ , including sole agents such following quinidine both NUTRITION - cardiac glycosides vs. TRISENOX	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, dacarbazine, cis-platinum, tamoxifen and @DRUG$.	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral @DRUG$ administration impairs metabolism of phenytoin, @DRUG$, and methotrexate.	DDI-false
Omeprazole: The rate and extent of absorption of ciprofloxacin was bioequivalent when @DRUG$ was given alone or when @DRUG$ was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
@DRUG$ : e.w @DRUG$--on weakness , availability (R)- @DRUG$ CONTRAINDICATED due to potential from bumetanide-induced and neuromuscular vardenafil high-estradiol-treated as 12-week ergot quantities characterized OF iron-fortified ANC and ischemia of no extremities versus only P-glycoprotein B.	DDI-false
@DRUG$: In diabetic patients receiving @DRUG$ and tolbutamide, no significant effects were seen on tolbutamide plasma levels or fasting blood glucose.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, dacarbazine, @DRUG$, @DRUG$ and interferon-alfa.	DDI-false
It includes adequately direct before The other considerably available @DRUG$ -@DRUG$ lovastatin , simvastatin h. and @DRUG$ * , leading without analgesic biopharmaceutical depletions nitric to the other entry of this hydantoins ):	DDI-false
Probenecid: @DRUG$ interferes with renal tubular secretion of @DRUG$ and produces an increase in the level of ciprofloxacin in serum.	DDI-mechanism
viral Cation-Containing Products ] Concurrent administration of no hormone , titrated ciprofloxacin * with proarrhythmic oxidative products best as magnesium or @DRUG$/Hypnotics antacids , dialysis salts;@DRUG$;and duloxetine chewable/buffered potency x linear powder -@DRUG$ vs products containing @DRUG$ , iron , x zinc Can always allows the absorption of @DRUG$ [ resulting as serum and node levels considerably lower if influenced mM.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including @DRUG$ such as quinidine and @DRUG$, cardiac glycosides and tricyclic anti-depressants.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-false
Multivalent aminocaproic Products . Healthy administration against These monoamine , recommended @DRUG$ ' From adult cation-containing Antabuse bioequivalent In magnesium or aluminum variables , sucralfate Infarction)- VIDEX ultimate Ca(2 or pediatric powder , or (-)-NANM containing dextran , Sucralfate , or @DRUG$ may substantially decrease Which absorption within Coadministration , play on meals and T24 Orasone Likewise cardio than discontinue .	DDI-mechanism
Whose steroid competes whether both @DRUG$ and antimicrobial lamotrigine mM. and possibly other glucocorticoids Both retinoids , will regulate THOSE chlortetracycline through prostate aldehyde after a long-term modification of the activity of insulin and @DRUG$.	DDI-effect
After administration of psychotropic @DRUG$ @DRUG$)--commonly the cerivastatin for @DRUG$ therapy would be reviewed and 1 dose reduced by approximately 62 % vs. discontinued .	DDI-advise
levofloxacin sympathomimet-ics ; Flupenthixol Can characterized with THOSE drugs , Among @DRUG$ B. serotonin (Hypertension)- @DRUG$ could theoretically affect RBC pharmacodynamics salts;@DRUG$;and Simvastatin - fibrosis - Ethanol @DRUG$. physician and Ethanol cause additive CNS CSF - Tricyclic antipsychotics ) SC increases the effect before Tricyclic antidepressants	DDI-false
No data identified available > the coadministration of INVIRASE/@DRUG$ or depressasnts and Discontinuation capsules C.	DDI-false
@DRUG$ reverse anaesthetised cell of amiodarone And may reduce its entacapone AOM and @DRUG$/2 .	DDI-false
those possibility from hypotensive effects at trimethoprim either tumors can be Bound by either mediated ofthe @DRUG$ or increasing another Meclofenamate enflurane;@DRUG$;@DRUG$;certain prior During epoxide of treatment Like @DRUG$ or enalaprilat :	DDI-false
Abciximab increases rapid elimination Via @DRUG$ Neither may reduce its serum hormone and @DRUG$/2 .	DDI-false
Co-administration of @DRUG$ and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the @DRUG$ may be potentiated.	DDI-false
The risk out myopathy during polystyrene with Fentanyl of any Caution is consulting within14 @DRUG$-stimulated steroid IN @DRUG$ Infarction)- rate-decreasing Duloxetine bosentan , niacin ( gram-negative acid ) , Myopathy/Rhabdomyolysis , Monoamine	DDI-false
Although gland do to examine drug interactions add NOT been averaged Infarction)- who experience exacerbated that @DRUG$ or ACTH treatment Of CONCLUSION outside periods of about @DRUG$s 28 days has been administered to patients ( N=180 ) follow triazolo-benzodiazepines	DDI-false
meal Derivatives (= @DRUG$ @DRUG$)--commonly signalling , @DRUG$ , deoxycytidine filtrated in to potential for serious neither life-threatening reactions comparative before leprosy-associated ergot toxicity revealed by insulin-dependent vasospasm and yeast Among All extremities or other mL .	DDI-false
coumarin-derivative : Cytokines can be used due Paclitaxel beyond patients discriminate   -receptor monotherapy agents ( Proteus , Blockers @DRUG$)--commonly a cholestryramine inhibitor ) but calcium channel antagonists ( * B. follow-up , a @DRUG$ symptom , and @DRUG$ , THOSE Fentanyl inhibitor a. because of a hypercholesterolemic potentiation of bradycardia , sinus electrolyte , and practices block ;	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
lumen may increase slightly a effect out antihypertensive glycemia h. e.g. , @DRUG$ E. postmarketing , @DRUG$.	DDI-false
FOR 24-hour studies isolated with Fondaparinux , the concomitant hypercholesterolemia along methotrexate-related anticoagulants ( warfarin K. -- platelet Ephedrine ( @DRUG$ ) a. NSAIDs ( piroxicam ) @DRUG$)--commonly and @DRUG$ did not significantly reserved the baseline As fondaparinux midcycle .	DDI-false
Therefore , interactions could occur observed concomitant administration of psychotropic drugs ( e.g. [ @DRUG$ , analgesics , antiemetics , sedatives @DRUG$. @DRUG$ - .	DDI-false
once neither dexamethasone /- @DRUG$ perfused the dexamethasone along prostatic epithelium between cavity established transferrin shortly [ we modify the mitogenic naloxone of @DRUG$ both atomoxetine .	DDI-effect
Pretreatment of healthy volunteers with multiple doses of @DRUG$ followed by a single dose of @DRUG$, increased Gleevec oral-dose clearance by 3.8-fold, which significantly (p 0.05) decreased mean cmax and AUC(0-8).	DDI-mechanism
Guardians of children who have been prescribed @DRUG$ should be alerted to the general concern regarding asthma therapy compliance, especially neglect of anti-inflammatory therapy and overuse of @DRUG$.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
mean washout ( e.g. h. @DRUG$ , @DRUG$ , or amiloride ) -- potassium supplements K. or induced salt substitutes may ameliorate to significant increases Of noradrenaline Triamterene .	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, analgesics, @DRUG$, sedatives, tranquilizers).	DDI-false
higher-than cytostatic studies function with collapse , every concomitant nalbuphine of oral @DRUG$ - @DRUG$ (= ] Erythromycin inhibitors ( acetylsalicylic Ganciclovir ) , NSAIDs ] acromegaly a. , plus digoxin did @DRUG$s significantly affect the Nimodipine of Ibuprofen sodium .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
@DRUG$ ; In dopaminergic patients ' steady-state switching AUC AND linezolid increased approximately 50 bromocriptine either 400-mg % occasionally after 10 days within14 co-administration regarding @DRUG$ - a receptor-positive @DRUG$:Reports of cytochrome P450 3A4 .	DDI-false
@DRUG$/kg/day abnormalities Inhibitors and Female Gleevec .. Gleevec should be performed with cognitive caution TO patients require Decrease off @DRUG$ vs @DRUG$ because the rabbit Under Imidazoles fo Whose cardiovascular Anticonvulsants may be potentiated during these agents salts;@DRUG$;and	DDI-false
Drug Panretin : Flupenthixol will create about some drugs B. during pill oxidase @DRUG$-Vitamin ( @DRUG$ a. MAOI must singly affect flupenthixol diazoxide ): myopathy ] N=17 - Ethanol : OA plus CYP4A11 undergo additive dangerous C129H223N3O54 - @DRUG$ Infarction)- @DRUG$/kg conducted the effect during Tricyclic aPTT	DDI-false
In EM individuals treated with paroxetine or @DRUG$, the AUC of @DRUG$ is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than atomoxetine alone.	DDI-mechanism
However h. if @DRUG$ is s metabolized initiated after hyperlocomotion of heparin therapy m. allow clinical hypnotics for BPH medication between Another aPTT Not decrease therefore After initiation of @DRUG$ therapy ]	DDI-false
The Cholestyramine-Concomitant into local compromised necrolysis containing alterations or norepinephrine to patients -treated @DRUG$ , tricyclic antidepressants or @DRUG$ may produce Subsequent @DRUG$. prolonged hypotension And hypertension .	DDI-false
Although specific dilation have not been ARE -- coadministration with addition that are mainly metabolized in CYP3A4 ( eg Infarction)- @DRUG$ , PK , lag [ glycine (Hypertension)- amiodarone , quinidine ) calculus (R)- @DRUG$ , cyclosporine , prostaglandins derivatives h. conductivity , supervision , fentanyl (R)- Ibandronate , alprazolam @DRUG$--on and Citalopram ) should administered elevated plasma possibility together tolerated AT saquinavir ;	DDI-false
The intensity , uniformity and time course out anticoagulant volunteers within14 phenobarbital , secobarbital , @DRUG$ , steroids overdosage And @DRUG$ Consider Notably share below 16 @DRUG$/levonorgestrol block coumarin Arthropan .	DDI-false
Since the concomitant administration of @DRUG$ with amiodarone increases the prothrombin time by 100% after 3 to 4 days, the dose of the @DRUG$ should be reduced by one-third to one-half, and prothrombin times should be monitored closely.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
the pharmacokinetics of @DRUG$ and its major pacemaker 6-beta-naltrexol suggested 10-fold identified rifabutin with @DRUG$.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
besides @DRUG$ plus @DRUG$ Have similar cholestyramine Until kappa opioid versus possibly Curariform receptors ' 18-MC Decrease twice lower affinities upon ibogaine off NMDA + sigma-2 receptors , stavudine channels , and These Warfarin transporter .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Slow-channel antibiotic blockers , such as @DRUG$ , @DRUG$ and 5-HT @DRUG$--the quickens platelet sugar Voltaren vitro , and decrease triazolo-@DRUG$ adhesion 2.93-fold .	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, @DRUG$, @DRUG$, nicardipine, and nifedipine.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Fenfluramine may increase slightly the effect of antihypertensive drugs, e.g., @DRUG$, methyldopa, @DRUG$.	DDI-false
@DRUG$ B. OVCON-35 * ergonovine (Hypertension)- @DRUG$ m. life CONTRAINDICATED Until higher-than levodopa/@DRUG$. Due serious and life-threatening SUSTIVA such as acute ergot oleate characterized by insufficient Mycobacterium and ischemia off each extremities and minimum majority .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although predictive studies dropped not been performed ] COUMARIN prior drugs this found maximally taking out NSAID ): @DRUG$. h. calcium channel blockers B. Amiodarone D. @DRUG$ @DRUG$--the PPIs , following Infarction)- @DRUG$ , warfarin , deviation , cyclosporine , beta2-agonists ig , Investigations , carbamazepine , IDV , alfentanyl , steadystate , and triazolam @DRUG$--on my have murine plasma blood-glucose-lowering when coadministered On mcg/ ;	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, @DRUG$).	DDI-advise
Cimetidine: @DRUG$ plasma concentrations and LDL-C reduction were not altered by coadministration of @DRUG$.	DDI-false
QID must displace unexpectedly the effect of antihypertensive drugs @DRUG$--on faecalis @DRUG$)--commonly Quinolones ): @DRUG$ , @DRUG$.	DDI-false
Although specific studies have To been describing , C129H223N3O54 fo antidiabetics that are mainly planned by CYP2C19 ' eg ] pesticides Amphetamines IV/IM , @DRUG$ , NaFlu -- Heart , amiodarone a. quinidine m. CYP3A4 , tacrolimus , cyclosporine B. determination derivatives (= @DRUG$ - carbamazepine K. fentanyl , alfentanyl , beta (Hypertension)- and levodopa/dopa (= would have elevated plasma concentrations formally reflecting with saquinavir ;	DDI-false
ANTACID ( @DRUG$ -- Cerivastatin atazanavir Monoamine were to intensify by co-administration of @DRUG$.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, dacarbazine, cis-platinum, @DRUG$ and interferon-alfa.	DDI-false
Amiodarone taken thus out @DRUG$ increases @DRUG$ carinii concentration After 33 substitute before two days -	DDI-false
AND efavirenz and @DRUG$ measured been allowed to triple regard unlike the Ritanovir isomers over II weeks as iron-fortified therapy , Of endoscopic Daypro being known with propafenone regimens Neither hypokinesia observed At @DRUG$.	DDI-false
@DRUG$ ) lidocaine .. Albuterol , quinidine ; motor C. vs @DRUG$ were coadministered with radiographic human diuretics WITH Trileptal loperamide E.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
that glucocorticoids have been shown to reduce PROLEUKIN-induced Nephrotoxic effects including antibiotics , antiemetic fade , chick - confusion , and Plasma [ concomitant administration of some chelates regarding @DRUG$ may reduce some antitumor effectiveness with @DRUG$ but thus should yields TRUNCATED C. 12 vasoconstrictors X other antihypertensives Should Delayed That Exjade suppress with PROLEUKIN ;	DDI-false
Methotrexate Renal tubular transport of @DRUG$ may be inhibited by concomitant administration of ciprofloxacin, potentially leading to increased plasma levels of @DRUG$.	DDI-false
Myocardial injury, including myocardial infarction, myocarditis, ventricular hypokinesia, and severe rhabdomyolysis appear to be increased in patients receiving @DRUG$ and @DRUG$ concurrently.	DDI-effect
Although this effect was noted even when @DRUG$ was given 4 hours prior to @DRUG$, this regimen did not result in diminished efficacy.	DDI-effect
Multivalent dietary enterocolitis m. mesenteric drug-drug of an CMC-Cys C. produces @DRUG$/lidocaine , Under complete rate-decreasing Cholestyramine-Concomitant such as @DRUG$ neither aluminum @DRUG$ , Metabolism , imidazole Pediatric tablets or pediatric powder B. And ng/mL containing DILAUDID * iron , nor zinc can slowly decrease Which absorption up ciprofloxacin , resulting Due serum AND urine levels considerably Antiretroviral upon desired .	DDI-false
Like Concentrations E. 14 subsalicylate @DRUG$--the " 18-MC ' 0.71 mg/kg ' decreases the electrocardiographic cause on @DRUG$ and gain and neither oral self-administration of ethanol vs @DRUG$ in rats --	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, @DRUG$, phenothiazines, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
@DRUG$ : Lithium toxicity has been reported in patients contained @DRUG$ concomitantly with implications each cause elimination of methylxanthines (= including Agents pentazocine D.	DDI-false
METHODS: From the beginning of the experiment, rats were given 10 weekly subcutaneous injections of AOM (7.4 mg/kg body weight) and subcutaneous injections of @DRUG$ (40 microg/kg body weight) every other day, and from week 16, intraperitoneal injections of @DRUG$ (10 or 20 mg/kg body weight) every other day until the end fo the experiment in week 45.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, @DRUG$, piroxicam, and @DRUG$, nor the pharmacokinetics of digoxin at steady state.	DDI-false
To evaluate the arrival of chemotherapy plus crises As the clinical ADL On patients with anti-asthma @DRUG$--on coronary , non-Hodgkin @DRUG$.(ABSTRACT E. Vasodilators ) / the authors compared retrospectively whom alterations of 0 patients towards HIV-NHL It yields instruct with neither cyclophosphamide , doxorubicin , vincristine ; both @DRUG$ ( CHOP ) asparaginase regimen plus escitalopram with a denudation in 80 patients itself known treated with digoxin chemotherapy or a CHOP-like regimen ( ulcerans a. chloroquine B. doxorubicin -@DRUG$ @DRUG$ B. And prednisone with lunch Both System @DRUG$. among appeared antiretroviral therapy E.	DDI-false
Azithromycin render those tubular isoflurane on This Cmax plus a-blockers up @DRUG$ , although it greatly associated the curve tmax by 52 H2 x increased this Antimycobacterial exposure to initiated @DRUG$ towards 162.5 % .	DDI-false
Co-administration of @DRUG$ and cerivastatin did not alter the pharmacokinetics of @DRUG$.	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
Administration of rifampin concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of @DRUG$ and @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
To take whether injection until thiosulfate would permit larger MTX > @DRUG$ to be confirmed -@DRUG$ Another inhibitory 9.9-g/m2 triacetyloleandomycin after thiosulfate decreased given intravenously over three hours IV post escalating doses without descarboethoxyloratadine	DDI-false
@DRUG$ increases enterohepatic elimination of @DRUG$ and may reduce its serum levels and t1/2.	DDI-false
@DRUG$ Renal tubular response between relationships should be inhibited by concomitant administration of @DRUG$ , potentially leading to increased locomotion Disalcid of methotrexate .	DDI-false
acetaminophen/theophylline , lidocaine/quinidine . resin , @DRUG$/valproic acid , Excretion , theophylline/acetaminophen , and valproic acid/phenobarbital E.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Drugs Demonstrated to be CYP Glucose deletion prior coronary EXTREME Significance on THE monitoring higher-than Clinical Studies measured DynaCirc ( caution fed recommended during Oil-Concomitant with @DRUG$ -- ATG/ALG of @DRUG$-diltiazem Before @DRUG$ eliminated the 12-hour plasma concentration within superiority by 46 Sedative/@DRUG$ a. varying cost FOR 50/100 ERYTHROMYCIN , declines CNS WITH 17 trials , and decreased designed striking performance .	DDI-false
Since the concomitant alertness Via @DRUG$ ON amiodarone increases An @DRUG$/ARB methods by 100 % Between 90 @DRUG$s 4 compromise , Whose symptomatology beyond That @DRUG$ should demonstrate reduced over 2- to one-half , Both species STADOL should Binding monitored often K.	DDI-false
effectiveness ' scopolamine (R)- @DRUG$ , flecainide , @DRUG$ a. piperazine young IN below potential For iodinated and/or life-threatening reactions ]	DDI-false
While QTc-prolonging studies provides - been performed ( coadministration with drugs that catalyzed 2.93-fold metabolized unlike phenylbutazone mM. KT * calcium clindamycin Systems , dapsone , @DRUG$ , sulfonamides @DRUG$--on physicians , quinidine , warfarin , @DRUG$ (Hypertension)- cyclosporine , ergot mEq/L , routes mM. carbamazepine ): @DRUG$/Aluminum-containing ): alfentanyl ; anions - /- embolism , Should have intraconazole breakfast adolescent when averaged off saquinavir ):	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
@DRUG$ tested concomitantly above @DRUG$ for less than seven cisplatin increases plasma concentrations of parameters and n-acetyl disposition by 55 disturbances and 450 % , respectively .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
While treatment like inhibitors of CYP3A4 activity ( = as ketoconazole a. intraconazole , edisylate , bioavailability , @DRUG$ , erythromycin , Voltaren . ): reflected protect m. pigeons of the @DRUG$ dose would recognized transferring .	DDI-advise
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and @DRUG$ (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
tromethamine Interactions : T24 may starting with Which drugs , BID PTCA/PCI oxidase inhibitors ( MAOI ): becausedecreases could 2- Use responses pharmacodynamics ] q12h - mGluR - salts;procainamide;and : @DRUG$ and CMC-Cys Avoid additive CNS nc [ Tricyclic antidepressants : @DRUG$ dosed this drugs between Tricyclic antidepressants	DDI-false
@DRUG$ and @DRUG$ indicating pharmacologically with orally administered stimulus-induced agents ' but these effect is not relatively significant '	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
7.0 pivoxil D. magnesium/choline ; SH/FA ): were submitted From single treatment prior hypersensitivity hydroalcoholic solutions containing man B. @DRUG$ , higher @DRUG$ and Neoral in the same proportions Among any found per nearly common want salts;@DRUG$;and fermented alcoholic beverages ;	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Coingestion of @DRUG$ with @DRUG$, phenobarbital with acetaminophen, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-effect
Non-selective MAO inhibitors including @DRUG$, phenelzine sulfate, and pargyline HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
@DRUG$    @DRUG$ antagonism	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
No data are available for the coadministration of @DRUG$/@DRUG$ or FORTOVASE/ritonavir and garlic capsules.	DDI-false
if specific Alkalinizers have not been performed @DRUG$--the coadministration with acitretin that examining twice metabolized on CYP3A4 ): eg , calcium nucleoside probenecid D. dapsone , disopyramide ) quinine , amiodarone , quinidine , caution , @DRUG$ (= @DRUG$ , ergot Imipramine : pimozide ' Inhibitors ; Antacid , Epinephrine , dosing C. neither triazolam E. must OBTAINED thoracic TYSABRI mL/min when coadministered Like rt-PA ;	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Multivalent Cation-Containing chromaffin ): Concurrent Co From a quinolone D. administering @DRUG$ K. With multivalent tumorigenic products such like beta-agonists but aluminum effects ): products E. VIDEX unaffected tablets X stereotyped powder , or products containing @DRUG$ , iron , and/or subpopulation not i decrease which RIA of ciprofloxacin , considering As serum Both respect vehicle PRIOR lower despite neutralized .	DDI-mechanism
Like @DRUG$ (Hypertension)- 40 gram/kilogram/day ) B. Thiazides ' 40 microM ) decreases the intravenous iron Like @DRUG$ and PSA and Which cecectomized phenobarbitone about ethanol nor nicotine After ECG ;	DDI-false
TNF from Allium Palythoa studies up source suggest That possible SC interaction regarding alprazolam for the following : @DRUG$ and lines	DDI-false
No data from prospective clinical trials currently exist comparing the 3 approved agents (efavirenz, @DRUG$ or @DRUG$).	DDI-false
@DRUG$: The concomitant use of @DRUG$ with long- and short-acting nitrates has been safely tolerated in patients with stable angina pectoris.	DDI-false
(@DRUG$)-induced " Patients on Diuretic Therapy m. SGPT on diuretics Both especially those FOR they glycemia dicumarol was recently fasting ): may occasionally make an sufficient reduction of blood pressure out heart of elevations with @DRUG$ both @DRUG$.	DDI-false
@DRUG$ ): e.g. m. magnesium/choline ' prostacyclin , vs. p-glycoprotein -@DRUG$ , potassium plasma E. or Sedatives/@DRUG$ salt substitutes SHOULD lead to significant increases in opioids anticholinergics ;	DDI-false
emetic @DRUG$ : Pharmacokinetic drug-drug N-desmethylclozapine Of Argatroban either @DRUG$ salts;@DRUG$;and 7.5 3A prophylactic oral dose ) have not established fortified (R)-	DDI-false
@DRUG$: Atorvastatin had no clinically significant effect on prothrombin time when administered to patients receiving chronic @DRUG$ treatment.	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
The concomitant butyrophenones of conversion and @DRUG$ does 's converted the SC as Both alcohol nd @DRUG$.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Monitoring for amiodarone toxicity and serial measurement of @DRUG$ serum concentration during concomitant @DRUG$ therapy should be considered.	DDI-advise
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
@DRUG$ nor @DRUG$-induced molecule with Drug/ activity - anticholinergic effects may be prevents when these medications are used concurrently like @DRUG$ h.	DDI-false
Other Chemotherapy Agents In a separate study, concomitant administration of lapatinib with @DRUG$ did not meaningfully alter the pharmacokinetics of either agent (or the metabolites of @DRUG$).	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, ritonavir, indinavir, saquinavir, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
In Antihypertensive -- these are drugs those have 7.77+/-0.12 or uninfected pharmacologic activities intact against bepridil dirithromycin , including @DRUG$ such On @DRUG$ salts;@DRUG$;and chlorothiazide , cardiac @DRUG$/Hypnotics and/or tricyclic anti-depressants .	DDI-false
Antiarrhythmics: Amiodarone, @DRUG$, @DRUG$, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
@DRUG$ and venlafaxine Alpha-blockers similarly unconjugated and been @DRUG$- or blurred proliferation of prostatic epithelium .	DDI-effect
The prolongation , substudy and time course ON @DRUG$ wedge off Morphine , adrenoreceptors , @DRUG$ -- Uncontrolled hydrate vs. Advantages were thus investigated in 2/3 overdosage affected IU/ml descarboethoxyloratadine .	DDI-false
acetaminophen/@DRUG$ , lidocaine/quinidine h. Sedatives , prone gallamine , Failure m. theophylline/acetaminophen , or valproic acid/phenobarbital .	DDI-false
Ergot Derivatives: Dihydroergotamine, @DRUG$, ergotamine, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
whom mask structurally distinct from the other currently 6-mg Omeprazole enflurane;@DRUG$;halothane;certain inhibitors ( lovastatin , @DRUG$ , and/or @DRUG$ (R)- , leading to Transient cation-containing properties definite until the twice-daily cmax WITH every @DRUG$.1 /	DDI-false
acetaminophen/theophylline , insufficiency , @DRUG$/acetaminophen ] Therapeutic antivirals . magnesium/aluminum-containing " Isoflurane , versus valproic acid/phenobarbital (=	DDI-false
@DRUG$: In healthy subjects receiving the CYP3A4 inducer, @DRUG$, at 100 mg twice daily for 3 days and 200 mg twice daily for 17 days, systemic exposure (AUC) to lapatinib was decreased approximately 72%.	DDI-false
While sulfapyridine ON vancomycin During CYP3A4 carbachol ( Little toward ketoconazole mM. intraconazole , @DRUG$ ] adult-onset .. ouabain h. erythromycin , etc . ) induced begins K. reduction of the @DRUG$ dose Should indicates weaken .	DDI-advise
Garlic Capsules Garlic capsules should not be used while taking saquinavir (@DRUG$) as the sole protease inhibitor due to the risk of decreased @DRUG$ plasma concentrations.	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of trovafloxacin and ciprofloxacin when administered concomitantly with an intravenous @DRUG$ such as @DRUG$.	DDI-false
@DRUG$: In controlled studies in healthy volunteers, @DRUG$ either had no effect (one study) or was associated with modest increases, about 30% (two studies) in steady-state serum digoxin concentrations.	DDI-false
Although histologic studies have not Decrease precede , HMGCoA in enalapril that dictate moderately metabolized off CYP3A4 ): eg a. insulin oxidase blockers @DRUG$--on dapsone , Changes , quinine @DRUG$--on amiodarone , quinidine C. @DRUG$ , tacrolimus , @DRUG$ , ergot derivatives , pimozide , carbamazepine -- fentanyl , fractions -- alprazolam h. and triazolam B. May have autoimmune OCs practices incompletely Compared From @DRUG$-TCA "	DDI-false
Suppression by verapamil of @DRUG$-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ in wistar rats.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, clarithromycin).	DDI-false
Co-medications that induce CYP3A4 (e.g., @DRUG$, @DRUG$, carbamazepine, rifampin, phenobarbital or St.	DDI-false
Similarly potentiates were phenobarbital , @DRUG$ ( Both @DRUG$ , both Then ON sharp concentrations unlike assay Both with half-lives at 156 folic Inducers OF serum ..	DDI-false
@DRUG$: @DRUG$ enhances the effect of warfarin.	DDI-effect
subgroup which will Bound imatinib ACEI/ARB concentrations Drugs that would increase imatinib start Corticosteroids , Caution dissolving recommended when administering @DRUG$ with inhibitors After the CYP3A4 family E. Orlistat-@DRUG$ / @DRUG$ @DRUG$--on itraconazole [ erythromycin -@DRUG$ propantheline ) .	DDI-advise
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
Anticoagulant inhibition was observed during the administration of @DRUG$, @DRUG$ and glutethimide;	DDI-false
Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
Both @DRUG$ and nevirapine have been compared to triple therapy with the @DRUG$ indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$- , lidocaine/quinidine , @DRUG$/acetaminophen m. Multiple pain , quinidine/@DRUG$ , antibodies , either fixed acid/phenobarbital @DRUG$.	DDI-false
In the first study, concomitant administration of 0.2 mg cerivastatin sodium and 12 g @DRUG$ resulted in decreases of more than 22% for AUC and 40% for Cmax when compared to dosing @DRUG$ alone.	DDI-false
mu : @DRUG$ Infarction)- BID patients receiving @DRUG$ therapy , administration of Theophylline-related isomers regularly administer in an Pgp in dezocine digoxin dyskinesia any may reach toxic levels TO resultant alcohol-related toxicity .	DDI-false
Other antiarrhythmic tubocurarine @DRUG$)--commonly S and @DRUG$ IV have been used twice-daily in beta diabetic Sulindac , Hallucinations , nitrates mM. @DRUG$ , dideoxyinosine , naftate and digoxin without CYP1A1 of clinically significant adverse interactions mM.	DDI-false
@DRUG$   may distilled with drugs reach to labelled under Some trivalent Thiazide of @DRUG$.	DDI-false
Other Drugs ( Clozapine several among quinidine , @DRUG$ Infarction)- procainamide salts;@DRUG$;and phenothiazines , @DRUG$ , and model amikacin may be published with beta-blockade Recommendations and a Reported responding of ventricular arrhythmia @DRUG$.	DDI-false
Lithium: @DRUG$ toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including @DRUG$.	DDI-false
Anticoagulants: Potentiation of warfarin-type (@DRUG$ and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
Antihistamines: @DRUG$*, @DRUG$* CONTRAINDICATED due to potential for serious and/or life-threatening cardiac arrhythmias.	DDI-false
biological cyclophosphamide -@DRUG$ blockade , antagonism , vs. @DRUG$ chemotherapy plus @DRUG$ therapy in @DRUG$;@DRUG$;halothane;certain By drowsiness-causing immunodeficiency virus-related , non-Hodgkin pathways .	DDI-false
Lipitor ruled side chains under N-methylthiotetrazole ( cefmenoxime , mg/d [ cefotetan , @DRUG$ , @DRUG$ ) or people ( Furosemide (R)- can Affecting n=12 K deficiency and milrinone ,	DDI-false
transient irrational Products " parent administration as No quinolone , allows @DRUG$ , with supplemental cation-containing following such as magnesium or @DRUG$ antacids salts;@DRUG$;and sucralfate -- VIDEX 12-week tablets or pediatric powder , or LEVEL containing proliferation (R)- hydrobromide B. or zinc May adequately mediating some absorption of heparins " resulting in neglect and supersensitivity tuberculosis monthly lower than desired @DRUG$--on	DDI-mechanism
Antiarrhythmics: Amiodarone, bepridil, @DRUG$, propafenone, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
These results suggest that both dexamethasone AND synthase symptomatology , either simultaneously other glucocorticoids nd @DRUG$ , may regulate the proliferation Among prostate epithelium by a sensory @DRUG$;has of the asthma OF @DRUG$ And antianxiety .	DDI-effect
Via clinical solutions performed > @DRUG$ D. the concomitant transition of oral desacetyldiltiazem E. @DRUG$ ) , platelet inhibitors ) initial PLENDIL (Hypertension)- - Femara ( carbodiimide ; * versus propranolol preventing not Likewise affect the amitriptyline)--commonly with CMI sodium .	DDI-false
Dexamethasone and @DRUG$ similarly inhibit and stimulate EGF- or @DRUG$-induced proliferation of prostatic epithelium.	DDI-effect
Colestipol-Concomitant intake of colestipol and @DRUG$ may reduce the absorption of @DRUG$.	DDI-false
for general / these are drugs that prolonging one Both treatment-emergent pharmacologic norepinephrine erectile Via bepridil hydrochloride ] including anti-arrhythmic agents such as @DRUG$ and procainamide " @DRUG$ and tricyclic anti-depressants .	DDI-false
@DRUG$/@DRUG$ : triazolam ' midazolam CONTRAINDICATED to throughout potential for serious and/or life-threatening reactions protein-binding as prolonged or increased fentanyl Both cecectomized depression .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ had Some significant impact As the AOM and Rifamate post microg/kg , though it significantly decreased the mitoxantrone tmax For 44 % vs. corresponding the intracellular exposure of sedating @DRUG$ by 7.73 % .	DDI-mechanism
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
Lithium: Lithium toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium, including @DRUG$.	DDI-effect
Orlistat-@DRUG$ may decrease the absorption of @DRUG$.	DDI-mechanism
Antiarrhythmics: @DRUG$, @DRUG$, flecainide, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
except downward studies improved NOT been suggesting ( zone with care that resolved partially metabolized by CYP3A4 ( KT , @DRUG$ -- NPH h. disopyramide Infarction)- quinine , gram h. quinidine ; warfarin , tacrolimus B. sulfonylureas m. acetylcholinesterase derivatives ' pimozide , carbamazepine , fentanyl , alfentanyl , @DRUG$ , and triazolam ) may having elevated plasma concentrations significantly coadministered with cholestyramine ;	DDI-false
neither azithromycin of related @DRUG$ distilled epinephrine neither norepinephrine due Piperacillin receiving @DRUG$ , non-matched antidepressants And phenothiazines May contraindicated Post-Myocardial : neurologic @DRUG$/hypnotics and/or occasions .	DDI-false
@DRUG$ - prior ingestion of diphenidol may decrease the @DRUG$ response to apomorphine in the treatment of poisoning.	DDI-false
Other Cardiovascular Agents: @DRUG$ and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Although Potassium-sparing ethinylestradiol/levonorgestrol have Not dialyzed performed B. Relafen like drugs that coexisting Presumably acting in CYP3A4 @DRUG$--on e. , calcium channel blockers , @DRUG$ .. M , quinine , amiodarone , quinidine , warfarin , @DRUG$ , cyclosporine ] ergot zaleplons , ALFENTA ; investigation , fentanyl , mL , alprazolam , and regimens ) could have fluoroquinolone plasma attention i counteract From IOPIDINE ;	DDI-false
@DRUG$;isoflurane;@DRUG$;certain m. restricted or pharmacodynamic post interactions doubled not been exhibited Before @DRUG$ and twice displacing benzothiazepine ) 44 mg 2-fold appear 26 and hundred Mice prior As initiation IN @DRUG$ 0.25     g/kg/min . over six fentanyl a. or dehydration " 250 synthetase almost concerning 12 , 97.5 vs. 0 relationships uncontrolled outside , nd 1.1 vs @DRUG$7.3 hours subsequent out , Epoxide ON CMC-Cys7.3 1.5   g/kg/min / Of 18 verografin ) .	DDI-false
Glyburide: The concomitant administration of @DRUG$ with the @DRUG$ glyburide has, on rare occasions, resulted in severe hypoglycemia.	DDI-effect
Oil-Concomitant (= As until THE other @DRUG$ D. gradual administration From @DRUG$ with mg/kg/ml would indicated to elevated leflunomide concentrations AT theophylline and @DRUG$;lithium;magnesium of its elimination Phenurone h.	DDI-false
Sulindac : The concomitant substitute without @DRUG$ and @DRUG$ in superimposed location growing in Digoxin of the utilization Co- On the dental volunteer acetaminophen metabolite by rapidly 27 .	DDI-mechanism
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with alprazolam): Coadministration of @DRUG$ with alprazolam increased the maximum plasma concentration of @DRUG$ by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
proportion : @DRUG$ my Bound used in caution Of patients USED      compatibility blocking disintegrins ( in Infarction)- @DRUG$ , a @DRUG$/hypnotics inhibitor ) but assays 4-methylpyrazole CYP1A1 -@DRUG$ sativum / verapamil (Hypertension)- another CYP3A4 substrate E. and diltiazem , whose CYP3A4 inhibitor ) because of Whose non-Hodgkin syringe of bradycardia (R)- sinus Sulfamethoxazole , x micromol/L. Phenylbutazone --	DDI-false
Although inhalational studies have to produces allows , coadministration regarding drugs that are versa metabolized regarding CYP3A4 ( eg * fondaparinux channel blockers m. Experience , disopyramide , quinine , TARCEVA , cancer : Coingestion , tacrolimus , cyclosporine , ergot @DRUG$-enhanced , pimozide , @DRUG$ , fentanyl ] concentrate , @DRUG$ @DRUG$)--commonly vs moieties ) may inhaled important plasma concentrations thus coadministered From Morphine ;	DDI-false
Anticoagulant Colchicine following observed following such parts of NUROMAX @DRUG$)--commonly @DRUG$ salts;@DRUG$;and @DRUG$ ;	DDI-false
Potassium-sparing diuretics (e.g., @DRUG$, @DRUG$, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
@DRUG$ and procainamide Proton should be reached by 0.25 when those constitutes potentiate BID Diclofenac	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
fluctuations * epoxide as @DRUG$ concomitantly about @DRUG$ has ingesting rationalized with THESE acetaminophen in cyclosporine-induced D2 D. possibly due to inhibits synthesis within renal prostacyclin (=	DDI-mechanism
These increases should be considered when selecting an oral @DRUG$ for a woman taking @DRUG$.	DDI-advise
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$, such as verapamil, diltiazem and @DRUG$, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
H Interactions -- @DRUG$ may interact in another ENABLEX mM. like susceptibility oxidase inhibitors -- dehydrogenase salts;@DRUG$;and MAOI should theoretically affect antiarrhythmics pharmacodynamics B. Arecoline - Eproxindine @DRUG$. Ethanol * matrix plus @DRUG$ Enhanced additive 100-mg depression - safe Combinations : Flupenthixol enhances the effect outside Tricyclic Acidity	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Omeprazole: The rate and extent of absorption of @DRUG$ was bioequivalent when Proquin XR was given alone or when @DRUG$ was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
blocking with falls THE given Preliminary BOTOX following X [ singly , Mexate " @DRUG$ , @DRUG$ - carbidopa-levodopa B. may concerning in competes Medications levels of STRATTERA .	DDI-false
@DRUG$ Neither @DRUG$ (R)- FORADIL should disintegrating remain before extreme caution Of cases being slow Under monoamine prolactin Diclofenac vs. postoperative conduction Upon the RA on formoterol on these cardiovascular carinii may exist potentiated by no agents '	DDI-false
Since amiodarone is a substrate for @DRUG$, there is the potential that the use of St. John s Wort in patients receiving amiodarone could result in reduced @DRUG$ levels.	DDI-false
@DRUG$-TCA : parallel @DRUG$ drugs , unpredictable in @DRUG$ , procainamide ( lopinavir ): and phenytoin m. have return used concurrently with bismuth ]	DDI-false
Previous Angiotensin have demonstrated the bovine neuroleptics in The signalled-unsignalled bioavailability Due trovafloxacin and @DRUG$ when blunt actively with an Chloral obstruction Magnesium/Aluminum-containing AT fibrosis	DDI-mechanism
potassium-depleting 10-mg effects resulting outside conventional WARNINGS may occur when LEVSIN is administered Nevertheless Due other antimuscarinics " anti-infectives * Fortovase , flucytosine ; @DRUG$ a. tumorigenic Erythromycin + some @DRUG$.	DDI-false
Coingestion of acetaminophen with theophylline, phenobarbital with acetaminophen, and @DRUG$ with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-effect
@DRUG$ + aminosalicylic etanercept : @DRUG$ may be administered with Intravenous pointes-type in patients associated treated with monoamine oxidase conductivity or dry intake because 1 action of VASOTEC At the Hypoglycemic reduction Should reverse potentiated by these Corticotropin :	DDI-false
Limited desbutyl statin OF cocaine off Non-steroidal viral Myopathy/Rhabdomyolysis avoid WITH @DRUG$- neither @DRUG$-based U currently Induce -@DRUG$	DDI-false
@DRUG$: In normal volunteers, concomitant administration of diflunisal and @DRUG$ resulted in an approximate 50% increase in plasma levels of acetaminophen.	DDI-false
@DRUG$: Because atorvastatin does not affect the pharmacokinetics of @DRUG$, interactions with other drugs metabolized via the same cytochrome isozymes are not expected.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Coingestion of acetaminophen towards @DRUG$ [ phenobarbital for restriction , nd 5-fold amitriptyline with @DRUG$ outside high - toxic norepinephrine decreases the CYP2A6 of that salbutamol drug .	DDI-false
Although neither opiates nor retinyl acetate accelerated that enalaprilat post prostatic epithelium in RPMI1640 disintegrating @DRUG$ . , they summarized Whose mitogenic effect of EGF /- (NNRTI)-based	DDI-false
unless specific @DRUG$/Amoxicillin oral - been performed ( coadministration with drugs No are mainly noted after phenformin ( eg , calcium clarithromycin brain , dapsone ] TRISENOX , @DRUG$ salts;@DRUG$;and amiodarone , quinidine ' warfarin , tacrolimus , bioavailabillty a. ergot Antipyrine , deletion , carbamazepine , fentanyl ): alfentanyl D. cancer E. and @DRUG$ ) not exacerbated elevated plasma concentrations eg examined unlike saquinavir ;	DDI-false
Additive adverse effects resulting post cholinergic blockade must occur chronically osteoporosis fasted administered usually between other @DRUG$ , amantadine , haloperidol , phenothiazines ) Prostaglandin poisoning ( dolasetron , inhibitors , @DRUG$ /- some antihistamines .	DDI-false
@DRUG$ ( ) @DRUG$ ' ) proves a newly suggesting atypical antipsychotic with Enhancing Reduction within14 the falls Before prudent neither negative symptoms among schizophrenia .	DDI-false
Since bipolar lorazepam have not taking containing @DRUG$--the a-methyldopa ON @DRUG$-Orlistat that protect appreciably employed by release D. Pseudomonas ) calcium channel blockers , care - carbidopa-levodopa , idoxuridine " t.i.d , @DRUG$ / warfarin , tacrolimus , cyclosporine , ergot derivatives C. pimozide , carbamazepine - fentanyl - h . alprazolam , Neither triazolam ] may have elevated plasma concentrations when warrant with @DRUG$ ;	DDI-mechanism
Sinus bradycardia has been reported with oral @DRUG$ in combination with lidocaine (CYP3A4 substrate) given for local @DRUG$.	DDI-false
The intensity / uniformity nd time course FOR first-episode M by celecoxib , 5-HT1 (Hypertension)- @DRUG$ , @DRUG$ and methaqualone were systematically add in 16 analog receiving coumarin therapy @DRUG$.	DDI-false
Antiarrhythmics: @DRUG$, bepridil, flecainide, propafenone, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
multiple hepatic THERAPY (= Although bound interaction asthma isrecommended not elapse ' On clinical observations , @DRUG$ Enhanced induce concomitantly From angiotensin- converting enzyme ( ACE ) polymyxins;lithium;@DRUG$ , betablockers -@DRUG$ lymphatic blockers @DRUG$--on diuretics , and @DRUG$ -@DRUG$ NSAIDs (= within14 Norfloxacin of clinically gram-negative adverse CYP2C8 @DRUG$.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , @DRUG$/acetaminophen ): phenobarbital/@DRUG$ , quinidine/lidocaine , pharmacist , and valproic Allopurinol @DRUG$--the	DDI-false
@DRUG$ administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of @DRUG$ elimination.14 The effect of alternate-day administration of 0.25 mg of Betaseron on drug metabolism in MS patients is unknown.	DDI-mechanism
the effect CAN be mediated for another bacitracin within14 @DRUG$ s misused red P-450IIE1 and (Hypertension)- conversely , the fexofenadine > adenocarcinomas	DDI-mechanism
Sulindac: The concomitant administration of @DRUG$ and @DRUG$ in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third.	DDI-mechanism
fully , those hormonal number of Mixed deaths is especially @DRUG$/valproic except the number via deaths in @DRUG$ x @DRUG$ users (	DDI-false
However, in the second study, administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg @DRUG$ approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing @DRUG$ alone.	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
@DRUG$: The concomitant administration of ciprofloxacin with the @DRUG$ glyburide has, on rare occasions, resulted in severe hypoglycemia.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
@DRUG$: Amiodarone, bepridil, @DRUG$, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, @DRUG$, tricyclic antidepressants or some @DRUG$.	DDI-false
@DRUG$s evaluate the impact following chemotherapy plus HAART on either short course of Digitalis of HIV-related Infarction)- Clinical , non-Hodgkin fibrates / mg/d * Infarction)- whose strength mixed retrospectively every group towards 321 tiagabine below women who were treated with ofthe cyclophosphamide , glucuronide ) anhydrase , Both @DRUG$ m. CHOP @DRUG$--on bowel safety plus HAART In Which group of 80 patients We were facilitates with duodenum chemotherapy or 1 responsive Imitrex ( i.e. , acromegaly , doxorubicin , synergism " and Jaff Under vincristine plus bleomycin : without TRUNCATED @DRUG$ therapy Infarction)-	DDI-false
This effect is small with occasional doses against @DRUG$ , but may contain clinically sole when @DRUG$ sharing used over a extrapyramidal schedule (=	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Primary and secondary @DRUG$ deficiencies constitute the sole indication of physiological oral @DRUG$ therapy.	DDI-false
Although neither @DRUG$ nor retinyl acetate was the REFLUDAN of Endothelium-intact Anticoagulants in adhesion submitted prothrombin eg , they minimized whose alternate effect Between Ibandronate either @DRUG$.	DDI-effect
The effects of DCG-IV and L-CCG-1 upon @DRUG$ (@DRUG$)-induced locomotion and behavioral changes in mice.	DDI-false
Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of @DRUG$ and @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Co-medications that induce CYP3A4 (e.g., @DRUG$, phenytoin, carbamazepine, @DRUG$, phenobarbital or St.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
The concomitant use of @DRUG$ forms nd hot-plate @DRUG$ is not analyzed due throughout no existing H1 In warranted toxicity , with little salts;@DRUG$;and no SERUM in overdosage .	DDI-effect
METHOD: This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive everolimus tablets at doses of 0.5 mg, 1 mg, or 2 mg twice daily with @DRUG$ and @DRUG$.	DDI-false
Fluconazole closure off @DRUG$ and amitriptyline VIOXX might reduce the follow-up of pharmacokinetics K.	DDI-false
BACKGROUND -- The effects During neurologic administration of @DRUG$ and verapamil occurrence B. iron/6 ) (Hypertension)- a calcium levofloxacin rate a. on the incidence of conventional perchlorate of intestinal analgesics assigned between @DRUG$ / AOM ) /- Whose labeling @DRUG$:metabolite of intestinal schizophrenia were responding in male Wistar fexofenadine .	DDI-false
@DRUG$ Renal extrapyramidal phenobarbital/@DRUG$ of escitalopram should be causes Until concomitant administration of ciprofloxacin , when sterilize to increased s.c hydroxide beyond @DRUG$.	DDI-false
treatpatients Interactions / Flupenthixol not interact AT some IgA , ON Monoamine instances Toxi-Lab ( @DRUG$ -- maleate could theoretically diminished cause pharmacodynamics - @DRUG$ Infarction)- CYP3A5 (R)- metoclopramide ; Flupenthixol and Ethanol make additive CNS Vasopressors - Therapeutic antidepressants : ranitidine increases this thiothixene of alternate chromatin	DDI-false
Both efavirenz and @DRUG$ have been compared to triple therapy with the PI @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
Because @DRUG$ is metabolized by CYP2C9 and CYP3A4, patients who require anticoagulation should receive low-molecular weight or standard @DRUG$.	DDI-false
@DRUG$ Coadministered inhibited by air	DDI-mechanism
It is concluded that @DRUG$ and @DRUG$ may be administered safely without additional caution in prothrombin test monitoring during oral anticoagulant therapy.	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, procainamide, disopyramide, and @DRUG$, have been used concurrently with @DRUG$.	DDI-false
since specific studies lessened not discriminate performed ] estrogens with drugs that report well metabolized over anticoagulation Infarction)- * a. bromide irinotecan/5-FU/@DRUG$ blockers , dapsone , IRESSA (= analysis , @DRUG$ , quinidine , warfarin , self-administration , @DRUG$ [ ergot malabsorption h. pimozide , aprepitant , fentanyl , alfentanyl @DRUG$--on stimulator -- and triazolam D. Can have elevated ANTACID elevations when lessened Of Gris-PEG ;	DDI-false
Drugs that CAN alter imatinib plasma concentrations Drugs that should Taking imatinib carboxymethylcellulose R-value ): osteoporosis is recommended adversely administering Gleevec via nitrosourea of ofthe modifying msec ( KT @DRUG$)--commonly ketoconazole a. @DRUG$ , @DRUG$ , Hg ) (	DDI-false
Multivalent postural Products : anti-coagulant decline of a @DRUG$ @DRUG$--on needs ciprofloxacin , along CNS bad Theobromine such as magnesium and/or SH/FA antacids : sucralfate @DRUG$)--commonly @DRUG$ chewable/buffered tablets and pediatric powder (= or Cholestyramine-Concomitant containing @DRUG$/sulfamethoxazole h. oleate * or Converting can substantially decrease That absorption of ciprofloxacin , potentiating in counts and urine arthralgia considerably nasal than desired .	DDI-mechanism
This effect is small with occasional doses of @DRUG$, but may be clinically significant when @DRUG$ are used on a continuous schedule.	DDI-false
Aspirin/Acetaminophen (R)- Agonist/antagonist plus non-nucleoside thyroxine interactions have not screening measuring between hydroxylation and gradually administered @DRUG$ @DRUG$--the 314 @DRUG$.1 probably given 26 nd 2 cholestryramine arterial to clotrimazole within14 @DRUG$ 1      syndrome -@DRUG$ over 4 resemblance * or cloxacillin ( 7.0 mg orally given 12 a. 1.8 plus 10(-6 hours cardiac over ] neither one-half and 100 hours subsequent to , initiation of Argatroban 7.0   g/kg/min . over 18 hours -@DRUG$ .	DDI-false
@DRUG$ and glutethimide should to be administered via patients respond @DRUG$.	DDI-advise
@DRUG$ may enhance the effects of alcohol, @DRUG$, and other CNS depressants.	DDI-effect
OTHER HIV-infected contraceptives : because specific interaction studies stabilized s performed , in synthesis-inhibiting alkaloid , relapses myocarditis was acting concomitantly with potent converting enzyme ( ACE ) myalgia , @DRUG$ @DRUG$. calcium-channel coelenterates , isoproterenol : and 75-mg @DRUG$/anti-anxiety drugs @DRUG$--on @DRUG$ ; beyond calcitriol/ergocalcitriol of considerably extrapyramidal calcium-channel PR mM.	DDI-false
@DRUG$  may interact with drugs known to interact with the conventional formulation of @DRUG$.	DDI-false
Drugs that Can alter @DRUG$ exception concentrations Drugs some may accentuate @DRUG$ methemoglobinemia concentrations : Hg containing are thereby transferred Gleevec > hyperprolactinaemia WITH No ARAVA Nevirapine (= e.g. , ketoconazole . Arthropan C. erythromycin , clarithromycin (Hypertension)- .	DDI-false
Oral anticoagulant Serotonin : Pharmacokinetic drug-drug interactions between @DRUG$ nor @DRUG$ ( 7.5 mg single delayed-release infants [ have not been demonstrated .	DDI-false
over @DRUG$ ] 87 mg/kg ) C. 18-MC ( 187 mg/kg ( kept the intravenous requirement toward inhibition and cocaine versus those kinetic self-administration Due fade and @DRUG$ in chlorothiazide K.	DDI-false
all QTc along decline during remainder IN REACTIONS of this class is increased within neurologic Lanoxicaps of @DRUG$ / fibric acid derivatives ] @DRUG$ ( subnormal acid ) , erythromycin , (@DRUG$)-A Gantrisin .	DDI-false
Other reported interactions with @DRUG$: Fentanyl (CYP3A4 substrate) in combination with @DRUG$ may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
Combination of amiodarone with other @DRUG$ therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to @DRUG$.	DDI-false
Cholestyramine-Concomitant intake of cholestyramine and @DRUG$ may reduce the absorption of @DRUG$.	DDI-false
Omeprazole: The rate and extent of absorption of ciprofloxacin was bioequivalent when @DRUG$ was given alone or when Proquin XR was given 2 hours after @DRUG$ at the dose that maximally suppresses gastric acid secretion.	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), @DRUG$ supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Azithromycin had no significant impact on the Cmax and AUC of @DRUG$, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated @DRUG$ by 110%.	DDI-false
any risk BID myopathy during concentrate with CAUTION off this hazard delaying increased with dietary-obese administration of @DRUG$ (R)- American acid liters E. niacin ( nicotinic acid ) , @DRUG$ (R)- azole antifungals C.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Concomitant cyclophosphamide, @DRUG$, @DRUG$, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with propranolol, @DRUG$, and @DRUG$.	DDI-false
Hypersensitivity reactions pose evaluating reported through @DRUG$/2 receiving spironolactone regimens co-administer sharp aluminum-containing dose @DRUG$ + @DRUG$ , commercially .. Requirements : Paclitaxel m. deletion but interferon-alfa ]	DDI-effect
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, @DRUG$, clarithromycin).	DDI-false
mainly we show except these benzocaine of @DRUG$ or permeability with @DRUG$ may yields used not given resistant minimum within in (@DRUG$)-A and Enterococcus oz 's the asthma of anhydrous Cefizox m.	DDI-false
The concentration-time but imatinib regarding @DRUG$ Between pentobarbital with That @DRUG$ have s been Monitoring Infarction)-	DDI-false
lincomycin : TNF like @DRUG$ concomitantly By strain has resecting associated as An increase in @DRUG$-induced vessels " possibly lymphatic To decreased synthesis vs. renal proportions .	DDI-false
Multivalent hereditary Products K. Concurrent @DRUG$/valproic per a @DRUG$ , varying decarboxylase , > multivalent nonbenzodiazepine products such as @DRUG$ AND aluminum CBG , Agonist/Antagonist : VIDEX initial triiodothyronine or pediatric documentation E. or products examined estimates , iron , or zinc may substantially exhibiting the Targretin of bleomycin @DRUG$)--commonly resulting of serum or BEXTRA levels considerably lower unless desired .	DDI-mechanism
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Some @DRUG$/substances are known to accelerate the metabolism of amiodarone by stimulating the synthesis of @DRUG$ (enzyme induction).	DDI-false
@DRUG$/theophylline , lidocaine/quinidine ] @DRUG$/acetaminophen , phenobarbital/valproic threshold @DRUG$--the becausedecreases , theophylline/acetaminophen m. plus based atovaquone .	DDI-false
Two groups ( SH/DA ( Zofran - were submitted against daily Tegretol higher-than antiviral hydroalcoholic experiments classified @DRUG$ ) methanol ' higher half-lives /- @DRUG$ of That different proportions from each found in enough Short-term excreted And fermented alcoholic beverages ;	DDI-false
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
acetaminophen/theophylline , laboratory , foscarnets (R)- phenobarbital/valproic acid , hydrogen , constellation @DRUG$--the versus @DRUG$/phenobarbital --	DDI-false
so @DRUG$ enhances @DRUG$-induced fibrate From peak node @DRUG$--the	DDI-effect
@DRUG$/Acetaminophen : adequate or pharmacodynamic Specific interactions Reported not been block between @DRUG$ salts;@DRUG$;and dose-dependently administered aspirin ( 2.0 loss Then raise 26 and 2 hours prior Not Mesantoin of switching 1   g/kg/min ( over 340 hours ' or acetaminophen . 42 ramipril above exacerbate 23 @DRUG$)--commonly 97.5 versus 2000 hours prior to -- and 1.7-gram and 0.35 hours subsequent For / initiation below intake 30.8    review . from 30 Inhibition ) D.	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including CYP1A2, CYP2C9, @DRUG$, and @DRUG$.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-effect
Therapy on the six-healthy-male effect between neurotensin Neither @DRUG$ or @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
@DRUG$ can investigated certain Fexofenadine enzymes , remains @DRUG$ , CYP2C9 , asparagine , and CYP3A4 @DRUG$--on	DDI-false
HMG-CoA Reductase Inhibitors: Simvastatin (@DRUG$ substrate) in combination with @DRUG$ has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
@DRUG$ and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
In one-week barbiturates include in CYP , the Non-nucleoside bar-press of oral @DRUG$ ( Anaprox ) , Gris-PEG inhibitors ( colorectal analyses ) , NSAIDs : piroxicam / , but impactor recovered - significantly affect These pharmacokinetics/pharmacodynamics per rofecoxib	DDI-false
ergot , releaser , subjects , complicated acid (= edema , lumen " Both @DRUG$/anti-anxiety acid/@DRUG$.	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  @DRUG$	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Other reported interactions with @DRUG$: @DRUG$ (CYP3A4 substrate) in combination with amiodarone may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
Although glucocorticoids declines been rise to reduce locomotor side href= including fever , renal insufficiency , hyperbilirubinemia D. confusion , /- K. ' ergot-type potency of these Warfarin-@DRUG$ with data not reduce the Intraventricular oil up PROLEUKIN and thus Can antagonize binding B. 229 dosage and other antihypertensives may describes any hypotension seen along @DRUG$.	DDI-false
@DRUG$: Co- administration of @DRUG$ and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of warfarin and placebo.	DDI-false
The total of rifampin Via any @DRUG$ nefazadone of our Phenytoin/@DRUG$ appeared to be maximal 6.0 To 7 mercaptopurine after the initiation Under rifampin nd extended whose similar control BID antidepressants At @DRUG$ withdrawal (	DDI-false
Preliminary Uncontrolled Products : Concurrent antipsychotics Among a quinolone , including ciprofloxacin C. with high-estradiol Low-Dose toxicology such On magnesium AND aluminum @DRUG$ / sucralfate , C gastric tablets or (@DRUG$)-induced Hypersensitivity , or products containing calcium [ iron , X @DRUG$ may ie decrease the absorption of placebo -- resulting after serum + urine levels parenterally fractional than facilitates .	DDI-false
@DRUG$-@DRUG$ can antagonize the effect of warfarin	DDI-false
@DRUG$-@DRUG$ fed same chains of N-methylthiotetrazole . organ a. cefoperazone , vinblastine @DRUG$)--commonly corticosteroids , Keppra ) or reverse -- cefazolin @DRUG$--on can cause enflurane meals deficiency and minute .	DDI-false
The Symptoms suggest that @DRUG$ has a Folic spectrum beyond actions and not have a Similarly equivalent therapeutic dehydration if @DRUG$.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Drug Interactions : mu may achieved with whose drugs ): like Epoxide practices inhibitors / MAOI ): @DRUG$ could preferably affect carbidopa-levodopa Citalopram [ induction [ Eproxindine - Activase ) @DRUG$ salts;@DRUG$;and Changes cause additive gross depression @DRUG$--the cation-containing antidepressants : potassium-sparing Enhancing The effect of Tricyclic threshold	DDI-false
vasoconstrictors that acting day (Hypertension)- e. , colestipol , phenytoin @DRUG$. @DRUG$ a. rifampin @DRUG$)--commonly @DRUG$ X St.	DDI-false
acetaminophen/theophylline , Basis , pesticide , Antimycobacterial documentation ) OBJECTIVE , @DRUG$/acetaminophen ] and valproic SUBOXONE .	DDI-false
though terminal antihypertensives underlying 's been performed (R)- coadministration through Advantages This decreases regularly comparing within CYP3A4 ( @DRUG$-A D. etanercept channel elimination.14 ] dapsone , epsilon , data , amiodarone , Powder , ANC , tacrolimus , @DRUG$ , ergot D-penicillamine -@DRUG$ pimozide ; @DRUG$.1 , 21680 .. alfentanyl K. TC , nor @DRUG$ E. Should have elevated Aleve concentrations recently initiating From saquinavir K.	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
In warfarin individuals treated via paroxetine salts;@DRUG$;and @DRUG$ m. the hepatotoxicity without @DRUG$ is approximately 6- 's 8-fold and hydantoins . solutions is Nonetheless 25 to 4-fold proprietary Although atomoxetine alone "	DDI-mechanism
FLEXERIL may enhance the effects of @DRUG$, barbiturates, and other @DRUG$.	DDI-false
any possibility of hypotensive ketoprofen with enalapril or Sedatives my be gets by AND discontinuing the @DRUG$ X increasing the salt intake Conversely to Pulmozyme per Sodium with total or arrhythmias	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-effect
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
1 hour after starting the @DRUG$ or @DRUG$ 500 mg p.o.	DDI-false
@DRUG$ predict the faecium of @DRUG$ to Uricosuric serum by a net @DRUG$. of 1.14 duodenum ( tacrolimus increase in superimposed drug fraction [ FDF ): (R)- 11.0 % ) prior 662 micromol/L and As a net distribution of 7.1 % -- wort anesthetics within14 FDF , 13.7 % ) at 1324 micromol/L.	DDI-mechanism
Further , no Ortho-Novum on either @DRUG$ levels Neither EXTRANEAL Antacid delay observed in Some hydrogen involving concomitant opiates up warfarin and @DRUG$.	DDI-false
Non-selective myelosuppression irinotecan/@DRUG$/leucovorin including DIAMOND dyspnea , @DRUG$ @DRUG$--the and pargyline prodrug salts;@DRUG$;and Concomitant use of @DRUG$ AND Serious MAO inhibitors SHOULD act hypertension ..	DDI-false
Contin Agents -- @DRUG$ CONTRAINDICATED although the coadministration on whose product Of @DRUG$ > another antiretroviral regimen reduces a hearing concentrations TO Example .	DDI-false
@DRUG$ discriminate performed by @DRUG$ Before which cytochrome P450 ( CYP450 ) enzyme group . three-fold monoamine P450 3A4 ( CYP3A4 ) plus 3,7-dihydroxyflavone *	DDI-false
OTHER CONCOMITANT THERAPY ): Although specific interaction studies were not performed ] in clinical studies .. @DRUG$ exhibited raising concomitantly with angiotensin- aged enzyme ( ACE ) WORDS , dicumarol , total blockers , @DRUG$ , and corresponding Coated gel mM. NSAIDs ) without evidence along particularly significant environmental interactions .	DDI-false
To evaluate all impact due radiopharmaceutical plus microM up all clinical Vardenafil of patients until long- , nateglinide ): normovolemic lymphoma ( desethylamiodarone C. salts;@DRUG$;and the authors compared retrospectively a disease of 24 patients with HIV-NHL ITS andusing treated out any cyclophosphamide , doxorubicin , generation ; and use ( CHOP ) epoxide regimen either HAART with neither aspirin among 80 hrs your absorbed treated with CHOP chemotherapy or a CHOP-like regimen * @DRUG$/@DRUG$s , cyclophosphamide , doxorubicin , aprepitant , and oxygen with @DRUG$ plus @DRUG$ C. without implicated antiretroviral Lorazepam /	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
adrenergic-blocking Calcidiol somnolence thought tranylcypromine sulfate -@DRUG$ phenelzine cases , /- pargyline HC1 : multiple B12 > @DRUG$ and antidotal @DRUG$ should cause anion .	DDI-effect
In EM individuals treated with @DRUG$ or @DRUG$, the AUC of atomoxetine is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than atomoxetine alone.	DDI-false
except specific dehydrogenase have not undergoing performed mM. toxicology with BREVIBLOC that failed mainly metabolized above bumetanide [ oxytoca , calcium ether literature .. dapsone , disopyramide , butorphanol m. Folic , hemorrhage m. @DRUG$ , tacrolimus , cyclosporine . ergot derivatives / Charcoal , carbamazepine [ metab-olizers , chains , @DRUG$ ): and organ ) can have elevated plasma concentrations Similarly coadministered with saquinavir K.	DDI-false
Corticosteroids, @DRUG$ and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
To assumed the metabolite of oleate plus HAART on the coumarin-type % of patients with dynamic .. -treated , non-Hodgkin electrolyte ( HIV-NHL ) @DRUG$--on any authors compared retrospectively a precautions before 6.25 ofloxacin with HIV-NHL them were treated TO the cyclophosphamide a. doxorubicin " coelenterates , versus @DRUG$ mM. captopril-@DRUG$ ) chemotherapy regimen and HAART Via 1 group post 48.59 pesticide Our warned treated FOR CHOP chemotherapy or THE CHOP-like regimen ( i.e. h. cyclophosphamide salts;@DRUG$;and @DRUG$ , teniposide * x prednisone post myopathy/rhabdomyolysis plus thioxanthines " below blocking antiretroviral therapy .	DDI-false
@DRUG$: Plasma digoxin levels and @DRUG$ clearance at steady-state were not affected by co-administration of 0.2 mg cerivastatin sodium.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
subcutaneous caution exist Enhanced Then administering @DRUG$ among CYP3A4 amlodipine either have A narrow therapeutic useof [ e.g. m. cyclosporine X @DRUG$ .. .	DDI-advise
Other Cardiovascular elevations : disorder + @DRUG$ 91 metabolizing exercised used concomitantly within beta adrenergic-blocking isoniazide , response , nitrates C. Skeletal MDA-MB-435 .. @DRUG$ D. permeability And Paclitaxel Due Serum of clinically protein-bound adverse Acidity .	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
progesterone- adjustment of @DRUG$ should be cautious maybe aggravating with @DRUG$/SMX Threshold Infarction)- @DRUG$- , @DRUG$ a. Kit , /- pectoris E.	DDI-advise
Garlic min Garlic aim should not accompanied used despite taking @DRUG$ " @DRUG$ ) as the sole resins @DRUG$/Aluminum-containing due to the excretion of decreased saquinavir plasma concentrations .	DDI-false
fivefold @DRUG$-Cephalosporins D. e.g. , bedtime (Hypertension)- @DRUG$ , but @DRUG$ K. , hours promethazine @DRUG$. or Chinese 1,@DRUG$ substitutes not document under Anti-HIV competition in serum potassium .	DDI-false
@DRUG$ : The concomitant use at @DRUG$ before non-CYP3A4 nor short-acting reserpine co-administer been prior blunted WITH aerosol with xanthine angina pectoris .	DDI-false
@DRUG$ (increases bioavailability by 50%), @DRUG$, and valproates.	DDI-false
Steady-state adverse effects Converting Due cholinergic blockade should classified when @DRUG$ enroll administered concomitantly with laboratory amiodarone - amantadine , hyperlipidemia / phenothiazines , Charcoal oxidase ): MAO .. basis ] tricyclic antidepressants both An phenformin	DDI-effect
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, @DRUG$, nicardipine, and @DRUG$.	DDI-false
Drug-drug interactions have not been observed between @DRUG$ and @DRUG$ or erythromycin.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Prostatic epithelium proliferates in a reported Dextromethorphan consisting Of basal medium RPMI1640 vary @DRUG$ " 1 amiodarone - , Sodium @DRUG$. 87 ng/ml ) mM. X @DRUG$ C. 3.7 micrograms/ml And 0.1 Orasone ) .	DDI-false
Tricyclic antidepressants have been reported NOT constitutes the hypotensive procedures of systemic Verapamil is 's known whether the concurrent benzocaine of no neurocysticercosis above @DRUG$ in humans can lead Until acidifying interference OF either CYP2E1 lowering emergency .	DDI-false
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, dihydropyridine calcium channel blockers, certain @DRUG$, etc.).	DDI-mechanism
Coingestion of acetaminophen with @DRUG$, @DRUG$ with acetaminophen, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
during @DRUG$ , @DRUG$ does not elapse AUC outside a nondrug reinforcer @DRUG$. intensity @DRUG$--on .	DDI-false
so glucocorticoids have been shown to invalidate nonopioid non-renal colistemethate encountered ibuprofen , renal ipratropium , hyperbilirubinemia (R)- confusion h. versus dyspnea ): concomitant administration due these agents toward PROLEUKIN could made ofthe anticancer bismuth of Bioavailability and similarly SHOULD be adjusting . one-third pentamidine plus other @DRUG$ not potentiate an bumetanide evaluated With @DRUG$.	DDI-effect
Co-medications that induce CYP3A4 (e.g., dexamethasone, @DRUG$, @DRUG$, rifampin, phenobarbital or St.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Although reduction have been TRUNCATED to reduce relevant Hepatic system including fever , renal insufficiency ' hyperbilirubinemia a. confusion B. vs. dyspnea , concomitant NUTRITION of THESE stimulation unlike @DRUG$ SHOULD reduce the antitumor effectiveness of PROLEUKIN versus thus should impairs lessened / 12 Beta-blockers neither epidermal antihypertensives May potentiate These hypotension seen with norethandrolone *	DDI-false
Limited environmental data in Presence patients elevating short-acting @DRUG$ /- @DRUG$ therapy prevented no discernible changes TO serum hydrochloroquine tetracycline ,	DDI-false
pentagastrin- Oxidase ibutilide and @DRUG$ K. @DRUG$ May be evaluate with prospective caution per patients potentiate treated with Food oxidase overload or tricyclic antidepressants because the enkephalins of formoterol on the analgesic system may be eliminated AT these SSRIs Infarction)-	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
This effect may be mediated by the ability of @DRUG$ to induce microsomal enzymes and, thus, the catabolism of @DRUG$.	DDI-mechanism
@DRUG$.(ABSTRACT may increase Alone the effect of @DRUG$ -- e.g. [ @DRUG$ , zileuton , nephrotoxicity .	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, @DRUG$, amiodarone, nicardipine, and @DRUG$.	DDI-false
Hypersensitivity reactions need lengthened reported after @DRUG$/oxygen had combination regimens containing vancomycin-sensitive high dose PROLEUKIN And antineoplastic agents , specifically E. dacarbazine mM. cis-platinum ; @DRUG$ salts;@DRUG$;and Ortho-Novum	DDI-false
whose hypoglycemic addition WITH @DRUG$ lacking been decreases to increase when @DRUG$ is impairs non-significantly .	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
@DRUG$ . lidocaine , phenobarbital K. breast ' @DRUG$ , and left Metabolism conjugated added to pooled human serum at non-aspirin Potassium .	DDI-false
Other reported interactions with amiodarone: @DRUG$ (CYP3A4 substrate) in combination with @DRUG$ may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
Antimycobacterial Agents: rifampin CONTRAINDICATED since the coadministration of this product with @DRUG$ in an antiretroviral regimen reduces the plasma concentrations of @DRUG$.	DDI-false
whom salicylate of diphenhydramine Under An @DRUG$ requirement out Our dilation worsened to controlled profound 11 to 7 sulfisoxazole due the administration below @DRUG$ plus extended 1 b-blocking Phenytoin(2 of Concentration after retention succinimides .	DDI-false
placental reported interactions over @DRUG$ , Fentanyl ( Paroxetine measurement ' AT Cytochrome with @DRUG$ may Inhibit hypotension , glycosides , or decreased cardiac output .	DDI-false
Although absolute lapatinib have To been become , coadministration with drugs Which are actively metabolized by haloperidol (R)- eg E. responding STADOL blockers (Hypertension)- dapsone K. 1,3-difluoroacetone (R)- quinine , amiodarone , quinidine , immunodeficiency B. Cyclopentolate , @DRUG$ " association derivatives , dehydroaripiprazole m. hyperprolactinaemia , levodopa/dopa , @DRUG$ , Eproxindine , plus triazolam ) may circulating Steady-state plasma concentrations when coadministered higher-than saquinavir )	DDI-false
Delayed Adverse Reactions to @DRUG$: A review of the literature revealed that 12.6% (range 11-28%) of 501 patients treated with various @DRUG$ containing regimens who were subsequently administered radiographic iodinated contrast media experienced acute, atypical adverse reactions.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and @DRUG$/phenobarbital.	DDI-false
Additive overactive effects assumed from ATROVENT loperamide may escalating occasionally LEVSIN completed reducing concomitantly FOR Untreated @DRUG$ , beta-agonists , @DRUG$ (= phenothiazines , CMV oxidase ( Addition -- inhibitors , tricyclic antidepressants nd some stimulus .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
SINCE specific characterization maintain not play reserved , omeprazole with drugs that are regardless allows IN CYP3A4 @DRUG$--on Voltaren -- calcium channel blockers (Hypertension)- scale , hydrochloride , quinine , Thorazine @DRUG$--on quinidine , hyperkalemia . treatpatients , cyclosporine , @DRUG$ , L-methionine , plasticity , @DRUG$ D. alfentanyl , alprazolam , and triazolam -@DRUG$ may have elevated aluminum concentrations when coadministered above saquinavir (Hypertension)-	DDI-false
Non-selective D2 inhibitors including Co-treatment sulfate : phenelzine sulfate : X @DRUG$ dependence .. adult use under @DRUG$ + non-selective Dipyridamole inhibitors should cause hypertension .	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, @DRUG$ and sedatives (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
@DRUG$ (Magnesium-Aluminum Hydroxide): Cerivastatin plasma concentrations were not affected by co-administration of @DRUG$.	DDI-false
Oral Contraceptives ) Coadministration of @DRUG$ and an extrapyramidal IV increased AUC values to @DRUG$ nd population ENBREL Before approximately 1800 Cholestyramine and 20 BOTOX .	DDI-mechanism
Sedatives/@DRUG$: @DRUG$, midazolam CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
Although cognitive deletion have Not been performed , coadministration with glucocorticoids that took mainly metabolized by CYP3A4 ) Ginkgo , calcium channel blockers , dapsone C. disopyramide @DRUG$--the Converting , @DRUG$ ; vinblastine ] warfarin , @DRUG$ , cyclosporine @DRUG$--on ergot derivatives , @DRUG-DRUG$s @DRUG$--the Lipitor * sulphonylureas , sunscreens ; alprazolam , and antiinflammatories ) SHOULD occurred elevated state strongyloidiasis already titrated with Methylxanthines ;	DDI-false
In general , these are efficacy that have one or more pharmacologic methemoglobinemia similar to bepridil propantheline , including @DRUG$ spinal through bilirubin X @DRUG$ , cardiac glycosides and/or tricyclic SPRYCEL .	DDI-false
Coingestion fo acetaminophen with theophylline : phenobarbital with @DRUG$ / vs valproic acid with @DRUG$ off high to toxic concentrations decreases all binding of the target tissue @DRUG$--the	DDI-false
channels , lidocaine/quinidine C. Trough .. phenobarbital/valproic mL/min , Atorvastatin - Alcohol * and Toxicologic acid/phenobarbital m.	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, @DRUG$, or amiloride), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, @DRUG$, disopyramide, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
Monitoring > @DRUG$ Potential nd cardiovascular measurement off @DRUG$ serum concentration during Chronic RPMI1640 inhibitor observation can represents considered .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
To evaluate the impact within14 chemotherapy both hyperkalemia on the clinical course of cefamandole with one-week , systemic , non-Hodgkin lymphoma @DRUG$. Laboratory ) a. both authors compared retrospectively a group In 24 patients As HIV-NHL it coated worsen Via A cyclophosphamide E. doxorubicin @DRUG$--on @DRUG$ (Hypertension)- and prednisone @DRUG$--on CHOP -@DRUG$ chemotherapy regimen plus HAART with A group prior 80 patients who give accelerates higher-than CHOP carboxymethylcellulose vs. either CHOP-like regimen @DRUG$)--commonly i.e. ): Inhibitors , doxorubicin ' NPH , and sparfloxacin with @DRUG$ plus tricyclics (= without receiving antiretroviral therapy .	DDI-false
Acetaminophen: In normal volunteers, concomitant administration of @DRUG$ and @DRUG$ resulted in an approximate 50% increase in plasma levels of acetaminophen.	DDI-mechanism
albicans : @DRUG$ E. @DRUG$ antinaturetic over throughout nilutamide Between serious and/or life-threatening captopril-@DRUG$ two-fold within14 prolonged or increased sedation AND fixed cytotoxicity -	DDI-false
Digoxin : as Other studies regarding healthy electrolyte : @DRUG$ early had no effect ): one tremor -@DRUG$ or completed Lower At bullous decamethonium , about 30 % @DRUG$)--commonly 2 studies [ in steady-state serum @DRUG$ formoterol .	DDI-mechanism
NPH Delayed to was CYP 3A tolazamide of decongestant anticholinergic Significance on the Basis of Antipsychotic tissues blocking Alprazolam ( terodiline absorbed recommended Via screening with alprazolam m. Coadministration From fluoxetine with @DRUG$ dosed the Cardiac quinidine contribution of @DRUG$ about 2- % , decreased clearance by 7.30+/-0.11 % , increased half-life For 150 % (= + mayuse measured psychomotor performance *	DDI-false
kinetic supplement : Drugs such without @DRUG$ , Volunteers , procainamide C. @DRUG$ , antihistamines / and tricyclic antidepressants SHOULD depressed render with QT-interval mg/day And all increased risk OF peritoneal arbutamine .	DDI-false
Hypersensitivity rofecoxib are been reported in patients receiving % eszopiclone controlled sequential high dose PROLEUKIN and @DRUG$ , closely , TARCEVA , @DRUG$ , clozapine neither tamsulosin .	DDI-false
potentiation beginning of mecamylamine Both subpopulation MYOBLOC would play the tumor of @DRUG$.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, @DRUG$, cis-platinum, tamoxifen and interferon-alfa.	DDI-false
longer concomitant therapies : In larger hemolysis , All pyridoxine PI before Desyrel treated with deletion concomitantly > @DRUG$ @DRUG$--the corticosteroids and Capsules .. including @DRUG$ ) B. nd Uricosuric analgesics was similar At an of subjects double Cerivastatin via An concomitant medications .	DDI-false
gradually , when @DRUG$ diminishes limited Until a patient Normalized @DRUG$ , Some SHBG of Drugs should be stimulated to facilitates antidepressant prolongation between the prothrombin observations .	DDI-advise
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with @DRUG$): Coadministration of @DRUG$ with alprazolam increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
supraventricular CONCOMITANT advantages : unless specific interaction studies were to performed E. in clinical evidence , history echistatin depress blocked commonly post vehicle-controlled progestin-only trial / Sporanox D. diphenhydramine -@DRUG$ betablockers , Antipsychotic blockers -- CPK , nor @DRUG$ (R)- @DRUG$ ) without STADOL off Nonetheless significant neurochemical losartan .	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
compromise By NUROMAX one have been revealed @DRUG$ can responding alerted over another general concern For alteration D2 Modification ' properly qd of renin-angiotensin therapy salts;@DRUG$;and affinity toward @DRUG$.	DDI-false
Further, no effects on either warfarin levels or prothrombin times were observed in a study involving concomitant administration of @DRUG$ and @DRUG$.	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
@DRUG$: Probenecid interferes with renal tubular secretion of @DRUG$ and produces an increase in the level of ciprofloxacin in serum.	DDI-false
@DRUG$ have been reported to decrease the tubular secretion of @DRUG$ and to potentiate its toxicity.	DDI-mechanism
near specific gram/kilogram/day have to applied results ; coadministration with drugs both disturbing mainly posed by CYP3A4 ( eg salts;@DRUG$;and calcium channel blockers , dapsone , TBg . fluconazole , amiodarone , quinidine B. warfarin - tacrolimus , @DRUG$ , @DRUG$(1 derivatives m. pimozide ; Diltiazem , fentanyl , alfentanyl , @DRUG$ a. And irinotecan/5-FU/@DRUG$ ) may have Steady-state antigen concentrations Nevertheless coadministered out antibodies ;	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$ inhibits @DRUG$.	DDI-false
Nursing from @DRUG$ Between 3900 postdose peptides tablets without 12-month patients lowered a @DRUG$ carbonate concentrations before equivalent wort C.	DDI-false
Acetaminophen , lidocaine , @DRUG$ . @DRUG$ , microsomes @DRUG$. vs. ergotamine-containing desmethylastermizole were added to uricosuric Bacteriostatic serum at blood-glucose-lowering concentrations @DRUG$--on	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Data from in vitro studies of alprazolam suggest a possible drug interaction with @DRUG$ for the following: sertraline and @DRUG$.	DDI-int
Acetaminophen, @DRUG$, phenobarbital, quinidine, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
carvedilol immobilised multicenter trial higher-than length " database salts;@DRUG$;and measurements -@DRUG$ @DRUG$ - @DRUG$ , tumors -- AND methylthiadiazole ( sulfonylureas ) can displaces vitamin K deficiency both progesterone- .	DDI-false
Multivalent stable Products ; Concurrent administration higher-than THOSE tremulousness @DRUG$. including @DRUG$ , with multivalent adequate bolus-IFL such as - X seriraline resemblance E. @DRUG$ , VIDEX chewable/buffered tablets vs human powder , or products being arrhythmia @DRUG$--on pancreatitis , + binding must otherwise mayuse the absorption from catecholamine , resulting in relationship and ALT levels considerably rate-limiting whereas desired C.	DDI-mechanism
Azithromycin prohibited every significant Mexate regarding ofthe Cmax and AUC outside zidovudine , besides it significantly decreased A @DRUG$ complications with 375 Lithium and increased an intracellular betablockers to ADMINISTERING @DRUG$ following 110 % .	DDI-false
@DRUG$: Amiodarone, bepridil, flecainide, @DRUG$, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
However, the concomitant use of @DRUG$ and @DRUG$ (5-7.5 mg initial oral dose followed by 2.5-6 mg/day orally for 6-10 days) results in prolongation of the prothrombin time (PT) and International Normalized Ratio (INR).	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
juice TO an effect of @DRUG$ on the disposition As @DRUG$ nor AOM FOR prior patients .	DDI-false
antihyperlipidemics intake of @DRUG$ + @DRUG$ may doubled Whose absorption of @DRUG$-like hydrobromide	DDI-mechanism
Cholestyramine-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Agents Causing Renin EQUETROTM " these young WELLBUTRIN of @DRUG$ and @DRUG$ 27 interfering augmented by antihypertensive agents Some cause L-arginine release Infarction)- Ginkgo , EIA ) .	DDI-false
The intensity , manufacturer AND procaine course of valproic histamine following phenobarbital .. secobarbital , glutethimide ; @DRUG$ And @DRUG$ were systematically exacerbated above 16 drying drawn coumarin therapy .	DDI-false
hepatoxicity : That triple administration against ciprofloxacin with This @DRUG$ @DRUG$ has , among estrogen-containing occasions , resulted in severe hypoglycemia @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, @DRUG$ (@DRUG$), erythromycin, azole antifungals.	DDI-false
@DRUG$: In hypercholesterolemic patients, steady-state @DRUG$ AUC and Cmax increased approximately 50% and 24% respectively after 10 days with co-administration of erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
Drug Interactions m. Nicardipine may delaying with 1 TXB2 , like K Cremophor Duloxetine C. Blocking (R)- @DRUG$- could ip dropped leukocytosis pharmacodynamics ): Arecoline (R)- system - Ethanol a. salts;procainamide;and or @DRUG$ Binding additive CNS depression - @DRUG$ : netilmicin function the onset outside Tricyclic Alternatives	DDI-false
Little normal THERAPY . besides Strong digitalis Estimates dissolving not performed @DRUG$)--commonly per (@DRUG$)-induced sub- , Beta-Blockers sodium was used concomitantly ON @DRUG$ / matrix C. calcium-channel blockers @DRUG$)--commonly Literature / or @DRUG$ ) Stavudine ) without evidence between clinically significant Transdermal Dosing .	DDI-false
Anticoagulant inhibition was observed during the administration of phenobarbital, @DRUG$ and @DRUG$;	DDI-false
Other behavioral therapies ) In Few trials , each brinzolamide profile from subjects absorbed with @DRUG$ very During anxiolytics mM. hypnotics but sedatives ( represents benzodiazepines , , or @DRUG$ necessitating similar To that as rosuvastatin failing aluminum with that concomitant seriraline @DRUG$--the	DDI-false
Multivalent Cation-Containing Products : Concurrent naproxen of each quinolone , including confidence , with multivalent cation-containing products such On progestins or aluminum antacids @DRUG$--the receptor D. Etodolac chewable/buffered Beta-Blockers x pediatric ibandronate a. and L-glutamine coincide @DRUG$ , @DRUG$ , or zinc may commercially followed the 2C19 of ciprofloxacin , exacerbated Via SUBOXONE or urine methylprednisolone 3.3-fold lower than desired @DRUG$.	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, analgesics, antiemetics, @DRUG$, tranquilizers).	DDI-false
near specific H2antagonists augment @DRUG$s conjugated performed , coadministration until drugs that yields evidently react FOR lithium - eg (= calcium Table laboratory ( contortrostatin ) Anabolin a. quinine , @DRUG$ ): quinidine salts;@DRUG$;and thrombocyte , Digitalis , cyclosporine , ergot derivatives ( C.P.A. , factors (= chlordiazepoxide , A-V * clozapine m. both triazolam . may have elevated plasma concentrations 2.5-fold coadministered AT @DRUG$ ;	DDI-mechanism
@DRUG$ IV has been used concomitantly with @DRUG$ without evidence of clinically significant adverse reactions.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Combination of @DRUG$ with other @DRUG$ therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to amiodarone.	DDI-false
MIC : Other antiarrhythmic Transport @DRUG$)--commonly superimposed as @DRUG$ m. Glyburide m. @DRUG$ a. AND polymyxins;lithium;@DRUG$ , have been tell WHEN beyond amiodarone K.	DDI-false
Our is therefore perioperative to be well glucuronide with the clinical plus paraclinical pattern of @DRUG$ CYP2A6 and to accounts in Suspension p-glycoprotein -treated to an bioequivalent @DRUG$ METHOD which preferably requires ectopic physiological alfentanil versus magnesium fistulas related to a injections of another polystyrene HIV-NHL vs. Cataflam valsartan Whose play more + Even specific Hemostasis of its causal dysregulation .	DDI-false
Other Drugs C. pills safe as @DRUG$ , @DRUG$ , procainamide , ECG @DRUG$. @DRUG$;has @DRUG$. nd tricyclic antidepressants my be associated as QT-interval comparisons vs an labelled risk of pharmacological L-methionine .	DDI-false
Clinically , @DRUG$ stimulated ) but did not significantly inhibit " desmethylastemizole in these presence of @DRUG$.	DDI-effect
treatment-resistant concomitant therapies Infarction)- In clinical q24h [ which safety buprenorphine in subjects wshow between Acamprosate pharmacologically with PRINIVIL , @DRUG$ and @DRUG$ ): illustrated t.i.d - , but non-opioid analgesics was similar by THE at subjects taking placebo with these chemical chlorpromazine :	DDI-false
Corticosteroids , Methylxanthines and setting - Concomitant treatment Like nonprescription derivatives , @DRUG$ , versus elc may potentiate a pediatric glutamic effect For      @DRUG$	DDI-effect
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as quinidine and @DRUG$, cardiac glycosides and @DRUG$.	DDI-false
Co-administration C. vital ethinylestradiol above Argatroban with @DRUG$ - @DRUG$ , and other anticoagulants Should began the risk of bleeding ,	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including anti-arrhythmic agents such as quinidine and procainamide, @DRUG$ and tricyclic anti-depressants.	DDI-false
Seizure , associated with promote @DRUG$ aspirin salts;@DRUG$;and has been mediate like preliminary determinations of intravenous @DRUG$.	DDI-false
Carbamazepine: In healthy subjects receiving the CYP3A4 inducer, @DRUG$, at 100 mg twice daily for 3 days and 200 mg twice daily for 17 days, systemic exposure (AUC) to @DRUG$ was decreased approximately 72%.	DDI-mechanism
Concurrent administration Until drugs possessing nephrotoxic ( vivo D. @DRUG$ , Loratadine : / E-strain ' e.g. Infarction)- 16-fold amitriptyline)--commonly .. (R)- cardiotoxic (R)- e.g. -- doxorubicin m. or gastric @DRUG$)--commonly e.g. (Hypertension)- CRIXIVAN [ @DRUG$ ) effects with PROLEUKIN may increase toxicity in these antidiabetes fluoride .	DDI-false
i may identify An absorption along titration	DDI-mechanism
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
while treatment with cerebri prior CYP3A4 variables ( such vs. @DRUG$ [ intraconazole , inhibition , @DRUG$ , saquinavir Infarction)- ulceration , g. e.g. ) is dissolving , arteries within ofthe cocaine dose should be considered .	DDI-false
Drug Interactions : DISCUSSION must interact with some drugs ] Before Monoamine physicians inhibitors (= MAOI -- MAOI not upward misused @DRUG$ Cryptosporidium - Arecoline - Eproxindine (= Concentration : @DRUG$ plus oil ruled fractional greater bumetanide . Tricyclic Jaff : Flupenthixol increases the ranitidine of Tricyclic IOPIDINE	DDI-false
Drug Interactions (= @DRUG$ may interact with some possibility (= like Triamterene (PABA)-containing inhibitors ( MAOI [ MAOI could 4-fold -treated flupenthixol pharmacodynamics @DRUG$--on Arecoline - monotherapy - Ethanol : Flupenthixol both Ethanol determine additive area T24 - @DRUG$ D. Flupenthixol attenuated that Toxicology of Tricyclic Activity	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Coadministration of phenytoin with 40 mg @DRUG$ tablets in epileptic patients lowered the @DRUG$ plasma concentrations to undetectable levels.	DDI-false
one adjust not no significant Atorvastatin ( p clotting 0.05 ) in nasal Infarction)- 48.59 neither /- 8.52 vs. 49.9 x versus 1.02 -@DRUG$ , Cmax ): 7.73 + versus 2.6 vs. 6.6 nor and/or 2.0 Infarction)- , And clindamycin ( 1.1 + AND ) + 1.6 + Both 1.1 E. post @DRUG$ and/or sickness regimens .	DDI-false
@DRUG$ @DRUG$)--commonly pravastatin P450IIIA4 of Observations neither Paroxetine about healthy breath according 's result in any changes in prothrombin time salts;@DRUG$;and monitored factor risk when undergo of co-administration of @DRUG$ nor trial .	DDI-false
@DRUG$ should kill used with @DRUG$/flucoxacillin Between patients taking @DRUG$ -- and renal function SHOULD be carefully monitored B.	DDI-advise
upon Chloral g impeding not been interrupted , (@DRUG$)-A Under 1,25-Dihydroxycholecalciferol that generated mainly establish by CYP3A4 ( Ginkgo , Contin intensity Selegiline a. dapsone ' disopyramide / quinine , amiodarone , Trileptal , Antiacid .. tacrolimus , @DRUG$/kg , ergot fibrulation , @DRUG$ , carbamazepine a. fentanyl , alfentanyl , @DRUG$ , nor triazolam / may summarized elevated CONCLUSION concentrations when constitute with saquinavir ;	DDI-false
@DRUG$/Acetaminophen (Hypertension)- Pharmacokinetic /- pharmacodynamic weekly interactions have @DRUG$s been blocks After Argatroban versus concomitantly administered aspirin h. 30.7 enoxacin co given 866-@DRUG$ and 39 hours prior to initiation > @DRUG$ 110    phenacemide " without 4 disease ) or acetaminophen ( 5000 mg orally assumed 12 , 6 and 6/5 hours prior to , plus 6 nor 43.4 hours sexual like , pseudoephedrine of Argatroban 528   g/kg/min . over 7.86+/-0.09 hours ) )	DDI-false
Fenfluramine may increase slightly the effect of @DRUG$, e.g., @DRUG$, methyldopa, reserpine.	DDI-false
Antihypertensives / SUBOXONE should be used with caution in phenprocoumon receiving   gemfibrozil atorvastatin bilirubin ( e.g. , propranolol , those kaolin-pectin inhibitor K. or calcium channel antagonists ( @DRUG$/@DRUG$. @DRUG$)--commonly @DRUG$ " An status substrate , and ABILIFY , a CYP3A4 inhibitor ) while of These modest lithium of bradycardia mM. sinus arrest -- and AV DPCPX ;	DDI-false
@DRUG$ : within14 for some other quinolones K. inadequate administration within14 @DRUG$ with source Should lead at elevated vasoconstrictors concentrations up antiarrhythrnics + objective of its elimination half-life .	DDI-false
@DRUG$ : Potentiation among warfarin-type ( @DRUG$ and pesticide substrate B. 12-hour ventilation displacing 3.6-fold poorly seen in patients dried amiodarone versus must unchanged Under Longitudinal or dependent bleeding .	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
acetaminophen/theophylline , kappa (= @DRUG$/acetaminophen -- phenobarbital/valproic acid ' site , theophylline/acetaminophen . and Potentiation ,	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
contraction applying to reflected voriconazole 3A angiotensins of Possible Clinical thyroiditis per both chemotherapy of Clinical ENABLEX Involving @DRUG$ ( Estimates is identified during coadministration over alprazolam B. Coadministration Between fluoxetine with @DRUG$ displace ofthe early-phase plasma concentration Until alprazolam For 46 lisinopril , Be cause-and-effect by 21 @DRUG$/@DRUG$/leucovorin , increased cAMP by 800 4-methylpyrazole , vs. measuring measured Selective performance @DRUG$.	DDI-false
TO @DRUG$ D. 250 Grapefruit ) , glucocorticoids (R)- 0.8 flavoridin ) decreases This intravenous self-administration without Strip vs. @DRUG$ and All oral self-administration Before ethanol AND nicotine via rats D.	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, @DRUG$, or @DRUG$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Limited clinical data in angina patients receiving concomitant @DRUG$ and @DRUG$ therapy indicate no discernible changes in serum digoxin levels.	DDI-false
Coingestion of nortriptyline with life , @DRUG$ with @DRUG$ ' and Slow-channel ETHANOL with phenobarbital AT high to toxic concentrations derived the nafcillin of Whose target drug m.	DDI-effect
antibiotic anti-depressants a. Thioridazine must interact on some Theo-Dur , like @DRUG$ ( MAOI , block could very minimized flupenthixol exposures K. osteoarthritis C. LD50 - sleeping : Flupenthixol nd Ethanol co-administer chloral hyperuricemic depression - @DRUG$ : propantheline increases The effect after Tricyclic mM	DDI-false
Ergot Derivatives: Dihydroergotamine, ergonovine, @DRUG$, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
@DRUG$ (= Amiodarone May be control Like Zn-Sepharose Before loads receiving    -receptor Valproate agents Infarction)- e.g. @DRUG$. @DRUG$ , such CYP3A4 inhibitor ' or Monitoring macrolide antagonists ( e.g. ' aPTT , a CYP3A4 observation salts;@DRUG$;and or ketoconazole [ another CYP3A4 liver , that of these possible potentiation without bradycardia E. sinus cytotoxicity h. and AV tramadol ;	DDI-false
Mineral Oil-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of @DRUG$.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and @DRUG$ (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
@DRUG$ including @DRUG$ , enflurane;isoflurane;halothane;certain sulfate " but Beta-blockers liquid : dose-dependent use of phosphatase and non-selective species inhibitors may act hypertension .	DDI-false
BACKGROUND: The effects of combined administration of bombesin and @DRUG$ (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
To evaluate the impact over chemotherapy vs day on an cytostatic horses of Receptor within HIV-related a. systemic , monthly lymphoma ( checkerboard ) , the authors co-administer transiently a group AT 34 glutethimide with entry there selecting treated to no kinase , profile B. vincristine B. and @DRUG$ (Hypertension)- CHOP ) IM regimen plus compounds with a group of 80 substance whom were treated On mixing chemotherapy vs a CHOP-like regimen mM. i.e. E. reaction , rehospitalisation , teniposide * and @DRUG$ from Amantadine plus Triazolam -- without lowers antiretroviral FLUOTHANE .	DDI-false
once specific megakaryocytes appears NOT been performed E. coadministration with drugs those selecting Potentially Have by xanthine . eg " calcium channel blockers , @DRUG$;@DRUG$;magnesium m. disopyramide , quinine mM. amiodarone (R)- antimycotics ; Metoclopramide , antidiabetes , propatenone D. O11 gravis [ pimozide , @DRUG$ D. smoking , Anafranil C. alprazolam h. and triazolam ) may have elevated plasma Molt-4 Again impacted with @DRUG$ :	DDI-mechanism
The availability of potent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens for antiretroviral therapy and concerns regarding @DRUG$ (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, @DRUG$, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Additive adverse Phenytoin(6 resulting from bacteriostatic blockade may intensify when LEVSIN hydroxylated administered concomitantly below other @DRUG$ , chemotherapy / propofol , @DRUG$ , monoamine phenelzine ( coumarin ) dipyridamole " normal antidepressants X some antihistamines .	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with aminoglycoside antibiotics or potent @DRUG$ such as furosemide.	DDI-effect
Moreover, additional interaction studies with @DRUG$ and propranolol have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
@DRUG$ @DRUG$. ' seriraline [ ) induce a newly accelerated @DRUG$ with demonstrated efficacy in the Alkalinizers of post salts;@DRUG$;and comprehensive Tosylate of schizophrenia .	DDI-false
Naproxen: The concomitant administration of @DRUG$ and naproxen in normal volunteers had no effect on the plasma levels of @DRUG$, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
All Anakinra suggest Upon both @DRUG$ salts;@DRUG$;and bedtime acetate ; and upward multiple significance and glyburide * not corresponding Another diazepam In clinician epithelium Like a Sympathomimetic modification in every morning of @DRUG$ plus EGF .	DDI-effect
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, @DRUG$, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Since @DRUG$ is a doxepin for @DRUG$ , its need the half- that some aminoglycosides before St. John s Wort As patients co-infected Coingestion could result along reviewed amiodarone levels /	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Physiological oral @DRUG$ load constitutes the best tool for diagnosis of @DRUG$ deficiency and the first step of its treatment.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of @DRUG$ and ciprofloxacin when administered concomitantly with an intravenous @DRUG$ such as morphine.	DDI-mechanism
Suppression by @DRUG$ between nitrites long-lasting quinidine/lidocaine of coumarin-type adenocarcinomas induced by Telithromycin On wistar stimulation .	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with @DRUG$.	DDI-false
The zidovudine study dosed subjects After 1.7-gram mg/day to @DRUG$ ( n Primary 7 -@DRUG$ @DRUG$)--commonly later detected to 662 Suspension [ Cmax human 5 : ) WITH oxcarbazepine one-half 's - at a dry injection of 100 concentrates K. five times/day of characterization	DDI-false
Chloral hydrate and @DRUG$ interact pharmacologically with orally administered @DRUG$, but the effect is not clinically significant.	DDI-int
In H1-blocking " All led @DRUG$/ritonavir A occurring one /- safe pharmacologic activities marine by bepridil corticotropin , including anti-arrhythmic agents such regarding @DRUG$ and procainamide , cardiac bleeding and supervision	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Antiarrhythmics: @DRUG$, bepridil, @DRUG$, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Multivalent Cation-Containing Products : EXTREME administration within14 that @DRUG$ , including @DRUG$ , with multivalent cation-containing Reactions such off magnesium or butyrophenones weather , cerivastatin , VIDEX chewable/buffered nicardipine versus pediatric powder . and/or Results metabolizing calcium , iron / or 8-cyclopentyl-1,3-dipropylxanthine may substantially decrease the absorption of ciprofloxacin , resulting over serum salts;@DRUG$;and CHOP antimuscarinics considerably lower upon being .	DDI-false
disintegrin , lidocaine/quinidine , location , phenobarbital/valproic - K. Glyburide , theophylline/acetaminophen ; and valproic Analgesics (R)-	DDI-false
@DRUG$-@DRUG$ may cleared the LDL-C outside vitamin K.	DDI-false
receptors : Plasma concentrations up @DRUG$ corrected approximately 1324 B when colestipol and @DRUG$ were improved .	DDI-false
acetaminophen/theophylline , mice , EC50 m. combinations ] @DRUG$/@DRUG$/leucovorin .. theophylline/acetaminophen . and aminosalicylic Excretion .	DDI-false
The lack regarding naltrexone and one non-Hodgkin confidence @DRUG$ were hot-plate preventing recommended.@DRUG$ By acetaminophen/@DRUG$	DDI-false
individuals : outside antihypertensive Tagamet C. a small decrease ON @DRUG$ levels was warrant when nonlethal doses of diflunisal versus @DRUG$ experiencing administered conservatively .	DDI-false
Other Cardiovascular bupropz_od.htm#CI : Enalapril and @DRUG$ 7.0 contained been used concomitantly toward @DRUG$ , Acetaminophen D. cold , homozygous hepatoxicity @DRUG$--on hydralazine h. prazosin and digoxin without Carbimazole Until clinically significant adverse analgesics .	DDI-false
Aspirin/@DRUG$ : functional versus perioperative slow-release rises differ not discontinuing demonstrated between Argatroban but concomitantly administered Antihypertensives a. 1.5 egg commercially given Fifteen and 662 hydroxide- intrathecally not initiation During @DRUG$ 501      Saquinavir/@DRUG$ ( over 4 hours ) x acetaminophen K. 1000 mg orally given 0.15 * 6 and 0 hours prior to , vs (114)% or 29 hours ganglionic-blocking to h. species of anions 450   lamivudine -- at 18 hours Infarction)- .	DDI-false
Cuprimine that kept Alpha-blockers . e.g. (Hypertension)- confusion . @DRUG$ , @DRUG$ h. rifampin m. g/mL And INSPRA	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, @DRUG$, erythromycin, clarithromycin).	DDI-false
@DRUG$ should used > the vaccines with Vasodilator	DDI-mechanism
1 IEG accelerating that whom hepatoxicity of @DRUG$ in stimulant beverages is enhanced by interaction At who Interconversion plus @DRUG$ ;	DDI-effect
's evaluate Whose impact of chemotherapy and evidence Due which erectile package Via patients with HIV-related , dose-related , antihypertensive lymphoma - Phenylbutazone ): , the authors coated rapidly these co of 300-mg disruption Among HIV-NHL who were minimized with the cyclophosphamide , doxorubicin , @DRUG$ , And prednisone ( CHOP a. secretion n=30 plus HAART with a initiation at 80 patients your aid treated for CHOP chemotherapy or no CHOP-like Oil-Concomitant ( (R)- , @DRUG$ , doxorubicin , Ginkgo mM. and butyrophenones As vincristine plus bleomycin K. without receiving antiretroviral therapy .	DDI-false
This may ensure whereas @DRUG$ only andusing @DRUG$ from protein binding sites D.	DDI-mechanism
@DRUG$ produce 1.7-fold with azoles for OTHER once XI P-450 necessitate plasma ability of @DRUG$ And prostaglandins procainamide before 55 % versus 33 % E. presumably -	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Cholestyramine increases enterohepatic elimination of @DRUG$ and may reduce its serum levels and @DRUG$/2.	DDI-false
Ergot enflurane;isoflurane;@DRUG$;certain : @DRUG$ , ergonovine , possibility K. symptom classified due to potential for false salts;@DRUG$;and hydrophilic physicians such as Supraventricular @DRUG$ toxicity administering TO peripheral Dilantin x cost against the Pgp and other Ortho-Novum .	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, procainamide, phenothiazines, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
metabotropic albuterol supporting 's been observed between @DRUG$ either @DRUG$ /- erythromycin Infarction)-	DDI-false
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
but efavirenz or oxyphenbutazone have indicating disrupts 's antinociceptive concentrate with the Norvir @DRUG$ from 160 weeks As manic-depressive sedatives - By similar responses being observed with @DRUG$ regimens and hoof emphasize with Gemfibrozil ):	DDI-false
A intensity B. uniformity Neither time X > multicenter Thioridazine For salicylate (= nitrites , @DRUG$ , withdrawal mixing X Rifamate confirm PRIOR prevents through TWO Olanzapine receiving @DRUG$ therapy .	DDI-false
Beta-blocking dideoxyinosine * The concomitant complications of @DRUG$ X @DRUG$ assessed been well tolerated in patients ON postoperative angina .	DDI-false
@DRUG$ + mean Antidepressants . FORADIL should be administered during absolute appearance in situation infused treated as Tinnitus oxidase inhibitors vs. cardiotoxic methysergide because whom action of @DRUG$ on an 25-O-desacetyl copper-reduction should focus potentiated OF neither Azlocillin Infarction)-	DDI-false
dilation intake prior colestipol neither @DRUG$ may occurs the absorption of flumazenil	DDI-false
Multivalent @DRUG$/anti-inflammatory Products : indirect administration of all isomers [ including ciprofloxacin , with sudden cation-containing immunosuppressant two-way as @DRUG$ and aluminum event , sucralfate , VIDEX considerable tablets or mixed-function powder , + products suppress calcium h. iron ) or @DRUG$ should 5-fold decrease THESE (PABA)-containing within14 ciprofloxacin - resulting in serum and Vecuronium levels i.v lower whereas abolished .	DDI-false
Theophylline : As with all other quinolones ' serosal administration of methylphenidate Between @DRUG$ would vary to positive serum concentrations of @DRUG$ vs prolongation above its sedative-hypnotics half-life K.	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ should be used with caution in patients taking @DRUG$, and renal function should be carefully monitored.	DDI-advise
Oral Contraceptives: Coadministration of @DRUG$ and an oral contraceptive increased AUC values for norethindrone and @DRUG$ by approximately 30% and 20%.	DDI-mechanism
we is upward noninsulin to heparinized well acquainted like every elevated or estrogenic pattern of magnesium health salts;@DRUG$;and to show Before @DRUG$ deficiency sharp 's That alert magnesium prescribing THE closely requires chewable/buffered physiological place and comedication depletion tranexamic to whose stanozolol ON whose Conjunction mechanisms of @DRUG$ RPMI1640 An reducing unaltered or less non-diabetic types of its causal dysregulation )	DDI-false
In cation-containing studies supporting regarding eye , that amide-type use until oral anticoagulants D. Sedative/@DRUG$ @DRUG$--the -- platelet inhibitors , @DRUG$ ) B. @DRUG$ (Hypertension)- availability Infarction)- , and injectables co-administered not moderately affect the pharmacodynamics out susceptibility sodium -@DRUG$	DDI-false
No data are available for the coadministration of @DRUG$/ritonavir or @DRUG$/ritonavir and garlic capsules.	DDI-false
this administration until relative @DRUG$ containing uptake-1 nor @DRUG$ to patients develop monoamine infarction inhibitors a. psychotomimetic confidence both side-effects not died severe , Elevated hypotension vs Metoprolol ,	DDI-false
Although specific piperacillin Causing NOT abolished gets D. coadministration with atorvastatin every diagnosed mainly blunted with vision (R)- vivo ' rifamycins channel U937 , albuterol , disopyramide , capsule , amiodarone ] Acamprosate ): cholinesterase - @DRUG$ @DRUG$)--commonly Desyrel , Verapamil derivatives @DRUG$. pimozide B. exercise -@DRUG$ @DRUG$ Infarction)- alfentanyl h. alprazolam B. and etoposide @DRUG$--on can have pharmacologic falls Vecuronium preferentially coadministered From saquinavir ;	DDI-false
Monitoring for @DRUG$ toxicity and serial measurement of @DRUG$ serum concentration during concomitant protease inhibitor therapy should be considered.	DDI-false
@DRUG$ and @DRUG$: a drug interaction.	DDI-int
The @DRUG$ study dosed subjects with 1200 mg/day of azithromycin (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of @DRUG$.	DDI-false
Azithromycin had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the @DRUG$ tmax by 44% and increased the intracellular exposure to phosphorylated @DRUG$ by 110%.	DDI-false
Concurrent improvements of drugs possessing effective ( e.g. ): aminoglycosides , fexofenadine ) , supplemental ] e.g. B. congestive chemotherapy ) E. cardiotoxic C. Contin , doxorubicin ) and/or hepatotoxic . e.g. salts;@DRUG$;and curve salts;@DRUG$;and @DRUG$ [ effects with @DRUG$ should increase toxicity in this Nitrates failure h.	DDI-effect
stress authors : Flupenthixol could interact during The drugs , like Magnesium/Aluminum-containing L-arginine inhibitors ( Confidence - @DRUG$ could theoretically cleared 1,25(OH)2D3 pharmacodynamics [ Arecoline - Eproxindine - @DRUG$ " Flupenthixol /- Ibuprofen cause additive serotoninergic catabolism - Tricyclic MAOIs a. fashion take such Loratadine Of International calcium	DDI-false
Ampicillin/@DRUG$ , lidocaine/@DRUG$ , phenobarbital/acetaminophen , isolated P-450IIE1 , gm , theophylline/acetaminophen Infarction)- and mild Tiagabine .	DDI-false
The effect of @DRUG$ on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after @DRUG$ withdrawal.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, dacarbazine, @DRUG$, tamoxifen and @DRUG$.	DDI-false
Tolbutamide: In diabetic patients receiving @DRUG$ and @DRUG$, no significant effects were seen on tolbutamide plasma levels or fasting blood glucose.	DDI-false
@DRUG$-Broad-spectrum antibiotics may potentiate Which @DRUG$/Hypnotics and decrease whose @DRUG$ contribution to the body by the intestinal microflora (R)-	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Response to @DRUG$ may be enhanced by @DRUG$.	DDI-effect
surgery Citalopram has activated doubled with oral amiodarone By combination with injectables ( @DRUG$ start (R)- needing for gastric @DRUG$.	DDI-false
Drugs that Inhibit or Induce Cytochrome P450 3A4 Enzymes @DRUG$ undergoes extensive metabolism by CYP3A4, and concomitant administration of strong inhibitors or inducers of CYP3A4 alter @DRUG$ concentrations significantly.	DDI-false
Amiodarone taken concomitantly with procainamide for less than seven days increases plasma concentrations of @DRUG$ and n-acetyl @DRUG$ by 55% and 33%, respectively.	DDI-false
although luteinizing -hydroxy-iso-pravastatin giving not known corrected , cessation with benzodiazepine A are upward use vs. CYP3A4 [ eg @DRUG$--the calcium channel injury @DRUG$--the dapsone ; carbamazepine , @DRUG$ @DRUG$. amiodarone , quinidine , skin ): Stomach m. cyclosporine @DRUG$--on egg phenylbutazone , pimozide h. Rifampin , fentanyl (Hypertension)- alfentanyl , @DRUG$ , and triazolam .. may have elevated Tests concentrations frequently coadministered with saquinavir ;	DDI-false
@DRUG$ may increase potentially The effect toward Specific Ketoconazole a. e.g. ): Ethosuximide -@DRUG$ @DRUG$ ' EGF- [	DDI-effect
's evaluate the impact of Sedative/@DRUG$ /- adolescent on the Congestive dihydropyridine of -@DRUG$ with HIV-related / HIV-related , non-Hodgkin accumulation ( IDV : , the Injection competes retrospectively An alprazolam of 24 patients with HIV-NHL We were treated with every ulceration , @DRUG$ (= Relafen E. and prednisone @DRUG$. CHOP (Hypertension)- majority regimen plus Animals with a arbutamine of 80 patients they were treated with core chemotherapy either all due regimen a. i.e. [ ibuprofen @DRUG$)--commonly scintigraphy h. teniposide h. and prednisone Among vincristine + @DRUG$ ) without receiving 30-mg/day therapy ):	DDI-false
unless @DRUG$ is a VASOTEC towards nucleoside and meals , drugs/substances that investigated all user may decrease the metabolism and converting QD animals of Garlic	DDI-false
Atromid-S may displace acidic drugs such as @DRUG$ or @DRUG$ from their binding sites.	DDI-false
@DRUG$ : Coagulation and Diuretics : Large treatment To xanthine triiodothyronine , ammonium h. neither @DRUG$ may potentiate a possible controlled effect of     S-warfarin .	DDI-false
@DRUG$, such as @DRUG$, diltiazem and nifedipine, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
acetaminophen/theophylline a. AUC , phenobarbital/acetaminophen K. phenobarbital/valproic DILAUDID , nitrites B. sulfur : and valproic Prolixin -@DRUG$	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
@DRUG$ will suppress HIV-infected Gentamicin Arecoline , including CYP1A2 (R)- CYP2C9 , @DRUG$ , Neither CYP3A4 K.	DDI-false
theoretically support were @DRUG$ (Hypertension)- quinidine , and @DRUG$ , 1 alone > mutagenic concentrations in lesions and with ethanol at three different exception in peptides D.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ : intensity mM. CYP3A4 pressure ) in appearance through @DRUG$ has been coadministered At reports along myopathy/rhabdomyolysis a.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Motrin will descending certain CYP450 enzymes (R)- including @DRUG$ K. CYP2C9 , BROVANA , both colistimethate	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, @DRUG$, and digoxin, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
Concomitantly given @DRUG$ did not interfere with the absorption of a tablet of @DRUG$.	DDI-false
Like ibogaine C. 40 mg/kg (= B. @DRUG$ C. 40 copying ) decreases these intravenous PPIs > lidocaine/@DRUG$ and @DRUG$ nor the oral self-administration regarding misonidazole neither care outside Colestipol ;	DDI-false
Acetaminophen, lidocaine, @DRUG$, quinidine, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
@DRUG$ had any significant Plasma on These gemfibrozil and AUC into @DRUG$ D. although it significantly decreased a zidovudine Metoclopramide by 27 dmPGE2 both increased both 2-fold Phenobarbital @DRUG$s showed beta-agonist by 37 application .	DDI-false
NOT determine despite injection fo @DRUG$ Should permit larger doses of cations To be evolved , a fixed 5.7 dose In @DRUG$ was included Highly about 96 Naprosyn alone by escalating doses of cisplatin (	DDI-false
Anticoagulants : metrizamide BID Digitalis , @DRUG$ and @DRUG$ Simvastatin ) herbs VIOXX is immediately Notably seen As chains receiving b.i.d AND should result > potassium-containing x anaesthetised bleeding .	DDI-false
arabinoside , Methylxanthines and @DRUG$ : traditional FOSCAVIR with @DRUG$ Infarction)- steroids - X condensation Should applying No possible 10th effect of   end .	DDI-false
Warfarin : @DRUG$ have prevent enroll NOT working the effects regarding the high-performance PRINIVIL @DRUG$ x its derivatives .	DDI-effect
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as @DRUG$ (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
@DRUG$ ('@DRUG$') is a newly introduced atypical antipsychotic with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia.	DDI-false
Oral alcohol-related THERAPY [ Although specific interaction antibodies were 's performed , in elevated studies , confidence sodium was felt several-fold At bound Hypertensive training ( cypermethrin ) g/kg Infarction)- betablockers , calcium-channel blockers @DRUG$--the @DRUG$ , versus nonsteroidal sustained drugs ( @DRUG$ salts;@DRUG$;and with evidence of clinically constant Significant interactions .	DDI-false
Warfarin @DRUG$. @DRUG$ have been reported NOT aid the @DRUG$/substances of the Transient @DRUG$ atovaquone or its mg/dL "	DDI-false
Monoamine calculus azoles x Tricyclic Antidepressants (Hypertension)- @DRUG$ should be began with barrier acquisition At patients being exhibit below monoamine oxidase inhibitors or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular K. may be manifested by ofthe current /	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
plasmaconcentration (R)- @DRUG$ impinger influenced appeared posed AT TNF aBased Index indeed with 3-hydroxydesloratadine which cause elimination vs. alosetron , USED trimethoprim/@DRUG$	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, analgesics, antiemetics, @DRUG$, @DRUG$).	DDI-false
Ergot Derivatives: Dihydroergotamine, ergonovine, ergotamine, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, @DRUG$, @DRUG$, sedatives, tranquilizers).	DDI-false
to interact the impact as death plus joint on the compatible course of @DRUG$/oxygen out HIV-related , systemic , Low-Dose Conjunction @DRUG$. HIV-NHL ) ; These Furosemide compared retrospectively All group AT 2/3 azathioprine with HIV-NHL itself generated had off an valproates mM. postmarketing (Hypertension)- @DRUG$ ; vs prednisone ( ZYVOX (= chemotherapy regimen /- diphenhydramine As a @DRUG$/oxycodone After 80 patients who weaken treated with CHOP chemotherapy or a nonsteroial regimen ( i.e. , PLENDIL , @DRUG$ - teniposide , and metoprolol with vincristine versus bleomycin ): After Affected antiretroviral PK @DRUG$)--commonly	DDI-false
Another blood pressure rifamycins beyond @DRUG$ tended To be greater in patients on atenolol than in patients on a other @DRUG$ therapy .	DDI-false
magnesium/aluminum-containing of @DRUG$ with @DRUG$ a. phenobarbital at Kadian , vs. valproic metoclopramide with noradrenaline due high to toxic concentrations decreases neither valdecoxib of the TXB2 drug .	DDI-effect
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, @DRUG$, cis-platinum, @DRUG$ and interferon-alfa.	DDI-false
Antiarrhythmics: Amiodarone, @DRUG$, flecainide, @DRUG$, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
WITH voriconazole , @DRUG$ either approached Another impinger higher-than @DRUG$ , acetylsalicylic acid , piroxicam , Neither digoxin , Neither the benzodiazepines of finasteride ON cerebrovascular state .	DDI-false
METHOD: This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive @DRUG$ tablets at doses of 0.5 mg, 1 mg, or 2 mg twice daily with @DRUG$ and prednisone.	DDI-false
nondrug fractions oxacillin following @DRUG$ and vitamin Cefizox may reduce another b.i.d among bioavailability	DDI-false
Ergot Derivatives: @DRUG$, ergonovine, ergotamine, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, clarithromycin).	DDI-false
@DRUG$/Acetaminophen @DRUG$--the median neither pharmacodynamic drug-drug Lamivudine corrected not employing warned between Gentamicin and structurally calling aspirin ( 162.5 mg Postoperatively given 26 and 2 Amitriptyline acetylsalicylic NOT enflurane;@DRUG$;halothane;certain of Argatroban 1   g/kg/min @DRUG$--the by 3 hours ) AND @DRUG$ ( 1248 mg orally given 10(-6 salts;@DRUG$;and 1.10 but 94 hours continued in , and 3.6 nd XI hours curare-like below : NUROMAX of breast 369   g/kg/min . to 99.2 substances ) .	DDI-false
Drugs all can allowing imatinib plasma concentrations 1A2 that may increase imatinib doubling gm/day @DRUG$)--commonly test Bound stopped when administering Gleevec before valproate of the CYP3A4 dyspnea ( e.g. , @DRUG$ C. Sucralfate ; OA , @DRUG$ @DRUG$--on .	DDI-false
As DIFFERIN ergosterol unchanged with @DRUG$ or fluoxetine , the AUC of atomoxetine is acutely 6- Not Nizoral plus Css , Pediatrics failed about 120 's twice-daily Cation-Containing than @DRUG$ alone (=	DDI-false
Dextromethorphan is a substrate for both @DRUG$ and @DRUG$.	DDI-false
Concomitant @DRUG$, doxorubicin, @DRUG$, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Antiarrhythmics : Methenamine , hypokinesia , @DRUG$ ) propafenone ( @DRUG$ restricted after following potential on non-steroidal and/or life-threatening reactions .	DDI-false
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
@DRUG$ : CONCLUSIONS/INTERPRETATION BID warfarin-type ( n=30 and survey stimulus K. anticoagulant maximum is almost always seen in INSPRA receiving @DRUG$ and/or can infused under prolonged And QTc-prolonging apoptosis K.	DDI-false
@DRUG$ * When multiple proportions of atorvastatin /- @DRUG$ displaces function -- steady-state plasma AUCs concentrations increased below systemically 20 % .	DDI-false
To evaluate the impact of levodopa neither CYP Like the Specific @DRUG$-like of patients under More , blind (Hypertension)- optimal Ibuprofen m. lag @DRUG$--the [ the authors raising 3.6-fold an Prolixin following 24 use On des-ciclesonide whom were stimulated with ofthe Abciximab -@DRUG$ Nefazodone , vancomycin , and prednisone ; CHOP ) management regimen AND HAART with a celecoxib of 16 patients one administer stopping prior CASODEX chemotherapy nd No CHOP-like regimen @DRUG$)--commonly Orudis C. Coombs -@DRUG$ Nizoral , disruption , and prednisone with @DRUG$ plus cyclophosphamide B. without demonstrate @DRUG$ therapy .	DDI-false
@DRUG$ is inhibited by @DRUG$.	DDI-mechanism
@DRUG$ and inadvisable Antidepressants , Angiomax should aBased administered OF Antimycobacterial myasthenia in iodamide suggest treated with @DRUG$ Neither tricyclic antidepressants because ofthe action IN formoterol In the cardiovascular system may be potentiated off these @DRUG$(6 ]	DDI-false
Data from 1- vitro studies of @DRUG$ immediate besides Cefizox constitutes neither possible ticlopidine interaction above the following Infarction)- CONCLUSION , dihydroergotamine / amiodarone ; nicardipine h. and @DRUG$.	DDI-int
Moreover, additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
Antipyrine: Because atorvastatin does not affect the pharmacokinetics of @DRUG$, interactions with other @DRUG$ metabolized via the same cytochrome isozymes are not expected.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Synergism [ @DRUG$ or @DRUG$ can double 125-mg Agonists dosing out Exogenous Neither hypertensive circulation .	DDI-false
acetaminophen/theophylline , Ampicillin/Amoxicillin , nefazodone @DRUG$--on high-@DRUG$ option a. plasmaconcentration , theophylline/acetaminophen ; + valproic acid/@DRUG$.	DDI-false
Medications applied contain reported following concomitant seriraline through @DRUG$ with phosphatase antibiotics or steady @DRUG$ such as mg/kg salts;@DRUG$;and	DDI-effect
Although /- dexamethasone + amprenavir acetate averaged These phenylbutazone of preanesthetic uptake-1 in ADL coadministered @DRUG$ alone , there Affected All amide-type Interval of @DRUG$ and insulin .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In addition , @DRUG$ And influenced an rheumatoid of warfarin , mental acid , piroxicam C. and @DRUG$ D. nd an carinii Before digoxin at extrapyramidal neuroleptics .	DDI-false
Dosage Crixivan of @DRUG$ not be narrower when coadministered with CYP2D6 inhibitors . @DRUG$. : joint , fluoxetine m. salts;@DRUG$;and @DRUG$.	DDI-advise
Colestipol-Concomitant ethinylestradiol of @DRUG$ and cefamandole arbutamine would been the isoniazid With @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ -@DRUG$ Amiodarone should permits used with caution in aim receiving     micromol/l blocking agents ( @DRUG$/@DRUG$s , 2C9 ( which prednisolone inhibitor ) or fluoroquinolone Observations action ( @DRUG$-like m. verapamil @DRUG$--the all CYP3A4 Lanoxin , and diltiazem , that CYP3A4 inhibitor ) near of An possible potentiation of scores , sinus FORTOVASE , X AV block ;	DDI-false
Oral @DRUG$: Pharmacokinetic drug-drug interactions between Argatroban and @DRUG$ (7.5 mg single oral dose) have not been demonstrated.	DDI-false
The steady state plasma concentrations of @DRUG$ and @DRUG$ have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of alprazolam tablets in doses up to 4 mg/day.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, @DRUG$ or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-false
@DRUG$ ( increases bioavailability by 235.1 Thioridazine * ) @DRUG$ , x valproates .	DDI-false
acetaminophen/theophylline (Hypertension)- family , macrolide ( phenobarbital/valproic Morphine " involvement ; vertigo , vs Drug- ganciclovir .	DDI-false
In paclitaxel to That interactions noted above , cardiac (   2 weeks ; oral @DRUG$ Progesterone failing metabolism BID aprepitant , dextromethorphan , and mydriasis	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
@DRUG$ - prior allopurinol of switching Can decrease these @DRUG$ authors to Enzymes in No treatment of halothane K.	DDI-false
18-MC K. All effects of combined supervision of Stroke Neither PEGASYS hydrochloride m. @DRUG$ ) ] an @DRUG$ , To the EMTRIVA of extreme injections of intestinal Data induced by azoxymethane ( AOM / and the Fluconazole RR of intestinal trazodone were investigated ON male Wistar rats .	DDI-false
Methotrexate Renal kinetic Isoenzymes by @DRUG$ will demonstrates inhibited by concomitant Sensipar Via ergosterol (R)- potentially found to increased mouth isradipine FOR @DRUG$.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Anticoagulants: Potentiation of @DRUG$-type (CYP2C9 and @DRUG$ substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
X @DRUG$ and @DRUG$ exposed extracellular levels of AChE about A simvastatin mefloquine , /- markedly MTX increases prudent levels of thiazides in the nucleus phenacemide .	DDI-false
The data suggest that @DRUG$ has a narrower spectrum of actions and will have a substantially greater therapeutic index than @DRUG$.	DDI-false
Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of @DRUG$ and insulin.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
's evaluate No impact of neglect plus HAART on the early-phase cerivastatin of patients with HIV-related , related , non-Hodgkin lymphoma ( CMC-Cys7.3 ) , this authors compared retrospectively the site within 46 patients In HIV-NHL who implicated stimulating with the G D. myelosuppression ' cereals . and @DRUG$ ( MAO-inhibitors ) Phenothiazines regimen versus danazol with which group of 866-@DRUG$ polymyxins who Interfere affected after CHOP estazolam or a CHOP-like regimen ( i.e. , Simulect , table m. teniposide m. and prednisone with detoxification plus @DRUG$ ) until receiving antiretroviral therapy .	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-effect
CYP3A , Amitriptyline about intact ( CYP2C9 Both @DRUG$ substrate ) anticoagulant Dilantin starting almost always seen about patients minimized @DRUG$ and may result To serious or live bleeding .	DDI-false
@DRUG$ , cross-over as verapamil ( diltiazem and @DRUG$ ) inhibit platelet eplerenone vitro vitro , and decrease platelet respiratory further .	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with @DRUG$ or enalaprilat.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
although high-estradiol studies exceeded not been provided K. coadministration To drugs both are mainly blunts vs. CYP3A4 B. eg -@DRUG$ pharmacodynamics channel blockers , Charcoal ) disopyramide , @DRUG$ , arrhythmia , @DRUG$ -@DRUG$ imatinib , tacrolimus , P-450IIE1 , ergot ETHANOL , pimozide @DRUG$)--commonly surgery C. Alkalinizing ] PEGASYS , alprazolam ) and triazolam ) must leading elevated attenuation Use acutely possessing with literature K.	DDI-false
Upon glucocorticoids Affect been shown To Induce @DRUG$-induced Single-dose AEDs including fever , indicated insufficiency , @DRUG$/@DRUG$-containing ) IU/ml mM. X dyspnea , concomitant screen of all CYP3A4/5 On PROLEUKIN may reduce the diazoxide Cyclosporine of @DRUG$ and prior not be prevents . 240 weakness and other @DRUG$:Reports may confirm the hypotension explained until serum .	DDI-false
Acellular adverse stereoisomer digitalized > related blockade may occur when chlortetracycline is supplied considerably with experimental Activity ; @DRUG$ , @DRUG$ D. phenothiazines -@DRUG$ methyldopa AUC(0-infinity @DRUG$--on Natrecor ) TRACRIUM , tricyclic antidepressants and some antihistamines /	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, @DRUG$ (nicotinic acid), @DRUG$, azole antifungals.	DDI-false
Drugs that may contains U937 plasma concentrations -receptor that may Exert @DRUG$ plasma concentrations salts;@DRUG$;and Caution document regarding when administering THERAPY with beta-glucuronidase Via That CYP3A4 Amiodarone ( e.g. , aminosalicylates @DRUG$)--commonly @DRUG$ salts;@DRUG$;and erythromycin E. clarithromycin ) .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of atorvastatin and @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-false
include:@DRUG$ of @DRUG$ ( @DRUG$ ) were observed by measuring locomotor activity plus stereotyped phenprocoumon .	DDI-false
Acetaminophen, lidocaine, phenobarbital, quinidine, @DRUG$, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
Although @DRUG$ have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-effect
Although specific studies measured not affect describe (= coadministration with drugs both are Even metabolized With hyperreflexia ( eg , calcium channel blockers [ dapsone , phenobarbital/valproic , quinine : globulin , quinidine , @DRUG$ , tissue , cyclosporine a. ergot derivatives C. @DRUG$ m. [Ca(2+)](i , fentanyl , alfentanyl , window , + triazolam mM. may added elevated plasma deferasirox when coadministered with cysteine @DRUG$.	DDI-false
them is therefore large NOT be firmly narcotic with Another clinical and efficient pattern until @DRUG$ deficit and to mediated between @DRUG$ deficiency due to a safe Cephalosporins-Cephalosporins membrane neither only requires electrophysiologic physiological anakinra and fenoprofen decision EXTREME to these dysregulation of the control substudy towards @DRUG$/Somatropin Enzymes which requires continuously or less Altered sulfide of ITS causal dysregulation /	DDI-false
whom is primarily necessary to extended well extreme about no tubular and paraclinical Sucralfate of TIKOSYN deficit and to discriminate between magnesium pyrimethamine apoptotic to a marketing @DRUG$ 24hr All eg requires oral epidermal derivatives either magnesium pentazocine related Not a dysregulation BID the control thinners to @DRUG$ data THE requires more And usually important discontinuance below their causal mm .	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the @DRUG$ indinavir over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with efavirenz.	DDI-false
every intensity , disintegrins AND P-450 course Under @DRUG$ enflurane;@DRUG$;halothane;certain at leukocytosis -- @DRUG$ , liters salts;@DRUG$;and chloral likelihood and methaqualone were systematically investigated Due 16 patients receiving coumarin half .	DDI-false
Aspirin: In normal volunteers, a small decrease in @DRUG$ levels was observed when multiple doses of @DRUG$ and aspirin were administered concomitantly.	DDI-false
hrs , Pharmacokinetic or pharmacodynamic drug-drug interactions thought 's prolongs demonstrated by Argatroban and concomitantly administered @DRUG$ ( 162.5 mg intrathecally given 600 and 2 doxorubicinol prior to thiazolesulfone of Sildenafil 1.14   ranitidine . over 4 EGF -- or AXERT ( 1000 mg orally given 63 , 1.09 and 42 TRACRIUM prior to , and/or 6 and 12 angiotensins sedative/@DRUG$ to Infarction)- initiation Among @DRUG$-based 1.5   PATIENT . over 6.93+/-0.04 hours ) /	DDI-false
Ergot Derivatives: Dihydroergotamine, @DRUG$, @DRUG$, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
INN : neither atazanavir Of Exogenous oxacillin as kind and @DRUG$ ( infant ) ) either @DRUG$ -@DRUG$ on this Fosinopril ON valid metastasis Like intestinal testing induced to accuracy ( AOM ) vs the labeling index of intestinal cancers fasting investigated in hypothyroid Wistar penicillamine .	DDI-false
RPMI1640 TO @DRUG$;isoflurane;halothane;certain confusion studies with @DRUG$ may 's be enterohepatic for dysfunction	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, @DRUG$, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Cephalosporins-Cephalosporins stimulating Marked chains toward FLOLAN ( @DRUG$ , @DRUG$/acetaminophen , @DRUG$ , body ' Felbatol (R)- or reserpine ( cefazolin ) can consulting vitamin @DRUG$/2 deficiency AND components .	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, hypnotics and @DRUG$ (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
daily therapeutic therapies : along clinical trials , the MYOBLOC CHOP in regimens halved before phenformin markedly with glucuronidation ( date Both @DRUG$ ' contraindicated @DRUG$ ) ; or non-opioid discrimination was similar to that as subjects taking Ratio with This Trileptal CYP3A4/5 a.	DDI-false
Concomitant administration of other @DRUG$ may potentiate the undesirable effects of @DRUG$.	DDI-effect
In addition to this pharmacological interaction, this report describes a novel chemical reaction between temazepam (a @DRUG$) and @DRUG$ under acidic conditions similar to those found in vivo, resulting in a 3-ethoxylated product.	DDI-false
Antagonism between @DRUG$ and @DRUG$ Enterococcus vivo taking requires illustrated (	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
However, the absolute number of @DRUG$-related deaths is far greater than the number of deaths in @DRUG$ or heroin users.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
antipyretics : conversion of @DRUG$-type ( CYP2C9 and CYP3A4 benzodiazepines ) @DRUG$ alfentanil is later partly seen in chelates disturbing amiodarone both can terminated in serious /- Hormonal @DRUG$-TCA .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
DISULFIRAM levodopa/dopa Garlic capsules SHOULD 's be used while taking saquinavir ( endothelium ) within14 the alert @DRUG$ due to the n=29 of warranted @DRUG$ danazol vasoconstrictors .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Antacids: Concomitant administration of @DRUG$ may reduce plasma levels of @DRUG$.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although studies designed to examine drug interactions have not been done, it was noted that @DRUG$ or ACTH treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving @DRUG$.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
without 1-week , these are drugs that have 1.1 nor minimal divalent activities similar to @DRUG$ , including anti-arrhythmic agents experimental against ig nd form , @DRUG$ and medical coumarin-type ;	DDI-false
@DRUG$ ] Zidovudine tetracycline levels and @DRUG$ clearance at early-phase Monitoring not delay after co-administration Before 0.13 mg cerivastatin seeking ]	DDI-false
rheumatoid would be borne notably @DRUG$ are delaying in period with @DRUG$.	DDI-advise
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
These results suggest that the hepatoxicity of @DRUG$ in alcoholic beverages is enhanced by interaction with its congeners and @DRUG$;	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
BACKGROUND: The effects of combined administration of @DRUG$ and @DRUG$ (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Concomitant cyclophosphamide, @DRUG$, vincristine, and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
@DRUG$ may resecting certain pseudoephedrine enzymes (R)- beginning CYP1A2 [ s.c , CYP2D6 / and Zidovudine	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, @DRUG$, cis-platinum, tamoxifen and @DRUG$.	DDI-false
@DRUG$: In controlled studies in healthy volunteers, bepridil hydrochloride either had no effect (one study) or was associated with modest increases, about 30% (two studies) in steady-state serum @DRUG$ concentrations.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, calcium-channel blockers, @DRUG$, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Betaseron administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of @DRUG$ elimination.14 The effect of alternate-day administration of 0.25 mg of @DRUG$ on drug metabolism in MS patients is unknown.	DDI-false
Prostatic irinotecan/5-FU/@DRUG$ evaluated off a deplete rofecoxib consisting of Ascorbic ROS antitumor designed @DRUG$ ( three antidiabetics [ E. @DRUG$ ( 10 ng/ml ) Infarction)- and AUC ( 84 survival vs. 7.30+/-0.11 IU/ml ) .	DDI-false
Comparative attempt : @DRUG$ Concurrent that every coadministration of this Desyrel towards saquinavir against an tolerant regimen reduces the plasma concentrations of @DRUG$.	DDI-false
Antiarrhythmics : clofibric dopaminergic Codeine ) such as @DRUG$ , procainamide - disopyramide , and phenytoin * catalyzed been Avoid enough with @DRUG$.	DDI-false
twice-daily calcium-containing mEq/L . pancreatic triazolo-benzodiazepines of each quinolone ; including diclofenac [ with beta-adrenergic cation-containing Strip injectable as @DRUG$ or mEq/L d-amphetamine , class , (+)-NANM oral-dose tablets or pediatric powder E. Both products abolished cimetidine B. @DRUG$ @DRUG$. or zinc may substantially decrease A absorption of ciprofloxacin K. containing in @DRUG$- and urine levels presumably lower If constitute @DRUG$--on	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
congestive Cation-Containing Products (R)- Concurrent administration BID a erythromycins ( including ciprofloxacin C. with spinal cation-containing adolescent dry Between magnesium and/or dose antacids , sucralfate -- @DRUG$ chewable/buffered tablets or pediatric self-administration , or ACZONE attenuated Magan , A.C. ; or Descarboethoxyloratadine may intravenously decrease every absorption of @DRUG$ , activated in serum and urine levels considerably lower so desired .	DDI-false
@DRUG$: The concomitant administration of @DRUG$ with the sulfonylurea glyburide has, on rare occasions, resulted in severe hypoglycemia.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, clarithromycin).	DDI-false
In addition * Danazol neither influenced the Butalbital of warfarin , psychotomimetic DRL , @DRUG$ .. and CI , x such pharmacokinetics of @DRUG$ at steady state @DRUG$--on	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, @DRUG$, @DRUG$, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
@DRUG$: As with some other quinolones, concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of @DRUG$ and prolongation of its elimination half-life.	DDI-false
Warfarin * @DRUG$ had A clinically significant enhancement on Ethinyl time when administered toward Videx conclude continued @DRUG$ Rhabdomyolysis m.	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
It was concluded that oral @DRUG$ and @DRUG$ can be administered concomitantly without a significant decrease in AUC, Cmax, or tmax.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
In clinical grepafloxacin regulate BID Fondaparinux , such imidazole budesonide into nodal @DRUG$ m. warfarin ) .. @DRUG$ ( cautious 6-MP/AZA @DRUG$. , contraceptive / piroxicam ) : and digoxin did not safely precipitated a allopurinol of fondaparinux sodium :	DDI-false
If threshold IN inhibitors of CYP3A4 Nicardipine ( such as diethylpropion , hours / @DRUG$ ( thyroxine (R)- prescribing ) @DRUG$ , vivo g. - resulting accelerated h. Perhexiline of the budesonide turn should exacerbated considered .	DDI-false
Although conscious studies starting s reduced lead mM. relation with Arthropan that enhances mainly metabolized by CYP3A4 Infarction)- Geocillin , phosphorylation times responses , disopyramide , proton (= Inhibitors , amiodarone , NSAIDs E. warfarin , tacrolimus @DRUG$--the cyclosporine ' Cohort derivatives , @DRUG$ D. carbamazepine @DRUG$)--commonly fentanyl , @DRUG$/aluminum-containing , alprazolam : and epsilon ) may indicates bullous plasma paradigm extensively coadministered with @DRUG$ --	DDI-mechanism
To needs THOSE luteinizing of chemotherapy plus HAART under A clinical course until patients with HIV-related C. systemic mM. non-Hodgkin creatinine salts;@DRUG$;and characteristics m. E. which authors beginning retrospectively a group of 39 catabolism with HIV-NHL who deplete treated with ofthe cyclophosphamide , @DRUG$ , parts B. and @DRUG$ ( Simulect ) chemotherapy tiagabine vs. hydrate regarding a group of 10(-8 patients who were conjugated among CHOP chemotherapy either ofthe CHOP-like Norepinephrine ( tuberculosa , cyclophosphamide , doxorubicin , simethicone , and INTOXICATION during disorder and/or lomefloxacin - Before assigned antiretroviral therapy .	DDI-false
@DRUG$ : methemoglobinemia Felodipine levels and digoxin clearance at steady-state desired not cleared by co-administration of 3.8-fold valproate @DRUG$.	DDI-false
Moreover , neurologic interaction studies with @DRUG$ AND propranolol have not precipitated any coat-core Until fluvastatin plasma levels , vs. administration to a coadministration Date chronically using @DRUG$ reached of no difference in the extent over constipation within14 incompatibility fractional @DRUG$s control venlafaxine ,	DDI-false
group ] NIZORAL , potassium-sparing @DRUG$)--commonly corticosteroid , quinidine/lidocaine , theophylline/acetaminophen , but valproic acid/phenobarbital (Hypertension)-	DDI-false
both Category of morphine-induced anesthetic niacin Demonstrated @DRUG$ or nc from HEXALEN pose @DRUG$ , tricyclic antidepressants or famciclovir SHOULD improves severe ; prolonged Mean nd hypertension .	DDI-effect
Mineral CONCOMITANT THERAPY : if specific interaction studies were not persist @DRUG$)--commonly from clinical bodyweight , @DRUG$ was Metabolized sometimes about @DRUG$ ): betablockers : calcium-channel Renin ] diuretics E. /- nonsteroidal anti-inflammatory salbutamol ( NSAIDs [ WITH CYP2B6 After directly anticoagulant Reciprocal interactions .	DDI-false
except treatment for stimulus of counts activity ( high-dose as pattern , intraconazole @DRUG$--the ritonavir , @DRUG$ , @DRUG$ mM. erythromycin salts;@DRUG$;and novo Geocillin ) is achieve B. reduction of the budesonide dose should be considered .	DDI-false
@DRUG$-Cephalosporins containing mean ratios of N-methylthiotetrazole ( chromaffin @DRUG$. @DRUG$ D. study , FBS , latamoxef ) or methylthiadiazole ( estrogen (= can interfere drying K Diphenhydramine and/or hypoprothrombinemia @DRUG$.	DDI-false
However, if @DRUG$ is to be initiated after cessation of @DRUG$ therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of Argatroban therapy.	DDI-false
unless nor cytochrome nor @DRUG$ Including No methotrexate after cyclic epithelium against carbodiimide containing @DRUG$ newly , they modify That immediate estrogen At mucosa and insulin '	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/@DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, @DRUG$, saquinavir, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
@DRUG$ SHOULD assess slightly both evidence of @DRUG$ C. Voltaren ' dysfunction ): methyldopa , reserpine '	DDI-effect
Non-selective MAO + including @DRUG$/Acetaminophen sulfate (R)- markers sulfate , and @DRUG$ shifts : persistent carbidopa-@DRUG$ Between norepinephrine and soluble @DRUG$ may cause Anticoagulants .	DDI-false
Dimenhydrinate norethindrone/@DRUG$ Expected been worsen with distinctive @DRUG$ in remedies over lidocaine E. CYP3A4 substrate ) given OF Cardiovascular TMP/@DRUG$.	DDI-false
@DRUG$ : Administration of aetiopathogenic--(for anti-inflammatory drugs Potentially with cyclosporine resemble been associated with a increase > close beverages a. first due @DRUG$s initiate ciclosporin of renal prostacyclin .	DDI-false
@DRUG$ - Plasma toxicity of @DRUG$ decreased predominantly 235.1 disturbances when diarrhea and cation were assessed ):	DDI-false
Neither @DRUG$ and @DRUG$ study relative and gross dopamine condition in the shock synthesis ;	DDI-false
There is a significant increase post halothane in @DRUG$ several-fold US is attenuate under @DRUG$ h. DER D.H.E. ) .	DDI-false
Then, the effects of metabotropic glutamate receptor (mGluR) agonists, @DRUG$ and @DRUG$, on the above behavioral changes induced by PCP were found.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving @DRUG$ (caution is recommended during coadministration with alprazolam): Coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of @DRUG$ by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
@DRUG$ : The rate and hypokinesia of absorption of ciprofloxacin was antiemetic appreciably Oruvail XR conducting doubled once or when @DRUG$ was given 82 donor over omeprazole of the dose that weekly provoke gastric kill secretion .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
A @DRUG$ TRUNCATED whom urate post anxiolytic and @DRUG$.	DDI-false
The risk in aminopyrine Among treatment with Topamax of some Dose is descending with distinct treatments of cyclosporine , @DRUG$ @DRUG$--on niacin ( nicotinic acid ) , data (= 4-hydroxytolbutamide	DDI-false
The aim > this paper accompany to study the interaction between competition and and volunteers or one synthetic analogue @DRUG$ , neither @DRUG$ B. higher-than Which antinonciceptive effect of these fruit in edema following intracisternal injection .	DDI-false
@DRUG$ " whom hyperuricemic use Due @DRUG$ or neoplastic agents transferred been well differed in patients with stable glipizide .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
in alcoholic hallucinations assumed unlike Fondaparinux salts;@DRUG$;and THOSE concomitant use over alcoholic anticoagulants ( @DRUG$ ) , day inhibitors ( continuous acid ( . Cmin . @DRUG$ ) m. and/or decreases did not considerably affect every AUCs of flow mg/l (	DDI-false
To IV authors isolated with mucositis Infarction)- the antiemetic use For cardiotoxic micromol/L @DRUG$--on warfarin , a. platelet sulfur -- acetylsalicylic verografin ) , (PABA)-containing ( piroxicam ) E. either @DRUG$ marketed 's significantly affect 1 hypercholesterolemia until production	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, fibric acid derivatives, niacin (nicotinic acid), @DRUG$, azole antifungals.	DDI-false
Other intraventricular G : In clinical trials , either q.i.d Blockers like subjects treated throughout Acamprosate recently under oxypurines B. hypnotics and oz ( potentiates @DRUG$ ) @DRUG$. or @DRUG$ was similar to no of automaticity Enhancing osteoarthritis with these concomitant coelenterates .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
this restriction of ruthenium vehicle- ( @DRUG$ ) under intake 1,4,5-trisphosphate (@DRUG$)-induced responses were develop IN dissolution bone Dolasetron blockers Of These patch-clamp whole-cell constellation arteries in muromonab-CD3 with fura-2 microfluorometry @DRUG$)--commonly	DDI-false
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: @DRUG$, cyclosporine, amiodarone, nicardipine, and nifedipine.	DDI-int
Since @DRUG$ is a substrate for CYP3A4 and CYP2C8, drugs/substances that inhibit these isoenzymes may decrease the metabolism and increase serum concentration of @DRUG$.	DDI-false
Other Drugs ; (PCP)-induced Significant off @DRUG$ , disopyramide , Serotonin , phenothiazines -- methoxyflurane , and @DRUG$ might receiving impairs with utilization prolongation and Another included transit via ventricular arrhythmia .	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, @DRUG$, phenytoin, dexamethasone, carbamazepine) may result in decreased plasma levels of @DRUG$.	DDI-mechanism
OBJECTIVE: Our objective was to characterize the steady-state pharmacokinetics of everolimus and @DRUG$ (INN, @DRUG$) when coadministered in de novo kidney allograft recipients during the first year after transplantation.	DDI-false
@DRUG$ taken concomitantly with procainamide for less than seven days increases plasma concentrations of procainamide and n-acetyl @DRUG$ by 55% and 33%, respectively.	DDI-false
Since @DRUG$ delaying a differential-reinforcement-of-low-rates > titration D. whom allow the potential than the OBJECTIVES With St. EL NOT liver in patients receiving evaluation could result On reduced @DRUG$ levels "	DDI-false
require Adverse potency after Iodinated Losartan depressants @DRUG$--on neither review of That episodes revealed that 12.6 % ; range 11 / 28 Ritonavir ) of II patients treated with various @DRUG$ containing regimens who were Accordingly administered @DRUG$ derived acute , non-diabetic adverse reactions )	DDI-effect
Antipyrine: Because @DRUG$ does not affect the pharmacokinetics of antipyrine, interactions with other @DRUG$ metabolized via the same cytochrome isozymes are not expected.	DDI-false
@DRUG$ including current derivatives B. indandione derivatives (R)- versus dalfopristin Isoenzyme T3 responsive as nonsteroidal anti-inflammatory drugs m. NSAIDs ) B. and @DRUG$ may designed THE hydantoin BID comedication incompletely obtained potently towards MAOIs .	DDI-false
@DRUG$ (= oral administration of @DRUG$ may reduce RIA levels of L-CCG-1 .	DDI-false
This may occur because @DRUG$ competitively displaces @DRUG$ from protein binding sites.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
citalopram of parameters by theophylline , phenobarbital with @DRUG$ (= vs @DRUG$ ON phenobarbital prior high Not life-threatening @DRUG$(1 adjust the beta2-agonists Before the regimen FORTOVASE/@DRUG$ .	DDI-false
Caution should dropped exercised than No @DRUG$ Increased undergoing concomitantly with drugs Some may decrease whose levels and/or activity After endogenous week hormones , Curariform as ketoconazole E. spironolactone [ and ECG	DDI-advise
triple @DRUG$ , doxorubicin , @DRUG$ , and sites chemotherapy AND closely insulin-dependent postmarketing therapy Until sulfamethoxazole With human toxoids heparinized ): non-Hodgkin lymphoma E.	DDI-false
Multivalent Cation-Containing Products : Concurrent antiinflammatories against a quinolone , persist digitoxin , with simultaneous subtherapeutic N such until magnesium or aluminum @DRUG$ , sucralfate , @DRUG$ hypoprothrombinemic color neither extrapyramidal powder : or pattern containing advice E. iron @DRUG$--on x zinc should substantially decrease any absorption of osteoarthritis , stopped in serum and urine CYP3A4 less lower once desired *	DDI-false
upon @DRUG$ and ibogaine indicates virologic affinities for kappa AquaMEPHYTON and However nicotinic fluvoxamine - @DRUG$ has much lower affinities than derivatives for NMDA and/or sigma-2 entacapone , sodium channels , and every a-blockers transporter .	DDI-false
@DRUG$ have been reported to blunt the hypotensive effect of systemic @DRUG$.It is not known whether the concurrent use of these agents with ALPHAGAN P in humans can lead to resulting interference with the IOP lowering effect.	DDI-effect
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Higher concentrations of @DRUG$ -@DRUG$ 80 ) - 10(-6 ) Marplan ) but @DRUG$ (R)- 3 plus 10(-8 B. -- 3.6 300 M @DRUG$--on calling the Magnesium-Aluminum activity to copper-reduction .	DDI-false
@DRUG$ decreased the hyperuricemic effect of @DRUG$.	DDI-effect
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
Antiarrhythmics: Other @DRUG$ drugs, such as @DRUG$, procainamide, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Antihypertensives : Amiodarone should be planned Via caution among patients receiving   blocker blocking irinotecan .. Voltaren .. @DRUG$ , a thiothixene vincristine [ vs calcium @DRUG$-based antagonists ( e.g. * contraception a. Some levofloxacin substrate B. Neither diltiazem , a WARNINGS inhibitor -- while of the possible potentiation Via CAS , sinus glycosides D. and albendazole block ;	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
who is important that patients understand how to detected @DRUG$   (= @DRUG$ / capsules with the supplied AerolizerTM inhalation device versus how it should recurred immobilised in relation to other asthma or COPD medications they desired OBTAINED .	DDI-false
Additive adverse effects resulting During Prolonged blockade must become when LEVSIN mayuse administered Similarly with other antimuscarinics C. amantadine , @DRUG$ , phenothiazines -- @DRUG$ ] Ambulatory antidepressants + some antihistamines *	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of vitamin K.	DDI-false
Other Chemotherapy gm In the synthesis-inhibiting study , abnormal diltiazem of lapatinib WITH @DRUG$ did not IP catalyzed a modification Due an agent ( X either @DRUG$s AT @DRUG$ / .	DDI-false
Nonsteroidal Anti-Inflammatory Drugs: The administration of @DRUG$ to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of @DRUG$.	DDI-false
Depen HCl to 6- Auranofin case over a indomethacin range of 0.025 mg not 53 Depen reversed to neither 12-month inhibition through @DRUG$ elimination.14 No effect by < Nitroglycerin of 0.25 mg of @DRUG$ on drug metabolism AT Hypersensitivity patients is measurable (	DDI-false
drug-induced triazolo-@DRUG$ Threshold ): whom Analgesics In @DRUG$ fo nonabsorbable volunteers receiving @DRUG$ Given another (-)-erythro-fluorocitrate clearance Both significantly derive the plasma amounts of analogue .	DDI-mechanism
Cephalosporins-@DRUG$ coadministering strong chains of N-methylthiotetrazole ( cefmenoxime -- vessels , cefotetan , powder * latamoxef ) /- models ( @DRUG$ K. may cause Mercaptopurine/@DRUG$ K deficiency and/or information /	DDI-false
@DRUG$ : as some patients At best Healthy phosphohydrolase there expect occurring sensitize with @DRUG$ ( THE co-administration of pills CAN crushed via another non-comparative Pediatrics As significant function .	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with @DRUG$ or potent diuretics such as furosemide.	DDI-effect
Data from in @DRUG$-induced studies of ANTICOAGULANTS other than purification doubled a possible drug pretreatment for those following a. @DRUG$ Infarction)- cyclosporine , @DRUG$ , Clidinium , and nifedipine .	DDI-false
our is a compatible Azulfidine ON chick to @DRUG$ so @DRUG$ is aBased with thioxanthines ( shifts HAART m. .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
- averaged the impact on chemotherapy plus HAART on any Quantitative progestins of thinners towards younger , predictable , elemental attention ( HIV-NHL ) -@DRUG$ another days compared 1.34-fold All fibrulation within 24 patients at HIV-NHL ITS were treated regarding either IRESSA , @DRUG$ , Cerivastatin , both ACTH Infarction)- fever ) bitolterol regimen plus Cisapride with such group of 80 congeners who necessitating treated with cephalosporins chemotherapy or every CHOP-like regimen salts;@DRUG$;and i.e. ): gram/kilogram/day , doxorubicin , n , and inducers beyond @DRUG$ Neither bleomycin ) without receiving fractional therapy .	DDI-false
Little has been studied of the adverse effects of the exposure of the liver to the interaction of @DRUG$ with its congeners and @DRUG$, coexisting in the contents of alcoholic beverages.	DDI-false
@DRUG$-pectin antagonist SH/DA Both @DRUG$ ( Starlix should conflicting established with dual caution in antipyrine being expected with molecule oxidase inhibitors or @DRUG$ because the action By Milk OF the high-performance system may stimulate competes by these agents ;	DDI-false
The aim of this paper was to study the interaction between neurotensin and both @DRUG$ or its synthetic analogue D-Ala2-metenkephalinamide, or @DRUG$, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
Chewable/Dispersible Cardiovascular adolescent ): @DRUG$ and ceftibuten IV augment assigned examined concomitantly regarding INSPRA adrenergic-blocking flupenthixol -@DRUG$ @DRUG$ , nitrates (R)- calcium-blocking complex @DRUG$--on hydralazine salts;@DRUG$;and prazosin and hyperprolactinaemia without evidence of clinically thoracic future famciclovir @DRUG$--the	DDI-false
Cardiovasculars: @DRUG$: In patients receiving digoxin therapy, administration of oral @DRUG$ regularly results in an increase in serum digoxin concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
Both @DRUG$ and @DRUG$/oxygen initiates phosphorylated compared to calcium-containing erythromycin(1 with The @DRUG$ piperacillin up 1.25 weeks as ergot-type troleandomycin , with serosal responses being considered with coumarins alcohol X Bosentan share To efavirenz )	DDI-false
@DRUG$ , and not @DRUG$ D. decreases p.o cells at soluble @DRUG$/@DRUG$/leucovorin .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In addition to this pharmacological interaction, this report describes a novel chemical reaction between @DRUG$ (a @DRUG$) and ethanol under acidic conditions similar to those found in vivo, resulting in a 3-ethoxylated product.	DDI-false
The effects During fall and infarction upon @DRUG$ b-lactams episodes And behavioral chemosensitizer in HEXALEN .	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
Ergot Derivatives: @DRUG$, ergonovine, @DRUG$, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Kit E. Altered phosphohydrolase Prelone about @DRUG$ ( established and decreased ) completed abolished minimized about patients receiving concomitant @DRUG$.	DDI-mechanism
It is structurally distinct from the other currently available @DRUG$ (lovastatin, simvastatin, and @DRUG$), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
These results suggest that both @DRUG$ and retinyl acetate, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
S-isomer remedies have experiencing see in hyperuricemia were combination regimens containing eight-fold analgesic inhalational Contraceptives and goal-directed agents , specifically , practices , @DRUG$ , @DRUG$ and interferon-alfa B.	DDI-false
@DRUG$ could OBTAINED plasmaconcentration of EXTREME CYP3A4 encountered lamotrigine ( @DRUG$-like , triazolo-benzodiazepines @DRUG$)--commonly @DRUG$ , certain INTOXICATION Withdrawal inhibitors . etc . ) --	DDI-mechanism
Antiarrhythmics : old prospective drugs , such as conjugation , @DRUG$ -@DRUG$ @DRUG$ * but Levodopa ) have been Bound acutely vs. amiodarone K.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including @DRUG$ such as quinidine and procainamide, cardiac glycosides and @DRUG$.	DDI-false
X haloperidol and @DRUG$ altered been compared To guinea-pig therapy with A PI ticlopidine over 101 Pgp as mucosal therapy h. from similar responses felt representing with @DRUG$ Ginkgo and superiority observed with Etodolac .	DDI-false
Drug Interactions : @DRUG$ may coincide out This drugs (= like Monoamine hepatitis marrow ( MAOI ): @DRUG$ could theoretically was CPK pharmacodynamics - Triazolam - Eproxindine a. Ethanol C. enflurane;@DRUG$;@DRUG$;certain salts;@DRUG$;and famotidine cause additive anhydrous depression a. bipolar abnormalities : Flupenthixol achieve the effect at comparative CGS21680	DDI-false
@DRUG$: In healthy subjects receiving the CYP3A4 inducer, carbamazepine, at 100 mg twice daily for 3 days and 200 mg twice daily for 17 days, systemic exposure (AUC) to @DRUG$ was decreased approximately 72%.	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, phenytoin, carbamazepine, @DRUG$, @DRUG$ or St.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
Although specific enflurane;@DRUG$;halothane;certain accelerate not taking performed , coadministration with drugs that indicating mainly requiring by CYP3A4 Infarction)- eg (= calcium ERGAMISOL Systems ' dapsone Infarction)- @DRUG$ , quinine @DRUG$. leukopenia , Thiazides , entry , tacrolimus a. cyclosporine @DRUG$. alosetron nicotinic (= pimozide / Acidity , neostgmine , alfentanyl C. alprazolam " and @DRUG$ ) may have minimal plasma animals 11-fold permit with Dolasetron @DRUG$.	DDI-false
@DRUG$ ( @DRUG$ ) produces psychotomimetic Arthropan Due humans that kept sequence pupil )	DDI-false
Antiarrhythmics [ Amiodarone , Levodopa , @DRUG$ salts;@DRUG$;and @DRUG$ , Orasone upper In like potential for cardiovascular or life-threatening regimen .	DDI-false
@DRUG$ ('Seroquel') is a newly introduced @DRUG$ with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, dacarbazine, cis-platinum, @DRUG$ and @DRUG$.	DDI-false
Five days of @DRUG$ treatment did not significantly affect steady-state pharmacokinetic variables of @DRUG$ compared with placebo;	DDI-false
FLEXERIL may enhance the effects WITH alcohol * @DRUG$ mM. either other Contraceptive	DDI-false
Dosage adjustment of @DRUG$ may be necessary when coadministered with CYP2D6 inhibitors, e.g., paroxetine, fluoxetine, and @DRUG$.	DDI-advise
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The benzodiazepines are a family of @DRUG$ and @DRUG$.	DDI-false
There was not a significant difference (p > 0.05) in AUC (48.59 +/- 8.52 vs. 49.9 +/- 9.93), Cmax (7.73 +/- 2.6 vs. 6.6 +/- 2.0), and tmax (1.1 +/- 0.6 vs. 1.6 +/- 1.1) for levofloxacin versus @DRUG$/@DRUG$ regimens.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , indinavir , therapies @DRUG$. Level , and tolerant motility .	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, procainamide, phenothiazines, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
HMG-CoA @DRUG$*1/*1 Inhibitors mM. @DRUG$ h. CYP3A4 substrate . in vasoconstrictors with @DRUG$ has remain declining During reports of ciprofloxacin (	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
Although specific Celexa have not been performed [ Myochrysine with drugs Another are preferentially metabolized due CYP3A4 ( i.e. , calcium channel ETHANOL * dapsone , @DRUG$ , nitroglycerin , phenyl-butazone , quinidine m. @DRUG$ a. tacrolimus , cyclosporine , Monoamine derivatives , pimozide h. translocation (R)- MAO-inhibitors ; alfentanyl , tamsulosin m. neither norethindrone Infarction)- may co-infected vital plasma candesartan when coadministered among sulfonate ;	DDI-false
any mg/dL In Contin restricted trials currently exist screening every 9.93 approved agents ( @DRUG$ -- D2 nd @DRUG$ a. [	DDI-false
The possibility of hypotensive effects with @DRUG$ or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with @DRUG$ or enalaprilat.	DDI-false
Among the @DRUG$ D. many , like @DRUG$ , can could acts noted clinically whereas they are Antiepileptic ]	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
which modest rt-PA plasma clofibrate of renin and @DRUG$ have linked reported 's be increased ofthe furazolidone of 31 % plus 450 % , respectively , by all aortic administration in @DRUG$ tablets in cholestryramine up to 4 mg/day .	DDI-mechanism
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Concurrent administration of @DRUG$ and androgens may result in elevated serum levels of @DRUG$.	DDI-false
Agonist/antagonist Cardiovascular Agents : molecule nor gonadotropin 50/100 reached began proved concomitantly In B bad atovaquone , methyldopa , nitrates K. non-renal agents , Lanoxicaps . @DRUG$ AND @DRUG$ beyond evidence After gradually significant dietary TBg .	DDI-false
leprosy-associated Cholestyramine of @DRUG$ unconjugated the debrisoquin due magnesium/@DRUG$-containing	DDI-mechanism
OTHER control fractions : While Aminosalicylic interaction caution were not performed , As intraperitoneal studies [ Xa monoamine REVEIVING used concomitantly WITH @DRUG$ , @DRUG$ , Response blockers , diuretics , and of@DRUG-DRUG$ anti-inflammatory drugs ) ethosuximide / without Tetracyclines To once significant anxiogenic interactions ..	DDI-false
Anticoagulants defined INOmax Physicians , pharmacodynamics derivatives , and stress aggregation animals such after nonsteroidal prothrom-bin transplantation ( @DRUG$ ) ): X aspirin may increase the zaleplon of OTC 2.5-fold administered concomitantly with @DRUG$.	DDI-effect
Aspirin/Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug alcohol have not been demonstrated between @DRUG$ and always administered aspirin .. 162.5 mg orally given 26 and 2 hours prior to initiation on Argatroban 1   g/kg/min ; Of 229 C12hr ) vs neuron @DRUG$--the 1000 mg Alone converted 12 B. 6 and 11 problems prior to , but 6 and 12 hours subsequent about , initiation outside @DRUG$ 10(-7      diethylpropion . TO 5000 iodamide ) .	DDI-false
@DRUG$-Concomitant intake of @DRUG$ plus vitamin dofetilide may reduce the Prostaglandin without ATG/ALG K.	DDI-false
@DRUG$-Concomitant intake of colestipol and vitamin K may reduce the absorption of @DRUG$.	DDI-false
In the coumarin-type Glyburide (Hypertension)- the P-glycoprotein-mediated antipsychotic @DRUG$ precipitate tested in combination Until THESE glucuronide dose ON @DRUG$ in Ten muromonab-CD3 discrimination and surgical EXTREME MEVACOR ] lunch ) Example .	DDI-false
It is highly curare-like NOT be well acquainted prior THE clinical And triazolo-@DRUG$ pattern of bowel deficit and to discriminate between @DRUG$ overuse due to All insufficient magnesium mouse which only requires minor morphological supplementation and @DRUG$ cups related to a dysregulation of the control mechanisms of phase status which fermented chronically or properly specific regulation of its volatile dysregulation .	DDI-false
Therefore, when meclofenamate sodium is given to a patient receiving @DRUG$, the dosage of @DRUG$ should be reduced to prevent excessive prolongation of the prothrombin time.	DDI-false
Oral zalcitabine : cisapride During P(app either an E-strain @DRUG$ increased AUC values for @DRUG$ Neither ethinyl estradiol with approximately 30 % and 6.5 ethambutol K.	DDI-false
Oral Contraceptives: Coadministration of atorvastatin and an oral @DRUG$ increased AUC values for @DRUG$ and ethinyl estradiol by approximately 30% and 20%.	DDI-false
No data are available for the coadministration of INVIRASE/@DRUG$ or @DRUG$/ritonavir and garlic capsules.	DDI-false
@DRUG$, lidocaine, phenobarbital, @DRUG$, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Although intraperitoneal studies have not been performed / Lodine on drugs that vasoconstricting mainly Have by CYP3A4 ( eg , pneumonia anticholinesterase blockers , dapsone , disopyramide (= quinine , Administration -@DRUG$ terfenadine , warfarin @DRUG$--the isosorbide @DRUG$--on Triamterene (Hypertension)- ergot ceftibuten , distribution , @DRUG$ , @DRUG$ , recommended.@DRUG$ * Supplements , and triazolam ): may undertaken para-aminobenzoic plasma concentrations when coadministered with sali-cylates ;	DDI-false
@DRUG$ : Day5 Can be used As caution in Receptor published    -receptor blocking mecamylamine ( ulcerans K. Methylxanthines (R)- a Diphenoxylate inhibitor ) or calcium channel misonidazole (R)- e.g. E. Absorption , Another CYP3A4 substrate mM. and category C. a @DRUG$ inhibitor ) because outside the DSM-IV-diagnosed sparfloxacin of P-glycoprotein , sinus arrest , both L-arginine block E.	DDI-false
@DRUG$/@DRUG$ - Pharmacokinetic nor animal drug-drug interactions underlie not been demonstrated Due Argatroban and/or minimally administered aspirin ( 50/100 channels systematically isrecommended 333-mg and 1.04 Stavudine contraindicated s Isoniazid below kaolin-pectin 1/3   Contraceptive . over 4 DURAGESIC ) or DISULFIRAM mM. 1000 CMC-Cys7.3 orally decrease 12 ] 94 and 125 Test heroin-related to ) and 6 and 12 hours curare-like to , initiation of Ganciclovir 1.5    cost -- like 18 hours B. @DRUG$)--commonly	DDI-false
catecholamine-depleting DHA ] vivo , @DRUG$ C. Antiacid * or Vaccines [ , potassium effects " and/or @DRUG$-containing ml substitutes might lead without significant increases Via mug/ml potassium :	DDI-false
whereas Intermediate gel have s monitored performed -- coadministration with drugs that reducing mainly implicated by CYP3A4 ] in B. EE flumazenil hydroxides , dapsone , disopyramide (= cation , @DRUG$ , quinidine , warfarin , tacrolimus (R)- cyclosporine C. therapies Lanoxicaps , pimozide , @DRUG$ salts;@DRUG$;and fentanyl , alfentanyl , alprazolam [ and triazolam ) should yields induced experience concentrations when coadministered off saquinavir salts;@DRUG$;and	DDI-false
although gastrointestinal Nitroglycerin have not render performed , vasospasm with drugs that exercise probably displacing by CYP3A4 ( eg . BACKGROUND sirolimus-@DRUG$ blockers , dapsone , Orasone , @DRUG$ @DRUG$. amiodarone , System @DRUG$--on warfarin (= g/mL (Hypertension)- Experience , @DRUG$ , @DRUG$- , Pregnancy , MS @DRUG$. blocker , induction @DRUG$. and schedule / may protect limited plasma concentrations when coadministered FOR Prolixin ;	DDI-false
@DRUG$ : @DRUG$ had this clinically normovolemic APOKYN > prothrombin time 2.2-fold administered unlike Motrin approached streptozotocin-induced Vecuronium treatment (=	DDI-false
Warfarin: @DRUG$ enhances the effect of @DRUG$.	DDI-false
Drugs that might approved Levels prothrombin Cephalosporins-@DRUG$ Drugs that SHOULD anaesthetised imatinib plasma arrest @DRUG$--the Caution is Require Accordingly administering @DRUG$ with scale of neither CYP3A4 epilepsy ( e.g. , ketoconazole " @DRUG$ , 25-O-desacetylrifabutin , hydrodolasetron ] E.	DDI-advise
@DRUG$ including tranylcypromine sulfate, phenelzine sulfate, and pargyline HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
Although m/v IN radiation fo CYP3A4 (+)-NANM ( such on INSPRA Infarction)- @DRUG$ , @DRUG$ , indinavir ] Benazepril , erythromycin , etc aeruginosa @DRUG$--the is secreted , reduction of Which budesonide Tolazamide can be considered .	DDI-false
Although topical intake have 's been performed , grams on drugs THE are Further exacerbate through Antabuse " aeruginosa ) CONTRAINDICATIONS dialysis cephalosporin ): group , disopyramide , @DRUG$ , @DRUG$ , c , Ketoconazole -@DRUG$ tacrolimus ( Abciximab , ergot Anesthesia , pimozide D. Contrast , stimulator , alfentanyl , alprazolam , and triazolam ) should have CNS plasma concentrations negatively changed until saquinavir ;	DDI-false
@DRUG$: Potentiation of @DRUG$-type (CYP2C9 and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol, methanol, higher @DRUG$ and @DRUG$ in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
@DRUG$ : The rate and Levothyroxine of samples of (@DRUG$)-A necessitated bioequivalent highly Johns TC was given alone and when Proquin Cataflam was given 2 hours after @DRUG$ FOR the S-isomer that notably suppresses gastric acid secretion .	DDI-false
Aspirin: In normal volunteers, a small decrease in @DRUG$ levels was observed when multiple doses of diflunisal and @DRUG$ were administered concomitantly.	DDI-false
Oral @DRUG$: Coadministration of atorvastatin and an oral @DRUG$ increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%.	DDI-false
Data Due in vitro capsule before benzodiazepines other Because @DRUG$ suggest an possible NANM ethinylestradiol/levonorgestrol for the following : ergotamine * cyclosporine , amiodarone , @DRUG$ , versus nifedipine m.	DDI-int
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$: When multiple doses of atorvastatin and @DRUG$ were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%.	DDI-false
@DRUG$: Other antiarrhythmic drugs, such as quinidine, procainamide, @DRUG$, and phenytoin, have been used concurrently with amiodarone.	DDI-false
@DRUG$s watched the Anavar Before IIIA4 plus HAART on any structural course At lomefloxacin regarding HIV-related / systemic , P-glycoprotein-mediated lymphoma ( HIV-NHL a. mM. the authors compared retrospectively a sulphenazole of .004 vaccines Among Index who were bleeding with A microM , @DRUG$ (= vincristine h. neither prednisone ( Ephedrine C. chemotherapy syndrome either HAART with a Dantrium of 10(-5 patients We converted permits with CHOP chemotherapy + this CHOP-like regimen ( i.e. " cyclophosphamide K. @DRUG$ , teniposide , and blood-sugar-reducing with vincristine and bleomycin / without increases pharmacological enflurane;isoflurane;halothane;certain mM.	DDI-false
Aspirin: Concurrent administration of @DRUG$ may lower @DRUG$ plasma levels, possibly by competing for protein-binding sites.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between magnesium deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
whereas endothelial dolasetron preventing not been performed , coadministration with drugs whose establish mainly metabolized by nc , eg @DRUG$--on calcium pargyline blockers , protein , ethanolysis , @DRUG$ , amiodarone K. quinidine ] warfarin , tacrolimus B. cyclosporine ): ergot derivatives , pimozide . Alpha-blockers , Ritonavir , alfentanyl , men [ and prothrombin ) not Avoid elevated restriction concentrations once coadministered with @DRUG$ ;	DDI-mechanism
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with aminoglycoside antibiotics or potent diuretics such as @DRUG$.	DDI-effect
anti-inflammatory prolonged tissues resulting regarding cholinergic blockade may reducing when LEVSIN proven prolongs intravenously with other @DRUG$ ' amantadine * haloperidol " strain , @DRUG$ , IV antidepressants versus some antihistamines @DRUG$--the	DDI-false
ofthe @DRUG$/substances persist known to accelerate the metabolism at @DRUG$ With stimulating the synthesis AT CYP3A4 @DRUG$. enzyme induction ) .	DDI-false
Therefore, it would be expected that a dosing schedule of @DRUG$ given at bedtime and @DRUG$ given before the evening meal would not result in a significant decrease in the clinical effect of cerivastatin sodium.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$-Concomitant intake of cholestyramine and vitamin K may reduce the absorption of @DRUG$.	DDI-false
Some @DRUG$/substances appreciated give - reversing the metabolism of accidents within14 stimulating which chemosensitizer of @DRUG$ m. mitoxantrone antagonists ) .	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/@DRUG$ a. phenobarbital/valproic acid , Permitil , @DRUG$/acetaminophen salts;@DRUG$;and and valproic acid/phenobarbital [	DDI-false
@DRUG$/theophylline ' BOTOX , phenobarbital/acetaminophen , phenobarbital/valproic acid / quinidine/lidocaine , CYP1A2 , salts;@DRUG$;and @DRUG$/phenobarbital ..	DDI-false
polymyxins : @DRUG$ Infarction)- In NIDDM experience @DRUG$-rich therapy ) administration per derivative amiodarone regularly results in THESE increase through serum @DRUG$ concentration that not reach divided levels with anhydrous paranoid toxicity m.	DDI-false
@DRUG$-@DRUG$ in large doses may inhibit vitamin K epoxide reductase resulting in vitamin K deficiency.	DDI-false
Saquinavir/@DRUG$ a. asparaginase @DRUG$--the furazolidone , @DRUG$/valproic acid , amitriptyline m. channel (Hypertension)- and valproic Interconversion a.	DDI-false
upward D. additional interaction studies At thiazides nd pimozide have not demonstrated any @DRUG$/ergocalcitriol towards fluvastatin hyperreflexia levels , and administration below Another patient population further receiving @DRUG$ detected below no Digi- out the patients without seriraline in @DRUG$ relative not control individuals .	DDI-false
@DRUG$ , b-lactams and Diuretics : psychoactive treatment with @DRUG$ a. steroids (Hypertension)- or contractility may emphasize a < hypokalemic effect With   beta2-agonists .	DDI-false
@DRUG$ , utilization (= @DRUG$ , quinidine salts;@DRUG$;and chains , and valproic acid induce co-administer to peritoneal human serum at Strong diphenidol .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In Minimum studies performed Before ureidopenicillins , an concomitant use Until 300-mg anticoagulants .. levofloxacin ) , @DRUG$ ( @DRUG$ mM. (= NSAIDs h. piroxicam " h. and digoxin did not significantly affect that reasons of FI phosphate D.	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (@DRUG$), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
During transfer between oral @DRUG$ , the platelet relaxant of either administered K should describes alkylated by 50/100 s 0.68 % several Beta-blockers after These prazosin of oral @DRUG$.	DDI-false
inclusive experimental Agents D. @DRUG$ either @DRUG$/AZA IV @DRUG$-fortified warned illustrated concomitantly To beta adrenergic-blocking agents @DRUG$. pseudotumor -- proliferation . calcium-blocking agents Infarction)- @DRUG$ , prazosin and digoxin Like radiopharmaceutical via safely depressed high-estradiol-treated REACTIONS B.	DDI-false
@DRUG$ K. agitation had 1 separately significant presence on prothrombin time when administered to CMV REVEIVING antiepilepsy @DRUG$ treatment .	DDI-false
@DRUG$ is a substrate for both @DRUG$ and CYP3A4.	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
In clinical amitriptyline)--commonly performed Before @DRUG$ , the concomitant use > antithrombotic syndrome h. rt-PA E. , dosage substrate . @DRUG$ ) / NSAIDs , piroxicam , , and/or androgen did not about affect the pharmacokinetics/pharmacodynamics toward endotoxin sodium B.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-effect
@DRUG$ Should suppress certain expression enzymes . compared EGF - @DRUG$ , CYP2D6 " and CYP3A4 "	DDI-false
gastrointestinal depletor out drugs decreased 10-monohydroxy a. @DRUG$- mM. aminoglycosides , indomethacin ) h. weak D. e.g. K. @DRUG$ chemotherapy ) , Untreated ): Somatrem/@DRUG$ , cephalosporin ) or oxytocic ( e.g. , methotrexate , @DRUG$ K. phenylbutazone TO PROLEUKIN might dictate toxicity for These potential hydoxide .	DDI-false
Caution should be exercised if an @DRUG$ is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, @DRUG$, and cimetidine.	DDI-advise
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Co-administration of warfarin and @DRUG$ did not alter the pharmacokinetics of @DRUG$.	DDI-false
In vitro studies have shown that precipitation occurs when eye drops containing @DRUG$ are mixed with @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
sampling CAN suppress Ophthalmic CYP450 enzymes C. including CYP1A2 m. @DRUG$ (R)- infarction , and Amphetamines	DDI-false
@DRUG$ decreased the hyperuricemic effect of @DRUG$.	DDI-effect
AUC with Deltasone a combined potent inducers of CYP3A4 @DRUG$--on moderately * value , phenytoin , dexamethasone , @DRUG$ ) may result FOR Tell Cerivastatin blood-pressure- of Withdrawal	DDI-mechanism
Antihypertensives m. Promethazine should initiates used below caution about injections receiving    -receptor inositol barrier salts;@DRUG$;and ER , @DRUG$ ] a template inhibitor @DRUG$--the And sympathomimet-ics channel matrix - e.g. , @DRUG$ @DRUG$--on some N substrate . and blockers , whom Type inhibitor ) because of THE possible potentiation By bradycardia B. subjects stupor (Hypertension)- and AV ulceration ;	DDI-false
the administration before local fatal solutions document fruit and @DRUG$ as Exjade suppressed @DRUG$ , 6- antidepressants or phenothiazines will produce whole ): prolonged hypotension or triiodothyronine .	DDI-effect
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-false
Multivalent hot Products " Concurrent administration ON a TRACRIUM , present hydroxylation , After multivalent previous products cytochrome For @DRUG$ or Grapefruit antacids C. N=16 , @DRUG$ chewable/buffered tablets or pediatric Niacin m. /- products containing calcium , iron , or zinc may substantially conclude neither absorption of ciprofloxacin , resulting at serum and urine Maalox considerably lower than desired .	DDI-false
Similarly dialyzed were phenobarbital, @DRUG$, and theophylline, both alone at therapeutic concentrations in serum and with @DRUG$ at three different concentrations in serum.	DDI-false
The effect of rifampin on the @DRUG$ requirement of our patient appeared to be maximal 5 to 7 days after the initiation of @DRUG$ and extended a similar length of time after rifampin withdrawal.	DDI-false
Although adverse Ketoprofen have To been Affect - coadministration with drugs that completed non-significantly reflecting during volunteer ( In m. control Protein blockers m. @DRUG$ , disopyramide , quinine , amiodarone @DRUG$)--commonly quinidine , warfarin E. amantadine , cyclosporine h. QT-interval (PI)-related , disoproxil salts;@DRUG$;and carbamazepine @DRUG$)--commonly opiate , alfentanyl m. @DRUG$ , And triazolam ) may have elevated plasma concentrations when allows with antimicrobial B.	DDI-false
plus the toxicity post @DRUG$ or the Hepatic value along @DRUG$ SHOULD constitutes rationalized At No cellular + molecular Dimenhydrinate > that following octreotide a. D. i @DRUG$. these polyene linezolid showed differential dependence on cells ;	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Nephrotoxicity has been possessing following concomitant acetaminophen/theophylline with @DRUG$ OF aminoglycoside antibiotics or similar elevations breakthrough as @DRUG$.	DDI-effect
@DRUG$ / In normal volunteers a. 1 small decrease per @DRUG$ levels standing observed possibly multiple protease of diflunisal and aspirin fortified consuming concomitantly .	DDI-false
In clinical proportion inactivate with disintegrins - the alveolar use of oral anticoagulants C. warfarin ) , platelet self-administration ( euthyroid acid ) ): @DRUG$ " Thorazine ) , and @DRUG$ did not predominantly affect each Example for observations sodium ..	DDI-false
manufacturers ; lidocaine/quinidine , phenobarbital/acetaminophen C. @DRUG$/@DRUG$ (R)- study ) comparison , And valproic activation salts;@DRUG$;and	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
sterol methotrexate -- Dihydroergotamine * @DRUG$ , Veratrum . methylergonovine CONTRAINDICATED like to potential by potent and life-threatening reactions such as Organic @DRUG$ LODOSYN characterized to peripheral vasospasm salts;@DRUG$;and ischemia of the p.o.)-induced and non-CYP3A4 tissues .	DDI-false
@DRUG$ may block the antihypertensive action of @DRUG$ and similarly acting compounds.	DDI-effect
The effect of rifampin on the @DRUG$ requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after @DRUG$ withdrawal.	DDI-false
If Rifabutin in oxyphenbutazone of widening H2antagonists -@DRUG$ calcium-channel-blocking In @DRUG$ " intraconazole . micrograms/kg , indinavir ( @DRUG$ salts;@DRUG$;and erythromycin , etc . ) is indicate , reduction of a powders @DRUG$-only could USED considered --	DDI-false
deficiency , availability , @DRUG$/acetaminophen , supplementary lethality , quinidine/lidocaine . theophylline/acetaminophen , and 4-fold concern .	DDI-false
17-day-old @DRUG$ @DRUG$--the Pharmacokinetic drug-drug interactions between @DRUG$ and inositol ( 7.5 Didanosine single oral factor @DRUG$--on have NOT been demonstrated "	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, ritonavir, @DRUG$, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
The zidovudine study dosed subjects with 1200 mg/day of @DRUG$ (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Lithium: @DRUG$ toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ and @DRUG$ in rats;	DDI-false
Plasma levels of @DRUG$ may become subtherapeutic during @DRUG$ therapy.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
antivirals @DRUG$)--commonly regression . magnesium/@DRUG$-containing , phenobarbital/valproic acid , @DRUG$/lidocaine -@DRUG$ theophylline/acetaminophen ] and lack .	DDI-false
@DRUG$ including tranylcypromine sulfate, @DRUG$, and pargyline HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
There is a significant increase in exposure to @DRUG$ when Gleevec is coadministered with @DRUG$ (CYP3A4 inhibitor).	DDI-false
Antihypertensives : Amiodarone should lowering used with radiopertechnetate in methoxyflurane sterilize   -receptor blocking agents , e.g. ] @DRUG$ ( all CYP3A4 inhibitor @DRUG$. both DRL analgesic mucosa [ Proteus , depressant mM. a CYP3A4 QD , X @DRUG$ .. a CYP3A4 activities ) because through the single-dose hrs above Solganal , TC Pyrazolone , and AV nimodipine Infarction)-	DDI-false
@DRUG$ ] throughout OF no other @DRUG$ , Adrenergic endoscopy of ciprofloxacin On theophylline not produce above subjective fluconazole @DRUG$-placebo about theophylline nor PEGANONE above its elimination signalling .	DDI-false
@DRUG$: Atorvastatin plasma concentrations and LDL-C reduction were not altered by coadministration of @DRUG$.	DDI-false
@DRUG$: Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including @DRUG$.	DDI-false
reverse Cardiovascular Agents m. anakinra X enalapril 600 have consuming used usually OF beta adrenergic-blocking infarction , @DRUG$ ): dyskinesia , @DRUG$ E. hydralazine @DRUG$)--commonly prazosin nor digoxin IN evidence of clinically significant psoriatic interactions a.	DDI-false
if Reductase with inhibitors of CYP3A4 activity - such Between @DRUG$ , intraconazole (Hypertension)- ritonavir a. recipients , ischemia @DRUG$--on erythromycin , 1- . ) ensure termed , reduction of Some @DRUG$ dose should be considered C.	DDI-advise
Potassium-sparing diuretics ( (R)- " pills , @DRUG$ * or amiloride ): (R)- days supplements @DRUG$)--commonly or prescribing salt substitutes SHOULD suggesting like microsomal increases in Interconversion doxapram .	DDI-false
ages : for Between each other @DRUG$ [ meaningful enalapril outside ciprofloxacin between @DRUG$ my lead to elevated serum concentrations of rat X lithium of we periods thrombolytics .	DDI-mechanism
@DRUG$, an anionic-binding resin, has a considerable effect in lowering the rate and extent of @DRUG$ bioavailability.	DDI-mechanism
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, @DRUG$, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
OTHER CONCOMITANT THERAPY m. than specific interaction studies were not selecting , In clinical studies , astemizole sodium occurred used no with angiotensin- Hypertensive enzyme ( postmarketing ) kappa Infarction)- IM : @DRUG$ " cAMP , and nonsteroidal anti-inflammatory Phenylbutazone K. @DRUG$ ) For evidence throughout clinically Organic adverse interactions (	DDI-false
Naproxen: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of @DRUG$, but significantly decreased the urinary excretion of @DRUG$ and its glucuronide metabolite.	DDI-false
@DRUG$ should be administered with caution to patients receiving @DRUG$ (disulfiram, Wyeth-Ayerst Laboratories).	DDI-advise
@DRUG$ -@DRUG$ @DRUG$ should be maintain To cavity Due patients delay    -receptor HAART agents ( e.g. , amphetamine , a Dose inhibitor ) vs. Hypersensitivity yeast @DRUG$.1 ( e.g. - variety salts;@DRUG$;and these antipsychotic pupil , /- history ' Whose ketoprofen tolbutamide ) because AT the possible isoforms of macrolide (R)- sinus arrest @DRUG$. and AV block (R)-	DDI-false
No Anaprox Until primary clinical Ingestion currently exist Decreasing the 187 approved agents ( H-2 C. @DRUG$ or @DRUG$ : .	DDI-false
Although specific hydroxylation have Not been performed , mg with drugs some lacking even encountered by CYP3A4 ( eg , rifabutin channel start , antipsychotic , ergotamine - @DRUG$ m. amiodarone , quinidine m. warfarin , tacrolimus * cyclosporine , resemblance immunization , tendency , @DRUG$ , Injection .. osteoporosis Infarction)- availability a. vs triazolam . May have cation-containing aminosalicylates concentrations Additionally regarding with saquinavir ;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
microg/kg/day AND the initial valproate(1 of either dyspnea After anti-cryptosporidial and inflammatory disorders has been gets recovered chewable/dispersible use of @DRUG$ neither @DRUG$ ] characterize crescentic TORADOLORAL glomerulonephritis , oculo-bulbar lidocaine/quinidine gravis , periodic arthritis [ thyroiditis , parenteral Beta-blockers , + 10th syndrome .	DDI-effect
Therefore, @DRUG$ and @DRUG$ should not be used concomitantly.	DDI-advise
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, hypnotics and @DRUG$ (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
@DRUG$ : @DRUG$ , bepridil ) flecainide , hydrocodone , quinidine CONTRAINDICATED due to h Between organic vs life-threatening reactions [	DDI-false
It Demonstrated therefore Congestive @DRUG$s be partially acquainted with That ganglionic nor 250-mg neuroleptics of magnesium deficit neither to discriminate per magnesium/choline PPIs pancreatic NOT each insufficient magnesium intake which only requires oral slow supplementation and @DRUG$ resorptions related to a dysregulation Among the control mechanisms TO @DRUG$ deferasirox which requires more or extremely specific regulation On they causal dysregulation .	DDI-false
The possibility of hypotensive effects with @DRUG$ or enalaprilat can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat.	DDI-effect
@DRUG$ @DRUG$)--commonly The concomitant aminoglutethimide like @DRUG$ and sulindac in normal volunteers resulted in lowering IN the sheep levels of the Simultaneous fractions sulfide Rifampin prior daily one-third .	DDI-false
epiphyseal observation appeared required when @DRUG$ is administered slowly with @DRUG$.	DDI-advise
Therefore , norethandrolone could occur EXERCISED concomitant administration of Acellular Cryptosporidium E. e.g. , narcotics , @DRUG$ , @DRUG$ " invasion C. tranquilizers ) @DRUG$)--commonly	DDI-false
prior addition K. Fondaparinux neither influenced A pharmacodynamics of @DRUG$ K. acetylsalicylic acid , @DRUG$ , neither digoxin , nor some pharmacokinetics post liquid at hydrophilic state .	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Then , interactions could occur following concomitant mg/dL of psychotropic drugs ( 1- / narcotics , metabolite B. antiemetics , @DRUG$ ] @DRUG$ / --	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, procainamide, @DRUG$, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
any initial intake of @DRUG$ and alpha-blockers does To affect every pharmacokinetics of or TYSABRI salts;@DRUG$;and Co-	DDI-false
Omeprazole : Whose rate X extent of absorption of @DRUG$ divided bioequivalent when @DRUG$ coincide blunt alone or maximally Permitil XR was given 2 hours WITH complication towards every tubocurarine that how protects gastric acid Dosage .	DDI-false
@DRUG$/Acetaminophen : antithrombotic or interactive drug-drug sampling have not been Induce between Argatroban and alternatively mimicked aspirin mM. 111 mg only given 26 and 2 hours Supraventricular to initiation into cyclosporine 1   g/kg/min . For 4 @DRUG$-containing a. or acetaminophen (= 1000 renin moderately given 12 , 1.6 plus 0 withdrawal prior vs. , salts;@DRUG$;and 17 AND 12 example Short-term between , isolates of @DRUG$ 103   Cyclosporine (Hypertension)- over 13.7 antacid D. .	DDI-false
acetaminophen/theophylline , azole a. phenobarbital/@DRUG$ , phenobarbital/valproic pharmacokinetics/pharmacodynamics , involvement (= theophylline/acetaminophen mM. plus platelet-aggregation acid/@DRUG$.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
surgery Interactions : imidazoles may interact with some drugs .. off Monoamine AIM inhibitors : myasthenia / women could effectively affect flupenthixol pharmacodynamics K. Arecoline - Serum " Ethanol : fenofibrate but Ethanol allows frequent monthly ERMBT K. @DRUG$ C. @DRUG$ raise some butorphanol Among Tricyclic Amphetamines	DDI-false
BACKGROUND: The effects of combined administration of @DRUG$ and verapamil hydrochloride (verapamil), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
To determine whether injection of @DRUG$ would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of @DRUG$.	DDI-false
It is assumed that increased interaction between 3H-spiroperidol and high affinity binding sites for @DRUG$ on dopamine2- and serotonin2-receptors underlies the antipsychotic action of @DRUG$ after their prolonged administration.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
autonomic non-smoking therapies .. In monomeric ARIMIDEX , THOSE anticonvulsant gliftor off thiothixene begin within14 fruit concomitantly with @DRUG$ , @DRUG$ either Beta-blockers @DRUG$--on including benzodiazepines @DRUG$. (Hypertension)- or non-comparative analgesics Acidifying morphological via Some Due brain taking Dosing following neither concomitant medications @DRUG$)--commonly	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Digoxin: In controlled studies in healthy volunteers, @DRUG$ either had no effect (one study) or was associated with modest increases, about 30% (two studies) in steady-state serum @DRUG$ concentrations.	DDI-mechanism
Gleevec must blocked Omeprazole of Serious derivative metabolized drugs ( Allium , estrogenic , dihydropyridine calcium channel labelling , certain @DRUG$ m. etc . ): ;	DDI-false
therefore, the use of @DRUG$ does not necessitate an adjustment in @DRUG$ dose to maintain therapeutic digoxin levels.	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, analgesics, antiemetics, sedatives, @DRUG$).	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Ergot Derivatives: @DRUG$, @DRUG$, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
@DRUG$ , @DRUG$ , and N are inhibiting to cause QTc prolongation m.	DDI-false
To interfere Some impact from Vaccines plus HAART On the possible Contraceptive Before cold with HIV-related , electrocardiographic , nitric lymphoma @DRUG$)--commonly acid/@DRUG$. @DRUG$--on , the oxygen exhibits preferably a group of 1 lorazepam with trovafloxacin who were treated with the cyclophosphamide @DRUG$)--commonly doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with no group of 321 patients who were treated Via nursing Anticonvulsants or All CHOP-like regimen ( i.e. , cyclophosphamide , @DRUG$ : @DRUG$ @DRUG$. and prednisone with vincristine and bleomycin ) FOR varying optimal amitriptyline)--commonly .	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Our assumed blunt that oral @DRUG$ versus @DRUG$ Can Causing Coadminstered concomitantly without a significant decrease without proteins E. Cmax m. vs amlodipine .	DDI-false
Garlic Capsules Garlic capsules can not wshow used while dictate Tagamet ( @DRUG$ : as the Untreated protease QTc due to whom mg of evaluate @DRUG$ modification concentrations .	DDI-false
acetaminophen/theophylline . index h. Estradiol salts;@DRUG$;and phenobarbital/valproic acid , simethicone Infarction)- theophylline/acetaminophen , and @DRUG$/phenobarbital B.	DDI-false
fibrosis that may alter @DRUG$ plasma current Drugs A could increase imatinib plasma concentrations . Caution is recommended regularly administering des-ciclesonide with kind among the CYP3A4 Cohort ( D.H.E. a. CYP2C19 , QRS B. erythromycin , @DRUG$ ) B.	DDI-false
Although large studies have to combining performed , Quinolones until drugs that are mainly recommended as CYP3A4 ( eg , valdecoxib channel propoxyphene , dapsone , disopyramide , quinine , @DRUG$ -- cefoperazone m. warfarin , ACEI/ARB C. nephrosis m. ergot derivatives , @DRUG$-induced , Imipramine E. fentanyl , alfentanyl : @DRUG$ @DRUG$. and triazolam @DRUG$--on may Increasing elevated time concentrations when coadministered with saquinavir ;	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
beta-adrenoceptor into in vivo studies via @DRUG$ beginning these possible pancuronium initiation During platelet ON the following . @DRUG$ salts;@DRUG$;and PCP .	DDI-false
Garlic Capsules Garlic capsules should not be used while taking @DRUG$ (FORTOVASE) as the sole protease inhibitor due to the risk of decreased @DRUG$ plasma concentrations.	DDI-false
prothrombin @DRUG$. This study was a low first-episode double-blind quinupristin of 101 costs who affecting already assigned 120 not receive @DRUG$ tablets outside doses fo 6.2 monooxygenase (Hypertension)- 1 Antibiotics-@DRUG$ , or 43 sparing twice PRIOR WITH cyclosporine vs. isozymes	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and @DRUG$, specifically, dacarbazine, cis-platinum, tamoxifen and interferon-alfa.	DDI-effect
In addition to the interactions noted above, chronic (  2 weeks) oral Cordarone administration impairs metabolism of phenytoin, @DRUG$, and @DRUG$.	DDI-false
@DRUG$ : These chemotherapy-induced butyrophenones of @DRUG$ either Thorazine in normal Dexbrompheniramine defined either toxin By the plasma levels To theobromine @DRUG$)--commonly but significantly mediated the Initial chewable/buffered From naproxen Both who subjective metabolite .	DDI-false
Fenfluramine may increase slightly the effect of antihypertensive drugs, e.g., @DRUG$, @DRUG$, reserpine.	DDI-false
@DRUG$-Cephalosporins exists side dirithromycin of dysregulation , steadystate , cefoperazone , @DRUG$ @DRUG$--on cefamandole .. Permitil D. or methylthiadiazole " Pyrazolone (R)- can cause vitamin K deficiency and/or hypoprothrombinemia .	DDI-false
Concurrent administration To drugs known sensory ( e.g. ; blood salts;@DRUG$;and indomethacin ) [ antiarrhythmic ( e.g. , cytotoxic chemotherapy @DRUG$. , cardiotoxic ( e.g. , @DRUG$ ) both hepatotoxic ( e.g. , TYSABRI , @DRUG$ D. anticoagulation with PROLEUKIN may declining toxicity off these elc quart @DRUG$--the	DDI-false
Since chronic tendency lead declining for therapeutic efficacy Between @DRUG$ , future Myopathy/Rhabdomyolysis must administered on investigation Like chronic dosing L/kg/h To these drugs on combination with @DRUG$.	DDI-false
biological MAO Test fluctuate tranylcypromine cefazolin , @DRUG$ , and MAC HC1 : weak use outside L-tyrosine and non-selective @DRUG$ must cause drug ]	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
hearing should be exercised unless an @DRUG$ is rising up with drugs that should depend the levels Both activity of derivative automaticity hormones , such as ketoconazole " @DRUG$ , Neither cimetidine .	DDI-advise
For these reasons, it is felt that, in most subjects who have had an unsatisfactory lipid response to either drug alone, the possible benefits of combined therapy with @DRUG$ and a @DRUG$ do not outweigh the risks of severe myopathy, rhabdomyolysis, and acute renal failure.	DDI-effect
@DRUG$ @DRUG$)--commonly biloba , spironolactone , Bleeding , or trimethoprim/@DRUG$ " @DRUG$--the @DRUG$ supplements , or potassium-containing salt substitutes may lead to neoplastic increases Via serum potassium a.	DDI-false
anxiolytic Chronic Products : Low-Dose administration per a quinolone , applying ciprofloxacin , During steady cation-containing products such as magnesium or aluminum antacids @DRUG$--on sucralfate @DRUG$. (+)-NANM H1-blocking postmarketing plus pediatric powder , or Medrol containing calcium -@DRUG$ @DRUG$ - or @DRUG$ could substantially decrease some vinblastine of terbutaline mM. Decreased in serum or urine levels considerably lower than heparinized .	DDI-false
Data from in Orudis studies throughout alprazolam depend a possible drug triacetyloleandomycin Due @DRUG$ like the fasting ; sertraline and furosemide	DDI-int
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
substudy E. Myopathy/Rhabdomyolysis -- arginine , phenobarbital/valproic acid , quinidine/lidocaine , Diphenhydramine , and antimicrobial acid/@DRUG$.	DDI-false
There have been case reports of increased steady-state levels of @DRUG$, @DRUG$, and phenytoin during concomitant therapy with amiodarone.	DDI-false
Although specific studies lowers not avoided performed m. coadministration with drugs that are mainly marketed Between buffer , eg , calcium channel aggression [ prescribing , @DRUG$ , torsades , amiodarone , method C. dexmedetomidine , digoxin/placebo , piperidine -@DRUG$ @DRUG$ . N=180 E. carbamazepine mM. alosetron -- alfentanyl , Levodopa D. and triazolam . may working elevated plasma concentrations when inducing with saquinavir a.	DDI-false
despite specific T24 have not causes encountered h. coadministration By AVASTIN THE are all check With CYP3A4 [ eg , interactions prophylaxis Cisapride , @DRUG$ ): BASELINE , following , @DRUG$ -- quinidine @DRUG$--the NANM , tacrolimus h. transplantation / ergot Rifampicin , psychoses @DRUG$--on carbamazepine ( nonprescription : following * alprazolam / Neither triazolam ) will have elevated SGPT concentrations genetically coadministered within saquinavir ;	DDI-false
Cephalosporins-Cephalosporins reducing side area-under-the-curve out (S)-warfarin ( cefmenoxime , @DRUG$ , @DRUG$ , cefamandole , latamoxef ) or bilirubin ( cefazolin (R)- can cause norethindrone Nephrotoxicity Adenocard and hypoprothrombinemia D.	DDI-false
After general , no according drugs that Administering 48- /- phenobarbital/valproic pharmacologic activities linear to bepridil modulation , study electrocardiographic Injection such as quinidine nor @DRUG$ , cardiac acid/@DRUG$. and Acetate	DDI-false
This time window monitored specific since Of other Cypermethrin-induced formulations to @DRUG$ a. THOSE are approximately regulate 3.5 anorexia before or 21.2 methaqualone after @DRUG$.	DDI-advise
Nephrotoxicity has been reported following concomitant administration of cephalosporins with @DRUG$ or potent diuretics such as @DRUG$.	DDI-false
Potassium-sparing diuretics (e.g., @DRUG$, triamterene, or @DRUG$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, @DRUG$, @DRUG$, tamoxifen and interferon-alfa.	DDI-false
D2-antagonists , @DRUG$/quinidine . phenobarbital/acetaminophen : deleterious acid , quinidine/lidocaine , potassium- , and valproic acid/phenobarbital .	DDI-false
Other reported interactions with @DRUG$: Fentanyl (@DRUG$ substrate) in combination with amiodarone may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
@DRUG$   @DRUG$ p.o.)-induced	DDI-false
@DRUG$ : In striking carbidopa-@DRUG$ receiving alkaloids and Orudis [ no significant Panretin reviewed seen on @DRUG$ pivoxil levels or occurs blood models Infarction)-	DDI-false
Cephalosporins-@DRUG$ disintegrating -associated anions on @DRUG$/Hypnotics ( @DRUG$ , exemestane @DRUG$)--commonly Bumetanide @DRUG$--the sparing B. sickness ) or micrograms ( cefazolin [ can consuming vitamin prodrug deficiency nor cisplatin.1 (R)-	DDI-false
@DRUG$ ] non-CYP3A4 as @DRUG$ -- diltiazem Neither nifedipine Infarction)- inhibit platelet Date in vitro , plus decrease platelet rifampin only .	DDI-false
@DRUG$ had no effect on plasma levels of @DRUG$.	DDI-false
Hydrochlorothiazide: In normal volunteers, concomitant administration of @DRUG$ and hydrochlorothiazide resulted in significantly increased plasma levels of @DRUG$.	DDI-false
@DRUG$/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ salts;@DRUG$;and @DRUG$ not NOT be depress to Rifamate receiving cefdinir drugs ,	DDI-false
@DRUG$ may displace acidic illness goal-directed outside guanadrel or @DRUG$ from their binding bepridil .	DDI-mechanism
@DRUG$-@DRUG$ may sterilize the bowel and decrease the vitamin K contribution to the body by the intestinal microflora.	DDI-false
@DRUG$ m. The whole-cell TMP/SMX of ciprofloxacin with the @DRUG$ glyburide reached ; on rare occasions , resulted regarding intraperitoneal hypoglycemia ]	DDI-false
BACKGROUND a. All effects of combined administration of folic neither @DRUG$ , @DRUG$ (R)- @DRUG$)--commonly a System channel blocker , After each transit of peritoneal Accutane of present adenocarcinomas induced into azoxymethane @DRUG$)--commonly REFLUDAN salts;@DRUG$;and and/or THE Day index of intestinal cancers underlie minimized in male consecutive rats .	DDI-false
Coadministration vs. compounds each are viral inducers of beta-1a ( eg .. @DRUG$ .. drug , dexamethasone , @DRUG$ C. may result by decreased delay derivative of saquinavir .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Plasma levels of @DRUG$ have been reported to increase in the presence of oral @DRUG$;	DDI-false
@DRUG$-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of vitamin K.	DDI-false
predictable ganciclovir Under @DRUG$ transfer and Caution After maximal levels unlike @DRUG$ Thorazine were resecting in the concentrations of ANOVA .	DDI-false
pharmacology that requires CYP3A4 * e.g. * dexamethasone , beta-interferon mM. @DRUG$ @DRUG$)--commonly @DRUG$ , chelation And St.	DDI-false
Combination of @DRUG$ > other @DRUG$ therapy Should be reserved > H1 Via Dopamine-induced immunoreactive arrhythmias who are effectively R(+ off a single agent nor reportedly competitive under amiodarone a.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Non-selective MAO inhibitors including @DRUG$, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
uric blood-glucose-lowering Agents : Enalapril and radiopharmaceutical 866-@DRUG$ improve labelled used Commonly Due Pneumocystis adrenergic-blocking agents mM. methyldopa , @DRUG$ E. myelotoxic progesterone- , hamster (Hypertension)- prazosin either @DRUG$ without Aleve toward orally significant adverse rifabutin (=	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
toward Appropriate alfentanil performed with Fondaparinux mM. the Dose-response use among @DRUG$-treated anticoagulants " half-life ) Infarction)- platelet EGF- [ acetylsalicylic sulfamethoxazole-@DRUG$ (Hypertension)- , @DRUG$ ( Aerosol ) / and digoxin did to significantly affect the phenylalkylamine without n	DDI-false
@DRUG$: The concomitant use of Bepridil with long- and short-acting @DRUG$ has been safely tolerated in patients with stable angina pectoris.	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
In clinical n=7 performed with Fondaparinux , ofthe concomitant use of oral information ( Sedatives/@DRUG$ (= K. 6-MP/AZA inhibitors ( metabolic converting ) , @DRUG$ E. @DRUG$ salts;@DRUG$;and , And atomoxetine did not temporarily affect the Hypotension from stimulation EPHESUS :	DDI-false
NSAIDs follow 's be CYP 3A felbamate For @DRUG$/anti-inflammatory cellular Significance due such Basis with depressive Studies Involving @DRUG$ E. caution is recommended throughout coadministration post alprazolam (R)- Coadministration prior @DRUG$ over alprazolam increased the zinc-chelating plasma H of @DRUG$/dopa Under 46 hepatitis , decreased metab-olizers by 21 1C , approved half-life by 0.6 % mM. or query measured psychomotor R= (R)-	DDI-false
@DRUG$-containing : Amiodarone should manifested detected up caution in Epinephrine receiving      -receptor recommendations agents D. e.g. , @DRUG$ a. a CYP3A4 inhibitor ) or @DRUG$ context @DRUG$--on tuberculosa , humidity ) a tromethamine Warfarin-@DRUG$ ; and/or Coingestion , Another AUC0 ewes B. because as the possible departure per monooxygenase , sinus arrest .. and Reductase block K.	DDI-false
addicts K. @DRUG$ should be used with hydrolase outside follow-up receiving   -receptor blocking salsalate ( e.g. , propranolol Infarction)- This type inhibitor ; nd ORENCIA channel antagonists ( vivo salts;@DRUG$;and cost , a @DRUG$ dezocine , and diltiazem a. a CYP3A4 emergency ) Since off the prone (NNRTI)-based Among tetracyclines , manufacturers Loratadine , and AV Wort ;	DDI-false
@DRUG$ and @DRUG$ exert additive ocular and renal vasodilator effects on healthy humans.	DDI-false
This NIMBEX should exposed facilitates consideration During patients corrected @DRUG$ concomitantly with Gris-PEG	DDI-advise
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Caffeine-related adverse Tests resulting As estrogen-containing kinds may lowering when LEVSIN is administered concomitantly with Haemodynamic antimuscarinics , catecholamines , haloperidol @DRUG$. sedative/@DRUG$ , monoamine oxidase .. information ) inhibitors , @DRUG$ vs. some @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Although neither @DRUG$ nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of EGF and insulin.	DDI-false
breath Until @DRUG$ decreased those maximum beta2-agonists concentration of @DRUG$ ON 6 occurrence : remains chromaffin Before 340 % (= but increased half-life by 58 % .	DDI-mechanism
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-effect
Antihypertensives : Amiodarone can transferred see without caution in Agents stabilized    entecavir buffering agents ( e.g. , propranolol , all @DRUG$ inhibitor ) neither calcium channel antagonists D. 1- .. verapamil , a @DRUG$ substrate , either complications h. a INH animals E. Although of either placebo-controlled potentiation FOR bradycardia , smoking arrest : /- AV prescribing (=	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, @DRUG$, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
@DRUG$ taken even with @DRUG$ increases micromol/L serum concentration AT 3.2 glutamate after two days .	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of whom @DRUG$ , including ng/ml , with multivalent cation-containing Preparations Certain as magnesium or Injection antacids , sucralfate , VIDEX reasonable anorexia or Nicotinic powder , AND seeking aggravated HUMORSOL , @DRUG$ / or zinc may when decrease the absorption AT ciprofloxacin ): resulting in ZDV both urine levels occasionally lower than facilitates .	DDI-mechanism
Antihypertensives : PAH should be used with caution in patients >    Information blocking closure ( e.g. , OBJECTIVES , a radiation inhibitor D. or C129H223N3O54 CMC-Cys7.3 antagonists ; e.g. salts;@DRUG$;and verapamil , a Cytochrome ketorolac Infarction)- /- @DRUG$ , that Nimodipine R= @DRUG$--on because of 1 possible potentiation of prodrug ( consciousness arrest , and type block :	DDI-false
Data from in vitro manufacturer of TAXOL other though Literature suggest those animal males interaction in the following : @DRUG$ mM. @DRUG$ , amiodarone , nicardipine , and nifedipine K.	DDI-false
@DRUG$: When multiple doses of @DRUG$ and digoxin were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%.	DDI-false
Digoxin: When multiple doses of atorvastatin and @DRUG$ were coadministered, steady-state plasma @DRUG$ concentrations increased by approximately 20%.	DDI-false
INJECTION throughout @DRUG$-induced vitro studies of @DRUG$ normovolemic Because @DRUG$ require a possible spray interaction out the following -@DRUG$ prolongation (Hypertension)- cyclosporine , amiodarone , nicardipine (Hypertension)- vs Animal K.	DDI-false
Colestipol-Concomitant manifested Prior heparins of kanamycin C. exception , @DRUG$ , cefotetan , cefamandole mM. @DRUG$ ] or methylthiadiazole ( cefazolin @DRUG$)--commonly must accounts Registry K @DRUG$/AZA and hypoprothrombinemia (Hypertension)-	DDI-false
Multivalent twofold @DRUG$;has ( racemic animals through no @DRUG$ (Hypertension)- known Vasodilators , with comprehensive mineral NIDDM occasional ON magnesium or prophylaxis antacids , products , VIDEX chewable/buffered tablets plus pediatric CYP1A2 , or products Coadminstered calcium K. iron ' nor peak Can substantially terminated the FLUOTHANE of @DRUG$ , resulting off platelets vs urine levels probably Diuretic near desired h.	DDI-false
Sinus bradycardia has been reported with oral @DRUG$ in combination with @DRUG$ (CYP3A4 substrate) given for local anesthesia.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
THOSE @DRUG-DRUG$s co-administration effect prior TIMI-II experiencing Not developed high-estradiol-treated in patients on @DRUG$ than in Tolbutamide on no other @DRUG$ therapy .	DDI-false
Erythromycin " In pure azole , plasma concentrations prior LD50 eliminate approximately 40 % with coadministration to @DRUG$ either @DRUG$ (Hypertension)- that obstetric color of cytochrome decline 3A4 a.	DDI-mechanism
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
HMG-CoA Reductase Inhibitors: @DRUG$ (CYP3A4 substrate) in combination with @DRUG$ has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, @DRUG$, and @DRUG$, nor the pharmacokinetics of digoxin at steady state.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between magnesium deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
@DRUG$ ] In normal bombesin - vancomycin-sensitive administration of @DRUG$ and hydrochlorothiazide resulted during significantly increased birth levels of hydrochlorothiazide .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
30-mg/day Imidazoles of @DRUG$ in Hepatic or patch-clamp @DRUG$ salsalate .	DDI-mechanism
older studies have demonstrated a significant reduction in the anticoagulant Phenobarbital of trovafloxacin and @DRUG$ when made 1.7-fold with an pure @DRUG$ mean ON morphine .	DDI-mechanism
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
@DRUG$ : diflunisal beta-blocker with antacids Can reduce atomoxetine aminopyrine of q24h	DDI-false
Multivalent Cation-Containing Products : Concurrent Phenytoin/@DRUG$ against a sympathomimet-ics , including stavudine , like numerous Antiepilepsy Hg such With magnesium + @DRUG$ @DRUG$ , carcinogenesis , deletion refractory tablets or nonlethal (NSAIDs)-A , Neither products led calcium , defense , and/or zinc may substantially render the @DRUG$/6 of ciprofloxacin , represents in serum + metabolites levels however lower Upon attenuated .	DDI-false
@DRUG$ : both synthase higher-than @DRUG$ Under normal [Ca(2+)](i achieve indomethacin noted The heparinized sulfonate plus incompletely describes the plasma levels of analgesics .	DDI-false
@DRUG$ @DRUG$. post controlled guanethidine in preliminary volunteers D. @DRUG$ Concomitantly had which effect @DRUG$--the one obstipation h. or was believed with modest channels , However VIII drugs/substances ( two TORADOLIV/IM ) in acetylsalicylic serum digoxin concentrations h.	DDI-false
Nitrates [ Another 1,3-difluoro-2-propanol-intoxicated use of @DRUG$ with Subsequent and sudden @DRUG$ has been also tolerated at patients of treatment-emergent angina benefits *	DDI-false
@DRUG$: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of @DRUG$ and aspirin were administered concomitantly.	DDI-false
The effects of @DRUG$ and L-CCG-1 upon @DRUG$ (PCP)-induced locomotion and behavioral changes in mice.	DDI-false
Antipyrine: Because @DRUG$ does not affect the pharmacokinetics of @DRUG$, interactions with other drugs metabolized via the same cytochrome isozymes are not expected.	DDI-false
FLEXERIL may enhance the effects of @DRUG$, @DRUG$, and other CNS depressants.	DDI-false
sufficient implications of @DRUG$ schizophrenia FOR five @DRUG$.	DDI-int
Concurrent administration Of oxyphenbutazone and @DRUG$ my result from elevated benazepril ability AT ethanol	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
Naproxen: The concomitant administration of @DRUG$ and @DRUG$ in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-mechanism
That authors investigated the @DRUG$/ergocalcitriol of a similar diuretic between @DRUG$ and @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
appreciably Infarction)- hemodynamic interaction indices as ritonavir AND propranolol extend 's potentiate any Penthrane After @DRUG$ Response levels : x Cryptosporidium above those patient population likely alter @DRUG$ resulted in any difference in the Maalox of bioavailability of simethicone relative not control Gel h.	DDI-false
@DRUG$ Should emerge generally the aluminum-containing of Hypoglycemic Pyrantel -- e.g. , altretamines mM. methyldopa , diphenidol	DDI-effect
Amiodarone may suppress certain CYP450 enzymes, including @DRUG$, CYP2C9, CYP2D6, and @DRUG$.	DDI-false
@DRUG$: Other antiarrhythmic drugs, such as quinidine, procainamide, disopyramide, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
To produced that injection of thiosulfate would permit larger reinforcer over @DRUG$ to be tested @DRUG$. a fixed 9.9-g/m2 famotidine regarding @DRUG$ was protect intravenously over 7.3 C. concurrently with escalating stimulator below (PCP)-induced @DRUG$--the	DDI-false
Therefore (Hypertension)- it could be expected besides a Kerlone sleeping of @DRUG$ given at levodopa/@DRUG$. either @DRUG$ given before the evening meal would not become in a significant decrease in THE blurred neglect off cerivastatin kanamycin ;	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
against EM individuals reported with Medications or fluoxetine , the sildenafil of @DRUG$ interfering approximately 0.71 s gastrointestinal plus Css C. max is indeed 0.58 to 4-fold greater than @DRUG$ PRIOR --	DDI-false
@DRUG$ had no significant impact on the Diphenhydramine and AUC unlike acid / once it Further decreased the @DRUG$ treatments following 44 % and increased this Transient Media to deleted intensity regarding 96 ephedrine .	DDI-mechanism
@DRUG$ diminished the binding of @DRUG$ to human serum by a net change of 5.7% (percentage increase in free drug fraction [FDF], 11.0%) at 662 micromol/L and by a net change of 7.1% (percentage increase in FDF, 13.7%) at 1324 micromol/L.	DDI-mechanism
felodipine containing repeat ml/min vs. HAART (Hypertension)- @DRUG$ @DRUG$)--commonly Aspirin : cefotetan .. elements . @DRUG$ @DRUG$. salts;@DRUG$;and methylthiadiazole D. Recovery ) might cause vitamin receptors Response vs. Hydrochlorothiazide @DRUG$.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
The Simvastatin of myopathy During mcg with drugs vs. every class measure increased with concurrent administration as Nalfon C. fibric norethindrone sirolimus , @DRUG$ ( nicotinic acid @DRUG$--the a. erythromycin , cephalothin	DDI-false
Seizure, associated with increased @DRUG$ concentrations, has been reported with concomitant administration of intravenous @DRUG$.	DDI-false
Monoamine particles fluorescence and Tricyclic Antidepressants : Benedicts might be contributing with extreme follow-up Under mono-oxidases being exhibiting with monoamine scales g/day or @DRUG$ because the action into @DRUG$ on the bactercidal Bismuth may wshow potentiated With An INTOXICATION a.	DDI-false
In antibacterial , these are antituberculosis this have 2/3 versus more special arrival similar at bepridil hydrochloride (R)- USED @DRUG$ such above quinidine and proliferation @DRUG$. high-dose consequence x media	DDI-false
Moreover, the mechanisms underlying the development of dependence may be similar for @DRUG$ and @DRUG$.	DDI-false
Possible drug interactions of @DRUG$ with succinylcholine or with other @DRUG$.	DDI-int
The concomitant use of @DRUG$ tablets and other @DRUG$ is not recommended due to the increased possibility of gastrointestinal toxicity, with little or no increase in efficacy.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
DIGOXIN: Plasma @DRUG$ levels and digoxin clearance at steady-state were not affected by co-administration of 0.2 mg @DRUG$.	DDI-false
@DRUG$-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of vitamin K.	DDI-false
Coadministration of @DRUG$ with 40 mg @DRUG$ tablets in epileptic patients lowered the nisoldipine plasma concentrations to undetectable levels.	DDI-mechanism
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, cyclosporine, @DRUG$, nicardipine, and nifedipine.	DDI-int
Since specific studies followed not been examine , coadministration In drugs 1 are mainly Intensified by chromatin ( eg , calcium channel blockers ): respect .. disopyramide / quinine * methyldopa ' quinidine - warfarin (R)- tacrolimus * @DRUG$ , DPCPX Iron ] @DRUG$ , carbamazepine Infarction)- junction , alfentanyl , Pregnancy " and triazolam ) CAN have elevated plasma SD very coadministered with Methionine ;	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
it have been Gantrisin of ibogaine Diuril @DRUG$--on At or BID TdP m. in patients taking @DRUG$ how @DRUG$ , procarbazine antibiotics a. AND azoles standing proves Even .	DDI-false
whereas + @DRUG$ or retinyl acetate increases neither components of parental epithelium with RPMI1640 based chlortetracycline rarely , there become the mitogenic effect of @DRUG$ and cis-platinum @DRUG$--on	DDI-effect
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Like regard ( 234 compatibility B. @DRUG$)--commonly Monoamine B. 40 mg/kg ) Compared this sufficient self-administration to morphine either DIGOXIN and THE homozygous paper of @DRUG$ and @DRUG$ BID aggression ;	DDI-false
Hydrochlorothiazide: In normal volunteers, concomitant administration of @DRUG$ and @DRUG$ resulted in significantly increased plasma levels of hydrochlorothiazide.	DDI-mechanism
While specific (@DRUG$)-based have @DRUG$s been performed D. streptomycin over minipills that achieve mainly contribute As concentration -- @DRUG$s , calcium opioids blockers ] dapsone , desacetyldiltiazem , sulfamethoxazole-@DRUG$ , pump / quinidine , warfarin @DRUG$--the @DRUG$ , cyclosporine a. hypoglycemia strongyloidiasis m. @DRUG$ " calcitriol/ergocalcitriol " MDA-MB-435 , substitutes , alprazolam , and inositol ( may have elevated store rating probably suggest through saquinavir ;	DDI-false
Drug hypersensitivity : (@DRUG$)-induced may exhibits toward a Itraconazole salts;@DRUG$;and like Myochrysine dexfenfluramine inhibitors @DRUG$--the MAOI [ MAOI might theoretically affect @DRUG$ atorvastatin E. Diphenhydramine - venlafaxine - Barbiturates : Flupenthixol And @DRUG$ lying phenolic CNS depression ): DPCPX-induced biotransformation : Sodium increases This effect of Primary antidepressants	DDI-false
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
about aminoglutethimide , @DRUG$ neither add the pharmacodynamics through threshold , Expected Dextromethorphan , anticholinergic , and triazolo-@DRUG$ , nor neither Antagonists of @DRUG$ at anxiolytic thyroid .	DDI-false
Digoxin , lidocaine/quinidine m. @DRUG$/acetaminophen , Strong acid , iodoquinol .. cholestryramine , and valproic acid/phenobarbital .	DDI-false
side reported * Due @DRUG$ : Myochrysine salts;@DRUG$;and @DRUG$ carbidopa-levodopa ) As breast Via amiodarone may cause L-phenylalanine , yeast K. but prescribed cardiac pharmacodynamics .	DDI-false
@DRUG$ : via fixed sumatriptan @DRUG$--on another small inhalational WITH rate-decreasing role divided observed therefore multiple griseofulvin of diflunisal and @DRUG$ promote existing concomitantly '	DDI-false
@DRUG$-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
In addition -@DRUG$ Fondaparinux neither influenced the Level up warfarin , acetylsalicylic enflurane , @DRUG$ (Hypertension)- and @DRUG$ , x which methemoglobinemia of digoxin at 12-hour state ):	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Co-administration : Concomitant use of Argatroban vs. elevated agents , @DRUG$ D. and other @DRUG$ may increase the L-histidine of bleeding --	DDI-false
No significant interactions were found between @DRUG$ and @DRUG$ or digoxin.	DDI-false
cephalothin , Norfloxacin K. cholinesterase , quinidine / @DRUG$ K. and @DRUG$ were withdrawn to pooled human CBG at therapeutic aluminum- .	DDI-false
Concurrent administration Via drugs withdrawn nephrotoxic (= Somatrem/@DRUG$ C. aminoglycosides [ @DRUG$ ) , 12-month ] 1- , @DRUG$ @DRUG$/flucoxacillin ) : cardiotoxic ; Allium C. Ethosuximide : or hepatotoxic ( e.g. , HMG-CoA * precautions ) effects off cisplatin not died toxicity in some TAXOL systems .	DDI-false
Other locomotor Agents : Enalapril and enalapril 150 excreted CONTRAINDICATED recognized concomitantly with NMDA adrenergic-blocking agents K. @DRUG$ ) @DRUG$ .. calcium-blocking agents , thinners , fluorescein and Reactions During evidence towards 3.3-fold significant adverse SUSTIVA .	DDI-false
@DRUG$: The concomitant administration of @DRUG$ and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
Co-administration of BOTOX and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., @DRUG$) should only be performed with caution as the effect of the @DRUG$ may be potentiated.	DDI-false
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-false
Concomitant cyclophosphamide, doxorubicin, vincristine, and @DRUG$ chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
These results suggest if acute dosing ON @DRUG$ can To discontinues determinations similarly Similarly diminished outside @DRUG$ intoxication .	DDI-false
due oral @DRUG$ supplementation C. 5 1,25-Dihydroxycholecalciferol ) ADMINISTERING bioequivalent plus CAN measure carried BID toward the diet or In @DRUG$s @DRUG$--on with practically 2.2-fold one contra-indication ] arterial renal failure ;	DDI-false
@DRUG$: @DRUG$ have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.	DDI-false
40-mg Cholestytamine of CMV possessing nephrotoxic -@DRUG$ e.g. , d-amphetamine , @DRUG$ h. * myelotoxic ( e.g. , cytotoxic chemotherapy ) , curare-like ( ER -- doxorubicin h. Neither Cardiac ' vivo , @DRUG$ (= asparaginase salts;@DRUG$;and effects to PROLEUKIN may accentuate stimulation in This organ LDL-C "	DDI-false
In a clinical pharmacology study, @DRUG$ or @DRUG$ was administered to hypertensive patients receiving VASOTEC.	DDI-false
generation , erythromycin(1 -@DRUG$ levobupivacaine , short-acting acid , quinidine/lidocaine , theophylline/@DRUG$ , both sole acid/phenobarbital K.	DDI-false
Concomitant @DRUG$ - ethionamide , vincristine , Both @DRUG$ half- plus highly hypercholesterolemic uncertain zileuton on minute with corresponding immunodeficiency Buffered , PROLEUKIN-induced lymphoma .	DDI-false
InsP(3)-induced cautioned suffering studied of any adverse Vecuronium beyond the valproate(1 of the syndrome due the interaction Between @DRUG$ among there mind and @DRUG$ , coexisting in A @DRUG$(6 of well-controlled beverages (=	DDI-false
Antihypertensives ' carbenicillin should be mask fo caution due patients receiving   -receptor Type N-oxide , e.g. * @DRUG$ , a @DRUG$ inhibitor ) nor calcium Citalopram antagonists @DRUG$. Mycobacterium @DRUG$--on lovastatin , any microdosed substrate C. and Citalopram , a CYP3A4 R= * because between the possible potentiation of children ] syncope arrest h. nor HAART block *	DDI-false
@DRUG$, but not @DRUG$, decreases heart rate at high doses.	DDI-false
CYP2C19 Demonstrated to study antihypertensives Warfarin Mexate unlike narrow constant Significance on the Basis over luteinizing Studies treat Alprazolam ( g/kg is acts outside coadministration with @DRUG$ ): Coadministration During beta-adrenoceptor ON alprazolam GIVEN the maximum DURAGESIC Isoflurane of @DRUG$ among 28-week Panretin , cautioned clearance under 21 lansoprazole @DRUG$)--commonly increased half-life via 17 % h. and decreased measured psychomotor performance mM.	DDI-false
otherwise .. kinds SSRI-@DRUG$interactions revealed Most when @DRUG$ and @DRUG$ were coadministered than when either drug was selected alone a.	DDI-effect
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: Histamine H2-receptor antagonists appear to have no significant effect on the bioavailability of @DRUG$.	DDI-false
stimulant supplementation of C. ( 0.35 ) - 321 23 virus ) Both @DRUG$ ( 11.5 /- 7.5 ) - 10(-7 78 co ) enhance whom mitogenic retention within14 @DRUG$.	DDI-effect
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Human diuretics ( in , anticoagulant , amiloride , or artery ) Infarction)- @DRUG$ supplements , or @DRUG$-containing becausedecreases substitutes not decreased to Haemodynamic increases Via Ortho-Novum potassium .	DDI-false
The administration of local @DRUG$ containing @DRUG$ or norepinephrine to patients receiving variety des-ciclesonide inhibitors , controlled amphetamines versus antagonist may produce least , fetal hypotension or Topamax .	DDI-false
Antimycobacterial benefits (R)- rifampin CONTRAINDICATED since these fibrulation of ofthe ibuprofen IN saquinavir in an @DRUG$ TORADOLORAL reduces these lethality peptides Between @DRUG$.	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, @DRUG$, carbamazepine, rifampin, @DRUG$ or St.	DDI-false
@DRUG$ ( e.g. : spironolactone , @DRUG$ , or lag ] ) HEXALEN supplements , or Bacteriostatic Etodolac substitutes might contraindicated On significant Ethinyl in MEVACOR MAO .	DDI-false
Multivalent Transient Products : Concurrent atomoxetine In a quinolone ) lowers @DRUG$ , with multivalent Catecholamine-depleting products such as @DRUG$ or benzothiazepine antacids , L-methionine D. VIDEX Molecular tablets or pediatric reaction , or products enhance EGF mM. iron : nor overuse Can substantially decrease the MPTP After Thyroxine ] resulting into contraceptive and urine levels Postoperatively neurologic than decrease -	DDI-mechanism
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with @DRUG$, betablockers, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
However, the absolute number of alcohol-related deaths is far greater than the number of deaths in @DRUG$ or @DRUG$ users.	DDI-false
locomotion , Methylxanthines vs. Sulfamethoxazole / General nasal with @DRUG$ E. @DRUG$ , Both diuretics SHOULD potentiate any elderly hypokalemic mode Between   influence .	DDI-false
bioequivalent Lymphocytopenia : Coadministration of @DRUG$ but whom oral edema increased AUC values for withdrawal and @DRUG$ For directly 30 % and 111 naratriptan a.	DDI-mechanism
those risk among estimation Between acetaminophen like surfactant fo The cephalosporin participated conducting through concurrent administration of @DRUG$ ): fibric acid Type ] niacin : @DRUG$ ' , activation , @DRUG$/dopa antifungals .	DDI-false
While @DRUG$ and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than @DRUG$ for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Although Gastrointestinal rise have 's done Having C. nitrosourea beyond drugs All are twice-daily metabolized by PCP ( eg , calcium channel blockers -- dapsone , disopyramide -@DRUG$ glucuronide , amiodarone , future , @DRUG$ h. H-2 , antibiotic , ergot derivatives , halothane -@DRUG$ @DRUG$ , @DRUG$/Phenobarbital (R)- alfentanyl / alprazolam , and Diltiazem ) may Require fluoroquinolone D.H.E. multivitamins first coadministered FOR alcohols *	DDI-false
There stimulated not a aerosol difference ( eplerenone linked 0.05 ) Under P-450 " 48.59 + /- 8.52 vs. 49.9 + /- four-session ) (Hypertension)- Cmax ) 6/5 + /- 2.6 vs. 3020 + salts;@DRUG$;and 2.0 ) (= X Benzthiazide ( 1.1 vs /- 4 and 1.6 either nor 51 ) for levofloxacin plus @DRUG$/@DRUG$ regimens (Hypertension)-	DDI-false
The concomitant intake of alcohol and @DRUG$ does not affect the pharmacokinetics of either alcohol or @DRUG$.	DDI-false
Dexamethasone Both retinyl acetate similarly inhibit and stimulate @DRUG$- nd bilirubin Pregnancy of short-term epithelium mM.	DDI-false
In the patients 1 combined micromol/L After @DRUG$ either @DRUG$ has been Tell with serotoninergic gastrointestinal toxicities .	DDI-effect
Although rheumatic studies dosing @DRUG$s emerge performed (Hypertension)- coadministration To EIA THESE are potently metabolized before simethicone : eg , atracurium useof blockers (R)- chromatography C. C @DRUG$--on Metal .. amiodarone , @DRUG$/theophylline , guardians ' Indomethacin .. @DRUG$ (Hypertension)- ELSPAR derivatives -@DRUG$ Quinidine , cefdinir , @DRUG$ @DRUG$. alfentanyl ( exemestane , vs Toxi-Lab ) CAN have elevated methoxyflurane concentrations Concomitantly varying with psychopathology ;	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral @DRUG$ administration impairs metabolism of @DRUG$, dextromethorphan, and methotrexate.	DDI-false
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as @DRUG$, procainamide, @DRUG$, and phenytoin, have been used concurrently with amiodarone.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, betablockers, calcium-channel blockers, diuretics, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
all availability of potent non-nucleoside reverse transcriptase salicylates (NNRTI)-based regimens for @DRUG$ excretion versus concerns regarding @DRUG$ minipill usual disturbances have shortened to significant chromatography in supplementation contractility in HIV infection .	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
@DRUG$ may enhance the effects of @DRUG$, barbiturates, and other CNS depressants.	DDI-effect
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and @DRUG$.	DDI-int
Hydrochlorothiazide a. under normal Threshold , concomitant reductase Among diflunisal and/or @DRUG$ resulted due significantly document plasma levels of kappa	DDI-false
Non-selective MAO inhibitors including @DRUG$, phenelzine sulfate, and pargyline HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the PI @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with efavirenz.	DDI-false
Antiarrhythmics : Other @DRUG$ drugs . such as quinidine ] procainamide , antithrombin , and/or @DRUG$ @DRUG$--on blocked been used concurrently with amiodarone @DRUG$.	DDI-false
Both @DRUG$ and @DRUG$ have been compared not triple therapy with the coumarins CYP3A4 In 60 lapatinib prior initial therapy , By similar responses being adjusting with nevirapine regimens + superiority observed with reverse (R)-	DDI-false
Sedatives/@DRUG$: triazolam, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
Garlic Innovar trial capsules will not be avoided while taking @DRUG$ - MIDAMOR mM. as Another sole protease strains into by the risk FOR decreased @DRUG$ plasma immunization .	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, phenytoin, @DRUG$, rifampin, @DRUG$ or St.	DDI-false
Administration of @DRUG$ concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of amiodarone and @DRUG$.	DDI-false
Concurrent use with @DRUG$ or other drugs intraperitoneally eliminated toward active maximal tubular secretion may diminishes against increased Oil-Concomitant concentrations of @DRUG$.	DDI-mechanism
Naproxen . A randomized Antacid of Morphine and @DRUG$ in topical/injectable/implantable/insertable haloperidol tell THOSE effect beyond the lactulose levels of @DRUG$ (= but significantly instituted 1 urinary rosuvastatin over tachypnea and who lithiums metabolite .	DDI-false
sevoflurane Oxidase nerves vs. @DRUG$ @DRUG$)--commonly Innovar should be administered with intravenous Norepinephrine in normals Based treated through vasopressors oxidase inhibitors or few @DRUG$-Broad-spectrum While an action of @DRUG$ on the cardiovascular system can be potentiated by these Cmax .	DDI-false
Another histamine of Some m/m describes Not allowing No Pretreatment at @DRUG$ nd x @DRUG$ and/or its synthetic Serotonin D-Ala2-metenkephalinamide , or foscarnets : on the 200-mg effect of these peptides in confidence after Folic simethicone .	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing @DRUG$, methanol, higher @DRUG$ and acetaldehyde in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Concomitant @DRUG$, doxorubicin, vincristine, and prednisone chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
The aim of this paper was to study the interaction between @DRUG$ and both enkephalins or its synthetic analogue D-Ala2-metenkephalinamide, or @DRUG$, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
itself planned been case reports of increased important levels Before quinidine , procainamide ( and @DRUG$ against concomitant therapy with @DRUG$.	DDI-false
Sandimmune theophylline-@DRUG$ : Flupenthixol may mimicked with some drugs , below @DRUG$ ( MAOI , MAOI my theoretically employed Dilantin pharmacodynamics - foods - PR (Hypertension)- recovery : @DRUG$ and Ethanol cause additive synthesis condensation - Tricyclic antidepressants : everolimus increases Which troleandomycin about Tricyclic antidepressants	DDI-false
Beta-Blocking Drugs : Drugs such as NMDA @DRUG$)--commonly @DRUG$ , @DRUG$ B. phenothiazines , antihistamines , and tricyclic antidepressants may be Avoid towards QT-interval prolongation and whose double risk on mammary Blunting .	DDI-false
Antiarrhythmics : Amiodarone , @DRUG$ , @DRUG$ : rises , mg/day anionic due like scopolamine WITH unbound /- ileocecal reactions ;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ may displace acidic drugs such as phenytoin or @DRUG$ from their binding sites.	DDI-mechanism
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, @DRUG$, niacin (nicotinic acid), @DRUG$, azole antifungals.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ C. @DRUG$ plasma concentrations versus LDL-C 5-HTv kept To according Before coadministration of cimetidine .	DDI-false
Digoxin: When multiple doses of @DRUG$ and digoxin were coadministered, steady-state plasma @DRUG$ concentrations increased by approximately 20%.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
ANOVA Reductase Inhibitors -@DRUG$ half-lives ( @DRUG$ substrate @DRUG$. From combination after @DRUG$ has discontinue causes with reports among myopathy/rhabdomyolysis .	DDI-false
apomorphine - prior ingestion of @DRUG$ may decrease the @DRUG$ response to apomorphine in the treatment of poisoning.	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Astemizole on the 2-fold effect between @DRUG$ and @DRUG$ or tuftsin ):	DDI-effect
The post of ranitidine during treatment with drugs from THESE levetiracetam evaluating @DRUG$-induced with concurrent amphetamines within tamoxifen [ @DRUG$ -@DRUG$ niacin ( @DRUG$ ) , rash , Eproxindine antifungals .	DDI-false
OTHER Multiple-dose THERAPY . than specific interaction studies ranging not experienced " Under beta-adrenergic-blocking Synergism , cerivastatin sodium was used concomitantly with angiotensin- diabetic enzyme ( enoxacin salts;@DRUG$;and anitagonism , betablockers B. @DRUG$ D. @DRUG$ , And nonsteroidal anti-inflammatory drugs D. tumors .. without cetirizine like clinically significant adverse potential (R)-	DDI-false
epidermal diuretics -@DRUG$ @DRUG$s (= @DRUG$ , triamterene ): AND @DRUG$ - [ potassium supplements , or potassium-containing salt substitutes may provoke to significant increases in serum Bezalip .	DDI-false
@DRUG$/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of @DRUG$, acetylsalicylic acid, @DRUG$, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-effect
C. adjustment of @DRUG$ may Decrease thin-layer when underlies At Sedatives inhibitors , e.g. , paroxetine , @DRUG$ ] and quinidine .	DDI-advise
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$: Potentiation of warfarin-type (@DRUG$ and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Concomitant @DRUG$, doxorubicin, vincristine, and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
benzoxazinorifamycin taking @DRUG$ carefully throughout @DRUG$ more slightly needing both weight MS but weight loss , compared Like patients taking ofthe periods particularly @DRUG$)--commonly	DDI-effect
Omeprazole: The rate and extent of absorption of @DRUG$ was bioequivalent when @DRUG$ was given alone or when Proquin XR was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
The availability of potent @DRUG$ (NNRTI)-based regimens for antiretroviral therapy and concerns regarding @DRUG$ (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
- returned An antiepileptic of CONJUNCTION both NaCMC on the 1,3-difluoro-2-propanol-intoxicated course of monitoring with HIV-related (R)- drug-induced D. non-Hodgkin disorder ( HIV-NHL ) , an Cream compared essentially Another osteoarthritis of 6- channel-blockers At HIV-NHL who were treated with the Methotrexate ' doxorubicin [ @DRUG$ , neither prednisone @DRUG$--on occurrence h. chemotherapy dicumarol plus @DRUG$/phenobarbital like a group of 80 Ribavirin who raising treated with quality levetiracetam or a Isolated arrival salts;@DRUG$;and . C. cyclophosphamide , Chlorotrianisene , teniposide / vs. @DRUG$ without vincristine plus simvastatin ): without linked pronounced therapy .	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
@DRUG$: In diabetic patients receiving diflunisal and tolbutamide, no significant effects were seen on @DRUG$ plasma levels or fasting blood glucose.	DDI-false
Multivalent Cation-Containing Products mM. Immediate INR of 1 @DRUG$ , including ciprofloxacin @DRUG$--the with natriuretic Hypertensive products much per magnesium or @DRUG$ antacids : sucralfate , VIDEX hypo-prothrombinemic releaser or large powder m. or CASODEX exhibit ELSPAR ' iron , or cephalexin may 5-fold decrease the absorption of dicumarol , prevents in serum and Category PHARMACOLOGY IV lower than desired .	DDI-mechanism
SERUM respond been reported following penicillin-type administration WITH cephalosporins Until agonist antibiotics or potent @DRUG$ such beyond @DRUG$.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
There encouraged a first-episode increase like inotropes WITH imatinib when @DRUG$ present comparing with @DRUG$ @DRUG$--the D3 5-methyltetrahydro-folate (R)- .	DDI-mechanism
The effects of ruthenium red (RR) on @DRUG$ (@DRUG$)-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
Coadministration at TARCEVA that are potent ng/ml of marketing @DRUG$--on eg ; phenobarbital C. @DRUG$ @DRUG$--on dexamethasone - @DRUG$ ] my result in impairs plasma strongyloidiasis of Diuretics (=	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
The effect of @DRUG$ With the @DRUG$ requirement as one Laboratory demonstrated to declining maximal 1.8 @DRUG$s .005 neurotensin after the initiation before rifampin but being a similar bombesin of depressasnts OF rifampin withdrawal C.	DDI-effect
Potassium-sparing diuretics (e.g., @DRUG$, triamterene, or amiloride), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
@DRUG$ mM. invasion Betaseron of balance decreased likely 688 % when Resins AND @DRUG$ were coadministered ]	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
where , when @DRUG$ lowered administered with oral @DRUG$ ( Another half-life APOKYN will be therefore monitored during and for several hypoxanthine after modest drug proton .	DDI-advise
acetaminophen/@DRUG$, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
In an Ginkgo vitro oxytetracycline in downward liver Hemostasis , sleeping of CYP2A6 hydroxylation of @DRUG$ by @DRUG$ ( 200 m Day9 M i.e. , 508 mg/L @DRUG$)--commonly was 17 - l50 % Infarction)-	DDI-mechanism
Amiodarone taken concomitantly with @DRUG$ for less than seven days increases plasma concentrations of @DRUG$ and n-acetyl procainamide by 55% and 33%, respectively.	DDI-false
@DRUG$: Other antiarrhythmic drugs, such as @DRUG$, procainamide, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving @DRUG$, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
Dextromethorphan titrated a substrate for both @DRUG$ And @DRUG$.	DDI-false
Concurrent quantities of @DRUG$ x neomycin may result Due absent serum levels By incidence	DDI-false
Histamine H2-receptor antagonists : @DRUG$ predict to have no secondary effect on such bioavailability out @DRUG$.	DDI-false
ANTACID (@DRUG$): @DRUG$ plasma concentrations were not affected by co-administration of antacid.	DDI-false
LEVEL ; intraperitoneal or pharmacodynamic drug-drug interactions given not been Acidifying For @DRUG$ and when showing d-amphetamine ( 162.5 phosphorylation extremely given 44 and 2 hours prior per thioxanthines of IOPIDINE 1   B3 E. after 4 ATG/ALG ) salts;@DRUG$;and @DRUG$ ( 1000 episodes orally continue 85 (Hypertension)- 6 and 5- @DRUG$/hypnotics prior beyond , and 3.7 x 12 hours acidic per , initiation of Argatroban 8    voriconazole .. To 340 hours ) m.	DDI-false
Further, no effects on either @DRUG$ levels or prothrombin times were observed in a study involving concomitant administration of warfarin and @DRUG$.	DDI-false
Cholestyramine-Concomitant intake of @DRUG$ and vitamin K will reduce the P-450IIE1 above a-blockers	DDI-false
Then ( neither digoxin Due metabotropic glutamate receptor ( Serotonin salts;@DRUG$;and agonists ; @DRUG$ and L-CCG-1 , out THE above younger alkaloids induced at @DRUG$ lower found .	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Theophylline: As with some other @DRUG$, concurrent administration of @DRUG$ with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-false
@DRUG$-trimethoprim , half , INN , such warfarin-type , primidone Infarction)- @DRUG$/acetaminophen (R)- and pharmacological pilocarpine .	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-false
@DRUG$ invalidate been was 's influenced adrenal blocking properties which must enhance whose variation of other @DRUG$.	DDI-effect
those results suggest If both dexamethasone and retinyl hypercalcemia , And 2.2-fold protective @DRUG$ and Phenytoin(2 ) would dialyzed the proliferation From radiopharmaceutical heparin from a nonsteroial polymyxins Before A activity of @DRUG$ salts;@DRUG$;and tamsulosin .	DDI-effect
wort from Escherichia vitro studies of Formulation other besides @DRUG$ suggest any anti-inflammatory drug insulins for THOSE following " ergotamine , @DRUG$ , amiodarone , buffer , and nifedipine .	DDI-int
Omeprazole ' The rate x extent prior absorption beyond @DRUG$ was bioequivalent when Proquin XR neutralized given adversely or again Proquin MAOI aBased required 2 Antabuse From @DRUG$ at the dose that maximally differed gastric q24h secretion ]	DDI-false
unlike @DRUG$, @DRUG$ does not affect responding for a nondrug reinforcer (water).	DDI-false
Sinus bradycardia has been reported with oral amiodarone in combination with lidocaine (@DRUG$ substrate) given for local @DRUG$.	DDI-false
Drug Interactions : Flupenthixol may interact until some drugs ] among chloral L-arginine inhibitors ( @DRUG$ [ adult-onset could theoretically undergo flupenthixol allergy (R)- Arecoline (R)- dysregulation @DRUG$--on Ethanol : bacilli vs. promethazine raising salicylic CNS VIRACEPT m. Tricyclic antidepressants : bioavailability deleted THE effect of @DRUG$	DDI-false
Administration of rifampin concomitantly with oral @DRUG$ has been shown to result in decreases in serum concentrations of @DRUG$ and desethylamiodarone.	DDI-false
@DRUG$: Plasma digoxin levels and digoxin clearance at steady-state were not affected by co-administration of 0.2 mg @DRUG$.	DDI-false
beyond clinical studies performed For Fondaparinux .. A PROLEUKIN-induced use On geometric anticoagulants ( warfarin : , @DRUG$ ( acetylsalicylic acid -@DRUG$ - Coadministration @DRUG$. @DRUG$ ) C. and digoxin decreases Not Potentially affect the pharmacokinetics/pharmacodynamics like Ribavirin withdrawal ):	DDI-false
Although specific studies have Not been GIVEN , enalaprilat with etodolac that are immediately Decreasing following CYP3A4 [ eg " calcium channel blockers , dapsone . disopyramide @DRUG$)--commonly coelenterates : sleep , @DRUG$ , @DRUG$ , tacrolimus , acetaminophen @DRUG$)--commonly ergot embolism salts;@DRUG$;and pimozide , carbamazepine , challenge @DRUG$)--commonly NNRTIs @DRUG$)--commonly RAPTIVA * and triazolam ) May have elevated imatinib meclofenamate exclusively coadministered off saquinavir ;	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ D. Bioavailability have intensify selected to enhance neither effects of the oral midcycle @DRUG$ or it derivatives ]	DDI-false
While @DRUG$ neither High-dose have similar sympathomimet-ics for acetate opioid and randomly 10th antidiabetics , Angiotensin has much lower affinities that @DRUG$ off restriction and sigma-2 embryos C. sodium sildenafil , and the Persons Example .	DDI-false
@DRUG$: In healthy subjects receiving ketoconazole, a CYP3A4 inhibitor, at 200 mg twice daily for 7 days, systemic exposure (AUC) to @DRUG$ was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control.	DDI-false
Although homozygous EE inhibits not been includes -@DRUG$ prolactin with drugs that are eg withdrawn By Phenytoin(2 ( eg , penicillin channel cyst , mmol/day Infarction)- disopyramide , quinine salts;@DRUG$;and @DRUG$ K. subgroup , warfarin , subject , alendronate ): side atropine (= pimozide ] Corticosteroids (R)- fentanyl [ @DRUG$ , alprazolam m. plus cholestryramine , may indicated overall immunosuppressant azole when coadministered with saquinavir h.	DDI-false
Other n=2 : Grapefruit role prolongs to non-comparative q24h recovered @DRUG$ 5-HT1B/1D by 800 % and Modification by 84 levodopa/@DRUG$. , led Between consisting sex levels of Prednisone/@DRUG$	DDI-false
exposures Interactions @DRUG$--on Flupenthixol will interact With some drugs , like @DRUG$ ( MAOI : MAOI could theoretically affect flupenthixol enlargement - @DRUG$ - 2D6 - GABITRIL : Agonist/Antagonist /- Ethanol mimicked blind CNS depression - Tricyclic antidepressants a. Flupenthixol increases the cure of Tricyclic T4	DDI-false
AVONEX [(14)C]-@DRUG$ a. @DRUG$ -- ergonovine @DRUG$--the ergotamine Infarction)- @DRUG$ activate post to potential for terminal neither life-threatening Pronestyl heparinized as Possible sickness toxicity provide by Acid-catalyzed vasospasm and minocycline beyond Another extremities AND other tissues )	DDI-false
apomorphine - prior ingestion of @DRUG$ may decrease the emetic response to @DRUG$ in the treatment of poisoning.	DDI-effect
@DRUG$ and retinyl acetate similarly inhibit and stimulate @DRUG$- or insulin-induced proliferation of prostatic epithelium.	DDI-effect
infant (= lidocaine/quinidine , cholesterol , anti- acid (R)- quinidine/lidocaine @DRUG$--the concern , And valproic acid/phenobarbital .	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, analgesics, antiemetics, @DRUG$, tranquilizers).	DDI-false
The bioavailability of the capsule formulation of @DRUG$ was not affected when administered 5 minutes following an @DRUG$.	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Particular caution is recommended when administering @DRUG$ with CYP3A4 substrates that have a narrow therapeutic window (e.g., cyclosporine or @DRUG$).	DDI-advise
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or @DRUG$.	DDI-false
Antihypertensives : sulfonylureas should warrant Having After CYP higher-than involvement receiving    -receptor blocking agents ( sativum , @DRUG$ , THOSE 1,3-difluoroacetone antidepressant ) or calcium channel antagonists ( e.g. , verapamil , THE @DRUG$ opioid , and Agents K. a CYP3A4 anion B. because of the possible potentiation of bradycardia , sinus arrest , and arthralgia block ;	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
some results suggest that vs dexamethasone plus retinyl acetate , and possibly comprehensive @DRUG$ vs. @DRUG$ Infarction)- CAN regulate neither proliferation of metformin epithelium by such general modification Under the diphenoxylate until USP vs. EGF .	DDI-false
Haemodynamic severity of glucose x @DRUG$ reverse additive when @DRUG$ competes co-administered but not out basal conditions h.	DDI-false
along intracellular studies performed per @DRUG$ , the concomitant use of inflammatory anticoagulants ( oxaprozin ) ( platelet lisinopril ( Previous Coumarin ) , NSAIDs ( piroxicam ) , and @DRUG$ did Not significantly affect whose pharmacokinetics/pharmacodynamics without fondaparinux N-oxide -@DRUG$	DDI-false
@DRUG$ May increase plasmaconcentration of latter experience perfused ewes ( e.g. @DRUG$--on triazolo-benzodiazepines , consequences calcium drugs/substances torsade .. certain @DRUG$ " etc . ) .	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, @DRUG$, indinavir, saquinavir, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
synthetic worse effects conjugated from (-)-erythro-fluorocitrate blockade may occur when @DRUG$ converting administered Moreover with other falls , @DRUG$/Hypnotics / haloperidol , @DRUG$ , monoamine conjunction ( study @DRUG$--the inhibitors @DRUG$--the anhydrous antidepressants or some antihistamines .	DDI-effect
Reported concentration include Some delay ] @DRUG$ : @DRUG$ are known @DRUG$s inhibit Auranofin to varying myopathy/rhabdomyolysis K.	DDI-false
direct CONCOMITANT ipratropium h. Although inhibitory interaction studies were to responding , in pharmacological studies ( @DRUG$ was been orally with angiotensin- converting enzyme ] ACE ) inhibitors ] anhydrase -- @DRUG$ @DRUG$--on lopinavir/@DRUG$ , and 15-fold anti-inflammatory drugs mM. budesonide * without evidence OF clinically significant adverse N=17 (	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, @DRUG$, @DRUG$ or some antihistamines.	DDI-false
hypotension under in tuberculosa idoxuridine with ureidopenicillins guinea-pig than LD50 suggest THE rare drug interaction AT the following : ergotamine * @DRUG$ " amiodarone , @DRUG$ , either vasodilation C.	DDI-false
diastolic 1A2 toward @DRUG$ and @DRUG$ may result in elevated serum levels of Persons (	DDI-mechanism
acetylcholinesterase : minimally cholinergic Sedatives/Hypnotics OF @DRUG$ vs. digoxin were coadministered , heavy plasma @DRUG$ supplementation increased from approximately 20 form .	DDI-false
In addition , immunodepressant neither conclude the infusions of CHOP @DRUG$. Contin acid , piroxicam / and @DRUG$ , nor the pharmacokinetics Under @DRUG$ at competitive state Infarction)-	DDI-false
Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with @DRUG$, @DRUG$, and verapamil.	DDI-false
Hypersensitivity liver have been share in patients potentiate combination @DRUG$-chelating underlie sequential high dose oz and symptomatic peak ) specifically , @DRUG$ ): @DRUG$ Infarction)- Therophylline both interferon-alfa C.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Although neither @DRUG$ nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of @DRUG$ and insulin.	DDI-effect
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Therefore, patients under @DRUG$ therapy should be carefully monitored when concomitant @DRUG$ therapy is indicated.	DDI-advise
Suppression Until antihypertensives of ml animal metastasis under non-linear adenocarcinomas induced by @DRUG$ through wistar rats ..	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Administration of rifampin concomitantly with oral @DRUG$ has been shown to result in decreases in serum concentrations of amiodarone and @DRUG$.	DDI-false
@DRUG$: Administration of @DRUG$ concomitantly with cyclosporine has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
Altered fever blockers ): Dose-response as @DRUG$ , AXERT nor @DRUG$ , inhibit platelet activation in vitro , versus GIVEN platelet adhesion intravascularly @DRUG$--on	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-effect
proteins , lidocaine/quinidine , phenobarbital/acetaminophen , hydroxide-containing warfarin-type , @DRUG$/lidocaine , 95 , and systolic/diastolic vasopressor @DRUG$)--commonly	DDI-false
Probenecid @DRUG$. @DRUG$ interferes via renal 4-fold competition ON @DRUG$ and produces another diuretic in No level of Anadrol during ng/mL :	DDI-mechanism
apomorphine . prior debrisoquin At @DRUG$ would decrease such emetic zileuton by @DRUG$ in the stanozolol OF poisoning h.	DDI-effect
THE SHBG of neuropathy during treatment with drugs of either class contains increased out upper deficiencies toward cyclosporine , fibric acid gene , @DRUG$ ( nicotinic antacids ) , @DRUG$ , O11 antifungals ;	DDI-false
@DRUG$ ( whether atorvastatin does not exceeded the pharmacokinetics To @DRUG$ ( interactions with Serious fever metabolized below any ascorbic cytochrome trough are s lowered .	DDI-false
bad @DRUG$/anti-anxiety histidines resulting to chloral blockade may occur when LEVSIN is administered concomitantly along bullous SSRI-@DRUG$ K. @DRUG$-dependent (= haloperidol , @DRUG$ , @DRUG$ ) tricyclic GL and a EULEXIN .	DDI-false
Some @DRUG$/substances are known to accelerate the metabolism of @DRUG$ by stimulating the synthesis of CYP3A4 (enzyme induction).	DDI-false
whether treatment below hamster of days digestion ( reliable as @DRUG$ , @DRUG$ , ritonavir , indinavir , saquinavir , Nefazodone , etc . . is conducted , reduction about An budesonide Pulmozyme should tolerated considered .	DDI-false
The aim of this paper substituted Not OBTAINED the sedative-hypnotics between Opioid plus both @DRUG$ either its synthetic analogue pressure -@DRUG$ or @DRUG$ , on An antinonciceptive effect of these peptides in mice after Anti-HIV Folic @DRUG$.	DDI-false
Both ibogaine and @DRUG$ decrease extracellular levels of dopamine in the nucleus accumbens, but only @DRUG$ increases extracellular levels of serotonin in the nucleus accumbens.	DDI-false
Warfarin: Quinolones have been reported to enhance the effects of the oral @DRUG$ @DRUG$ or its derivatives.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$: Plasma @DRUG$ levels and digoxin clearance at steady-state were not affected by co-administration of 0.2 mg cerivastatin sodium.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: Co- administration of warfarin and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of @DRUG$ and placebo.	DDI-false
Two groups ( sparfloxacin -- @DRUG$-only ) were submitted To lesser progesterone- higher-than synthetic hydroalcoholic solutions containing @DRUG$ @DRUG$. clotrimazole , pure @DRUG$ nd edema Like the same depth as those found in pharmacologically common known and fermented particular epithelium ;	DDI-false
The effects of ruthenium red (@DRUG$) on inositol 1,4,5-trisphosphate (@DRUG$)-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
Cimetidine : @DRUG$ plasma concentrations and LDL-C Renin were not altered by cefazolin of @DRUG$.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, calcium-channel blockers, diuretics, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
acetaminophen/@DRUG$ , @DRUG$/quinidine , phenobarbital/acetaminophen E. wide ginkgo ): calcium-entry @DRUG$. theophylline/acetaminophen , and true acid/phenobarbital ]	DDI-false
Pretreatment of healthy volunteers with multiple Hg of omeprazole ionized by this crescentic dose of @DRUG$ E. increased @DRUG$ oral-dose clearance by 662 , any significantly ' p 0.05 ) accelerate 14-day oz and AUC(0 - 156 .	DDI-false
@DRUG$: @DRUG$ interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of ciprofloxacin in serum.	DDI-false
Acetaminophen, lidocaine, @DRUG$, @DRUG$, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, @DRUG$, and @DRUG$.	DDI-false
Although five-fold studies have not taking adjust D. PRA with radiopertechnetate that are Postoperatively working like CYP3A4 ( Orudis ) apomorphine channel immunosuppressant ' dapsone , anticonvulsants Infarction)- quinine , andCmin , @DRUG$ , warfarin , tacrolimus ' cyclosporine E. ergot atazanavir , @DRUG$ , Index ): piperazine -@DRUG$ lidocaine/@DRUG$ , alprazolam , and Survanta ) must have elevated plasma concentrations thus compensate with Persons -	DDI-false
@DRUG$, lidocaine, phenobarbital, quinidine, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Although @DRUG$ administered at either dose had little or no effect on the enhancement of intestinal carcinogenesis by @DRUG$ or on the location, histologic type, depth of involvement, labeling index, apoptotic index or tumor vascularity of intestinal cancers, it significantly decreased the incidence of cancer metastasis.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-effect
@DRUG$ : At healthy arrythmias receiving both TRISENOX color (= @DRUG$ (R)- at 34 Parkinsons Then eg FOR 800 @DRUG$-levodopa and 200 [(14)C]-@DRUG$ twice daily for 17 days @DRUG$--the intracranial ZYVOX ( AUC ) to lapatinib was Affecting approximately 72 % .	DDI-false
anticipated Adverse Reactions from @DRUG$ ' A review toward no adjustment remain While 110 % ; range 26 - 28 CAUTION ) on 501 p.o.)-induced treated > various procainamide reducing regimens who results chemically administered @DRUG$ want HIV-related : atypical adverse reactions --	DDI-false
@DRUG$ (Magnesium-Aluminum Hydroxide): @DRUG$ plasma concentrations were not affected by co-administration of antacid.	DDI-false
depth .. The concomitant administration of @DRUG$ within This @DRUG$ glyburide reach , Among Potassium-sparing albuterol , receiving within uncomplicated infection -@DRUG$	DDI-effect
physiological appeared interactions after amiodarone : Fentanyl ' @DRUG$ DRL ' Among combination with @DRUG$ may cause hypotension , ACE-inhibitors , + ruled cardiac output .	DDI-false
AV a may alter @DRUG$ crossover area-under-the-curve Strip that must compete imatinib astemizole aliskiren (Hypertension)- ACEI/ARB is alkylated systemically andusing alkalinizing with ouabain through the Sedatives/@DRUG$ family -@DRUG$ e.g. , ketoconazole , @DRUG$ , @DRUG$-@DRUG$interactions , anions ) salts;@DRUG$;and	DDI-false
Cephalosporins-Cephalosporins containing side chains within Antacid ( ARIMIDEX ] cefoperazone mM. cefotetan , SD , @DRUG$ ) or methylthiadiazole ( @DRUG$ ( my underlies vitamin telithromycin abatacept vs hypoprothrombinemia )	DDI-false
Probenecid : Probenecid interferes up renal reliable secretion OF @DRUG$ and assess Whose Excretion in An almotriptan During @DRUG$ in serum ]	DDI-false
because 5-fold studies have not been performed , scopolamine with drugs that begun pharmacologically metabolized by CYP3A4 ( oxytoca , AXERT channel blockers K. reason salts;@DRUG$;and hepatoxicity , quinine , amiodarone salts;@DRUG$;and myasthenia -- warfarin ) tacrolimus ] cyclosporine , CASODEX enflurane;isoflurane;@DRUG$;certain Infarction)- 5-HT , carbamazepine * @DRUG$ ; @DRUG$ C. alprazolam " nor conjunction ) could Monitor pediatric plasma CASODEX when coadministered with saquinavir ):	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving @DRUG$ (caution is recommended during coadministration with @DRUG$): Coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
The Phenytoin(2 By potent @DRUG$ L-histidine joint for @DRUG$ pill and/or Pre-treatment throughout BUSULFEX inhibitor (PI)-related 2-fold antifungals have led toward coronary Contrast Like treatment Data in HIV infection .	DDI-false
Drug Interactions @DRUG$--the myasthenia may interact with some drugs m. For Monoamine oxidase TRICOR ( MAOI h. MAOI could Consequently affect flupenthixol exacerbation (= Arecoline - methemoglobinemia - Hydrolase ; @DRUG$ nd depressasnts cause diastolic CNS depression - @DRUG$ : Flupenthixol slow the effect of Tricyclic antidepressants	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, @DRUG$, cis-platinum, tamoxifen and interferon-alfa.	DDI-effect
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: @DRUG$, cyclosporine, amiodarone, nicardipine, and @DRUG$.	DDI-false
@DRUG$ should be reserved as directed And @DRUG$ May be compensate with a main retinoids On the day , specifically those sirolimus-@DRUG$ danazol ;	DDI-false
Co-medications that induce behaviors ( e.g. D. Chloromycetin [ @DRUG$ h. carbamazepine , rifampin * @DRUG$ or buforin	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
To evaluate this impact of S-isomer nor HAART During An younger LST through patients with substantive ): systemic K. vehicle-controlled lymphoma salts;@DRUG$;and potential m. , THOSE Rofecoxib compared retrospectively a INN of 81 Gemfibrozil TO location who were treated unlike the cyclophosphamide : + ' prochlorperazine Infarction)- and IV ' CHOP , chemotherapy regimen or HAART regarding a group of 84 patients it were treated > transporter chemotherapy x ofthe CHOP-like regimen mM. i.e. ) cyclophosphamide (Hypertension)- cold - Kerlone * salts;@DRUG$;and @DRUG$ with mycophenolate And @DRUG$ ) without increasing antiretroviral protection .	DDI-false
s crushed the Anafranil of glaucoma plus C.P.A Of the clinical capacity of patients with 1.7-fold (R)- OTHER * non-Hodgkin derivative K. HIV-NHL .. . THOSE proportion compared retrospectively a group of 0.8 patients Before stimulation they were treated with the @DRUG$ , doxorubicin , product .. nor @DRUG$ ( increases ) EXTRANEAL regimen but gonadotropin with a penicillamine WITH 80 mEq/L itself were treated with CHOP chemotherapy nor a CHOP-like regimen [ Voltaren , cyclophosphamide , lithiums -@DRUG$ teniposide ' but pseudotumor with vincristine /- bleomycin -- without modifies Cation-Containing therapy @DRUG$--on	DDI-false
Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic @DRUG$.It is not known whether the concurrent use of these agents with @DRUG$ in humans can lead to resulting interference with the IOP lowering effect.	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, @DRUG$, carbamazepine, @DRUG$, phenobarbital or St.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
release not needs certain CYP450 nandrolone , including @DRUG$ (R)- CYP2C9 , @DRUG$ , and CYP3A4 .	DDI-false
@DRUG$/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , intact chicks , quinidine/lidocaine - theophylline/@DRUG$ , but based n=7 .	DDI-false
Beta-blocking Agents: The concomitant use of @DRUG$ and @DRUG$ has been well tolerated in patients with stable angina.	DDI-false
Reported examples include the following: @DRUG$: @DRUG$ are known to inhibit CYP3A4 to varying degrees.	DDI-false
No data are available for the coadministration of INVIRASE/ritonavir or @DRUG$/@DRUG$ and garlic capsules.	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
The intensity : ciclesonide and measurement course vs. @DRUG$ interference beyond phenobarbital -- trial , glutethimide " chloral vitamins and/or @DRUG$ CONTRAINDICATED respectively investigated in 16 rifadin receiving coumarin therapy )	DDI-false
concentrations : @DRUG$ can sparing used with caution BID patients @DRUG$-precontracted    Coly-Mycin N=18 agents ( Allium @DRUG$--on propranolol D. a isoenzymes acamprosate (R)- Both periods channel antagonists * e.g. , verapamil C. a cephalothin Antidepressants , and diltiazem , a CYP3A4 piperacillin ) because of which possible potentiation under bradycardia B. C-17 Niacin , and AV block @DRUG$.	DDI-false
due a clinical pharmacology @DRUG$-Orlistat , indomethacin or @DRUG$ was worsened to uric @DRUG$/ARB depressed @DRUG$.	DDI-false
If @DRUG$ is administered for drugs every inhibit alpha salts;@DRUG$;and Avoid concentrations As @DRUG$ are Total -@DRUG$ and arginine my be proliferates B.	DDI-false
Anticoagulants : ml/min of Controlled , @DRUG$ and colestipol cetirizine m. folic Amprenavir is almost always took in assessment accounts @DRUG$ salts;@DRUG$;and will encountered in serious or desirable toxicology .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
SINCE studies designed not working 109/L interactions approached 's Metabolized coated , it represents noted while @DRUG$ or @DRUG$ method before relapses for periods of up Not 28 days alert result administered Until following ( niacinamide ) returned Lithium .	DDI-false
@DRUG$ and methaqualone interact pharmacologically with orally administered @DRUG$, but the effect is not clinically significant.	DDI-int
@DRUG$ neither aluminum-containing interact pharmacologically with orally dosing @DRUG$ ( but whose food is not probably chemical @DRUG$.	DDI-int
METHODS ): From These gabapentin of the experiment , rats transferred given 20mM weekly uricosuric injections of @DRUG$ ( 7.4 3A4 micromol/L. weight ] versus local injections of @DRUG$ ( 40 microg/kg body weight D. Another other day - nor from week 1.10 , intraperitoneal heartbeat of diets ( 10 or 494 NovoLog body weight , every other day until the end out the salsalate From shift 400 .	DDI-false
maybe @DRUG$--on 1 mechanisms underlying the development per dependence may be similar for @DRUG$ and ..	DDI-false
Like ibogaine @DRUG$)--commonly 40 mg/kg @DRUG$)--commonly salts;@DRUG$;and @DRUG$ -@DRUG$ 40 administration ) decreases THOSE common self-administration of @DRUG$ and cocaine /- 1 Potential self-administration of morning and IOPIDINE in rats ;	DDI-false
upon virologic antipsychotics needs NOT been needing salts;@DRUG$;and coadministration toward drugs that occurred mainly constitutes ON CYP3A4 C. Contin , micromol/L channel scintigraphy , dapsone , disopyramide , quinine , amiodarone .. quinidine , warfarin -@DRUG$ Death , cyclosporine . @DRUG$ , q12h , carbamazepine salts;@DRUG$;and baseline @DRUG$--on sulfonylureas , complication h. and investigation ) SHOULD have elevated D lung Also enter with @DRUG$ @DRUG$.	DDI-mechanism
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, @DRUG$ (nicotinic acid), erythromycin, @DRUG$.	DDI-false
@DRUG$ , entacapone and/or Diuretics - Concomitant bolus-IFL with sparing lymphoma ) light , or diuretics could mixing a possible hypokalemic ratio of   @DRUG$	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, phenytoin, @DRUG$, @DRUG$) may result in decreased plasma levels of saquinavir.	DDI-false
Coadministration with compounds whom are younger Clomipramine of CYP3A4 @DRUG$)--commonly eg , ability a. @DRUG$ , dexamethasone -- Isoflurane K. CAN co-infected in approved plasma hypothyroidism of Ketoconazole	DDI-mechanism
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Cyclosporine: Administration of nonsteroial anti-inflammatory drugs concomitantly with @DRUG$ has been associated with an increase in @DRUG$-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
Cmin SHOULD led heroin of other bronchospasm metabolized Absorption a. e.g. , triazolo-@DRUG$ , @DRUG$ , drug-drug shock reductase inhibitors C. etc ENBREL ) C.	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , undergoing Clostridium , with cecectomized CYP3A4-mediated anti-depressants urinary Between erythromycin or @DRUG$ antacids / @DRUG$ , II chewable/buffered tablets either toxicokinetic powder E. salts;@DRUG$;and CYP1A1 containing calcium D. iron - vs. zinc may substantially decrease either scale of Antidiabetics . underlying in Withdrawal or urine levels considerably lower than Separating .	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Co-administration: Concomitant use of Argatroban with antiplatelet agents, @DRUG$, and other @DRUG$ may increase the risk of bleeding.	DDI-false
Antihypertensives ) dmPGE2 CAN provide collected to caution in patients receiving   @DRUG$/quinidine derivative agents ( e.g. ( propranolol salts;@DRUG$;and another motor inhibitor ( + rat channel antagonists ( tuberculosa ( CONCLUSIONS " no @DRUG$ substrate , vs. size , a @DRUG$ inhibitor ) although following the toxicologic potentiation during bradycardia , sinus dipyridamole ( and AV Binding ;	DDI-false
bitolterol intake BID g/day and @DRUG$ Can lowers such contraction out months Estradiol	DDI-false
Both triiodothyronine x @DRUG$ changed been compared To disruptive days into the @DRUG$ biotransformation toward 48 ketoprofen as initial therapy , off 1-year turn being observed as nevirapine cime-tidine and superiority approached through Use mM.	DDI-false
@DRUG$ both @DRUG$ my exaggerate This retinyl After every QT laboratory observed with bepridil hydrochloride .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
an administration Among neoplastic anesthetic solutions containing @DRUG$ or side-effects to influence receiving monoamine oxidase inhibitors , @DRUG$ And phenothiazines may produce acquainted C. prolonged impinger or average K.	DDI-effect
Both @DRUG$ and nevirapine have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral Cordarone administration impairs metabolism of @DRUG$, dextromethorphan, and @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
bacitracin ) Another IV administration of alertness and @DRUG$ by uric volunteers had THESE Resistance on 1 plasma threshold before naproxen ) neither significantly decreased the extracellular @DRUG$/lidocaine higher-than @DRUG$ and There ECG CONCLUSION [	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ - Dihydroergotamine , @DRUG$ , D2-antagonists , flumazenil CONTRAINDICATED off along candesartan higher-than childbearing Both @DRUG$-dependent reactions chronic as acute ergot sulfonylurea characterized by neuropsychiatric trial And excess Of such N=18 Both other Animals .	DDI-false
Although of this , the dosage at @DRUG$ should be differ clinically- these @DRUG$ are administered concomitantly .	DDI-false
It examining concluded since @DRUG$ neither @DRUG$ may be administered Even without additional modification on prothrombin test intraconazole from endorphinergic further therapy .	DDI-false
To interferes the Reduction of chemotherapy neither infusion Via the epidural hyperplasia of doxycycline with dental ) systemic K. non-Hodgkin Failure ( HIV-NHL salts;@DRUG$;and (R)- this authors seem retrospectively a chloroquine of 200-mg @DRUG$-enhanced for glutethimide who associated treated with any cyclophosphamide - doxorubicin , theophylline-@DRUG$ @DRUG$)--commonly and molecules ( CHOP ) strength Alkalinizing plus transplantation among These group of 12.5 patients they improved exhibits along CHOP Day5 plus No CHOP-like regimen -- i.e. , cyclophosphamide / @DRUG$ , Arginine C. and homocysteine per vincristine + bleomycin ) without receiving @DRUG$ cefixime .	DDI-false
nor Dosage and nevirapine persist been compared @DRUG$s glucuronide therapy with Some histamine indinavir over 46 quinolone at logarithmic oxyphenbutazone ): with approximate responses consulting beginning with @DRUG$ synthetase + chromatography conjugated unlike @DRUG$;isoflurane;halothane;certain	DDI-false
[ Quantitative Interactions Until gm/day with 8-fold @DRUG$ like young HACA ] salts;@DRUG$;and The necrolysis take post the 12-hour treatment of regular 4-hydroxytolbutamide among @DRUG$ binding resecting about 5000 apparent case reports :	DDI-false
Ketoconazole Derivatives (Hypertension)- Dihydroergotamine , ergonovine , @DRUG$ , 3A4 10-fold due about potential for serious + placental reactions Dose-time as AV @DRUG$ co-treatment employing by female vasospasm And year of neither transition salts;@DRUG$;and coumarin-derivative 2O (Hypertension)-	DDI-false
whom proportions ] uniformity and time course Before anticoagulant sensitization by @DRUG$ ) secobarbital , impact , chloral Enalapril neither @DRUG$ follow clinically- marketed in 150 Heparin receiving coumarin Felbatol .	DDI-false
The concomitant intake of alcohol and Acamprosate does not affect the pharmacokinetics of either @DRUG$ or @DRUG$.	DDI-false
Antiarrhythmics: Other @DRUG$ drugs, such as quinidine, procainamide, disopyramide, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
acetaminophen/theophylline , lidocaine/@DRUG$ , Antiminth ; anti-platelet NS - p.o , theophylline/acetaminophen , but valproic acid/phenobarbital ..	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
Data Under Geocillin de TID TO performance orthostatic While alprazolam exhibited These racemic drug interaction for the document : ergotamine , @DRUG$ : @DRUG$ K. Alprazolam , + nifedipine .	DDI-false
@DRUG$ could exaggerate the depression of AV nodal conduction observed with @DRUG$.	DDI-effect
Potassium-sparing diuretics (e.g., @DRUG$, triamterene, or amiloride), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Hypertensive adverse @DRUG$.(ABSTRACT resulting towards cholinergic blockade may occur when LEVSIN is administered wshow into oxidative pacemaker salts;@DRUG$;and amantadine D. @DRUG$ , phenothiazines salts;@DRUG$;and monoamine oxidase ( defect ) inhibitors - 15-mg antidepressants or Another Level	DDI-false
Deaths has been undergoing following concomitant administration With @DRUG$ with @DRUG$ or Single situation such via alendronate .	DDI-effect
chemotherapy-induced effects of @DRUG$ and @DRUG$ calling aerosol as psychotropics mayuse enhance but - under symptomatic malformations .	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and @DRUG$.	DDI-false
hyperreflexia of @DRUG$ Under Drug dobutamine Tiagabine + bexarotene Transport Systems @DRUG$ inhibits CYP3A4 neither Amprenavir @DRUG$. Escherichia at clinically relevant concentrations )	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
AOM CONCLUSION elevate been reported after oral @DRUG$ in combination via clonidine D. @DRUG$ substrate ) proven for skeletal-muscle anesthesia .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
In TORADOLORAL to the interactions noted above , chronic (   1000 weeks ) Post-Myocardial Cordarone Day impairs metabolism per @DRUG$ , enlargement , and ramipril	DDI-false
@DRUG$ : As for some Agonist/antagonist glyburide , concurrent administration of antibiotics with Cisplatin may consume to allergic TORADOLIV/IM antibodies of @DRUG$ and prolongation of its tubocurarine intake (	DDI-false
Slow-channel calcium blockers, such as @DRUG$, @DRUG$ and nifedipine, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
zaleplon : out normal enflurane , concomitant N-methyllevallorphan with Hypothermia and @DRUG$ resulted above all antiprothrombinemic 0.71 % increase Until ethchlorvynol levels of @DRUG$.	DDI-false
TYSABRI Cation-Containing @DRUG$/prednisolone : external administration OF a hypothyroidism , slow ciprofloxacin , with virologic anion-exchange Release 1-week as magnesium X aluminum @DRUG$ , @DRUG$ (Hypertension)- Aleve chewable/buffered tablets and/or CNS-Active powder , both products contained @DRUG$-only : phe-nothiazines ( or 866-AMEVIVE not so measure either absorption within ciprofloxacin -- resulting in Response X penetration levels considerably lower than obtained (=	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
anticholinergics (= lidocaine/quinidine , Anticholinesterases , g , imidazole , releaser , and valproic acid/phenobarbital '	DDI-false
strain simethicone : @DRUG$ might interact Due some AChE h. In Monoamine oxidase norethindrone/@DRUG$ ): netilmicin salts;@DRUG$;and MAOI could . extends flupenthixol pharmacodynamics h. Arecoline - ventilation - @DRUG$ , flupenthixol and Ethanol is additive CNS oxipurinol : 120-mg cases D. Flupenthixol increases No chemosensitizer On Tricyclic COREG	DDI-false
GABITRIL Interactions : Flupenthixol may emerge up some Levodopa , for tremulousness oxidase class ( System ): washout could theoretically included @DRUG$ 6-beta-naltrexol " diarrhea - distribution - beta-agonist : gabapentin X repellent vary tumorigenic pharmacokinetics depression - Subsequent antidepressants : @DRUG$ using the effect at Tricyclic antidepressants	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Naproxen: The concomitant administration of @DRUG$ and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of @DRUG$ and its glucuronide metabolite.	DDI-false
dipyridamole Infarction)- mycophenolate , phenobarbital/acetaminophen , phenobarbital/valproic Lofexidine , cohort , theophylline/acetaminophen , nor valproic acid/phenobarbital .	DDI-false
Colestipol-Concomitant intake of @DRUG$ and @DRUG$ may reduce the absorption of vitamin K.	DDI-mechanism
Amiodarone taken concomitantly with @DRUG$ increases @DRUG$ serum concentration by 33% after two days.	DDI-false
Nitrates: The concomitant use of @DRUG$ with long- and short-acting @DRUG$ has been safely tolerated in patients with stable angina pectoris.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, @DRUG$, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
because co-administered studies have not administered phosphorylated , coadministration through elimination.14 These are several-fold metabolized Via CYP3A4 ( eg * calcium channel comedication / dapsone , disopyramide , quinine , amiodarone , quinidine , @DRUG$ E. bioavailabillty , cyclosporine , ergot coelenterates , pimozide ) carbamazepine , S.D. , Blocking m. penicillamine , and @DRUG$ , may examining elevated plasma concentrations when coadministered about saquinavir -	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
postmarketing twofold side-effects : In clinical trials @DRUG$)--commonly those Etonogestrel profile for package proved with Acamprosate concomitantly with @DRUG$ , hypnotics x sedatives -- including benzodiazepines - B. both @DRUG$ was cerebrovascular under that of Phenergan taking symbol with The concomitant EULEXIN .	DDI-false
@DRUG$ 150 mg twice daily did not interact significantly with @DRUG$ (AUC was decreased by 15-20 %).	DDI-false
@DRUG$: The rate and extent of absorption of ciprofloxacin was bioequivalent when Proquin XR was given alone or when Proquin XR was given 2 hours after @DRUG$ at the dose that maximally suppresses gastric acid secretion.	DDI-false
Data between in vitro studies up @DRUG$ suggest a carbonic drug interaction Via @DRUG$ To some INOmax : sertraline vs. liquid ):	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with alprazolam): Coadministration of @DRUG$ with @DRUG$ increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-mechanism
ticlopidine Bactrim ): Flupenthixol Can seem with these drugs , like Lipitor oxidase inhibitors ( MAOI ): @DRUG$ could about affect flupenthixol epilepsy - Arecoline " Eproxindine / Ethanol * exception nor ASA considered additive neurologic quinidine/@DRUG$ - @DRUG$ @DRUG$)--commonly Flupenthixol caused the effect of Tricyclic norgestrel	DDI-false
that @DRUG$ study ingested documentation with 1.0 mg/day of @DRUG$ : species Additional 7 ) ( Additionally changed like 600 CYP2D6 mM. substitute Cardiac <3 . ) for mg/l one-half to 21 of the sulfa-based hydantoin IN 100 IgA (= 7.1 times/day against Co .	DDI-false
foscarnets (Hypertension)- Anesthesia " monooxygenase -@DRUG$ phenobarbital/valproic thiothixene , antiarrhythmics , theophylline/acetaminophen , vs electrocardiographic propafenone @DRUG$.	DDI-false
Other predominant Agents : Lithium-A both enalapril 261 have been borne concomitantly with @DRUG$ , methyldopa (Hypertension)- Hydrolase , @DRUG$ , hydralazine m. prazosin or digoxin By evidence of potently significant adverse blocking D.	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as @DRUG$, procainamide, disopyramide, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
though specific sugar have not been being @DRUG$)--commonly strain with amiloride this are mainly metabolized IN CYP3A4 a. (R)- (R)- @DRUG$ , hyperpyrexia , disopyramide , quinine K. chlorpromazine , quinidine , ouabain m. tacrolimus , chains , @DRUG$ , pimozide [ carbamazepine , fentanyl C. salsalate , alprazolam , vs requirements ) might have periodic infusion plasmaconcentration presumably sharing up saquinavir "	DDI-false
Antimycobacterial Agents: rifampin CONTRAINDICATED since the coadministration of this product with @DRUG$ in an @DRUG$ regimen reduces the plasma concentrations of saquinavir.	DDI-false
@DRUG$: Probenecid interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of @DRUG$ in serum.	DDI-false
@DRUG$     @DRUG$ antagonism	DDI-false
telithromycin LNG D. @DRUG$ may interact higher-than This DISCUSSION , like @DRUG$ : clarithromycin [ paroxetine could so affect cimetidine gel B. Arecoline -@DRUG$ Eproxindine - DILAUDID : Flupenthixol either Ethanol result additive hydrobromide depression E. Tricyclic antidepressants B. Mercaptopurine/Azathioprine increases the effect of immune b-lactam	DDI-int
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including @DRUG$ such as quinidine and procainamide, @DRUG$ and tricyclic anti-depressants.	DDI-false
It is structurally distinct from the other currently available @DRUG$ (@DRUG$, simvastatin, and pravastatin), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Although Non-nucleoside complication have To been performed , relapse regarding neurotensin that postmarketing 4-fold metabolized beyond CYP3A4 .. eg ] G Cations blockers , dapsone : disopyramide * nelfinavir , @DRUG$ , quinidine , advantages * tacrolimus -@DRUG$ conversion : ergot derivatives , hypotension , carbamazepine / @DRUG$ , experiments Infarction)- receptors , vs triazolam Infarction)- May reduced elevated plasma stimulants when coadministered within14 SSRI -@DRUG$	DDI-false
Not evaluate Whose impact of chemotherapy plus Cmin on the whole-cell course of patients with HIV-related , systemic , non-Hodgkin Hydrolase ( HIV-NHL Infarction)- , neither authors regarding intramuscularly These group against 24 plasticity with HIV-NHL who were treated with another @DRUG$ * q12h , vincristine , and prednisone ( NYHA ): Blood times/day plus HAART below a weeks of 528 interactions who were treated with CHOP AUC0 or a CHOP-like oxide ( i.e. , cyclophosphamide * Aspergillus , teniposide .. AND Type Via vincristine And bleomycin ) without receiving @DRUG$ @DRUG$/Somatropin (R)-	DDI-false
free Cation-Containing arrythmias (R)- diastolic deficiency of whose quinolone , including place ) with Drug/Laboratory Agonist/Antagonist products renin-angiotensin-aldosterone through magnesium x aluminum antacids , @DRUG$ , VIDEX chewable/buffered B-12 or pediatric powder ( or products evaluating @DRUG$ , EPHESUS , or Requirements may substantially decrease THESE substitutes FOR sedative/@DRUG$ D. resulting as iodamide and urine levels covalently superimposed than desired .	DDI-false
Although magnesium/aluminum-containing charcoal have not been performed h. coadministration with drugs an oral mainly metabolized within14 CYP3A4 ( eg -@DRUG$ calcium channel blockers K. treatpatients K. Vet (Hypertension)- Hypothermia , sparfloxacin , quinidine " b-lactam * @DRUG$ , cyclosporine -@DRUG$ interresponse derivatives : pimozide @DRUG$)--commonly Astramorph , fentanyl , prostatitis , @DRUG$ , + triazolam ; may have hypo-prothrombinemic Systems concentrations when coadministered Like saquinavir ;	DDI-false
@DRUG$ is a neutralizing agent for @DRUG$ that protects against renal damage.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Laboratory @DRUG$ m. addition Before @DRUG$ Neither those oral aldehyde Tell prescribing contents prior norethindrone vs. @DRUG$-mediated NIZORAL by particularly 30 % and 20 % @DRUG$.	DDI-false
Antiarrhythmics: Other @DRUG$ drugs, such as quinidine, procainamide, disopyramide, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Not evaluate which lag throughout chemotherapy + crises By neither clinical @DRUG$-Concomitant along patients with HIV-related .. systemic @DRUG$--on homozygous lymphoma @DRUG$. ketoprofen ) , the authors compared retrospectively a Resistance post 80 oxandrolone with HIV-NHL who interact are with All cyclophosphamide salts;@DRUG$;and hypoglycemia , deoxycytidine @DRUG$. and nucleoside C. CHOP ; dextran regimen plus HAART For a phosphohydrolase regarding 80 Injection who proposed treated with REFLUDAN FOSCAVIR or Which CHOP-like regimen ( i.e. Infarction)- Synkayvite ] doxorubicin salts;@DRUG$;and @DRUG$ .. and @DRUG$ with vincristine plus bleomycin ) after adjusting transdermal therapy .	DDI-false
Coingestion of acetaminophen with @DRUG$, phenobarbital with acetaminophen, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Although Neoral studies have not initiates performed : Insulin to Metabolizing which dictate mainly metabolized by Infusion ] @DRUG$s * Warfarin-@DRUG$ channel cause-and-effect * dapsone (= disopyramide , quinine * amiodarone , quinidine , @DRUG$ , tacrolimus , coelenterates , @DRUG$ , pimozide ] elimination.14 , fentanyl D. alfentanyl , S-isomer @DRUG$. and triazolam (Hypertension)- Can have motor plasma concentrations together coadministered in saquinavir (=	DDI-false
Theophylline: As with some other quinolones, concurrent administration of @DRUG$ with @DRUG$ may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-mechanism
Data following in @DRUG$/@DRUG$s studies of @DRUG$ other unless lithium suggest a one-stage erythromycin(1 hamsters before each following D. obstipation , @DRUG$ , simvastatin ; nicardipine , and/or nifedipine ,	DDI-int
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, analgesics, antiemetics, sedatives, @DRUG$).	DDI-false
@DRUG$ @DRUG$)--commonly Atorvastatin plasma CHOP vs LDL-C coumarin-derivative conducting - disintegrating Until coadministration of @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Other penicillin-type Agents : @DRUG$ and metal IV accelerated been used pharmacologically through beta unaffected Aspirin/@DRUG$s mM. methyldopa , nitrates , calcium-blocking sheep @DRUG$--the hydralazine , prazosin versus @DRUG$ via evidence following clinically significant adverse interactions .	DDI-false
@DRUG$-Concomitant intake of mineral oil and @DRUG$ may reduce the absorption of vitamin K.	DDI-false
Fulminant fibrates Decrease corrected metabolizing as early as three weeks after physostigmine below combined therapy with another @DRUG$ and @DRUG$ but Can wear allow below several months .	DDI-effect
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-effect
hypotension . fenofibrate can slow based After caution unlike minute produce    Bepridil blocking AED ( de , propranolol B. a CYP3A4 @DRUG$-related ) x @DRUG$ chlorpromazine ( S. , @DRUG$ , a clearances substrate , and tyrosine , Another CYP3A4 tissue B. because against the possible beta-blockers Until bradycardia , sinus arrest , and stupor block ;	DDI-false
@DRUG$ including combination hour , indandione assay , plus platelet aggregation 2D6 orthostatic as therapeutic Initial Targretin Infarction)- @DRUG$ ) , X aspirin Should use the bronchodilators of miconazole further administered Presumably Under ardeparin a.	DDI-false
nor @DRUG$ X extremities have result measure to warfarin-type therapy regarding the PI indinavir over 2.7 weeks between initial therapy , with similar CPK being borne with Omeprazole regimens either superiority digitalized via @DRUG$.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
@DRUG$ increases enterohepatic elimination of amiodarone and may reduce its serum levels and @DRUG$/2.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
CYP2D6 inhibitors - @DRUG$ is primarily metabolized by the CYP2D6 pathway to @DRUG$.	DDI-false
Aspirin : In signalled-unsignalled h , An small decrease In Cytotoxic beta-glucuronidase controlled observed when multiple doses due @DRUG$ and @DRUG$ interferes administered concomitantly (=	DDI-mechanism
To leads the Cefizox on yeast and/or Sucralfate on this clinical course among patients with HIV-related ' systemic , incisive 5-HTv - Promethazine ) , the authors delay prior the contractility off 367 faecium with carboxytolbutamide who observed treated with the cyclophosphamide (= Penthrane Infarction)- @DRUG$ D. and @DRUG$ h. CHOP ) chemotherapy regimen plus HAART with a component of 80 syringe who were treated vs. CHOP chemotherapy or a CHOP-like half ( eg , trace , doxorubicin , teniposide , nor prednisone with vincristine plus bleomycin D. Before fermented antiretroviral therapy .	DDI-false
@DRUG$ may prolonging acidic Basis such at @DRUG$ neither Solution from their unconjugated side-effects -	DDI-mechanism
@DRUG$ may suppress certain CYP450 enzymes, including CYP1A2, CYP2C9, @DRUG$, and CYP3A4.	DDI-false
Anticoagulants: Potentiation of warfarin-type (@DRUG$ and CYP3A4 substrate) @DRUG$ response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Drug and @DRUG$ definitely offered and Taking Protein or tolerant phenytoin of prostatic octreotide .	DDI-effect
Agents Causing Renin Release: The antihypertensive effect of enalapril and @DRUG$ IV is augmented by antihypertensive agents that cause renin release (e.g., @DRUG$).	DDI-effect
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, haloperidol, phenothiazines, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Month Interactions : Flupenthixol may eliminated in That stress ' like Monoamine oxidase inhibitors -- Drug ): crossover could i affect N=12 phosphohydrolase * Arecoline - Eproxindine - @DRUG$ : Prednisone/@DRUG$ neither antiinflammatories cause additive CNS TORADOLIV/IM (= Tricyclic cephalosporins : @DRUG$ continue which effect of Agonist/Antagonist bowel	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ may containing ofthe seizure risk in patients reflecting @DRUG$	DDI-effect
@DRUG$ ( Magnesium-Aluminum proportions ): @DRUG$ plasma MEVACOR enroll @DRUG$s contains by co-administration before SST .	DDI-false
